Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.7322893824093273,-2.0026995979154845,0.0,0.028059299191374662,0.03,16/57,5.76%,TAGLN;TWIST2;TPM2;ITGA8;DKK3;JPH2;ACTA2;LMOD1;MYL9;SERPINH1;FOXL1;MSRB3;COL5A2;IGFBP7;ADGRA2;COL13A1
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.631300653977798,-1.901063683065312,0.0,0.09820754716981134,0.15,19/76,8.12%,TAGLN;TPM2;KCNMB1;PRRX1;ACTA2;MYH11;SYNPO2;LMOD1;MYL9;COL14A1;COL5A2;LAMB2;FBLN2;PTPN21;FKBP9;PAMR1;COL15A1;MYLK;EDNRA
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.6582964672848046,-1.8916654487869344,0.0,0.07170709793351301,0.17,16/55,10.86%,TAGLN;ACTA2;MYH11;SYNPO2;LMOD1;MYL9;COL14A1;SLIT3;LAMB2;PAMR1;COL15A1;MYLK;EDNRA;COL1A2;TNS2;CXCL12
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.649484990499479,-1.8508759309697944,0.0,0.10522237196765499,0.32,18/64,9.11%,TAGLN;PRRX1;ACTA2;LMOD1;MYL9;COL14A1;CPED1;MSRB3;COL5A2;IGFBP7;ADGRA2;FBLN2;PAMR1;COL15A1;MYLK;PRKG1;SPARC;COL1A2
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.8583510273229571,-1.824887936915735,0.03571428571428571,0.13655525606469004,0.43,1/7,1.04%,PRPSAP1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.8772127160875146,-1.8226432828615229,0.0,0.11691374663072776,0.45,4/12,4.06%,SPRY3;SLIT2;SPRY1;MAPKAP1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.8778522204766079,-1.7846698380686523,0.0,0.17370042356565266,0.68,2/9,0.80%,NRP1;SLIT2
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.7307057292280716,-1.7631205451448495,0.0,0.2151212938005391,0.78,5/14,9.91%,OSBPL6;CYP27A1;PER2;AKR1C3;FAXDC2
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.9432442686572768,-1.7090967042167393,0.0,0.40218328840970347,0.95,2/6,5.29%,BCL2L11;NCK1
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.9107201835490834,-1.7074535803140027,0.0,0.37038274932614557,0.95,1/8,0.34%,CAV2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.5544141000963538,-1.7022721204198006,0.0,0.3596691987258025,0.96,14/65,8.12%,TWIST2;SLIT2;PRRX1;TRABD2B;LAMC1;LMOD1;SERPINH1;COL14A1;COL5A2;LAMB2;PTPN21;FKBP9;NOTCH3;EDNRA
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.9195548840041525,-1.6680752345105774,0.02857142857142857,0.5074056603773585,1.0,1/5,0.80%,SLIT2
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.9090481477074501,-1.6348916374884335,0.0,0.6971656645241551,1.0,2/7,3.38%,NFU1;NUBPL
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.9413599188725998,-1.621998388834243,0.0,0.7469118213323065,1.0,2/6,1.17%,SPRY3;SPRY1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.5697258370993092,-1.621594310582135,0.0,0.7021060197663971,1.0,27/95,8.12%,TAGLN;TPM2;ITGA8;KCNMB1;DKK3;PRRX1;JPH2;ACTA2;MYH11;SYNPO2;LMOD1;MYL9;COL14A1;SLIT3;NOX4;MSRB3;COL5A2;NEXN;IRAG1;LAMB2;FBLN2;PAMR1;COL15A1;MYLK;NOTCH3;PRKG1;EDNRA
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.8675485118945514,-1.6109010704384639,0.0,0.7330491913746631,1.0,1/10,0.82%,CD4
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.7342133670882859,-1.6103476230908156,0.05263157894736842,0.6965308387505946,1.0,4/12,11.90%,JPH2;RYR2;MCU;AFG3L2
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.7946429687215782,-1.5963665463510897,0.0,0.7669541778975741,1.0,2/9,3.59%,OSBPL6;CYP27A1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.8264374892318863,-1.5887875614687168,0.0625,0.7876294509859555,1.0,2/7,7.99%,SLIT2;PRKG1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.5533390292771729,-1.588482567917747,0.0,0.7505862533692723,1.0,16/62,9.11%,TAGLN;DKK3;PRRX1;ACTA2;LMOD1;MYL9;COL14A1;COL5A2;IGFBP7;ADGRA2;FBLN2;PAMR1;COL15A1;EDNRA;SPARC;COL1A2
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.8948758185404155,-1.5881617444685676,0.03571428571428571,0.7175163650365807,1.0,1/6,0.13%,SPRY3
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.8112227744391795,-1.568517805010911,0.0,0.8422041166380788,1.0,2/6,6.37%,DERL1;VCP
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.835857686535333,-1.5585347801107836,0.0,0.8844779092933318,1.0,3/8,7.91%,PLA2G4C;AKR1C3;MGLL
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.7840627704201419,-1.5559742726098083,0.034482758620689655,0.8682794249775381,1.0,1/11,0.69%,CDK6
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.8705062153447622,-1.5513236032861244,0.0,0.8664711590296496,1.0,3/9,5.25%,SPRY3;SPRY1;DSTYK
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.7987776715882611,1.5494822058430104,0.0,1.0,0.94,2/30,0.43%,SRSF12;HNRNPL
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.786418011428488,1.5488882298132027,0.010869565217391304,1.0,0.95,10/38,8.23%,NELL1;NKAIN3;ELAVL3;NXPH1;DPP10;CRMP1;DNER;CACNA1B;ADGRB3;SNAP25
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.853987772077942,1.5479054059596753,0.0,1.0,0.95,4/19,3.10%,ADAMTS9;GJA1;NRG1;SGCZ
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.9123136629777424,1.5427297364070334,0.0,1.0,0.97,1/10,0.10%,SRSF12
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.9171237567222821,1.5377836831055747,0.0,0.9233789696541991,0.98,1/10,3.10%,SGCZ
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.8969772285263333,-1.5358483723068512,0.05714285714285714,0.9294209843266446,1.0,2/5,6.58%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.8969772285263333,-1.5358483723068512,0.05714285714285714,0.9294209843266446,1.0,2/5,6.58%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.8241170404991977,-1.5267750336453179,0.13043478260869565,0.9650394686176357,1.0,1/8,0.80%,SLIT2
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.8504167464297391,1.52661899264169,0.0,1.0,1.0,7/23,5.53%,STC1;NKAIN3;SYT1;SPTBN4;NEDD4L;ANK3;SNX6
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.8727949589019411,1.5191775408667998,0.0125,1.0,1.0,1/15,0.10%,SRSF12
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.8300477670281261,-1.5184035521687729,0.0,0.9994915884375872,1.0,1/6,0.14%,ATP10A
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.8474806792473555,-1.5178868685908535,0.0,0.9696046720575022,1.0,2/7,6.58%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.7980130273944588,1.5177455286795385,0.0,0.9648191601976005,1.0,4/24,1.68%,NELL1;SRGN;ANKH;ADGRV1
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.9217050701754104,-1.5173634516503693,0.03225806451612903,0.942551082514564,1.0,3/5,5.92%,NSUN3;TFB1M;DIMT1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.7820193403637316,-1.5170054815325276,0.14285714285714285,0.9160192048517521,1.0,3/8,12.72%,DDB2;CUL4B;XPC
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.9888115828846713,1.514216263192498,0.0,0.9254128440366972,1.0,2/5,0.90%,TAF7;TAF1B
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.6838959864654712,-1.511590015550168,0.08695652173913043,0.9327591276647881,1.0,5/17,7.52%,WDFY4;NRP1;CD4;ETV6;DOCK8
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.502242235228088,-1.5096178803249047,0.0,0.9215554146186777,1.0,9/41,7.33%,CAV2;NTN4;JPH2;ACTA2;MYH11;MYL9;LAMB2;FKBP9;MYLK
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.9429003610031251,1.502329371193791,0.0,0.9818066337332393,1.0,4/8,3.66%,SYT1;PLAA;NEDD4L;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.9429003610031251,1.502329371193791,0.0,0.9818066337332393,1.0,4/8,3.66%,SYT1;PLAA;NEDD4L;RIMS2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.8957159780170859,1.5021895384418933,0.0,0.9076164431898377,1.0,1/12,0.27%,WWC1
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.8157517442588004,-1.5017929080075405,0.12903225806451613,0.9521455525606468,1.0,1/6,1.14%,PLA2G4C
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.9123322084715433,1.5000781318334908,0.0,0.8761305032300092,1.0,1/9,0.10%,SRSF12
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.9813008876490095,1.4941694176700426,0.0,0.9363085996572236,1.0,2/5,0.91%,TAF7;KLF15
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.8098968777051136,-1.4900057848153063,0.07142857142857142,1.0,1.0,2/7,7.91%,PLA2G4C;MGLL
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.8201541769221734,-1.4881781468787452,0.047619047619047616,0.996989873971006,1.0,2/8,4.09%,PLA2G4C;INPP5F
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.7983973965905042,-1.4876685513543622,0.07407407407407407,0.975183714001986,1.0,1/7,4.40%,PIP4K2B
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.842862753889039,1.4866427373216593,0.0,1.0,1.0,1/11,0.24%,NELL1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),-0.7085410204907318,-1.4866008228156409,0.045454545454545456,0.9578533416269266,1.0,3/10,7.41%,PPIP5K2;CYP27A1;IPPK
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.7785495469370277,-1.4858476278452273,0.14285714285714285,0.9404541778975741,1.0,2/8,3.38%,NFU1;NUBPL
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.5378698385371058,-1.481145483333071,0.125,0.9515068042863717,1.0,17/67,9.11%,TAGLN;TPM2;DKK3;PRRX1;ACTA2;LMOD1;MYL9;COL14A1;SLIT3;COL5A2;LAMB2;PAMR1;MYLK;PRKG1;EDNRA;SPARC;COL1A2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.9116410292304085,1.4800766873854614,0.0,1.0,1.0,3/9,2.39%,CD44;TPT1;KDM1A
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.8407449028736554,-1.4793428006169966,0.08333333333333333,0.9402092157617765,1.0,5/5,16.01%,MCAM;ITGA3;XPNPEP3;SULF2;MYO1E
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.7902279795934795,1.477382241274409,0.0,1.0,1.0,5/18,13.33%,NELL1;FMN2;EGFR;CST3;MDM4
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.7335722179901976,-1.477216384110051,0.0,0.9318297498903029,1.0,2/12,3.59%,OSBPL6;CYP27A1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.7401951243405966,1.4730059225378982,0.023255813953488372,1.0,1.0,6/31,8.37%,CD44;DDX3X;EPHA7;RAF1;DELE1;NAIP
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.6175796217932982,-1.4720258979867147,0.0,0.9472139181573144,1.0,4/16,10.51%,OSBPL6;CYP27A1;PER2;ACACA
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.8099895977950782,-1.4719680710876235,0.07407407407407407,0.9263725666367176,1.0,3/6,5.92%,NSUN3;TFB1M;DIMT1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.8347491802480735,-1.471552496707306,0.09090909090909091,0.9090806281495372,1.0,3/5,7.44%,HECW2;CDC27;TPR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.8274175855519976,1.4712064129617066,0.05,1.0,1.0,4/15,4.97%,STC1;PRKACA;KCNQ1;PDE4B
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.7771939260938265,1.470576296622983,0.0,1.0,1.0,8/28,9.64%,EPM2A;TSC2;DDIT4;RHEB;SLC38A9;SEC13;UBR1;TNFAIP8L1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.8119933321162139,1.4681651454523825,0.012048192771084338,1.0,1.0,4/17,9.03%,OS9;AMFR;MARCHF6;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.8494716369862123,1.466642644822757,0.036585365853658534,1.0,1.0,3/11,8.60%,MTMR9;TGFB1;SYMPK
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.8680733074396141,1.4639466009615332,0.014285714285714285,1.0,1.0,3/10,8.87%,ZC3H7B;AGO2;ZC3H7A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.9643888399314924,1.4616734009955723,0.0,1.0,1.0,1/5,0.24%,NELL1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.8898777666614456,-1.461656828213015,0.02857142857142857,0.9591902276767794,1.0,1/5,2.13%,RPL30
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.7732494869104698,1.4606580864305478,0.05813953488372093,1.0,1.0,5/21,9.75%,CD44;DDX3X;RAF1;NAIP;RNF34
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.9305588597579442,1.4599011516482612,0.0,1.0,1.0,2/8,3.66%,SYT1;RIMS2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.7296856636706768,1.4593569556040993,0.0,0.9954685172116365,1.0,10/31,13.86%,IPO9;TSC2;NUP153;SEC13;IPO5;NUP88;CSE1L;NUP133;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.7936409458145052,1.4581694111269987,0.07792207792207792,0.978802046577276,1.0,5/13,16.47%,ANKH;TGFB1;CEBPB;ROCK2;TWIST1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.8358640073483076,1.4567199249811675,0.0379746835443038,0.9745063636142409,1.0,1/11,0.34%,HS3ST5
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.9628246477955188,1.4555780170663073,0.0,0.9643954363679135,1.0,1/5,0.66%,SYT1
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.7677102916946198,1.4532677920618786,0.0,0.9742914380677034,1.0,12/39,14.47%,SOD1;SLC23A2;GNPAT;DHRS3;CADM1;CACNA1B;SOD2;ESR2;ACSL4;PABPC1;SIAH1;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.7475185108007547,-1.4531828388855332,0.03571428571428571,0.9955205525606468,1.0,4/7,10.89%,NRP1;BAIAP2L2;NTF3;CDC42
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.9456833398676319,1.4527967696916497,0.0,0.9521074453069865,1.0,2/6,4.52%,DDX3X;AGO2
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.5644194270560993,-1.4519344888760413,0.1875,0.9845569063204797,1.0,4/18,12.69%,SDAD1;MRPL1;RPL6;RPL23A
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.8834527968722732,-1.4485663130958124,0.037037037037037035,0.9867520215633424,1.0,1/5,0.43%,FGF13
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.8623337368453396,-1.4471309727725354,0.14285714285714285,0.9756566777654458,1.0,1/5,9.08%,RBL1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.8025167198460599,1.4466741547266628,0.024390243902439025,1.0,1.0,4/19,4.68%,VAPB;MYDGF;WIPI1;ACADVL
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.957138220361132,1.4454967504243552,0.0,1.0,1.0,1/5,0.29%,TAF7
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.7361506101711002,1.443985142811199,0.04597701149425287,1.0,1.0,6/28,11.45%,SOD1;CPD;ENPEP;SEC11A;CPM;GSR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.8269571815314122,-1.4429138874563687,0.09375,0.9883708272859216,1.0,1/5,2.39%,ATP2B4
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),-0.8010967406155616,-1.441759983718045,0.06451612903225806,0.9778401057824341,1.0,2/7,7.41%,PPIP5K2;IPPK
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.9849763117698854,1.4413389327822637,0.0,1.0,1.0,1/5,0.67%,TBC1D20
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.7579330659892067,1.4409545686565142,0.011235955056179775,1.0,1.0,10/39,9.87%,SYT1;PLAA;NEDD4L;DDX3X;RIMS2;SEMA4D;ADAM17;EGFR;ADNP2;SDCBP
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.7907095661129329,-1.4392829655289316,0.0967741935483871,0.9555466797353589,1.0,2/7,3.06%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.7907095661129329,-1.4392829655289316,0.0967741935483871,0.9555466797353589,1.0,2/7,3.06%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.7883563710806978,1.4391237736114382,0.0,1.0,1.0,9/22,9.00%,SLC2A3;BTD;MMUT;SLC23A2;MTHFD2L;PANK2;ALDH1L1;SLC2A1;MCCC2
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.6650136868610199,-1.4372528172875625,0.04,0.9530140546784752,1.0,2/10,6.37%,DERL1;VCP
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.7952860457633929,1.4370840367673121,0.025,1.0,1.0,5/22,6.14%,SYT1;PLAA;NEDD4L;RIMS2;SEMA4D
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.492369142868393,-1.43565408742217,0.0,0.9446630727762804,1.0,16/76,6.45%,TAGLN;TPM2;DKK3;PRRX1;ACTA2;LMOD1;MYL9;COL14A1;SLIT3;KCNJ8;PDZRN3;COL5A2;IGFBP7;LAMB2;PTPN21;PAMR1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.8181671465037303,1.434963647049468,0.0,1.0,1.0,2/15,1.75%,STC1;GRIN1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.7649151889538165,-1.434163425935,0.1951219512195122,0.9411153452923136,1.0,3/5,10.86%,PGF;NTF3;CXCL12
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.791667490613642,-1.4333867766382846,0.14285714285714285,0.9315053223080084,1.0,1/5,2.29%,ATM
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.8206043659026266,1.4327896905910245,0.012658227848101266,1.0,1.0,4/11,13.19%,TBC1D20;SEC24A;SEC13;SEC24D
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.8339871806240889,-1.4312146364778926,0.03125,0.9296981132075471,1.0,3/5,15.32%,COL13A1;BMPR1B;FOXC1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.7708555202641012,1.4311317559725676,0.012195121951219513,1.0,1.0,3/26,6.27%,CD44;MID1;NCAM1
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.9105614824861681,-1.4275865680613629,0.13333333333333333,0.9197717589774803,1.0,3/5,8.12%,EDN3;ACTA2;EDNRA
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.9105614824861681,-1.4275865680613629,0.13333333333333333,0.9197717589774803,1.0,3/5,8.12%,EDN3;ACTA2;EDNRA
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),-0.6250318330672788,-1.4266531499482453,0.04,0.9102199118641168,1.0,3/17,3.48%,NRP1;SLIT2;SLIT3
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.9186956459387774,1.426419165885853,0.02666666666666667,1.0,1.0,2/7,3.75%,KLF15;BASP1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.9553510975569185,1.4218039478691147,0.013888888888888888,1.0,1.0,3/7,2.98%,ADAMTS9;KLF2;EPN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.8121554237756755,-1.4203344823418245,0.21428571428571427,0.9373559636118599,1.0,1/5,0.43%,FGF13
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.8311835504324363,1.4192322455991526,0.06097560975609756,1.0,1.0,1/10,0.34%,HS3ST5
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.8897375209799481,1.4187404553140497,0.0,1.0,1.0,2/7,2.39%,GJA1;KDM1A
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.8334589753381143,1.4179608714840963,0.024390243902439025,1.0,1.0,2/11,2.65%,SRSF12;STRAP
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.6867198289289029,1.4177708906144157,0.022727272727272728,1.0,1.0,13/52,13.86%,IPO9;TSC2;TOR1AIP2;NUP153;SEC13;IPO5;NUP88;CSE1L;NUP133;EIF4ENIF1;TBRG1;MDM2;STAT3
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.8261417925956738,1.4176488751325824,0.02702702702702703,1.0,1.0,3/12,9.96%,SRSF12;PTBP2;TMBIM6
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.7554581040933178,1.4152167427107378,0.024096385542168676,1.0,1.0,4/22,8.37%,CD44;DDX3X;RAF1;NAIP
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.8182791979396629,1.4137575512152472,0.02702702702702703,1.0,1.0,3/13,6.24%,CD44;ITGA5;ADAM17
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.8081343666337626,1.4132814097273187,0.012345679012345678,1.0,1.0,4/14,3.85%,CADM1;TENM2;PTPRD;TENM3
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.8515596628340318,-1.4125385303179996,0.08571428571428572,0.9705639643375492,1.0,1/5,3.95%,SNAPC3
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.9161443538834128,1.411210154128039,0.014925373134328358,1.0,1.0,1/5,0.90%,TAF1B
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.48933752572152517,-1.4100221401868267,0.0,0.9713052356448583,1.0,25/94,11.20%,TAGLN;MCAM;PRRX1;ACTA2;SYNPO2;LMOD1;COL14A1;SLIT3;KCNJ8;COL5A2;INPP4B;ADGRA2;FBLN2;PAMR1;COL15A1;VIM;NOTCH3;EDNRA;SPARC;GNB4;COL1A2;PDE5A;TNS2;CXCL12;SLC38A11
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.7947238870902625,1.4089627593099892,0.047058823529411764,1.0,1.0,6/19,3.43%,ADAMTS9;KLF2;RHOJ;EPN1;CEMIP2;ITGA5
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.7426132797101139,1.408759295916441,0.034482758620689655,1.0,1.0,12/31,12.22%,CADM1;CDH18;CDH2;CSF1R;NECTIN2;PRKCI;TGFB1;CDH12;CTNND2;CADM2;CDH20;CDH10
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.7894049437325298,-1.4078487183664918,0.14814814814814814,0.9718847809470169,1.0,3/8,15.13%,CACNA1D;HCN2;CACNB2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.9364554339134392,1.406267073541692,0.015151515151515152,1.0,1.0,2/5,3.03%,KCNE4;KCNQ1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.697615844591469,1.4061852775042043,0.023255813953488372,1.0,1.0,10/39,13.86%,IPO9;TSC2;NUP153;SEC13;IPO5;NUP88;CSE1L;NUP133;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.7230363500228016,1.4046887468574698,0.04819277108433735,1.0,1.0,2/25,1.68%,SYT1;ADGRV1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.832511640853949,1.4042359195498157,0.012987012987012988,1.0,1.0,4/13,9.03%,OS9;AMFR;MARCHF6;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.8849544573373809,1.4023528059504895,0.013333333333333334,1.0,1.0,2/6,9.46%,NR4A3;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.8768433905895134,1.4017832653271611,0.02564102564102564,1.0,1.0,3/9,7.68%,RIMS2;RNF10;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.8021423842188657,1.4014320750890215,0.03614457831325301,1.0,1.0,3/15,1.35%,STC1;ADAMTS9;MCC
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.775077490730421,1.3999744331712323,0.05263157894736842,1.0,1.0,4/16,11.05%,ZC3H7B;AGO2;ZC3H7A;TUT7
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.9419876253089137,1.3995965324576087,0.0,1.0,1.0,2/6,3.03%,GJA1;KCNQ1
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.9519203984062125,1.3995017899854758,0.0,1.0,1.0,1/5,0.38%,SOD1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.797884814152701,-1.3987821353973084,0.17142857142857143,1.0,1.0,1/6,4.38%,ARSB
prerank,MSigDB_Hallmark_2020__Glycolysis,0.6867018766101659,1.3981240564282518,0.0,1.0,1.0,26/76,22.62%,STC1;SOD1;CD44;COG2;DDIT4;ENO1;RARS1;STMN1;EGFR;GLRX;HDLBP;HSPA5;PDK3;AK3;PGK1;ADORA2B;ME2;ANGPTL4;ECD;TPI1;IRS2;GCLC;PKP2;MXI1;GPC4;FUT8
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.9188211831285287,1.3976534938242933,0.0273972602739726,1.0,1.0,1/7,1.24%,GJA1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.8274378192932099,1.3976450488537353,0.012987012987012988,1.0,1.0,1/9,0.47%,CD44
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.7740783922469145,-1.3946776684505107,0.12903225806451613,1.0,1.0,2/6,2.95%,MAPK14;CACNA1D
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.7037882777262919,1.3937375880983325,0.021739130434782608,1.0,1.0,19/55,16.78%,CSF1;NFKBIA;ITGA5;PDE4B;RAF1;SLC7A2;IL18;SEMA4D;SELENOS;TNFRSF1B;EIF2AK2;HIF1A;F3;PTPRE;ABCA1;SLC1A2;ACVR2A;ADORA2B;ACVR1B
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.6727512443585728,1.393180288304255,0.020833333333333332,1.0,1.0,13/76,8.25%,STC1;WWC1;SRGN;HS3ST5;GJA1;MCC;WWC2;RHEB;ADAM17;ROBO1;ACOT11;TGFB1;EGFR
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.8858717586611311,1.3927795709270667,0.014285714285714285,1.0,1.0,1/6,0.38%,SOD1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.8888191493289941,1.3923650397827732,0.0410958904109589,1.0,1.0,2/6,4.97%,NOS1AP;PDE4B
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.875334448714876,1.392262294257144,0.05970149253731343,1.0,1.0,1/7,0.66%,SYT1
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.873514614722713,1.3913168188330443,0.02631578947368421,1.0,1.0,2/8,4.97%,NOS1AP;PDE4B
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.6858334717518474,1.3904273460427938,0.021739130434782608,1.0,1.0,8/55,8.73%,STC1;GPR161;COL4A6;MID1;GJA1;TENM3;NXN;EFNB2
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.8936974919963616,1.389440748877173,0.02857142857142857,1.0,1.0,1/6,0.66%,SYT1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.8264685907378975,1.3890633375772576,0.05555555555555555,1.0,1.0,3/9,11.82%,SRGN;TGFB1;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.8863178435720374,1.3888413661498797,0.024691358024691357,1.0,1.0,3/7,7.62%,SNX6;ERRFI1;PPARA
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.7355169491698451,1.38856417305197,0.047058823529411764,1.0,1.0,3/20,6.93%,DDX3X;EPHA7;ERRFI1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.8429626551877598,1.3884308330897022,0.0547945205479452,1.0,1.0,1/8,0.10%,SRSF12
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.8789734721260305,1.3878128135726362,0.039473684210526314,1.0,1.0,3/7,7.49%,NR4A3;SLC2A1;PRKCB
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.7065518869891,1.387326624432174,0.011494252873563218,1.0,1.0,12/37,18.53%,TBC1D20;SEC24A;VAPB;CSNK1D;SEC13;VAPA;NSF;SEC24D;COL7A1;CNIH3;GOLGA2;ANKRD28
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.5318334512606286,-1.3868298134156858,0.058823529411764705,1.0,1.0,8/30,5.12%,CTNNA3;FGF13;GALNT16;HFM1;ATP1B2;RYR2;FILIP1;LRP1B
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.5970199610107273,-1.3863042050080594,0.09090909090909091,1.0,1.0,2/13,6.37%,DERL1;VCP
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.8882934975310113,1.385503893647041,0.02564102564102564,1.0,1.0,3/8,7.62%,GRIN1;RAB27A;PPARA
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.7811412046427078,1.3847487302951986,0.0,1.0,1.0,2/15,3.83%,CD44;ANK3
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.7388718875895764,1.383708205613551,0.0379746835443038,1.0,1.0,15/22,23.37%,SOD1;PDLIM1;MGST1;SOD2;SELENOS;MBP;GLRX;OXSR1;GSR;NDUFS2;PRNP;JUNB;GPX3;GCLC;SCAF4
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.8863319823373508,1.3832931303289002,0.05333333333333334,1.0,1.0,1/6,4.52%,AGO2
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7836858687767568,1.3828288649362885,0.06097560975609756,1.0,1.0,4/14,11.07%,MDGA2;ZC4H2;AGTPBP1;SIN3A
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.43342291702665886,-1.3822130181329908,0.0,1.0,1.0,24/123,7.14%,TAGLN;IL34;TWIST2;EDN3;DKK3;PRRX1;ACTA2;SYNPO2;LAMC1;LMOD1;MYL9;SERPINH1;COL14A1;NR4A1;SLIT3;NOX4;COL5A2;IGFBP7;TNXB;COL13A1;FBLN2;PAMR1;COL15A1;VIM
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.8162403911438914,-1.3819838180106194,0.18421052631578946,1.0,1.0,3/6,14.13%,ATP2B4;DAB2IP;ADAMTS12
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.9331252172112843,1.3815228413161789,0.0,1.0,1.0,2/5,2.39%,CD44;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.9331252172112843,1.3815228413161789,0.0,1.0,1.0,2/5,2.39%,CD44;KDM1A
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.5442997254878664,-1.380807242896453,0.11764705882352941,1.0,1.0,5/24,5.69%,NRP1;SLIT2;PGF;NR4A1;ADGRA2
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.8209859193554885,1.3804336866329352,0.04878048780487805,1.0,1.0,3/9,8.85%,TSC2;GIGYF2;IRS1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.5291098264012501,-1.380116456418139,0.058823529411764705,1.0,1.0,5/38,1.17%,SPRY3;IL34;FGF1;EDN3;SPRY1
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.8971002523405213,1.3778493763047985,0.04,1.0,1.0,2/7,5.74%,CSF1;IL18
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.6734879059573287,-1.3768748939200408,0.14285714285714285,1.0,1.0,3/15,3.74%,CTNNA3;FGF13;RYR2
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.7894208914855868,1.376593107368671,0.058823529411764705,1.0,1.0,7/16,14.95%,PANK2;PDK1;ACADVL;PPARA;PDK3;PDK4;ACADL
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.85461697710491,-1.3762646502095073,0.13636363636363635,1.0,1.0,2/5,1.92%,WNT5B;ACTA2
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.8522640303458459,1.3758909895684344,0.05194805194805195,1.0,1.0,1/8,0.16%,STC1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.8774759360670958,1.3749063969331117,0.07317073170731707,1.0,1.0,2/6,6.93%,SNX6;ERRFI1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.9259161167389662,1.3743702712389103,0.014492753623188406,1.0,1.0,3/7,4.75%,KCNE4;KCNQ1;NOS1AP
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.8234855219841625,1.3741848144244642,0.0625,1.0,1.0,3/10,6.54%,ADAMTS9;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.9419991845495037,1.3739419103438677,0.015625,1.0,1.0,1/5,2.69%,CCP110
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5647894097494196,-1.3738053661103735,0.05,1.0,1.0,4/19,3.32%,NRP1;PGF;MAPK14;NR4A1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.9244578808364254,1.373773073811416,0.02631578947368421,1.0,1.0,1/5,0.75%,KLF2
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.7639913391292255,-1.373154719208194,0.16129032258064516,1.0,1.0,4/8,8.28%,GPC6;GLB1;HGSNAT;GPC3
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.8294687055804687,1.3725152282663826,0.05128205128205128,1.0,1.0,1/7,2.44%,SPTBN4
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.5154848416370252,-1.3720321751986781,0.0,1.0,1.0,20/70,9.11%,SLIT2;ITGA8;PRRX1;ACTA2;MYH11;SYNPO2;LMOD1;COL14A1;SLIT3;KCNJ8;MSRB3;COL5A2;ADGRA2;PAMR1;COL15A1;MYLK;PRKG1;EDNRA;SPARC;COL1A2
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.7476719974074584,1.3720286866674858,0.04878048780487805,1.0,1.0,4/20,9.61%,ZC3H7B;AGO2;ZC3H7A;CNOT8
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.8771863891620753,1.3719645331364154,0.05,1.0,1.0,5/8,7.81%,TAF7;HDAC2;AP2A1;SELENOS;TGFB1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.9092119258358728,1.3718927285924178,0.0,1.0,1.0,3/7,4.20%,WWC1;SOD1;WWC2
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),-0.8500745482471037,-1.3716526981163517,0.21875,0.9891473275918743,1.0,3/5,3.48%,NRP1;SLIT2;SLIT3
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),-0.8500745482471037,-1.3716526981163517,0.21875,0.9891473275918743,1.0,3/5,3.48%,NRP1;SLIT2;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.804764476078023,-1.3714738540654838,0.125,0.9783567693956418,1.0,1/6,4.40%,PIP4K2B
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.7929624070454371,1.3711339370876638,0.0759493670886076,1.0,1.0,2/16,1.24%,STC1;GJA1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.852942400974084,1.3709101852229997,0.07792207792207792,1.0,1.0,1/9,3.75%,BASP1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.8422455414514842,1.370129247333275,0.08641975308641975,1.0,1.0,1/10,2.09%,RAD21
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.7900904452750739,-1.3699895159573183,0.034482758620689655,0.9765081504299833,1.0,3/6,9.64%,NRP1;PLXNC1;PLXNB2
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.5686004731602335,-1.3698110399170755,0.07142857142857142,0.9663402568574601,1.0,2/27,0.69%,SPRY3;CDK6
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.951035391681226,1.3697301198828764,0.0,1.0,1.0,1/6,3.96%,RPS21
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.8327949051996116,1.369580503252549,0.05714285714285714,1.0,1.0,4/9,12.45%,PSMB1;PSMB2;PSMA7;PSMA4
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.879860515114079,1.368149023995951,0.08695652173913043,1.0,1.0,3/6,7.17%,SLC2A3;SLC23A2;SLC2A1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.8808525094864375,1.3679208108185996,0.05405405405405406,1.0,1.0,2/6,8.95%,CD44;MBP
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.7616437793243664,1.3678023677503455,0.06493506493506493,1.0,1.0,4/17,7.81%,SOD1;GRIN1;RAB27A;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.684292308682911,1.3675676864460689,0.022727272727272728,1.0,1.0,12/35,17.85%,SOD1;CSF1;SNX6;PRKCI;SOD2;TNFRSF1B;NAIP;PPARGC1A;PTPRZ1;LRRK2;CPEB4;UNC5B
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.9291264143674662,1.3672309929848792,0.047619047619047616,1.0,1.0,2/5,3.03%,NRG1;KCNQ1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.6291220860362488,-1.3667111465554302,0.13636363636363635,0.9703297185482355,1.0,2/14,0.80%,NRP1;SLIT2
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.8163780363427549,1.365970969993482,0.06172839506172839,1.0,1.0,4/14,2.73%,ELAVL3;GRIN1;NXPH1;DNER
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.8603678327922496,1.3658009542743526,0.058823529411764705,1.0,1.0,1/7,2.09%,RAD21
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.8053335966033794,1.3656667031307796,0.023809523809523808,1.0,1.0,2/12,5.66%,TAF7;TBPL1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.6960606686267952,1.3655677389844851,0.060240963855421686,1.0,1.0,3/28,3.50%,PLAA;NEDD4L;RAB27A
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.746360439950609,-1.3640593134086052,0.1724137931034483,0.9720773306069337,1.0,4/7,17.48%,CORO1C;CHMP4B;TMCC1;SLC25A46
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.6496758488296869,1.364012429246641,0.0967741935483871,1.0,1.0,8/42,8.25%,CD44;SPTBN4;DDIT4;RAF1;STK4;TBK1;TGFB1;EGFR
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.6659795524114938,1.3637077245092333,0.02197802197802198,1.0,1.0,21/58,16.97%,PHYHIPL;ELAVL3;FAT3;NXPH1;LSAMP;DCLK1;CACNA1B;EPHA7;ROBO2;ROBO1;ADGRB3;HIVEP2;CTNNA2;SNAP25;CTNND2;ZNF536;CADM2;NOVA1;NRXN1;PURG;UNC79
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.691774495797618,1.3633645968399482,0.05434782608695652,1.0,1.0,5/51,4.25%,TAF7;SOD1;CSF1;TSC2;CAMKK2
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.9014534494817763,1.3628177148856813,0.057971014492753624,1.0,1.0,1/5,4.52%,AGO2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.9014534494817763,1.3628177148856813,0.057971014492753624,1.0,1.0,1/5,4.52%,AGO2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.5795136017647601,-1.362385870151794,0.08333333333333333,0.9694275300171526,1.0,3/14,3.22%,IQGAP2;NRP1;BAIAP2L2
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.6625211252181483,1.3619199830897297,0.0,1.0,1.0,24/91,15.78%,STC1;SLC2A3;MTHFD2L;PDK1;DDIT4;ACTR3;ENO1;ETF1;SCD;GBE1;SEC11A;SLC2A1;TBK1;PPA1;GLRX;FADS2;GSR;GMPS;PSMA4;HSPA5;CD9;PGK1;PSMD14;CANX
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.7383894616484815,1.3603715688517566,0.034482758620689655,1.0,1.0,7/23,6.56%,CADM1;TENM3;CDH2;NECTIN2;ROBO2;ROBO1;KIRREL3
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.7171051054614876,-1.3602527760487222,0.20833333333333334,0.9693594597050184,1.0,1/8,0.82%,CD4
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.6548441540147512,-1.3593993644278657,0.12,0.9626418089248278,1.0,2/10,1.88%,NRP1;PGF
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.8112552762108809,1.3593692275336016,0.07042253521126761,1.0,1.0,2/9,6.95%,CD44;NR4A3
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.7993431334020822,1.3592030187720283,0.07228915662650602,1.0,1.0,1/12,0.26%,RNMT
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.7993431334020822,1.3592030187720283,0.07228915662650602,1.0,1.0,1/12,0.26%,RNMT
prerank,PanglaoDB_Augmented_2021__Platelets,0.6849517868764663,1.3566162414283967,0.054945054945054944,1.0,1.0,7/37,9.16%,SLC2A3;SRGN;PDLIM1;WIPF1;FHL1;TNFRSF1B;RAP1B
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.8695731997038705,1.3561908332814225,0.05405405405405406,1.0,1.0,1/8,0.75%,KLF2
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.68270576898553,1.3559953590492442,0.10465116279069768,1.0,1.0,10/35,10.33%,SRGN;PITRM1;CPD;ADAM17;SEC11A;MMP16;CPM;F3;C1R;CTSL
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.8235280009176895,1.3559386448384425,0.06329113924050633,1.0,1.0,3/10,6.93%,SNX6;ADAM17;ERRFI1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.8194519115034409,1.355842297095672,0.09333333333333334,1.0,1.0,1/8,5.09%,MTMR9
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.5837027713164493,-1.3548954266118756,0.09090909090909091,0.9752919048606381,1.0,4/14,10.46%,GPC6;ACTB;GPC3;STX8
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.6038309348539606,-1.3546070347570296,0.1,0.9666225243173563,1.0,1/14,0.43%,FGF13
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.8347611929831913,1.354506511793853,0.0547945205479452,1.0,1.0,2/9,11.05%,AGO2;TUT7
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.7884217349773139,-1.3536272405123086,0.07692307692307693,0.9604527142567313,1.0,3/9,13.81%,ATM;UBE2V2;MRE11
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.8698785527791243,1.3529647250114523,0.09210526315789473,1.0,1.0,3/8,8.08%,GJA1;KDM1A;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.9047315094346426,1.3529311788202614,0.07246376811594203,1.0,1.0,1/7,0.79%,AKAP8
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.8651418553064333,1.3526869601587124,0.07042253521126761,1.0,1.0,1/6,1.65%,KCNC2
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.7178831897654924,1.3524346312610667,0.021505376344086023,1.0,1.0,9/39,11.42%,LPIN1;GJA1;KDM1A;SCD;IL18;CEBPB;PPARGC1A;PRLR;KDM3A
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.6970687599268526,1.3520176609020687,0.020833333333333332,1.0,1.0,13/45,12.38%,ETV5;PHYHIPL;ELAVL3;NXPH1;CRMP1;DCLK1;GFAP;ADGRB3;SYNDIG1;SNAP25;CTNND2;ZNF536;CORO2B
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.7255699889193383,1.3511274832882814,0.06896551724137931,1.0,1.0,4/26,2.17%,RHOB;RIPOR1;CDC42EP4;RHOJ
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.9165656249165743,1.3507583788217739,0.039473684210526314,1.0,1.0,3/6,4.91%,OS9;UBAC2;UBE2J1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.9165656249165743,1.3507583788217739,0.039473684210526314,1.0,1.0,3/6,4.91%,OS9;UBAC2;UBE2J1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.9165656249165743,1.3507583788217739,0.039473684210526314,1.0,1.0,3/6,4.91%,OS9;UBAC2;UBE2J1
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),0.8576391516330468,1.3507411879894484,0.06756756756756757,1.0,1.0,3/8,7.81%,CD44;CEMIP2;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.8526040301436444,1.3500642361536876,0.10294117647058823,1.0,1.0,3/5,14.37%,NR4A3;PDE8A;LRRK2
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.8643756158849062,1.349983295350722,0.02702702702702703,1.0,1.0,1/7,1.07%,ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.8123788604964872,-1.3495468408126212,0.16129032258064516,0.9736178815163159,1.0,1/5,2.60%,MYL9
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.8818103086179145,1.3493778002132888,0.02564102564102564,1.0,1.0,1/8,1.49%,UBA5
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.7698156343773328,1.3488409671242474,0.08333333333333333,1.0,1.0,3/13,6.59%,GPR161;SUFU;BTRC
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.8896733765576469,1.3486481404157136,0.0625,1.0,1.0,2/5,7.81%,IL18;TGFB1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.8141028474584072,1.3482740871432661,0.05747126436781609,1.0,1.0,4/10,14.45%,PDK1;SCARB2;PDK3;PDK4
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.6887396494801212,1.3479566733366473,0.05434782608695652,1.0,1.0,15/62,14.66%,STC1;CD44;ANKH;ADAMTS4;GJA1;SUFU;PAPSS1;MMP16;ZBTB16;TBX3;DEAF1;FGFR2;CREB3L2;PAPSS2;PPIB
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.7516210620905761,1.3478418114742345,0.075,1.0,1.0,3/16,7.81%,NELL1;ADGRV1;TGFB1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.7933130380814695,1.3476424662407958,0.07792207792207792,1.0,1.0,3/13,3.10%,SOD1;KCNQ1;SGCZ
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.6733534032387322,1.3466727727502774,0.02127659574468085,1.0,1.0,18/61,14.98%,EPM2A;ATP6V1G1;PRKACA;TSC2;ATP6V1H;RHEB;SNX6;SLC38A9;BNIP3L;TBK1;ATP6V1E1;LZTS1;EXOC1;WAC;SESN1;KDR;LRRK2;C9ORF72
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.8490198801806944,1.3462849277403026,0.039473684210526314,1.0,1.0,1/7,0.10%,SRSF12
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.7614993088924744,1.3460447078263684,0.125,1.0,1.0,7/14,16.99%,HDAC2;EMP1;UGCG;CCN2;FGFR2;COL7A1;SVEP1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.86192526685839,1.345996686486334,0.04285714285714286,1.0,1.0,2/8,11.42%,KDM1A;KDM3A
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.8636629056107916,1.3456143123661986,0.07352941176470588,1.0,1.0,3/5,12.72%,NELL1;EIF2AK2;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.8557172688265716,1.3454582906950134,0.06666666666666667,1.0,1.0,1/8,1.04%,PLAA
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.8046022819802828,1.3453452384222542,0.07894736842105263,1.0,1.0,3/10,7.17%,SLC2A3;SLC23A2;SLC2A1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.6724248724381059,-1.3452928584218562,0.045454545454545456,0.9833553695559655,1.0,1/11,0.43%,FGF13
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.7409775899533989,1.345045630706101,0.075,1.0,1.0,2/15,8.60%,TGFB1;SYMPK
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.5994331436683387,-1.3448297183516442,0.14285714285714285,0.976327212488769,1.0,2/19,4.40%,TTC7A;PIP4K2B
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.7019132870787145,1.343805754381593,0.054945054945054944,1.0,1.0,12/38,20.92%,TAF7;TSC2;PTPRQ;PTPN1;CAMK2N1;SH3BP5;CDKN1B;ABL1;PPM1E;NF1;UBASH3B;YWHAG
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),0.7072267875480652,1.342848145871874,0.047058823529411764,1.0,1.0,3/32,6.27%,CD44;MID1;NCAM1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.873627500707147,1.342288821849485,0.08108108108108109,1.0,1.0,2/5,4.78%,PTPN1;NIBAN2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.664143129476104,1.3408108425271823,0.08045977011494253,1.0,1.0,9/40,13.27%,SRGN;SOD1;CADM1;IGF2BP2;TNFRSF1B;TBK1;EIF2AK2;BCL6;MAPKAPK2
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.7833653622161698,1.340801173258807,0.08860759493670886,1.0,1.0,2/11,11.05%,AGO2;TUT7
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.9011176943703518,1.3406483931653321,0.031746031746031744,1.0,1.0,2/5,7.52%,NOS1AP;SELENOS
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.6845592752008363,-1.3402587690937076,0.10714285714285714,0.9794985972825787,1.0,4/11,16.94%,PHLDB2;CORO1C;THBS1;PTEN
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.6845592752008363,-1.3402587690937076,0.10714285714285714,0.9794985972825787,1.0,4/11,16.94%,PHLDB2;CORO1C;THBS1;PTEN
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.807046486025535,1.3402165219371374,0.039473684210526314,1.0,1.0,2/9,6.22%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.5955686897135336,-1.33968267552268,0.14285714285714285,0.97196656592883,1.0,2/15,4.12%,ZDHHC15;CAPRIN2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.7349550261742501,1.3396226296473182,0.03571428571428571,1.0,1.0,4/22,7.81%,NFKBIA;KDM1A;HABP4;TGFB1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.7362709050892231,1.3394358102685067,0.03614457831325301,1.0,1.0,6/22,12.30%,AZI2;NFKBIA;TBK1;RPS27A;ROCK2;TANK
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.7916397643237998,1.3387529662995392,0.04938271604938271,1.0,1.0,4/15,9.79%,PLAA;CTNNA2;NEXMIF;ULK4
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.8081217918673816,1.3384449481159746,0.0410958904109589,1.0,1.0,3/11,3.66%,SYT1;RAB27A;RIMS2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.7971787826988515,1.3376240222956997,0.07894736842105263,1.0,1.0,4/11,10.94%,GRIN1;EPHA7;DELE1;GRIN2B
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.8568915734153829,1.3371259953931474,0.09210526315789473,1.0,1.0,1/7,10.99%,TRAF3IP1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.818586550403777,-1.3368016968090621,0.24242424242424243,0.977211859838275,1.0,1/5,1.54%,DDI2
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.8632637118329253,1.3366069050691047,0.036585365853658534,1.0,1.0,4/7,13.46%,CSF1R;TGFB1;FLT1;KDR
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.8388987597308076,1.3366065283759798,0.08974358974358974,1.0,1.0,4/10,10.94%,KCNC2;GRIN1;FARSB;GRIN2B
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.7792710691719862,1.3365572201286486,0.10843373493975904,1.0,1.0,4/11,14.08%,DDX3X;DELE1;CASP8AP2;TNFRSF10B
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.7198800917326386,1.3361883990164838,0.06172839506172839,1.0,1.0,9/23,14.47%,SLC23A2;SLC7A2;SLC16A12;SLC16A7;SLC3A2;SLC13A3;SLC1A2;SLC36A4;SLC25A4
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.8029773247223895,1.3359740171109606,0.0945945945945946,1.0,1.0,1/10,0.61%,ADAMTS9
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.6974486464571343,1.3354307390362163,0.05263157894736842,1.0,1.0,11/43,14.95%,LPIN1;GJA1;KDM1A;SCD;IL18;CEBPB;PPARGC1A;PRLR;KDM3A;INSR;ACADL
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.6717829003645476,1.335178578319357,0.10752688172043011,1.0,1.0,5/34,6.72%,STC1;TPT1;VAPB;TMEM165;TMCO1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.7145354375981972,1.3345778413476637,0.0875,1.0,1.0,6/23,14.18%,SYT1;RIMS2;MCTP2;SNCAIP;NSF;RAB12
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.7201427619409172,-1.3344522316339853,0.16,0.9780934589415815,1.0,1/7,6.58%,DAG1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.6709107884784565,1.3340970410494164,0.043478260869565216,1.0,1.0,13/48,14.37%,SYT1;NRG3;CACNA1B;RIMS2;DGKI;CDH2;BTBD9;GRIK2;SYN3;MCTP2;SNCAIP;GRM7;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.8418727886520861,1.333683594901344,0.11392405063291139,1.0,1.0,1/7,0.29%,TAF7
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.6381432176767743,-1.3334426335714407,0.16666666666666666,0.9729974631361978,1.0,1/7,2.29%,ATM
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.9125462763706382,1.3332698292739422,0.028169014084507043,1.0,1.0,1/6,0.45%,COL4A6
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.7588795771057932,-1.3332471699379693,0.21428571428571427,0.9644589537591919,1.0,1/5,0.34%,CAV2
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),0.8257706377370643,1.3331212974352415,0.09722222222222222,1.0,1.0,1/7,0.38%,SOD1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.8145642490523768,1.3324290408855453,0.056338028169014086,1.0,1.0,5/10,13.86%,GRIN1;MBP;GRIN2B;ROCK2;STAT3
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.6462422536545422,-1.3323632465059074,0.13636363636363635,0.9585128550694589,1.0,1/12,0.79%,NRP1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.7014727562696712,1.332071074953926,0.07142857142857142,1.0,1.0,6/26,4.96%,SOD1;ADGRV1;SPTBN4;KCNQ1;HOMER2;NDUFB9
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.8451239037408039,1.3319667068904484,0.11475409836065574,1.0,1.0,1/5,7.52%,SELENOS
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7732157444882097,1.331895688795347,0.11428571428571428,1.0,1.0,3/11,16.39%,CHST11;CHSY1;CHST15
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.8067148236482599,1.3313617871431138,0.07317073170731707,1.0,1.0,5/12,9.96%,GLRB;GRIN1;SLC38A9;IPO5;TMBIM6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.8352262696209829,1.3312232344873938,0.06329113924050633,1.0,1.0,2/6,8.73%,TGFB1;EFNB2
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.7354940301763447,1.331092332075038,0.075,0.9973438464124855,1.0,4/17,10.51%,NELL1;ADGRV1;TGFB1;CEBPB
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.6176592423253016,-1.3310621875199886,0.10526315789473684,0.9551741753305096,1.0,2/16,3.02%,SERPINI1;SERPINH1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.7422432999485358,1.3305172649524202,0.03571428571428571,0.998875963008704,1.0,4/18,4.60%,PLEKHG4B;CRMP1;CACNA1B;EPHA7
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.7754614922871199,-1.3293772431439346,0.10714285714285714,0.9527808574479989,1.0,1/5,1.17%,SPRY1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.6046941568156555,-1.329145080238881,0.11764705882352941,0.9453623699523892,1.0,2/14,5.00%,ZDHHC15;VPS35
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.7689569767876233,1.3280566368169762,0.08108108108108109,1.0,1.0,2/11,11.57%,CAMKK2;SREBF1
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.6716377799019126,1.3280546404383629,0.01098901098901099,1.0,1.0,14/55,9.54%,ELAVL3;FAT3;CRMP1;FMN2;LSAMP;DCLK1;PTPRD;CACNA1B;PCDH17;ROBO2;ADGRB3;CTNNA2;SNAP25;TRPM3
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.9151084337061317,1.3279336914552307,0.0547945205479452,1.0,1.0,1/5,0.45%,COL4A6
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.8753577886062027,1.3274982016733838,0.16176470588235295,1.0,1.0,2/6,11.07%,TAF7;SIN3A
prerank,MSigDB_Hallmark_2020__Apoptosis,0.6292109459611236,1.3270810700329232,0.06382978723404255,1.0,1.0,12/71,11.58%,SOD1;CD44;ANKH;RHOB;CD38;ETF1;EMP1;IL18;SOD2;BNIP3L;GSR;MADD
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.826845760610913,1.3266518750940781,0.14084507042253522,1.0,1.0,2/6,11.82%,TGFB1;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.5896805500252479,-1.326530901242389,0.045454545454545456,0.9502056503943295,1.0,1/14,0.83%,FGF1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7454958629187669,1.3264520959633725,0.08536585365853659,1.0,1.0,4/18,8.44%,NRG3;CACNA1B;BTBD9;GRIK2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.7298401789816645,1.3262493232029124,0.0963855421686747,1.0,1.0,7/24,17.55%,SOD1;HNRNPF;SOD2;RAP1B;CFL1;PDCD4;ARF1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.6635268583794696,1.3261210125474645,0.043010752688172046,1.0,1.0,10/53,9.46%,SRGN;CSF1;DARS1;RARS1;IL18;PRKCB;TGFB1;EGFR;APBB1;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.720003061580639,1.3256949123310942,0.07317073170731707,1.0,1.0,4/19,10.36%,NELL1;ADGRV1;TGFB1;ZBTB16
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.688023380504456,1.325479274537474,0.054945054945054944,0.9981514056964863,1.0,7/31,10.67%,LPIN1;GNPAT;ACOT11;PPARA;SGPL1;ACSL4;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.8625467811162798,1.3249542684268085,0.0641025641025641,0.9994897394384713,1.0,1/7,0.75%,KLF2
prerank,PanglaoDB_Augmented_2021__Monocytes,0.7323199698646319,1.3242012020204845,0.07317073170731707,1.0,1.0,6/19,11.85%,CD44;ZFP36L2;CSF1R;TNFRSF1B;CEBPB;NFKBIZ
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.7664815403886083,1.3241755463285345,0.05952380952380952,0.9980300580331753,1.0,6/16,12.46%,HDAC2;GRIN1;RAB27A;PPARA;TGFB1;RUNX1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),0.8619817215841744,1.3238629321608943,0.0958904109589041,0.9968932118273961,1.0,3/7,7.81%,CD44;CEMIP2;TGFB1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.43908652891179006,-1.323582262333218,0.0,0.9547026385420015,1.0,16/80,10.06%,NTN4;SPRY1;JPH2;LAMC1;LMOD1;COL5A2;LAMB2;PTPN21;FKBP9;DAG1;NOTCH3;EDNRA;ARHGEF17;ADCY6;ZNF423;TNS2
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.7861792036524925,1.32355845471583,0.10714285714285714,0.9949850374572499,1.0,2/10,4.20%,WWC1;WWC2
prerank,PanglaoDB_Augmented_2021__Interneurons,0.6328237719670907,1.3232753188780315,0.021052631578947368,0.993387066820191,1.0,20/96,11.36%,SYT1;PHYHIPL;ELAVL3;KCNC2;PCBP3;NXPH1;DHRS3;DNAJC6;CACNA1B;ADGRB3;HIVEP2;PRKCB;CTNNA2;SNAP25;KCNQ5;CTNND2;ACSL4;CCN2;TRIM9;CADM2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.7116727132485228,1.3232362955630663,0.056818181818181816,0.9889472056994992,1.0,9/34,9.00%,BTD;MTHFD2L;PANK2;CPD;ALDH1L1;ACOT11;SGPL1;CPM;MCCC2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.8039362363636556,1.3232235346264687,0.10126582278481013,0.9845494285704731,1.0,1/9,4.52%,AGO2
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.8566337856760979,1.3231836908066232,0.04477611940298507,0.9805289210529821,1.0,2/5,10.51%,SOD1;CEBPB
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.4985723495910116,-1.3230361918634712,0.0,0.9482342563097279,1.0,9/44,8.12%,TPM2;ACTA2;MYH11;LMOD1;MYL9;MYOM1;VIM;MYLK;EDNRA
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.8189217966066498,1.3221108273932438,0.10126582278481013,0.9867155366922777,1.0,2/9,4.14%,WASF3;WASF1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.7102318901232902,1.321643162596679,0.08045977011494253,0.9874270045310946,1.0,8/26,14.37%,TPT1;DDX3X;ENO1;SOD2;SELENOS;TMBIM6;MDM2;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.8339781927491499,1.3212851555239693,0.1111111111111111,0.986003380873447,1.0,2/7,4.14%,WASF3;WASF1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.7449267672254367,1.321283068390758,0.09411764705882353,0.9814385504064403,1.0,5/15,14.45%,PDK1;SELENOS;IRS1;PDK3;PDK4
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.7014229882646315,1.3202855740462904,0.0963855421686747,0.9867102563018514,1.0,6/27,4.96%,SOD1;ADGRV1;SPTBN4;KCNQ1;HOMER2;NDUFB9
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.886355665314246,1.3200023732501371,0.0958904109589041,0.9854028086213928,1.0,1/5,4.52%,AGO2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.6905765973757887,1.3198852297057346,0.10843373493975904,0.9820641396222647,1.0,9/30,16.96%,GPR161;S1PR3;ADGRB3;GNB1;ADGRG2;ABCA1;ADGRE2;LGR4;PTH1R
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.8061707007400754,1.319551351120933,0.1038961038961039,0.9803274523641496,1.0,2/10,7.78%,DDX3X;TBK1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.8686830403920333,1.3190942755141637,0.07692307692307693,0.9816895039868182,1.0,1/5,1.19%,RIPOR1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.8766595186513148,1.3190741515251094,0.06666666666666667,0.9774507111204358,1.0,1/5,5.68%,CSF1R
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.7101599612440708,1.318687291875091,0.12222222222222222,0.9778101907965733,1.0,6/26,9.56%,PHYHIPL;ELAVL3;NXPH1;CACNA1B;SNAP25;CTNND2
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.6794858451292572,1.3185844980052164,0.10714285714285714,0.9744437443290654,1.0,6/31,6.72%,STC1;TPT1;VAPB;GRIN1;TMEM165;TMCO1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.7472318605337301,-1.3183459808347353,0.175,0.9593246885699716,1.0,1/5,0.83%,FGF1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.645942466640621,1.317943151032613,0.030303030303030304,0.9767568728926527,1.0,20/77,13.36%,SLC2A3;CSF1;CD44;KLF2;RHOB;NFKBIA;PDE4B;IL18;NR4A3;KLF9;SOD2;DUSP1;SLC16A6;F3;CEBPB;PTPRE;BCL6;TANK;ABCA1;CEBPD
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.8419292944220845,1.317851072538584,0.08333333333333333,0.9733348842437908,1.0,1/7,0.38%,SOD1
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.882877455401851,-1.3176183096760372,0.08333333333333333,0.9546007412398921,1.0,2/5,2.52%,PARP9;ZNF618
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.6906895451239257,1.3175640572982041,0.08333333333333333,0.9718246030734411,1.0,7/24,19.38%,WWC1;KDM1A;REEP5;LRRK2;ADGRE2;STXBP4;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.8693805557950796,1.3173590401949846,0.1,0.9694355198157708,1.0,2/5,7.68%,RNF10;TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.7928077306265264,1.3173477040935422,0.0625,0.965379807884916,1.0,7/15,9.46%,DDX3X;CSF1R;IL18;ADAM17;EIF2AK2;MBP;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.7289647995117771,1.3170678553694979,0.10526315789473684,0.9640122426436746,1.0,6/19,16.71%,AGO2;TGFB1;EGFR;EIF4ENIF1;STAT3;MAP2K1
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.9022302682172763,1.3161225959845295,0.041666666666666664,0.9693040293040293,1.0,1/5,0.16%,STC1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.6601343894369567,1.3155433032870179,0.06896551724137931,0.9720955211349864,1.0,6/31,8.25%,CD44;RAF1;STK4;TBK1;TGFB1;EGFR
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.8185100097959401,1.3152408711416061,0.08955223880597014,0.97150235794052,1.0,2/7,9.27%,MCTP2;SNCAIP
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.7254458859030086,-1.3147564271489747,0.21875,0.9505702936586751,1.0,2/6,10.94%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.7254458859030086,-1.3147564271489747,0.21875,0.9505702936586751,1.0,2/6,10.94%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.719329882830651,1.314696615486512,0.17333333333333334,0.9724787832727141,1.0,3/16,10.97%,DDX3X;TBK1;RIOK3
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.7586868355547225,1.3141495066391322,0.12345679012345678,0.973446898602081,1.0,5/12,11.52%,SYT1;PHYHIPL;EBF4;SHC2;PTOV1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.46799512433752166,-1.3134186146594535,0.0,0.9472656744404079,1.0,14/59,9.11%,TAGLN;DKK3;PRRX1;ACTA2;LMOD1;MYL9;COL14A1;COL5A2;FBLN2;PAMR1;COL15A1;EDNRA;SPARC;COL1A2
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.6594571947256441,1.3129790044000318,0.041666666666666664,0.9807842122890328,1.0,18/74,20.69%,NFKBIA;CD38;PTPN1;PDE4B;PELI1;PSMB2;SOD2;EIF2AK2;HIF1A;C1R;ZNFX1;CFH;STAT3;LATS2;PTPN2;IFIT3;IFITM3;MARCHF1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.8433037037982598,1.3121582381109567,0.13043478260869565,0.9835112810388621,1.0,1/5,6.24%,ADAM17
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.6195127347111103,-1.3112997692888106,0.22727272727272727,0.9483720606004276,1.0,1/11,1.97%,PARP9
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.6531871218037604,1.3112741007997266,0.15853658536585366,0.9886082266357494,1.0,10/30,23.12%,NELL1;MTMR9;RUBCN;CST3;WDR6;STAT3;GOLGA2;MTMR2;TAB2;MT3
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.6823905941337007,1.311189669091311,0.10752688172043011,0.9852376846599717,1.0,8/32,10.94%,CSF1;RRAS2;DDIT4;TNFRSF1B;TBK1;EFNB2;PPARGC1A;GRIN2B
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.7311456161225446,1.3103711700929224,0.10975609756097561,0.9897764937661727,1.0,7/23,17.55%,SOD1;HNRNPF;SOD2;RAP1B;CFL1;PDCD4;ARF1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.7129584693781404,1.3098536044457687,0.08974358974358974,0.991155090674296,1.0,2/20,0.61%,STC1;ADAMTS9
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.7743842446657464,1.309832668422343,0.08108108108108109,0.9872274972733688,1.0,7/11,22.02%,TGFB1;FGFR2;MYL3;TTN;ZFPM1;SMAD7;PKP2
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.7379538138780137,1.3098184610755965,0.11688311688311688,0.9832903804769247,1.0,4/17,5.53%,GJA1;GRIN1;CACNA1B;SNX6
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.6766403417979627,1.309355014884805,0.1111111111111111,0.9835949882573436,1.0,5/25,7.73%,DPM1;TMEM165;UBE2J1;MGAT4A;MGAT1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.6240095213595599,1.3091484384239966,0.01020408163265306,0.9819877579825154,1.0,19/85,18.16%,TBC1D20;SEC24A;VAPB;COG2;SPTBN4;ANK3;COG7;SEC13;ATL2;VAPA;NRBP1;ARFGAP3;NSF;CAPZB;SEC24D;COL7A1;ARF4;CNIH3;GOLGA2
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.6514739463481185,1.308221544867138,0.08695652173913043,0.9867184478831381,1.0,2/55,0.43%,SRSF12;HNRNPL
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.7731588596943717,1.3080903659341458,0.17391304347826086,0.9799912070025271,1.0,1/10,1.88%,PDLIM1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.7731588596943717,1.3080903659341458,0.17391304347826086,0.9799912070025271,1.0,1/10,1.88%,PDLIM1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.6936589479623326,1.3075705045748636,0.12048192771084337,0.9810789240235466,1.0,4/21,11.82%,RHOB;ANK3;STMN1;ROCK2
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.8444206393462046,1.3067870451521941,0.08,0.9852087508821454,1.0,5/10,9.46%,CSF1R;IL18;ADAM17;EIF2AK2;HIF1A
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.8605807287687688,1.306251917449011,0.06666666666666667,0.98679371434516,1.0,1/6,0.98%,NRCAM
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.8786059771635479,1.3056401970238483,0.11267605633802817,0.9890924824411064,1.0,1/6,0.79%,AKAP8
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.6413423869266696,-1.3053195686886376,0.125,0.968885202847467,1.0,3/8,10.99%,ACTB;MPP7;ACTG1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.8127493798659207,-1.3052449503452137,0.09090909090909091,0.9613876833112521,1.0,2/8,3.74%,CTNNA3;RYR2
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.8077225399251879,1.3050676523485878,0.13157894736842105,0.9907701512687553,1.0,2/9,7.78%,DDX3X;TBK1
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.8670480392070488,1.3045096489701373,0.0759493670886076,0.9919942042354092,1.0,3/6,12.67%,TNFRSF1B;TGFB1;CST3
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.7117579808315309,1.3035747473207608,0.08433734939759036,0.9973960452211936,1.0,5/29,3.26%,WWC1;SLC22A6;CRMP1;SPTBN4;GLIS3
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.8609814466142092,1.3032265563954892,0.11594202898550725,0.9969162402964008,1.0,1/6,2.29%,CADM1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.7905144466473281,1.3031859016693124,0.06578947368421052,0.993274606020831,1.0,3/11,9.30%,KDM1A;CTR9;DNMT1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.8084112691176837,1.3027104323977967,0.1267605633802817,0.9932874891270455,1.0,1/6,0.47%,CD44
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.7776175986624657,1.302564875172568,0.12195121951219512,0.9910622256493816,1.0,1/10,0.38%,SOD1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.696085865479381,1.3021333165712603,0.07954545454545454,0.991357309592313,1.0,11/35,11.36%,PHYHIPL;ELAVL3;KCNC2;NXPH1;SPTBN4;GFAP;ADGRB3;SNAP25;CTNND2;ZNF536;CADM2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.8391280844237654,1.302097600958971,0.09090909090909091,0.983983768525053,1.0,2/5,6.22%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.8391280844237654,1.302097600958971,0.09090909090909091,0.983983768525053,1.0,2/5,6.22%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.7869120502057902,-1.301974023353741,0.17857142857142858,0.9654128066320868,1.0,2/5,15.09%,SLC8B1;JAM2
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.7108436624715351,1.301570586132665,0.08641975308641975,0.9853850715510464,1.0,6/18,17.63%,SOD1;NRCAM;SIN3A;INSR;LATS2;ABL1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.8840601901551084,1.3009564288053312,0.10810810810810811,0.9882395318748529,1.0,2/5,7.49%,LPIN1;PRKCB
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.8373207451523281,1.3007433665144912,0.04285714285714286,0.9875035751854169,1.0,2/6,6.22%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.8718549752143857,1.3006742039954755,0.058823529411764705,0.9844028472734413,1.0,2/5,3.10%,SOD1;SGCZ
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.66712670074556,1.3005148474288115,0.05747126436781609,0.9821632715633334,1.0,9/44,13.65%,NELL1;DDX3X;IGF2BP2;GIGYF2;EIF2AK2;CNOT8;EIF4ENIF1;CST3;CAMK2N1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.6201666636611306,1.3003338200363965,0.05263157894736842,0.9803957541158007,1.0,20/70,17.76%,RIPOR1;FSIP2;DDX3X;UBAC2;MTCH2;COG7;IFT140;CSNK1D;TMEM30A;VAPA;WASHC2C;MDM2;LRRK2;PACSIN2;CNTLN;ZBTB7A;DCP1A;PRNP;RPA1;DNAJA1
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.6817899359288585,1.299909446393596,0.058823529411764705,0.9738205553544598,1.0,10/32,18.53%,TBC1D20;SEC24A;CSNK1D;SEC13;NSF;SEC24D;COL7A1;CNIH3;GOLGA2;ANKRD28
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.6817899359288585,1.299909446393596,0.058823529411764705,0.9738205553544598,1.0,10/32,18.53%,TBC1D20;SEC24A;CSNK1D;SEC13;NSF;SEC24D;COL7A1;CNIH3;GOLGA2;ANKRD28
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.6817899359288585,1.299909446393596,0.058823529411764705,0.9738205553544598,1.0,10/32,18.53%,TBC1D20;SEC24A;CSNK1D;SEC13;NSF;SEC24D;COL7A1;CNIH3;GOLGA2;ANKRD28
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.7231279876677369,-1.2998358168347308,0.21212121212121213,0.9681237646001797,1.0,3/8,7.20%,SLIT2;DAPK2;RIPOR2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.7653784410624116,1.2997624489044903,0.0641025641025641,0.9722218647515463,1.0,5/12,9.46%,PTPN1;ITGA5;NIBAN2;PRKCB;HIF1A
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.6789714258432623,-1.2997214439943199,0.2692307692307692,0.9605865318215232,1.0,1/5,10.96%,SETDB1
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.778465665564481,1.2980217352895553,0.11904761904761904,0.9856095656871946,1.0,5/13,12.53%,CSF1;NFKBIA;IL18;PPARA;ABCA1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.7593001337523894,1.2977236800985856,0.1125,0.9806232886379674,1.0,3/11,13.35%,AGO2;ZFP36L2;PABPC1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.7593001337523894,1.2977236800985856,0.1125,0.9806232886379674,1.0,3/11,13.35%,AGO2;ZFP36L2;PABPC1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.7689463592059528,1.2975248360365157,0.11842105263157894,0.9783967455227927,1.0,3/12,12.26%,USP15;RIOK3;ANKRD17
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.6865832375245281,-1.2971907888519492,0.1935483870967742,0.9630626132296407,1.0,3/12,15.34%,MAPK14;HMGB1;THBS1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.6954206151151513,1.297145240736788,0.16091954022988506,0.9783156055020393,1.0,2/21,4.57%,STC1;HOMER2
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.6862244151956305,1.2970363345171565,0.19230769230769232,0.9758207379050888,1.0,2/15,4.72%,PRKACA;CRY1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.6950316240068026,1.2969477151079305,0.1111111111111111,0.9729792610467366,1.0,9/28,21.72%,TAF7;TSC2;CAMK2N1;CDKN1B;PPM1E;NF1;UBASH3B;YWHAG;IRS2
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.8007550246115586,1.2963908924331393,0.10126582278481013,0.9746253402560742,1.0,1/8,1.24%,GJA1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.6323993943273917,1.2959033109951128,0.030303030303030304,0.9755720948221519,1.0,30/121,19.41%,SOD1;LPIN1;GJA1;CADM1;KDM1A;ENO1;AGO2;NIBAN2;SCD;IL18;TGFB1;EIF2AK2;SDCBP;ZBTB16;CEBPB;PPARGC1A;PRLR;KDM3A;SMURF2;ABCA1;TAPT1;TP53BP1;PPIB;ACADL;CFL1;TWIST1;ACVR1B;SMAD2;SNX4;NLGN1
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.7532084791606289,-1.2957171642173038,0.13793103448275862,0.9627609405474109,1.0,1/7,1.43%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.8083521399106475,1.2952120128511668,0.10666666666666667,0.9788200773785392,1.0,2/9,9.46%,SOD2;HIF1A
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7000377213468584,1.2949499153415442,0.2077922077922078,0.9780564124176144,1.0,4/14,16.39%,CHST11;DSE;CHSY1;CHST15
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.89846732211941,1.2946260001056087,0.06153846153846154,0.9777278171499001,1.0,1/5,2.39%,KDM1A
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.8214399046584127,1.29409492293788,0.08333333333333333,0.9791856281494139,1.0,6/10,14.95%,ACADVL;NR4A3;PPARA;PPARGC1A;PDK4;ACADL
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.7633794267557616,1.293356201680251,0.075,0.9829800228000651,1.0,5/15,13.33%,FMN2;PPARA;EGFR;CST3;MDM4
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.7646478738184015,1.2930115831546862,0.09411764705882353,0.9825314068343829,1.0,1/14,2.21%,CYTH1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.7411933767488329,1.2926742361079582,0.13043478260869565,0.9822624578530542,1.0,5/15,8.65%,SYT1;RIMS2;LIN7A;SNAP25;SYN3
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7450578712968955,1.2926096546903034,0.136986301369863,0.9796377648572817,1.0,2/11,1.38%,GJA1;PRKACA
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.7773833768325139,1.292510699305928,0.1282051282051282,0.9771013067919111,1.0,2/9,12.11%,ADGRV1;TTC8
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.6783973991061107,1.290802627163715,0.10975609756097561,0.9906575772347076,1.0,10/27,17.85%,SOD1;SNX6;PRKCI;SOD2;NAIP;HIF1A;PPARGC1A;PTPRZ1;CPEB4;UNC5B
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.8392799761577776,1.2899054291695269,0.08955223880597014,0.9954839957076981,1.0,1/5,3.37%,DDX3X
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7725582647722874,1.2896529251424562,0.12048192771084337,0.9909949159621506,1.0,2/11,4.75%,KLF2;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.7725582647722874,1.2896529251424562,0.12048192771084337,0.9909949159621506,1.0,2/11,4.75%,KLF2;NOS1AP
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.6419078235252955,1.2887896885027879,0.046511627906976744,0.9966329198712965,1.0,15/52,16.14%,WASF3;DARS1;WASF1;WIPF1;LIN7A;SLC2A1;NUP133;PPARGC1A;ST13;RANBP9;MDM2;MDM4;NAPG;SPG7;TEAD1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.627819668730112,-1.288641838374579,0.21428571428571427,0.9859223111033822,1.0,3/22,5.69%,NRP1;PKN1;ADGRA2
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.9030352220535116,1.2886146367259208,0.07462686567164178,0.9947088681836388,1.0,1/5,6.93%,ERRFI1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.7062629923140212,1.2875047369278458,0.056179775280898875,1.0,1.0,7/25,7.81%,PLAA;PDE4B;IL18;CTR9;SELENOS;TNFRSF1B;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.6344908828081832,1.2874326929689648,0.09090909090909091,0.9989872260612979,1.0,14/50,14.98%,EPM2A;TSC2;CAMKK2;BNIP3L;TBK1;RNF152;EIF2AK4;WAC;SESN1;TRIM5;KDR;LRRK2;ATF6;C9ORF72
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.6754463576573122,1.2873442497023087,0.11363636363636363,0.9963603684830403,1.0,6/30,13.35%,TBC1D20;VAPB;DDX3X;PPARA;RAB7A;PABPC1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.8382039312680132,1.2869260308804613,0.05263157894736842,0.9976153846153847,1.0,3/6,15.06%,ENO1;RHBDD1;LPCAT3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.6623272317746325,1.2867444477357624,0.06666666666666667,0.9957538152054901,1.0,10/36,17.55%,SEC24A;AP2A1;SEC13;CTSL;RAB7A;CAPZB;SEC24D;CANX;AP2B1;ARF1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.6712285683644273,1.2863584038671563,0.053763440860215055,0.9957229385839873,1.0,7/40,3.16%,PHYHIPL;ELAVL3;NXPH1;CRMP1;DNER;DCLK1;GFAP
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.6351782528588317,1.2863189526938843,0.0989010989010989,0.9929401585183218,1.0,16/48,24.57%,SYT1;ADGRV1;ANK3;EGFR;LRRK2;MAPK1;CDKN1B;PRNP;CAMK2D;NLGN1;BNIP3;RYR3;TF;JUN;MT3;HVCN1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.7693881994993671,1.2861102192288747,0.08536585365853659,0.9918482802808009,1.0,3/12,7.81%,RHBDD1;ADAM17;TGFB1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.6474541764594187,-1.2852798932188927,0.15625,0.9931495417789757,1.0,5/7,10.86%,SLIT2;ANO6;NBL1;HMGB1;CXCL12
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.8123582033460768,1.2852392584265537,0.14102564102564102,0.9962983675972096,1.0,3/7,12.08%,NFKBIA;SUFU;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.8154670428676034,1.2850592299399664,0.15,0.9945047532068579,1.0,1/8,0.79%,AKAP8
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.6575121053199302,1.2849390562653042,0.10989010989010989,0.9923584487114355,1.0,9/31,19.62%,RARRES1;ACADVL;EMP1;TP63;GYPC;CD9;LGALS3;SLC25A37;BNIP3
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.8450007256977103,1.2848025227835114,0.1111111111111111,0.9906222905534833,1.0,2/5,14.37%,KDR;LRRK2
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.645380300860711,1.2846178702946902,0.12087912087912088,0.9892593861410107,1.0,7/37,6.75%,STC1;TPT1;VAPB;NEDD4L;TMEM165;TMCO1;ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.7580094058960861,1.2844940772123314,0.14473684210526316,0.9871179684476519,1.0,1/14,0.27%,WWC1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.8272392821140707,1.2834912753590084,0.1791044776119403,0.9893951423194541,1.0,1/6,7.83%,DSE
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.8272392821140707,1.2834912753590084,0.1791044776119403,0.9893951423194541,1.0,1/6,7.83%,DSE
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),0.7264317000230779,1.2833309900109595,0.08433734939759036,0.9873063056766196,1.0,3/14,2.39%,CD44;TPT1;KDM1A
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.8904694924844305,1.2832692419582672,0.08450704225352113,0.9848745218434928,1.0,1/5,5.34%,CDH2
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.8124870546687222,1.2825623405531612,0.10666666666666667,0.9884306661737855,1.0,1/9,2.05%,NRG1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.7704530127078402,1.2819948567117394,0.10666666666666667,0.9901943176438008,1.0,4/9,14.89%,ZNFX1;SMCHD1;MBD2;EZH1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.7897444099552084,1.2813070473351853,0.17333333333333334,0.9936150039293037,1.0,3/6,19.38%,ANK3;PDE4D;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.7937290663424013,1.2811455931464455,0.21428571428571427,0.9891706616698707,1.0,1/7,7.52%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.7937290663424013,1.2811455931464455,0.21428571428571427,0.9891706616698707,1.0,1/7,7.52%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.6740791266067354,1.279968051068413,0.11494252873563218,0.998346308221595,1.0,12/37,23.03%,NFKBIA;KDM1A;HABP4;SYMPK;TMBIM6;PSME3IP1;LRRK2;ZFPM1;GOLGA2;MITD1;JUN;LEF1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.8413570313507648,1.2796404421804588,0.10666666666666667,0.9982458223133864,1.0,1/7,1.33%,HDAC2
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.7913037420336841,1.2792144384565867,0.10256410256410256,0.9989355080499875,1.0,3/9,13.30%,HS3ST5;NECTIN2;TRIM5
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.7424255287767235,1.278913902191907,0.1267605633802817,0.9985189789617887,1.0,4/15,14.37%,WWC1;PTPN1;REEP5;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.6435001942596622,1.2783608855664204,0.06521739130434782,0.9998626902602438,1.0,19/52,19.54%,CSF1;KLF2;NFKBIA;NEDD4L;IL18;TGFB1;ROCK2;SMURF2;RAB7A;NSF;RANBP9;TIPARP;WWP1;HECW1;CDKN1B;CSNK2A1;ABCB10;AREL1;SLC25A37
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.6561037525730644,1.2780264916653976,0.125,0.9998839368112481,1.0,4/25,12.27%,SOD1;ATP6V1G1;CP;NDFIP1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.6042131657797747,-1.277856759350718,0.14285714285714285,1.0,1.0,4/14,13.81%,MTERF1;ANXA1;HMGB1;MRE11
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5981437768347575,1.2775149231663254,0.08602150537634409,1.0,1.0,16/79,13.20%,SRGN;ADAMTS9;ADGRV1;SUFU;PITRM1;CPD;ADAM17;ENPEP;DESI2;MMP16;CPM;UFSP2;F3;CTSL;MDM2;SENP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.7928934370126668,1.2772267796748944,0.13513513513513514,1.0,1.0,3/9,4.75%,KCNE4;KCNQ1;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.8188966544544175,1.2771168001097932,0.078125,0.9989547653062981,1.0,2/9,2.39%,CD44;KDM1A
prerank,MSigDB_Hallmark_2020__E2F Targets,0.6408768020245634,1.2768893921275692,0.10869565217391304,0.9984530441255016,1.0,18/55,23.80%,RAD21;CCP110;DUT;NUP153;STMN1;CSE1L;DNMT1;NAA38;EED;MELK;CDKN1B;RPA1;DONSON;NAP1L1;NUP205;CTCF;TRA2B;RBBP7
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.7499849716484082,1.2764454402593304,0.13513513513513514,0.9988788520348154,1.0,4/10,17.05%,PRKACA;ROCK2;RUNX1;CBFB
prerank,MSigDB_Hallmark_2020__Hypoxia,0.6292487710713691,1.2755969334207855,0.03125,1.0,1.0,35/90,22.99%,STC1;SLC2A3;PDK1;NEDD4L;DDIT4;ENO1;GBE1;ERRFI1;SLC2A1;BNIP3L;EGFR;CP;DUSP1;GLRX;F3;CCN2;PPARGC1A;KDM3A;HDLBP;HSPA5;PDK3;PGK1;TIPARP;SCARB1;ADORA2B;CDKN1B;RBPJ;KLF6;ANGPTL4;TPI1;IRS2;MXI1;GPC4;HK1;JUN
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.7719450495474278,1.2754872312983534,0.1375,1.0,1.0,3/9,11.53%,NAA11;AGTPBP1;VKORC1L1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.7279099467783837,1.2754506201695388,0.11538461538461539,0.998522382650823,1.0,4/18,14.85%,AKAP8;KDM1A;PPARGC1A;GLYR1
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.4604161913627375,-1.2753967451341672,0.09090909090909091,1.0,1.0,8/41,8.12%,TPM2;PRRX1;JPH2;SYNPO2;LMOD1;NOTCH3;PRKG1;EDNRA
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.5862964930896936,1.2745105678540236,0.06060606060606061,1.0,1.0,32/126,19.68%,TBC1D20;SEC24A;WASF3;DARS1;WASF1;WIPF1;CSNK1D;CSNK1A1;SEC13;LIN7A;SLC2A1;CDC123;PPARGC1A;PDE4DIP;ST13;NSF;RANBP9;MDM2;SEC24D;MDM4;NAPG;LRRK2;RBX1;COL7A1;SPG7;TEAD1;CNIH3;GOLGA2;ANKRD28;SMARCA4;WDR19;SKP1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.6480267362219598,1.2744323125363224,0.10989010989010989,1.0,1.0,15/38,26.10%,SEC24A;AP2A1;SEC13;CTSL;RAB7A;CAPZB;SEC24D;CANX;AP2B1;ARF1;MARCHF1;SEC23A;DNM2;CLTC;AP2M1
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8153751191525501,1.2742925823601703,0.1388888888888889,0.9999882380616326,1.0,4/6,15.06%,VAPB;ATL1;ATL2;LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.7207837161633901,1.2738021186144615,0.13253012048192772,1.0,1.0,2/14,5.49%,ACTR3;AKIRIN1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.7980874971635658,1.2734143829098121,0.16666666666666666,1.0,1.0,2/7,11.45%,SOD1;GSR
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.6253123042373051,-1.2733647317135919,0.30434782608695654,1.0,1.0,2/12,2.37%,CSRP2;LMOD1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.8246331696476442,1.2731445926443876,0.07792207792207792,1.0,1.0,2/8,12.40%,SDCBP;RAB7A
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.7006631061388934,1.2723459593048672,0.12195121951219512,1.0,1.0,2/21,7.31%,NELL1;TP63
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.6050623321078424,-1.2720907695183339,0.18181818181818182,1.0,1.0,1/10,0.83%,FGF1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.8597241268934219,1.271572257211194,0.1095890410958904,1.0,1.0,2/5,7.62%,CRY1;PPARA
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6747847681418891,1.2712816330016963,0.08602150537634409,1.0,1.0,13/38,12.18%,ELAVL3;KCNC2;NXPH1;KCND2;GFAP;KCNQ3;CACNA1B;ADGRB3;CTNNA2;SNAP25;GRIN2B;CADM2;CDH20
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8221127748916395,1.2709334069845166,0.1232876712328767,1.0,1.0,3/7,7.67%,KLF2;DHRS3;CTBP2
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.8212096747341895,1.270729454219493,0.078125,1.0,1.0,1/6,1.97%,DHRS3
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.7785608570061942,1.2706869911778316,0.10526315789473684,1.0,1.0,4/10,14.66%,PDK1;CD38;CD9;PPIB
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.7796302989467321,1.270335272337413,0.13095238095238096,1.0,1.0,3/11,7.91%,TMEM232;GFAP;MYO16
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.8303819170921138,1.2702431434221948,0.09090909090909091,1.0,1.0,2/5,12.72%,TGFB1;FGFR2
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.676634510947834,1.270173553685342,0.1518987341772152,0.9995206807323226,1.0,6/20,21.53%,TGFB1;SDCBP;SNX25;ACVR2A;SMAD6;SMAD7
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.5745376466326713,-1.2699995528426988,0.2777777777777778,1.0,1.0,3/20,5.69%,NRP1;NR4A1;ADGRA2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.7675812663496686,1.269576255687717,0.13157894736842105,1.0,1.0,5/11,16.47%,CD44;KDM1A;RNF34;MDM2;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.7164121453119504,1.2691463249025081,0.075,1.0,1.0,4/18,9.30%,GJA1;IL18;NR4A3;DNMT1
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.8212572398207715,1.268472295104292,0.09090909090909091,1.0,1.0,1/6,0.91%,KLF15
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.762264037776438,1.2682046958362143,0.13043478260869565,1.0,1.0,4/10,13.23%,GJA1;SLC22A6;SLC13A3;SLC1A2
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.7707813467443201,1.268077958996901,0.15476190476190477,1.0,1.0,3/11,12.93%,LPIN1;GK5;PLAAT3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.8080721503993342,-1.267881406813812,0.3,1.0,1.0,2/5,10.75%,MAPK14;HMGB1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.7189018117223307,1.2675605149667692,0.1,1.0,1.0,5/16,13.55%,MUCL1;C1GALT1;GALNT15;GALNT11;GALNT7
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.6317333552320306,-1.2663251240548425,0.18518518518518517,1.0,1.0,3/9,9.50%,CDK6;RBL1;AKT3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.7265680789688933,1.2658707764515211,0.10975609756097561,1.0,1.0,7/15,20.71%,PTPRQ;PTPN1;DUSP1;PTPRZ1;PTPN9;PTPN2;UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.8113539571032259,1.2658201476787523,0.17105263157894737,1.0,1.0,3/6,13.86%,AGO2;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.8113539571032259,1.2658201476787523,0.17105263157894737,1.0,1.0,3/6,13.86%,AGO2;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.6258894339021802,1.2654753334581477,0.10752688172043011,1.0,1.0,10/44,13.86%,IPO9;TSC2;NUP153;SEC13;IPO5;NUP88;CSE1L;NUP133;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.7226615244115859,1.2653450793675527,0.17333333333333334,1.0,1.0,3/12,13.44%,AGO2;TUT7;MOV10L1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.6697405857303387,1.2652436849855022,0.09090909090909091,1.0,1.0,8/38,10.70%,HNRNPL;PCBP3;IGF2BP2;HNRNPF;RC3H2;TNFRSF1B;PTBP2;GRSF1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.6633413309277264,1.2651867366842078,0.16279069767441862,1.0,1.0,8/35,12.72%,NRCAM;SPTBN4;ANK3;ATL1;CTNNA2;APBB1;GRM7;FGFR2
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.6439430586411444,1.2650126304552147,0.10638297872340426,1.0,1.0,19/46,21.94%,PHYHIPL;ELAVL3;LSAMP;DPP6;CACNA1B;PCDH17;ROBO2;ADGRB3;SNAP25;CTNND2;CADM2;NOVA1;EZH1;NRXN1;UNC79;GRIA2;GABRB3;MAPK4;FGF12
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.7099537192073484,1.2647002876163687,0.12048192771084337,1.0,1.0,5/18,13.12%,KLF2;NEDD4L;SSH1;ROCK2;MDM2
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.8114411056171175,1.2645014680998907,0.0945945945945946,1.0,1.0,2/6,9.00%,BTD;MCCC2
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.6259390593623709,1.264442919926435,0.07216494845360824,1.0,1.0,10/45,12.22%,NRCAM;DNER;CDH18;CDH2;KIRREL3;CDH12;CTNND2;FARP1;CDH20;CDH10
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.7401218487423388,-1.2639651229399855,0.2,1.0,1.0,5/6,24.08%,PGS1;ABCA3;SLC27A1;LPGAT1;PNPLA8
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.7119125453641418,1.2637708313424358,0.14285714285714285,1.0,1.0,5/15,16.55%,RIMS2;MCTP2;SNCAIP;LRRK2;PREPL
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.7981394070299829,1.262862200268938,0.1232876712328767,1.0,1.0,2/8,9.80%,KLF15;DIP2B
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.7090065182899704,1.2625373527625217,0.15476190476190477,1.0,1.0,5/16,17.05%,PRKACA;RAP1B;ROCK2;RUNX1;CBFB
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.6649080215113365,1.2624200226629898,0.16666666666666666,1.0,1.0,10/31,12.80%,KCNC2;KCNE4;KCND2;KCNQ1;KCNH7;KCNQ3;ATP1B3;KCNQ5;ABCC9;NALCN
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.6377605961484455,1.2622960153008551,0.09523809523809523,1.0,1.0,11/35,22.87%,PRKACA;CCP110;TUBA1A;CSNK1D;CEP70;CEP57;ATAD5;PAFAH1B1;CNTRL;YWHAG;CEP290
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.6376802279626611,1.2621855787113214,0.16666666666666666,1.0,1.0,13/39,21.00%,KCNC2;ATL1;APIP;ATL2;SOD2;ELAVL1;SLC1A2;TP53BP1;ZBTB1;STEAP4;GOLGA2;RYR3;ALDH1A2
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.7275395188876852,1.2620604907612405,0.20238095238095238,1.0,1.0,4/17,13.35%,VAPB;DDX3X;PPARA;PABPC1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.8477867257308918,1.2619617809364938,0.2,0.9974413632778447,1.0,2/5,14.47%,PELI1;SLC25A4
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.8477867257308918,1.2619617809364938,0.2,0.9974413632778447,1.0,2/5,14.47%,PELI1;SLC25A4
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.6998779667711471,1.261621214371892,0.1643835616438356,0.9980086003293344,1.0,6/19,21.46%,ANKH;ZBTB16;CHSY1;TWIST1;RBPJ;SMAD6
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.8105170492226859,1.261559937972161,0.14285714285714285,0.9958681999729726,1.0,4/5,17.48%,UBA5;AGTPBP1;NRXN1;PAFAH1B1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.7762800453787821,1.2614199186809592,0.10256410256410256,0.99427864375179,1.0,1/9,1.04%,PLAA
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.5985495457239122,-1.2613995511484313,0.13043478260869565,1.0,1.0,2/11,3.32%,NRP1;NR4A1
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.7293447859200866,-1.260723648660282,0.2857142857142857,1.0,1.0,1/6,0.79%,NRP1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.8064200976165953,1.2606216038583706,0.125,0.9979705055393129,1.0,2/9,7.51%,SOD1;SOD2
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.7572925401740742,1.2602047092124888,0.10810810810810811,0.9995499801691857,1.0,3/11,11.15%,SLC22A6;SLCO1A2;SLC13A3
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.6241605665491841,1.259822947110981,0.14606741573033707,1.0,1.0,8/39,11.29%,HABP4;DDX3X;AGO2;EIF2AK4;CDC123;CEBPB;CSDE1;UHMK1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.632159062592615,-1.259772412833208,0.14285714285714285,1.0,1.0,2/9,4.65%,ZDHHC21;PER2
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.7868564758430034,1.2595202818400568,0.17721518987341772,1.0,1.0,1/6,1.65%,KCNC2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.5896138215773529,1.2592914483648232,0.03,0.9995534219850949,1.0,45/185,18.72%,SOD1;CD44;TPT1;HDAC2;NFKBIA;MYDGF;FMN2;CD38;DDX3X;ITGA5;RHBDD1;NIBAN2;RAF1;SNX6;SEMA4D;PRKCI;APIP;SOD2;BNIP3L;EGFR;NAIP;RPS27A;WDR73;TMBIM6;PPARGC1A;PRLR;PTRH2;TBX3;NAA38;HSPA5;KDR;PTPRZ1;PDK4;FZD3;CFL1;CPEB4;MAPK1;ARF4;NAA15;DNAJA1;UNC5B;IFIT3;CSNK2A1;AREL1;GLO1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.7376453667784035,1.2588382609188218,0.12162162162162163,1.0,1.0,5/13,15.22%,PDE7B;RIMS2;PDE7A;AKAP6;PDE4D
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.8403235073950143,1.2587936127999602,0.15492957746478872,0.998107963567396,1.0,2/5,9.79%,ADGRV1;ULK4
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.6291349916594382,-1.2585605396928188,0.1724137931034483,1.0,1.0,4/10,8.97%,FOXQ1;GPRC5C;AKR1C3;SPP1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.7947444553707317,1.258438809110193,0.14285714285714285,0.9989228752898478,1.0,2/7,16.52%,WIPI1;WDR45B
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.8379121521285049,1.2583254381461255,0.08064516129032258,0.9972834310244586,1.0,1/6,3.37%,DDX3X
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.8129520438262962,1.2581143321502337,0.1232876712328767,0.9965984474241354,1.0,3/8,10.94%,GRIN1;FARSB;GRIN2B
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.7316004952075901,-1.257579201693195,0.2222222222222222,1.0,1.0,4/5,26.77%,ANXA1;THBS1;COL3A1;F13A1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.7673878752900949,1.257542352085854,0.11864406779661017,0.9988524834665949,1.0,1/5,7.17%,SLC2A1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.8289478858007184,1.2570760826533316,0.16901408450704225,0.9999185251436378,1.0,2/6,4.97%,KCNQ1;PDE4B
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.6002772753490618,1.256673430530183,0.08247422680412371,1.0,1.0,24/92,21.96%,RNMT;TAF7;TAF1B;TEFM;GLIS3;TBPL1;CTR9;PKNOX1;PWP1;DDX21;CCNH;DEAF1;FUBP3;CEBPD;POLR1C;CBFB;MLLT1;NFIX;AFF4;RTF1;SUPT16H;CCNK;KLF13;ELL
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.6305047310276903,1.2566247892264995,0.042105263157894736,0.9987571632009559,1.0,19/76,16.57%,SYT1;ELAVL3;FAT3;NRG1;CRMP1;DCLK1;KCNH7;CACNA1B;HOMER2;EPHA7;LZTFL1;ADGRB3;SNAP25;ZNF536;CADM2;CNTNAP2;NOVA1;PREPL;PURG
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.6907320061514998,1.2564062884532985,0.1728395061728395,0.9984144066942231,1.0,8/18,13.17%,EPM2A;TSC2;DDIT4;RNF152;UBR1;TNFAIP8L1;SZT2;SESN1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.7225195026047949,1.2562316574076986,0.14457831325301204,0.9974264878852035,1.0,3/16,12.19%,TAF1B;PWP1;FUBP3
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.7708134995896806,1.254905111104835,0.1388888888888889,1.0,1.0,3/11,14.45%,NOS1AP;TNFRSF1B;PDK4
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.8525120456565793,1.2545961245989454,0.09859154929577464,1.0,1.0,1/8,0.16%,STC1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.8299034959006414,1.254536267270507,0.13432835820895522,1.0,1.0,3/5,14.66%,TBC1D20;VAPA;PPIB
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.7437320247359529,1.2534211689154842,0.20833333333333334,1.0,1.0,6/10,22.38%,ERRFI1;CTSL;ROCK2;RUNX1;CBFB;SGPP1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6007884132862423,-1.2532541126192125,0.25,1.0,1.0,3/11,5.68%,JPH2;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.8486839030385847,1.252479101196545,0.057971014492753624,1.0,1.0,4/5,13.86%,NR4A3;EIF2AK4;SGIP1;STAT3
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.7505396800905657,1.2524278804844742,0.21518987341772153,1.0,1.0,3/10,8.12%,WASF3;WASF1;CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.8600899772802587,1.2522977572757268,0.14084507042253522,1.0,1.0,3/5,11.66%,TGFB1;SRA1;TBX3
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.7700101494663778,1.2519787702603227,0.20833333333333334,1.0,1.0,3/9,11.66%,NRG1;PRLR;TBX3
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.8248716252551815,1.2518263769363185,0.21212121212121213,1.0,1.0,1/5,14.90%,BRD1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.6516745693536251,1.2515184948342621,0.11363636363636363,1.0,1.0,4/28,12.27%,SOD1;ATP6V1G1;CP;NDFIP1
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.7289691533784285,-1.2500323365387622,0.3333333333333333,1.0,1.0,1/5,2.45%,OAZ2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.6463556776929509,1.249698541426442,0.12087912087912088,1.0,1.0,10/39,17.55%,SEC24A;AP2A1;SEC13;CTSL;RAB7A;CAPZB;SEC24D;CANX;AP2B1;ARF1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.7208810007013747,1.2495405718430386,0.12345679012345678,1.0,1.0,7/14,17.81%,ETV5;SCD;CSF1R;SOAT1;DDX3Y;CEBPD;STEAP4
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.7995457865147282,1.2486703937815908,0.11842105263157894,1.0,1.0,3/7,14.05%,ENO1;RPS27A;PGK1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.6835262391759502,1.2480723572234498,0.19753086419753085,1.0,1.0,7/22,19.65%,HDAC2;KDM1A;FUBP1;GMPS;ATAD5;NAP1L1;SUPT16H
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),0.7225364578006171,1.2480626229217096,0.13414634146341464,1.0,1.0,5/22,14.73%,DARS1;RARS1;FARSB;PPA1;YARS1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7353729233382773,-1.2478203978192322,0.22580645161290322,1.0,1.0,2/6,13.44%,ANXA1;CALCRL
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.6611039894464366,1.247630215085656,0.2,1.0,1.0,6/30,9.74%,RHOB;MCC;SCD;CP;KIF13B;GLUL
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.7361529615137916,1.2472133339077651,0.11392405063291139,1.0,1.0,4/16,9.22%,RHEB;SLC38A9;SEC13;GPR137C
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.43620502553881313,-1.2470470551170942,0.1111111111111111,1.0,1.0,14/68,10.06%,TPM2;LMCD1;PRRX1;JPH2;LMOD1;PDZRN3;COL5A2;LAMB2;PTPN21;FKBP9;PRKG1;EDNRA;COL1A2;TNS2
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.7543987246884781,1.2468337879681284,0.20833333333333334,1.0,1.0,2/8,10.88%,SRGN;CHSY1
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.8191971054947218,1.2465413190721697,0.24,1.0,1.0,3/5,17.58%,LGALS3;PRNP;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.8191971054947218,1.2465413190721697,0.24,1.0,1.0,3/5,17.58%,LGALS3;PRNP;PTPN2
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.8621293877509817,1.246477861306077,0.15151515151515152,1.0,1.0,4/5,13.41%,KCNE4;ANK3;NOS1AP;AKAP6
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.7672004643642563,1.2463159232445338,0.1,1.0,1.0,1/12,0.16%,STC1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.6728717320085086,1.2453502029183585,0.1927710843373494,1.0,1.0,6/16,22.47%,PELI1;ADAM17;MAPKAPK2;ERBIN;SMAD6;TAB2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.6336655658410855,1.245083837079152,0.13636363636363635,1.0,1.0,9/40,13.76%,NRCAM;SPTBN4;ANK3;ATL1;CTNNA2;APBB1;FARP1;FGFR2;DCDC2
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.7920479786588441,1.2450251858613317,0.15789473684210525,1.0,1.0,3/10,14.81%,SNX6;ERRFI1;SH3BP5
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.8400702258565075,1.2447589703756692,0.10294117647058823,1.0,1.0,1/6,0.61%,ADAMTS9
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.8644565390522765,1.2446766694232927,0.1038961038961039,1.0,1.0,2/6,6.71%,TET3;CTR9
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.6938725453373752,1.2444689865755345,0.13580246913580246,1.0,1.0,7/20,23.52%,SYT1;DNAJC6;CANX;NLGN1;GAK;PIP5K1C;DNM2
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.737372850746955,1.2441794537155357,0.11428571428571428,1.0,1.0,3/9,13.46%,TSC2;TGFB1;KDR
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.6949551422072981,1.2441240430413971,0.12941176470588237,1.0,1.0,5/16,16.04%,NFKBIA;KDM1A;HABP4;SIN3A;TNKS
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.772357707310679,1.2438465740213678,0.19230769230769232,1.0,1.0,4/8,17.48%,SPTBN4;SZT2;C12ORF57;PAFAH1B1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.7244781212344688,1.2434887635164373,0.14457831325301204,1.0,1.0,3/13,13.35%,AGO2;EIF4ENIF1;PABPC1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.5711662291586879,1.2427832178981106,0.02,1.0,1.0,67/285,19.07%,WWC1;TAF7;KLF2;ETV5;HDAC2;PRDM6;KDM1A;TENM2;NEDD4L;GLIS3;ENO1;ZNF608;SUFU;WWC2;HCFC2;CRY1;SAP130;SEMA4D;CTR9;NR4A3;PPARA;CTBP2;ESR2;APBB1;RPS27A;CXXC5;SDCBP;MTF2;ZBTB16;CEBPB;SIN3A;ZNF536;ZFPM2;BCL6;TBX3;CREM;DEAF1;SMURF2;RUNX1;FGFR2;MXD4;MDM2;MDM4;TCERG1;PHF21A;EED;STAT3;RARB;MYT1L;MBD2;EZH1;HIVEP1;LCOR;MZF1;ZBTB7A;TWIST1;ZBTB1;CBFB;ZFPM1;ZMYM5;NFIX;PER1;RBPJ;SMAD2;RTF1;FOXP2;SMARCA4
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.7833016028604398,1.2425913918657492,0.13513513513513514,1.0,1.0,3/8,13.38%,EAPP;RNF168;TCERG1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.795836572229144,1.2422157824044913,0.16455696202531644,1.0,1.0,1/7,0.98%,NRCAM
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.7906813043860014,1.2420581960354138,0.13414634146341464,1.0,1.0,1/7,5.41%,ZFP36L2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.5864997232138055,1.2419479861775065,0.08163265306122448,1.0,1.0,33/93,20.90%,SYT1;PRKACA;GLRB;GRIN1;PDE7B;KCND2;KCNQ3;CACNA1B;CAMKK2;GABRE;LIN7A;SNAP25;GRIK2;SYN3;MBP;SDCBP;GRIN2B;GRM7;SLC1A2;NOVA1;NRXN1;GABRB1;MAPK1;PAFAH1B1;DLGAP1;GRIA3;NLGN1;RPS6KA2;PRKAR2A;GRIA2;ERC2;NAPB;PLP1
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.796916523999676,1.2419417927722132,0.15,1.0,1.0,3/7,14.95%,PANK2;ACADVL;ACADL
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.38700636971238417,-1.2413846437119924,0.0,1.0,1.0,18/81,10.81%,FAT1;SLIT2;GPC6;FAM13C;DKK3;LMOD1;PDZRN3;DZIP1;PTPN21;EML1;EDNRA;SEMA6D;NFASC;CSRNP3;ADCY6;ZNF423;EDIL3;MAGI1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.7528307432549144,1.2410425869862902,0.13414634146341464,1.0,1.0,2/10,6.71%,TET3;CTR9
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.8260859554904072,1.2408989299611277,0.16883116883116883,1.0,1.0,2/6,12.40%,SDCBP;RAB7A
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.8391881119641974,1.2407582179284895,0.14925373134328357,1.0,1.0,3/6,14.82%,PCBP3;IGF2BP2;NOVA1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.7266776488254875,1.240638845176316,0.23943661971830985,1.0,1.0,6/12,18.59%,KLF2;HIF1A;CEBPB;HSPA5;ATF6;RBPJ
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.6275675881622573,1.240586050914893,0.19101123595505617,1.0,1.0,5/33,11.89%,RHOB;ANK3;STMN1;ROCK2;SPIRE1
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.7923765975560091,1.2405620120677712,0.21052631578947367,1.0,1.0,3/5,17.16%,ADAM17;OXSR1;STK39
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.7923765975560091,1.2405620120677712,0.21052631578947367,1.0,1.0,3/5,17.16%,ADAM17;OXSR1;STK39
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.7600359765227807,1.2402771024330272,0.20512820512820512,1.0,1.0,3/10,13.30%,HS3ST5;NECTIN2;TRIM5
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.6839271876530794,1.2399267119285644,0.1794871794871795,1.0,1.0,9/20,20.81%,RHEB;ADAM17;ACOT11;PLCL1;MAP2K6;NOVA1;LGR4;RBPJ;LNPEP
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.6665143739952126,1.239822493145367,0.17647058823529413,1.0,1.0,4/22,12.91%,IFT52;IFT140;TRAF3IP1;IFT57
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.7946321401586922,1.239579023356305,0.14084507042253522,1.0,1.0,3/7,6.75%,KCNE4;KCNQ1;ATP1B3
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.5502369102480372,-1.2391458624406209,0.15,1.0,1.0,1/13,1.97%,PARP9
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.8365721668166004,1.23908040930344,0.16883116883116883,1.0,1.0,1/5,12.72%,FGFR2
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.6098952242276161,1.2390525486620882,0.10989010989010989,1.0,1.0,28/72,19.97%,SYT1;PRKACA;GLRB;GRIN1;PDE7B;KCND2;KCNQ3;CACNA1B;CAMKK2;GABRE;SNAP25;GRIK2;MBP;SDCBP;GRIN2B;GRM7;SLC1A2;NOVA1;NRXN1;GABRB1;MAPK1;PAFAH1B1;DLGAP1;GRIA3;NLGN1;RPS6KA2;PRKAR2A;GRIA2
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.7892262361247654,1.2390060998366794,0.14666666666666667,1.0,1.0,1/7,1.04%,PLAA
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.7095940451291513,1.2385516470344875,0.21686746987951808,1.0,1.0,6/15,18.74%,OLFM2;ARFGAP3;ABCA1;RAB12;CANX;RAB8B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.7715465732479936,1.2383849867457506,0.20481927710843373,1.0,1.0,3/9,14.08%,DDX3X;RNF34;TNFRSF10B
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.7121135027767962,-1.2383708284429413,0.25925925925925924,1.0,1.0,2/5,11.95%,KIFC3;ITGB5
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.7345432076040241,-1.238033522063514,0.2,1.0,1.0,2/5,2.71%,CDK6;EIF2B3
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.5846413567449842,1.2380027855040698,0.09090909090909091,1.0,1.0,22/103,14.36%,BTD;NRCAM;GRIN1;DNER;DCLK1;DDIT4;EPHA7;SLC6A17;CDH2;SMARCA1;ROBO2;SLC2A1;MBP;SZT2;ZBTB16;GRIN2B;RAB18;TBX3;SH3GL3;PTPRZ1;STAT3;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.615437744477136,1.2379776907466604,0.14130434782608695,1.0,1.0,8/37,17.85%,MYDGF;IL18;SEMA4D;EPOR;FLT1;KDR;INSR;UNC5B
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.7764464189331136,1.2375785160569328,0.2236842105263158,1.0,1.0,1/8,1.19%,RIPOR1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7393861002887618,1.2374588679476404,0.2,1.0,1.0,4/11,18.59%,ZFPM2;FGFR2;AKAP6;RBPJ
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.7143442055085075,1.2373943561288454,0.16,1.0,1.0,3/18,6.95%,OGN;IL18;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.750981405689337,1.2372897731517478,0.1506849315068493,1.0,1.0,3/10,14.37%,SOD2;PDE8A;LRRK2
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.6276057850033249,1.2370977922879667,0.14736842105263157,1.0,1.0,14/35,22.47%,PLAA;PDE4B;PELI1;ADAM17;CTR9;SELENOS;TNFRSF1B;MAPKAPK2;ERBIN;SCARB1;PDCD4;SMAD6;AXL;TAB2
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.7560226473224816,1.236718424673433,0.2465753424657534,1.0,1.0,1/9,2.09%,RAD21
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.7050535466106842,1.2366610829129414,0.1794871794871795,1.0,1.0,4/17,16.14%,WWC1;STK4;LATS2;TEAD1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.6754330541616309,1.2366470293114067,0.18518518518518517,1.0,1.0,9/22,20.81%,RHEB;ADAM17;ACOT11;PLCL1;MAP2K6;NOVA1;LGR4;RBPJ;LNPEP
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.6941918393053178,1.2365477297031975,0.22077922077922077,1.0,1.0,3/14,15.59%,TGFB1;SDCBP;ACVR2A
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.8239926702797276,1.236353076311679,0.17391304347826086,0.999943927072907,1.0,1/6,10.46%,SYTL4
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.7581102040538006,1.2363430757796237,0.15789473684210525,0.9978585652480747,1.0,2/11,2.17%,PARVB;RHOJ
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.5838196995017336,1.2361441593500033,0.061855670103092786,0.9971499318011686,1.0,25/74,24.88%,NRCAM;SPTBN4;DCLK1;ANK3;ATL1;MYO16;CTNNA2;APBB1;CTNND2;EIF2AK4;FARP1;FGFR2;DCDC2;CNTNAP2;LRRK2;NLGN1;GPM6A;CCK;BTBD3;TMEM106B;DNM2;TAOK3;ALCAM;CNTN4;MAP1B
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.7262345669198685,1.2359754958615734,0.12987012987012986,0.9961362032462949,1.0,3/14,14.85%,TAF7;PPARGC1A;GLYR1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.7706637570200756,1.235691061589064,0.08,0.9959834530104211,1.0,4/10,11.29%,HABP4;DDX3X;CDC123;UHMK1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.7772119822330215,1.2347030116171158,0.20270270270270271,1.0,1.0,2/8,2.39%,CD44;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.6873206600774182,1.2345027018441592,0.14772727272727273,1.0,1.0,9/24,20.89%,NRG1;NDFIP2;RUBCN;NDFIP1;RAB7A;PIP4P2;LGALS3;ITGAV;MTMR2
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.7556131840027625,-1.2343925789123344,0.3076923076923077,1.0,1.0,2/5,4.92%,NFU1;YAE1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.7396602221247763,1.2343221098473003,0.1744186046511628,0.9980138846282296,1.0,2/9,12.86%,TRIOBP;CAPZB
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.7396602221247763,1.2343221098473003,0.1744186046511628,0.9980138846282296,1.0,2/9,12.86%,TRIOBP;CAPZB
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.730073381391295,1.2339016555905808,0.22077922077922077,0.9990973315479315,1.0,2/10,8.08%,MID1;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.636019862321334,1.2333499413744864,0.12790697674418605,1.0,1.0,8/34,13.86%,NUP153;AGO2;SEC13;NUP88;TGFB1;ELAVL1;NUP133;STAT3
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.5677689084905496,-1.2329700262001717,0.21428571428571427,1.0,1.0,4/23,3.00%,SPRY3;SPRY1;TNIP1;WNK2
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.7136995001712637,1.2326856558741206,0.20512820512820512,1.0,1.0,5/10,22.01%,ACADVL;SREBF1;ACADL;LPCAT3;LDLRAP1
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.6195616688380071,1.2321921882230764,0.05434782608695652,1.0,1.0,23/78,17.10%,ATP6V1G1;RIPOR1;ATP6V1H;SIK2;WIPI1;RHEB;SLC38A9;SEC13;PPARA;EIF2AK2;RNF152;ATP6V1E1;SZT2;EIF2AK4;CEBPB;SREBF1;HSPA5;SESN1;LRRK2;PDK4;WDR45B;CPEB4;MAPK1
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.7898213358070307,-1.2315654192520753,0.2647058823529412,1.0,1.0,1/5,1.27%,JADE3
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.6511919032760488,1.2314781246052484,0.15476190476190477,1.0,1.0,13/33,21.88%,ELAVL3;CRMP1;CACNA1B;EPHA7;NCAM1;EGFR;TSHZ1;PURG;ERC2;PPM1E;PROS1;DAB1;MAPK4
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.7543702829937984,1.2309534875450976,0.2077922077922078,1.0,1.0,2/8,9.80%,DDX3X;DIP2B
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.4938110321691367,-1.2307822997809348,0.1111111111111111,1.0,1.0,4/24,7.41%,PPIP5K2;INPP4B;PLCH1;IPPK
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.7252369710103883,1.2306340923532464,0.265625,1.0,1.0,3/12,10.97%,DDX3X;TBK1;RIOK3
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.5954984777996895,1.2306219410587376,0.125,1.0,1.0,6/49,6.72%,STC1;TPT1;PRKACA;VAPB;TMEM165;TMCO1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.6407764630127462,1.2303306982117006,0.17391304347826086,1.0,1.0,9/31,18.19%,AGO2;ZFP36L2;GIGYF2;CNOT8;EIF4ENIF1;ROCK2;PABPC1;METTL14;PRR5L
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.7466503940459147,1.2302794502905008,0.2894736842105263,1.0,1.0,4/6,25.25%,ARID1A;SMARCA4;SUPT16H;ARID2
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.7466503940459147,1.2302794502905008,0.2894736842105263,1.0,1.0,4/6,25.25%,ARID1A;SMARCA4;SUPT16H;ARID2
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.7861969685688652,1.2294898255399949,0.20253164556962025,1.0,1.0,3/6,18.59%,EGFR;MVB12B;RBPJ
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.7070803625877777,1.2294372193990322,0.2375,1.0,1.0,6/13,22.38%,ERRFI1;CTSL;ROCK2;RUNX1;CBFB;SGPP1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.679368461764068,1.2293345109031977,0.21428571428571427,1.0,1.0,4/17,15.78%,SEC24A;SEC13;SEC24D;CANX
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.7951453660963478,1.22917679272601,0.16216216216216217,1.0,1.0,3/7,13.38%,EAPP;RNF168;TCERG1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.7677394180431717,1.2291155575256036,0.2361111111111111,1.0,1.0,3/7,20.61%,SSH1;ABCC9;RYR3
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.7784284748180632,1.2291074248456513,0.16455696202531644,1.0,1.0,3/11,6.88%,KLF2;SLC38A9;IPO5
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.6714420769954395,1.2289956508099256,0.1511627906976744,1.0,1.0,5/24,9.38%,CSF1;NFKBIA;SSH1;TGFB1;RBM4B
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6218494333210217,1.22898662379916,0.17857142857142858,0.9984398151778374,1.0,11/34,22.38%,CSNK1G2;VAPB;SGPL1;AGK;VAPA;SAMD8;ACER3;ELOVL5;CERS6;SPTLC1;SGPP1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.8553368827253909,1.2285281617263233,0.1527777777777778,0.9995845258296514,1.0,3/5,13.86%,CDH2;PTPRZ1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.6845556878533967,1.2276778398701156,0.21428571428571427,1.0,1.0,5/18,17.28%,ZFP36L2;TGFB1;ZFPM2;ANKRD26;ZFPM1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.7235841086963861,1.2274560093971942,0.20238095238095238,1.0,1.0,5/10,24.03%,CNOT8;DCP2;DCP1A;DIS3;PATL1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.777248494383957,1.227419411350171,0.20253164556962025,1.0,1.0,2/7,8.73%,TGFB1;EFNB2
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.8190161262806311,1.226770380817309,0.18571428571428572,1.0,1.0,3/5,18.05%,CRY1;CLOCK;PER1
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.6242880382961649,1.2267612673137804,0.19101123595505617,1.0,1.0,10/34,23.12%,SOD1;ATP6V1G1;CP;NDFIP1;PRNP;ARF1;GLRX3;SKP1;TF;MT3
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.8125180203587044,1.2265983748577087,0.1232876712328767,1.0,1.0,1/5,3.83%,ANK3
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.7358402916439757,-1.2262136873378118,0.23684210526315788,1.0,1.0,3/6,11.66%,DAPK2;RIPOR2;MCU
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.7358402916439757,-1.2262136873378118,0.23684210526315788,1.0,1.0,3/6,11.66%,DAPK2;RIPOR2;MCU
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),0.7722817988471289,1.226147394409371,0.1282051282051282,1.0,1.0,2/8,11.05%,RPS27A;TUT7
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.7775049890637713,1.2258604361685903,0.19753086419753085,1.0,1.0,6/8,21.72%,NR4A3;PPARA;IRS1;PPARGC1A;TWIST1;IRS2
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.8058322420959867,1.2254954805353335,0.20833333333333334,1.0,1.0,3/5,17.63%,LRRK2;MAPK1;ABL1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.8058322420959867,1.2254954805353335,0.20833333333333334,1.0,1.0,3/5,17.63%,LRRK2;MAPK1;ABL1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.7787961915401564,1.2254416336163365,0.125,1.0,1.0,6/8,22.02%,ADAMTS9;TGFB1;FGFR2;MYL3;SMAD7;PKP2
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.7056491062498401,1.2252224535819682,0.28378378378378377,1.0,1.0,4/12,5.15%,DPP10;DPP6;ANK3;FHL1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.5947402553866951,-1.2243114688468606,0.22727272727272727,1.0,1.0,3/17,1.75%,CDK6;BTBD2;ERCC6
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.7311224179391995,1.224164040643821,0.13580246913580246,1.0,1.0,3/11,13.35%,AGO2;EIF4ENIF1;PABPC1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.6456391086638439,1.2237772381502283,0.21839080459770116,1.0,1.0,7/27,18.16%,KDM1A;SYMPK;TMBIM6;PSME3IP1;LRRK2;ZFPM1;GOLGA2
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.6365564670614356,1.2237618948011735,0.17647058823529413,1.0,1.0,6/31,8.25%,CD44;ITGA5;EPHA7;SEMA4D;TGFB1;EGFR
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.7964587847850431,1.2236276851400631,0.12345679012345678,1.0,1.0,2/7,12.67%,TGFB1;CST3
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),0.6842178176048999,1.2236262195356558,0.1686746987951807,1.0,1.0,5/25,14.73%,DARS1;RARS1;FARSB;PPA1;YARS1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.7262828588442926,1.2236131603680496,0.20833333333333334,1.0,1.0,2/13,12.64%,DNAJC15;HSPA5
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.6994316094006561,1.223156338962588,0.2345679012345679,1.0,1.0,4/17,21.62%,KDM1A;KDM3A;KDM6A;KDM2A
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.5965349348948172,-1.2231039802037265,0.14285714285714285,1.0,1.0,2/12,3.40%,SMARCAL1;THOC1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.6713465890228236,1.2230805026420588,0.2222222222222222,1.0,1.0,2/18,1.19%,TBC1D20;RIPOR1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.7608819517219962,1.2228016980857677,0.14473684210526316,1.0,1.0,2/8,14.39%,TMEM165;TRPC4
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.6021425425688398,1.222329288789362,0.14893617021276595,1.0,1.0,12/69,17.60%,HNRNPL;RBMS2;PCBP3;DDX3X;AGO2;HNRNPF;ADARB2;HNRNPC;METTL14;NOVA1;RBM39;HNRNPUL1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.8004691799287608,1.222068412562934,0.1527777777777778,1.0,1.0,2/6,18.88%,DGKI;DGKH
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.7464288591328498,1.2219144471782948,0.1780821917808219,1.0,1.0,4/7,25.25%,ARID1A;SMARCA4;SUPT16H;ARID2
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.6338884929178132,-1.2217785115499002,0.32,1.0,1.0,5/8,24.16%,HSPA1A;CLU;HSPA4;PTGES3;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.7560828710789494,1.221038563286093,0.189873417721519,1.0,1.0,6/9,13.41%,NRG1;NIBAN2;ATP11A;TGFB1;EFNB2;AKAP6
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.7729201588192915,1.2210247780860475,0.24242424242424243,1.0,1.0,1/6,6.53%,SEC11A
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.6304416546356884,1.2209463356293686,0.19767441860465115,1.0,1.0,9/35,17.28%,PTPRQ;ZFP36L2;TGFB1;ZBTB16;CEBPB;ZFPM2;ANKRD26;TMEM64;ZFPM1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.5804443328598831,1.2208706248653578,0.061855670103092786,1.0,1.0,18/101,14.49%,SRGN;TBC1D20;VAPB;TOR1AIP2;COG2;FAM174B;ANK3;COG7;CSNK1D;ATL1;CSNK1A1;ATL2;VAPA;ARHGEF7;REEP5;LRRK2;AP3D1;WASHC5
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.6671757578019099,1.2208010156935931,0.17777777777777778,1.0,1.0,7/26,16.78%,DDX3X;DELE1;CASP8AP2;TNFRSF1B;TGFB1;TNFRSF10B;ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7744017043671433,1.2207817133972185,0.2077922077922078,0.9984080842054687,1.0,1/6,6.22%,NECTIN2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.6686638518234687,1.2206557518166534,0.1686746987951807,0.9954815799886596,1.0,3/15,7.73%,DPM1;UBE2J1;MGAT1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6686638518234687,1.2206557518166534,0.1686746987951807,0.9954815799886596,1.0,3/15,7.73%,DPM1;UBE2J1;MGAT1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.8248114305736632,1.2206011771368945,0.18055555555555555,0.9940365479615655,1.0,3/7,13.41%,NEDD4L;KCNQ1;AKAP6
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.699231409223996,1.2204385508707538,0.2,0.993085036782584,1.0,2/12,9.87%,PELI1;SDCBP
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.6192987297016332,-1.2202731087817187,0.17391304347826086,1.0,1.0,1/13,0.43%,FGF13
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.7315498559783922,1.2197723495528678,0.19753086419753085,0.9953711094346969,1.0,5/9,24.03%,CNOT8;DCP2;DCP1A;DIS3;PATL1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.4964053945222282,-1.2197584950149207,0.10526315789473684,1.0,1.0,4/23,7.41%,PPIP5K2;INPP4B;PLCH1;IPPK
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.6374548894566909,1.2192786226478274,0.189873417721519,0.9964817815895753,1.0,11/30,22.38%,CSNK1G2;VAPB;SGPL1;VAPA;SAMD8;ACER3;SCCPDH;ELOVL5;CERS6;SPTLC1;SGPP1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.6972188381480668,1.2192156298718042,0.16216216216216217,0.9950652787579393,1.0,3/16,5.53%,GJA1;GRIN1;SNX6
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.7177614001399999,-1.2191356361511085,0.375,1.0,1.0,3/7,20.40%,CDC42;OPHN1;RAP2A
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.7337690179643738,1.2190417966799514,0.21518987341772153,0.9944289814161373,1.0,5/14,16.19%,DDX3X;RNF34;MADD;TNFRSF10B;LGALS3
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.7886797076956771,1.2189075050207354,0.175,0.9936597696091191,1.0,4/8,12.67%,IL18;TGFB1;RUNX1;CST3
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.7094782870967244,1.2185574487701551,0.2077922077922078,0.994031983544892,1.0,4/13,16.20%,ITGA5;PTRH2;PDK4;ANKRD13C
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.7440779746149537,1.2183324753989266,0.12345679012345678,0.9939212832274759,1.0,4/14,12.40%,RAB27A;SDCBP;SYTL4;RAB7A
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.8042247686414548,1.2181728381103645,0.2112676056338028,0.9932919597701686,1.0,2/5,13.46%,SELENOS;KDR
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.6310919836747635,1.2175678343264111,0.19101123595505617,0.9958309476571551,1.0,6/33,12.53%,SOD1;SLC23A2;GNPAT;SLCO1A2;FADS2;ABCA1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.7135203788802783,-1.217474364556223,0.2692307692307692,1.0,1.0,2/5,11.47%,NT5C3A;DERA
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.772887308516589,1.2171925252739753,0.20253164556962025,0.9964260851883306,1.0,5/7,20.44%,IL18;CEBPB;CEBPD;LGALS3;ANGPTL4
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.5561378753740764,-1.2169418138156147,0.21052631578947367,1.0,1.0,1/19,0.69%,CDK6
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.6906349110347494,1.2168910550171828,0.23170731707317074,0.9966366781456111,1.0,5/14,5.20%,KCNE4;KCND2;KCNQ1;ANK3;SCN3A
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.646686712036175,1.2167091421375567,0.19318181818181818,0.9961214599985965,1.0,6/24,13.83%,GGA3;RPS27A;SNCAIP;CST3;MDM2;SIAH1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6724589600296424,1.2161453631879666,0.20930232558139536,0.9984837804191479,1.0,7/18,15.80%,SYT1;DGKI;CDH2;GRM7;TSHZ3;LRRK2;NRXN1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.5185801793422318,-1.215972510913964,0.25,1.0,1.0,2/12,3.48%,SLIT2;SLIT3
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.6004254141172357,1.2159376507465947,0.07216494845360824,0.9981761256834565,1.0,23/83,24.16%,SLC2A3;CSF1;CD44;RHOB;DHRS3;EMP1;TNFRSF1B;PTRH2;NFKBIZ;MAPKAPK2;CA2;PTH1R;PRNP;IFITM3;KLF6;MAP3K8;PHTF2;ITGAV;CD81;CCND3;RABGAP1L;CYFIP1;ALCAM
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.7069814511395477,1.215628435461854,0.21428571428571427,0.9980972914187005,1.0,4/14,8.65%,SYT1;LIN7A;SNAP25;SYN3
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.8140635392821296,1.2154521140609573,0.14925373134328357,0.997545316317291,1.0,4/6,16.20%,OS9;HSPA5;TAPT1;ANKRD13C
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7122760552931183,1.2152522641259569,0.2608695652173913,0.9971655127724156,1.0,3/12,16.39%,CHST11;CHSY1;CHST15
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.6875733922081215,1.2148229436731361,0.26582278481012656,0.9986738294470928,1.0,9/17,26.28%,ZFP36L2;TGFB1;BCL6;HECA;FZD3;CDKN1B;RGCC;TOM1L1;ANGEL2
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.850056023302511,1.2147612738639773,0.140625,0.9954518084469415,1.0,1/5,5.23%,MGST1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.850056023302511,1.2147612738639773,0.140625,0.9954518084469415,1.0,1/5,5.23%,MGST1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.5641322082690378,1.2145233354170566,0.05,0.9953225852653728,1.0,55/205,20.63%,SOD1;CSF1;CD44;MID1;PRKACA;NFKBIA;PSMB1;PELI1;PSMB2;CSF1R;IL18;HNRNPF;ADAM17;NCAM1;BTRC;CTR9;PSMA7;SOD2;TNFRSF1B;TGFB1;UGCG;IRS1;RPS27A;RAP1B;HIF1A;F3;PRLR;BCL6;TMSB4X;PSMA4;TRIM5;CEBPD;PTPRZ1;STAT3;RBX1;PSMD14;CANX;CFL1;TWIST1;CDKN1B;PDCD4;ARF1;MAP3K14;ST18;LIFR;IFIT3;JUNB;SMARCA4;CAMK2D;ABL2;IFITM3;SKP1;MAP3K8;GRB2;GAB2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.7832784768134153,1.214250550930549,0.17333333333333334,0.9953998474197167,1.0,2/7,9.30%,KDM1A;DNMT1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.7186481858074214,1.2140992328329185,0.21794871794871795,0.9948038523807546,1.0,5/16,12.98%,NRG1;CDH2;SEMA4D;SEMA3B;TAPT1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.6485177840690736,-1.2140687010686468,0.24,1.0,1.0,2/12,0.88%,CAV2;EDN3
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.705521319227776,1.2138704837457637,0.14285714285714285,0.9946951888276692,1.0,1/15,0.16%,STC1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.6362252931982224,1.2138373832241605,0.14285714285714285,0.9930782802236578,1.0,12/38,13.17%,ATP6V1G1;ATP6V1H;RHEB;SLC38A9;SEC13;EIF2AK2;RNF152;ATP6V1E1;SZT2;EIF2AK4;CEBPB;SESN1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.6788128860513953,1.213753280099295,0.21518987341772153,0.9920064275660271,1.0,6/20,25.33%,MICALL2;SREBF1;LRRK2;ARIH2;UBE2D3;UBE2L3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7161510984412425,1.2131945331671572,0.2535211267605634,0.9945200356464,1.0,3/10,18.59%,ZFPM2;FGFR2;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.5984799967386353,1.2128044709366783,0.11827956989247312,0.9951536186278253,1.0,7/52,9.37%,CSF1;HDAC2;NFKBIA;DDX3X;BTRC;TGFB1;ELAVL1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.7320505048712594,1.2124460307370466,0.21794871794871795,0.9959513055751588,1.0,2/10,13.41%,GRIN1;AKAP6
prerank,PanglaoDB_Augmented_2021__Microglia,-0.523041417836398,-1.2124235553555804,0.2,1.0,1.0,2/20,0.82%,WDFY4;CD4
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.7615691582000127,1.2123037682094757,0.25675675675675674,0.9950296695428982,1.0,1/6,0.47%,CD44
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.6189800628454625,1.212113612270685,0.1797752808988764,0.9925895449342202,1.0,5/27,10.52%,NUP153;AGO2;SEC13;NUP88;NUP133
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.6189800628454625,1.212113612270685,0.1797752808988764,0.9925895449342202,1.0,5/27,10.52%,NUP153;AGO2;SEC13;NUP88;NUP133
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.7597904117847318,1.211763156752578,0.16901408450704225,0.9931474692300049,1.0,1/7,1.01%,TPT1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.7445527693500714,1.211050537659296,0.22972972972972974,0.9967633561578516,1.0,2/6,14.57%,KDM1A;FZD3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.7781970754922004,1.2103387268070112,0.2236842105263158,0.9997626584688496,1.0,3/6,9.46%,ITGA5;PRKCB;HIF1A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.6234397786457999,-1.210277937080283,0.28,1.0,1.0,2/10,1.97%,ERCC6;PARP9
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.7800110314873119,1.2098133557024298,0.22727272727272727,1.0,1.0,1/6,1.03%,RHOB
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.7561220767119491,1.2091829690989193,0.24358974358974358,1.0,1.0,3/9,10.75%,BASP1;WNT2B;CSDE1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.6340955997821041,1.208908727487784,0.21176470588235294,1.0,1.0,7/25,11.15%,SLC22A6;SLC23A2;SLC38A4;SLC7A2;SLCO1A2;SLC3A2;SLC13A3
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.6409590374442371,1.2088646822686577,0.2054794520547945,1.0,1.0,6/22,11.24%,TSC2;PTPN1;SIK2;PRKCB;IRS1;PTPRE
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.829087027484384,1.208832102597819,0.22388059701492538,1.0,1.0,3/6,12.98%,NRG1;CDH2;TAPT1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.7642726511486004,1.2088015339754403,0.18309859154929578,1.0,1.0,3/8,3.03%,NEDD4L;KCNE4;KCNQ1
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.7728171977941626,1.2087456472503448,0.2,0.9986034212825485,1.0,6/8,21.61%,PURB;PRKCB;RUNX1;LGALS3;CBFB;MYSM1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7439998106898652,1.2084677605426613,0.2289156626506024,0.9988522975820456,1.0,1/9,1.91%,NAA11
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.5958379045340825,-1.208260762498907,0.2903225806451613,1.0,1.0,4/9,7.31%,SCN1A;CACNA1D;SCN7A;HCN2
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.7785383058468571,1.2082358136712816,0.125,0.9987043173599964,1.0,4/8,17.28%,PDE4B;IL18;PDE4D;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.6920686557683974,1.2082270689288577,0.2625,0.9970116904523816,1.0,1/10,2.15%,NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.729057812842881,1.2079512398390513,0.21052631578947367,0.9972082510308811,1.0,3/10,9.30%,GJA1;NR4A3;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.6295506327579826,1.2076330498463135,0.16853932584269662,0.9975294462611944,1.0,7/36,12.26%,NFKBIA;USP15;IL18;TGFB1;RIOK3;NFKBIZ;ANKRD17
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.7855620203670636,-1.206439327465653,0.2222222222222222,1.0,1.0,1/5,3.74%,RYR2
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.7474694350409394,1.2063885483413668,0.29577464788732394,1.0,1.0,3/7,17.24%,ROCK2;RANBP9;PRNP
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.6706543792538322,1.2062949034285833,0.24050632911392406,1.0,1.0,6/16,21.96%,EAPP;RNF168;WDR43;TCERG1;SUPT16H;ELL
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.6591622329701167,1.2061393448077409,0.1839080459770115,1.0,1.0,8/20,17.55%,PANK2;SSH1;PPARA;RNF34;PDK3;PDK4;ARF4;ARF1
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.7965823963930414,1.2061160896190104,0.17142857142857143,1.0,1.0,3/7,16.67%,ADAMTS9;CTSL;MANBA
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.6548810936629623,1.205961048926809,0.16853932584269662,1.0,1.0,9/28,19.46%,CSF1R;EGFR;PRLR;FLT1;FGFR2;KDR;INSR;ABL1;ABL2
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.7426806371425024,1.205622776309236,0.19753086419753085,1.0,1.0,4/9,22.76%,METTL14;VIRMA;WTAP;METTL16
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.5880804058289348,1.2053445051687603,0.08421052631578947,1.0,1.0,22/102,17.69%,NELL1;CSF1;NRCAM;GJA1;CDH2;AKIRIN1;IL18;ZC4H2;TP63;TGFB1;CTNNA2;SDCBP;CCN2;ZBTB16;CEBPB;SIN3A;KDR;ACVR2A;TMEM64;TWIST1;ABL1;ZHX3
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.655832396137305,1.204640628413938,0.23076923076923078,1.0,1.0,4/23,16.67%,ADAMTS9;DENND3;RAB12;MANBA
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.7474067210430089,-1.2044820579145565,0.2857142857142857,1.0,1.0,2/5,4.62%,TSEN2;C2ORF49
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.7474067210430089,-1.2044820579145565,0.2857142857142857,1.0,1.0,2/5,4.62%,TSEN2;C2ORF49
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.6304864735046589,1.2043315310726785,0.24358974358974358,1.0,1.0,5/22,16.47%,SELENOS;MBP;MAPKAPK2;STAT3;TWIST1
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.7849726294390896,1.2033530384970221,0.17105263157894737,1.0,1.0,1/8,2.05%,NRG1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.6324849362522929,1.2030922153440793,0.1797752808988764,1.0,1.0,9/28,19.62%,AP2A1;BNIP3L;CTSL;RAB7A;MDM2;DENND3;RAB12;AP2B1;BNIP3
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.6819695306296508,1.2029987182371364,0.13095238095238096,1.0,1.0,8/22,18.74%,SYT1;RAB27A;RIMS2;SYTL4;NSF;RAB12;STXBP6;RAB8B
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.6375339485626939,1.2028963718355379,0.14606741573033707,1.0,1.0,10/31,20.89%,TSC2;NEDD4L;PTPN1;RUBCN;PACSIN2;LGALS3;RUFY1;ABL1;ABL2;MTMR2
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),-0.636287728156109,-1.2028863512148038,0.15384615384615385,1.0,1.0,3/7,15.32%,LTBP3;SOX5;FOXC1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.7735043996394657,1.2027938130854303,0.208955223880597,1.0,1.0,2/5,15.06%,SREBF1;LPCAT3
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.7735043996394657,1.2027938130854303,0.208955223880597,1.0,1.0,2/5,15.06%,SREBF1;LPCAT3
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.6299586312882437,1.202369544514447,0.22727272727272727,1.0,1.0,2/29,2.39%,STX6;KDM1A
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.6216939408225395,1.2022954457645008,0.1276595744680851,1.0,1.0,16/44,21.00%,BTD;GNPAT;PANK2;PDHX;ACOT11;PPARA;SGPL1;MCCC2;ACSL4;CYP3A5;CKB;CKMT2;PTGR1;GLO1;ME2;ALDH1A2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.6031179607643067,1.202287949888093,0.1368421052631579,1.0,1.0,8/53,8.47%,TP53TG5;GJA1;DDX3X;ENO1;FHL1;TGFB1;ESR2;APBB1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.6326504327878719,1.2018771597684776,0.20224719101123595,1.0,1.0,5/29,9.46%,SOD1;CAMKK2;SOD2;EGFR;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.47117196355684177,-1.201584874077412,0.07142857142857142,1.0,1.0,4/39,3.00%,SPRY3;SPRY1;TNIP1;WNK2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.7827800787406523,1.2014372135267721,0.2,1.0,1.0,2/8,6.35%,LPIN1;SELENOI
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.7290531822750062,1.2014302948683346,0.21052631578947367,1.0,1.0,1/11,0.66%,SYT1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.7201922532206771,1.2013273010141583,0.18421052631578946,1.0,1.0,4/16,13.65%,HDAC2;BTRC;CST3;CAMK2N1
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.7760830719600302,1.201276572560438,0.2,1.0,1.0,3/6,16.71%,TGFB1;EGFR;MAP2K1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.7568911303236834,1.201253171061622,0.1780821917808219,1.0,1.0,2/7,13.49%,NECTIN2;CEP57
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.7077748341875115,1.2010137523477291,0.17073170731707318,1.0,1.0,6/17,14.77%,HDAC2;RHBDD1;BTRC;TNFRSF1B;TANK;WDR48
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.7514377114276486,1.2009222917135693,0.25757575757575757,0.9998170365142842,1.0,1/8,1.78%,ATP6V1H
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,0.7387813210397967,1.2007541110259208,0.2328767123287671,0.9993501598239861,1.0,3/10,10.36%,CD44;NCAM1;ZBTB16
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.661551427098344,1.2006439257060852,0.2413793103448276,0.9982364670610469,1.0,8/17,27.13%,PPARA;TGFB1;MBP;NEXMIF;NF2;RGCC;VEGFA;ASS1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.5080858808133264,-1.2003704756711948,0.3333333333333333,1.0,1.0,2/21,1.17%,SPRY3;SPRY1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.7433456687056048,1.2003383914768821,0.2236842105263158,0.9986936446523372,1.0,3/8,19.62%,ETF1;INSR;BNIP3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.6830340384386595,1.200292323072846,0.2631578947368421,0.997397712440669,1.0,4/15,3.03%,GJA1;NEDD4L;KCNE4;KCNQ1
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.7268415162568839,1.2002502026743926,0.2597402597402597,0.9959872664744699,1.0,4/8,21.72%,SELENOS;IRS1;INSR;IRS2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7778321417786671,1.2002410295587977,0.21333333333333335,0.994378134556575,1.0,3/8,13.86%,PTPN1;PRLR;STAT3
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.7114536546456207,1.2000785259954505,0.2597402597402597,0.9938065233549823,1.0,3/13,12.37%,NIBAN2;HNRNPC;DCP2
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.624031958963081,1.200000856927226,0.22988505747126436,0.9925948907077562,1.0,8/25,23.23%,TGFB1;HIF1A;TBX3;ROCK2;RBPJ;LOXL3;LEF1;OLFM1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.752996900446521,1.1998705026328278,0.21794871794871795,0.9917920278635053,1.0,4/8,22.76%,METTL14;VIRMA;WTAP;METTL16
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.7826289151852197,1.1995706165820428,0.26153846153846155,0.9921030462641435,1.0,3/5,21.53%,SNX25;SMAD6;SMAD7
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.6812331841799837,1.1992483113783567,0.1794871794871795,0.9924802720215565,1.0,3/14,4.36%,CAMKMT;PCMT1;ETF1
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.7507061648805311,1.1992364962314541,0.2318840579710145,0.9909432026477172,1.0,3/8,16.52%,WIPI1;UGCG;WDR45B
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.6985749651004933,1.199234428237288,0.25333333333333335,0.9893106767784458,1.0,4/10,14.66%,TBC1D20;VAPA;EIF2AK4;PPIB
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.7181926667688235,1.1990443945039753,0.23376623376623376,0.9890383222523492,1.0,1/12,0.66%,SYT1
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6926344568953279,1.198919490907409,0.19480519480519481,0.9882158124486502,1.0,5/13,21.72%,EPOR;ERBIN;GRB2;ITGAV;IRS2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.7389229058453173,1.1989154154783825,0.21621621621621623,0.9866291287295951,1.0,2/11,7.39%,UBA5;DESI2
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.5773231081774823,1.198551288251767,0.050505050505050504,0.9874609921377892,1.0,24/140,14.82%,SRSF12;RNMT;HNRNPL;PRKACA;RBM17;RAVER2;CDC5L;HNRNPF;CCAR1;ALKBH5;CPSF2;CWC27;SYMPK;HNRNPC;ELAVL1;RBM4B;PPARGC1A;CCNH;CSTF3;PABPC1;TCERG1;METTL14;SRSF10;NOVA1
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.69484749934424,1.1985450682785295,0.20833333333333334,0.9859139602677109,1.0,6/12,20.89%,GRIN1;RIMS2;LRRK2;NRXN1;NLGN1;MTMR2
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.6542515585076979,1.1983683560572498,0.22580645161290322,0.9855166522568531,1.0,8/24,18.25%,DDX3X;ADAM17;EGFR;ADNP2;SDCBP;AKAP6;INSR;CSNK2A1
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.7250316131594177,1.198164147152051,0.22666666666666666,0.985186888388783,1.0,2/7,15.42%,EGFR;ATAD5
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.7453429087654655,1.1979064593969686,0.2191780821917808,0.9854038705383525,1.0,3/8,4.36%,CAMKMT;PCMT1;ETF1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.5619731680997799,1.1978064183999055,0.125,0.9844810464764593,1.0,21/107,16.14%,WASF3;RAD21;PARVB;RHOJ;DARS1;ANK3;WASF1;WIPF1;LIN7A;SLC2A1;TGFB1;PPARGC1A;ST13;RANBP9;MDM2;MDM4;NAPG;PAWR;RTN3;SPG7;TEAD1
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.687263376835247,1.1970906275668476,0.21518987341772153,0.9876487408625753,1.0,6/15,19.62%,MICOS10;CHCHD3;SLC25A4;SPG7;DNAJC11;BNIP3
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7526304928936406,1.1968447427211941,0.2597402597402597,0.9879100520037546,1.0,2/8,7.81%,USP15;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.6323603807534479,-1.1965232486143884,0.20689655172413793,1.0,1.0,3/8,9.50%,CDK6;RBL1;AKT3
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.5866894220369647,1.1961895754351766,0.22105263157894736,0.9906512541570567,1.0,21/66,23.12%,SOD1;ETV5;PYROXD1;CAMKK2;SOD2;SELENOS;EGFR;HIF1A;ADNP2;PPARGC1A;GSR;VKORC1L1;LRRK2;MAPK1;ABL1;PRR5L;STX2;GPX3;ERCC6L2;JUN;MT3
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.7447174286391691,1.196158288505986,0.2597402597402597,0.9892830605322467,1.0,2/12,4.59%,WIPI1;AP2A1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.40059433733523453,-1.1960565108486176,0.0,1.0,1.0,17/78,11.08%,TAGLN;DKK3;PRRX1;LMOD1;COL14A1;SLIT3;PDZRN3;COL5A2;IGFBP7;PAMR1;COL15A1;EDNRA;SPARC;COL1A2;COL10A1;CXCL12;RUNX2
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.7963569268960957,1.195673163657706,0.208955223880597,0.9909160447612781,1.0,1/6,0.79%,AKAP8
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.7111251818491631,1.1955658817121515,0.3055555555555556,0.9899932605227746,1.0,2/6,8.41%,MTMR9;MTMR1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.7941732514409463,1.1953937239776706,0.20253164556962025,0.9895468123259072,1.0,3/5,20.23%,PDE4D;MGRN1;UBE2B
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.709116219025097,1.1953405587508728,0.1388888888888889,0.9882543473933735,1.0,3/13,11.07%,NRCAM;ZC4H2;SIN3A
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.8030751931405745,1.1945998136570166,0.22535211267605634,0.9885375577263554,1.0,1/5,1.65%,KCNC2
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.8030751931405745,1.1945998136570166,0.22535211267605634,0.9885375577263554,1.0,1/5,1.65%,KCNC2
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.8030751931405745,1.1945998136570166,0.22535211267605634,0.9885375577263554,1.0,1/5,1.65%,KCNC2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.731670586085562,1.1945687746643994,0.2261904761904762,0.9872225456130966,1.0,4/11,18.35%,LPIN1;SELENOI;PLAAT3;CHKA
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.7570664723971021,1.1945183365068486,0.189873417721519,0.9859278823013308,1.0,4/8,18.24%,KLF9;FGFR2;CASK;STXBP4
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.7335124932906485,1.1944263083670044,0.19480519480519481,0.9849117406548599,1.0,1/11,0.38%,SOD1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.8109620674054666,1.1943191045029637,0.23880597014925373,0.9839310523001766,1.0,3/7,12.98%,NRG1;CDH2;TAPT1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.7360641553424933,1.193446972120707,0.2692307692307692,0.9879737902325291,1.0,2/7,17.74%,HIF1A;SYBU
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.5678597527397957,1.1933295860389475,0.10101010101010101,0.9871680820013355,1.0,38/163,16.78%,NELL1;BTD;NRCAM;ADGRV1;GLRB;NRG1;CRMP1;LSAMP;DNER;DCLK1;IGF2BP2;DPYSL2;CDH2;ZC4H2;ROBO2;ROBO1;KIRREL3;SLC2A1;TGFB1;NAIP;MBP;MOBP;SZT2;ZBTB16;TBX3;FARP1;SH3GL3;APAF1;PTPRZ1;SIAH1;STAT3;NDUFS2;MYT1L;WWP1;NRXN1;SPG7;TEAD1;ACVR1B
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.40627051183779866,-1.19259114119774,0.25,1.0,1.0,11/69,10.86%,CAV2;NTN4;FGF1;COL5A2;LAMB2;PTPN21;FKBP9;EDNRA;COL1A2;TNS2;CXCL12
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.8165216242077825,1.1921716131125162,0.23880597014925373,0.9931177633468317,1.0,3/5,7.51%,SOD1;KLF2;SOD2
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.4152092975600872,-1.1920221123503236,0.25,1.0,1.0,5/62,3.22%,FAT1;TPM2;LMOD1;EVL;BAIAP2L2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.6863686654191261,-1.1920023107665911,0.2571428571428571,1.0,1.0,3/7,11.66%,DAPK2;RIPOR2;MCU
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.6599214328639751,-1.1919179055573572,0.20833333333333334,1.0,1.0,1/5,4.09%,INPP5F
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.7013157077849224,1.1918003399359969,0.2702702702702703,0.9939880417206142,1.0,5/12,19.41%,RIMS2;RAP1B;LRRK2;PREPL;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.5905133229763952,1.191561538837795,0.19318181818181818,0.994168031495364,1.0,9/53,17.24%,HDAC2;NFKBIA;KDM1A;SUFU;BTRC;EIF2AK4;TMSB4X;ERBIN;PRNP
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.6949383790764568,-1.191422401659715,0.3181818181818182,1.0,1.0,1/15,0.19%,WDFY4
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.5700723224757464,1.1913734727211063,0.16,0.9936130902064968,1.0,19/78,15.34%,WWC1;CD44;GJA1;DHRS3;AMFR;FKBP5;SLC7A2;TMEM164;SLC2A1;UGCG;KAZN;SEMA3B;ELF1;FARP1;PLAAT3;PAPSS2;SH3BP5;TIPARP;SCARB1
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.6892746342382845,1.1908959893503537,0.27631578947368424,0.9952595332538389,1.0,4/16,15.35%,PITRM1;AGK;DNAJC15;IMMP1L
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.7492940965714254,1.1908857394151433,0.2361111111111111,0.9937497501278352,1.0,3/8,16.11%,MIGA1;CHCHD3;SPG7
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6651507836498871,1.1905580746545126,0.2261904761904762,0.9943262283874382,1.0,3/21,16.47%,HDAC2;TBX3;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.7375027260258649,1.1904703795772216,0.29333333333333333,0.9931557739373795,1.0,2/9,4.09%,SUFU;NUP153
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.5904515856932318,-1.1902200824375686,0.32142857142857145,1.0,1.0,2/8,7.46%,RALBP1;SLC25A26
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.6604419881462573,1.1901890457653599,0.29069767441860467,0.9934304187909606,1.0,4/17,14.52%,KLF2;NOS1AP;ROCK2;INSR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6825800029186558,1.1901659310244552,0.3125,0.9920119499830431,1.0,4/13,18.59%,ZFPM2;RUNX1;FGFR2;RBPJ
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.6350690609833334,1.1899271910085607,0.19753086419753085,0.9918295804713834,1.0,15/31,27.30%,FMN2;KCND2;BNIP3L;HIF1A;MDM2;MDM4;PGK1;TWIST1;CPEB4;BNIP3;MT3;RGCC;P4HB;VEGFA;UBQLN1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.7739194110659999,1.1898227966125785,0.21518987341772153,0.9909698183190823,1.0,3/7,16.47%,CSF1R;TGFB1;TWIST1
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.5961860831541457,1.1897292970787403,0.20430107526881722,0.9900025235366219,1.0,8/41,9.58%,SRGN;NAA11;PITRM1;CPD;ADAM17;MMP16;CPM;F3
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.6036384185642983,-1.18963576859926,0.15,0.9986512428870918,1.0,2/8,4.44%,MYH11;SORBS2
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.6052947196834564,1.188934035347101,0.17582417582417584,0.9934077480451005,1.0,13/39,18.09%,CD38;CHL1;CSF1R;ALDH1L1;SOD2;PPARA;CPM;CP;OMG;ABCA1;LRRK2;CPEB4;ANKUB1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.5815697445646001,1.1887639951265065,0.1839080459770115,0.992988948134208,1.0,18/58,20.21%,TSC2;PDK1;ACTR3;RAF1;PPP2R1B;SLC2A1;PRKCB;TBK1;EGFR;MAP2K6;CFL1;MAPK1;CDKN1B;ARF1;VAV3;SMAD2;PRKAR2A;GRB2
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.8005041653658683,1.188698755888974,0.1323529411764706,0.9918036434099256,1.0,1/5,6.71%,CTR9
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.782524439561584,1.1886823823073813,0.24675324675324675,0.9904185983388525,1.0,2/6,14.74%,EHD2;PACSIN2
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5684926105095144,1.1885161464946221,0.17204301075268819,0.9897407603740839,1.0,20/70,13.67%,PHYHIPL;ELAVL3;GJA1;NRXN3;CDC42EP4;LSAMP;GFAP;DPP6;CHL1;ALDH1L1;ADGRB3;CTNNA2;EGFR;TRPM3;GRIN2B;CADM2;CDH20;SLC1A2;AKAP6;PTPRZ1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.6140024199344949,1.1883985325799893,0.1797752808988764,0.9888934325088431,1.0,13/37,20.97%,SOD1;EPHA7;SNX6;PRKCI;SOD2;NAIP;PPARGC1A;PTPRZ1;CPEB4;PRNP;UNC5B;NF1;LANCL1
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.6055072482928322,1.1882103329524147,0.2,0.9885470457721325,1.0,19/44,20.90%,ELAVL3;PCBP3;GRIN1;NXPH1;CACNA1B;ADGRB3;HIVEP2;CTNNA2;SNAP25;CTNND2;CADM2;CNTNAP2;TSHZ1;NRXN1;DLGAP1;GRIA3;GRIA2;PPM1E;PLP1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.6681686290297036,1.1879114835214823,0.24358974358974358,0.9891191387239701,1.0,6/22,14.26%,ZFP36L2;RC3H2;GIGYF2;TUT7;ROCK2;METTL14
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.6992274534318907,-1.1878734080135305,0.29411764705882354,0.9845154107582328,1.0,2/5,7.44%,ATM;TPR
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.6992274534318907,-1.1878734080135305,0.29411764705882354,0.9845154107582328,1.0,2/5,7.44%,ATM;TPR
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.6992274534318907,-1.1878734080135305,0.29411764705882354,0.9845154107582328,1.0,2/5,7.44%,ATM;TPR
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.6992274534318907,-1.1878734080135305,0.29411764705882354,0.9845154107582328,1.0,2/5,7.44%,ATM;TPR
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.5706083027125555,1.1876748227110077,0.2222222222222222,0.9891305575158786,1.0,18/55,26.42%,SRGN;HOMER2;SELENOS;PPARA;TBK1;TRAF3IP1;TMSB4X;LGR4;PRNP;ZFPM1;PDCD4;NAV3;AXL;LEF1;SARS1;RPS6KA5;RGCC;NPLOC4
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.6001253756179674,1.187323087252738,0.1827956989247312,0.9898085314215881,1.0,14/53,14.16%,CADM1;TENM2;PTPRD;TENM3;CDH18;CDH2;NECTIN2;ROBO2;ROBO1;KIRREL3;CDH12;CDH20;CDH10;LRFN5
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.5556331220363113,-1.1872592986449761,0.26666666666666666,0.9809632111896261,1.0,3/19,4.06%,SPRY3;SPRY1;MAPKAP1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.8078420001388397,1.187101276830673,0.2638888888888889,0.9898033876530797,1.0,3/5,13.62%,DENND4C;MADD;DENND3
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.6552314478747945,1.1870513454940848,0.20930232558139536,0.988623681608261,1.0,5/22,7.68%,PLAA;PDE4B;CTR9;SELENOS;TNFRSF1B
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.7528951401755918,1.186795729599884,0.2916666666666667,0.9885277622796242,1.0,6/8,23.12%,ZFP36L2;KDR;MAP2K1;MAPK1;ITGAV;MT3
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.5982512548128746,1.186629905034824,0.16666666666666666,0.9879236650199953,1.0,9/43,16.96%,GPR161;S1PR3;ADGRB3;ADGRG2;ABCA1;ADGRE2;GNAI1;LGR4;PTH1R
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.7202213334842998,1.1866234685076935,0.17333333333333334,0.9865059996562169,1.0,1/8,2.55%,RBM17
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.7829737915178614,1.186159199615209,0.23880597014925373,0.9879037880548455,1.0,2/5,11.76%,ADAM17;GALNT11
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.6109068887578423,1.1861557586060858,0.2682926829268293,0.9864290755116443,1.0,9/29,23.12%,MTMR9;RUBCN;LZTS1;WDR6;STAT3;LRRK2;GOLGA2;TAB2;MT3
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.6809925600651834,1.1856105405755282,0.2875,0.9882362831707919,1.0,6/16,14.52%,ENO1;PPARA;HIF1A;PPARGC1A;TMSB4X;INSR
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.6941654318895965,1.1852862659753782,0.16901408450704225,0.9885699959142741,1.0,5/13,22.38%,DGKI;CYP3A5;LPCAT3;DGKH;SGPP1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.7531471674774496,1.1851154126156271,0.2361111111111111,0.9881545094847847,1.0,3/9,10.22%,KDM1A;DNMT1;MTF2
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.5935724466821004,1.1844918750258555,0.21739130434782608,0.9901949448705428,1.0,14/54,18.00%,CSF1;MPZL1;PTPRD;EPHA7;CSF1R;EGFR;SHC2;FLT1;FGFR2;KDR;INSR;ACVR2A;ACVR1B;LIFR
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.45373773079408,-1.1843678777437026,0.13333333333333333,0.9850926006434223,1.0,4/26,4.68%,IL34;FGF1;EDN3;RPS3
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7148885433849316,1.1842918290139908,0.2916666666666667,0.9900827420670303,1.0,1/8,7.83%,DSE
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.7355986132177923,1.1841015704648654,0.273972602739726,0.9884325935600755,1.0,3/8,16.28%,TAF1B;CCNH;POLR1C
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.7355986132177923,1.1841015704648654,0.273972602739726,0.9884325935600755,1.0,3/8,16.28%,TAF1B;CCNH;POLR1C
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.6619509377978833,1.183851516924228,0.189873417721519,0.9885660076124808,1.0,11/27,23.20%,HDAC2;CRMP1;CBFA2T2;EFNB2;OMG;PTPN9;NLGN1;KANK1;GAK;MT3;SPOCK1
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.5533676297644662,1.182915822943088,0.16494845360824742,0.9928757309204557,1.0,28/87,23.84%,RANBP10;USP15;MINPP1;BTRC;ALDH1L1;SLC2A1;ELL2;BNIP3L;SDCBP;RIOK3;GYPC;EPOR;GMPS;AGPAT4;RNF19A;EZH1;CA2;DCUN1D1;KLF3;SLC25A37;GCLC;MARK3;MXI1;CCND3;LAMP2;TSPAN5;ARHGEF12;GAPVD1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.6016972129418757,1.182576904904825,0.22826086956521738,0.9936216773397955,1.0,8/36,22.14%,PTPN1;MADD;ELF1;RUNX1;CBFB;PTPN2;LIFR;AXL
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.5841618671046793,1.182408523686939,0.1935483870967742,0.9932036274236749,1.0,10/62,11.00%,GRIN1;DDIT4;EPHA7;SLC6A17;CDH2;SMARCA1;ROBO2;CTNNA2;GRIN2B;RAB18
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.8058638687777553,1.1820956316934867,0.17391304347826086,0.9939318121226378,1.0,1/5,5.92%,RNF10
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.7484192296434429,1.181756127547135,0.26666666666666666,0.9948082769247473,1.0,2/5,7.52%,PRKCB;SELENOS
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.6860703769813629,1.1817512264432781,0.23376623376623376,0.9933688832274064,1.0,5/13,27.98%,CTR9;STAT3;ST18;IL6ST;PTPN11
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.7764351469750068,1.1816745956264043,0.2777777777777778,0.9923987068113073,1.0,5/7,17.63%,SOD1;RUNX1;ZBTB1;CBFB;ABL1
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.7177198870134123,1.1813226445959852,0.25675675675675674,0.992764339604404,1.0,3/9,7.49%,NEDD4L;SLC2A1;PRKCB
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.6596460755961527,1.181163625140393,0.22666666666666666,0.9924409689069701,1.0,3/11,22.28%,NR4A3;SYTL4;TMEM106B
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.5803237487755459,1.180905779852854,0.21978021978021978,0.9925964038521126,1.0,9/49,18.16%,DPM1;TET3;TMEM165;COG7;MGAT4A;MGAT1;GALNT7;MAGT1;GOLGA2
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.6726085264503165,1.1808926488090477,0.18292682926829268,0.9911558950076262,1.0,9/19,14.32%,SLC23A2;SLC6A17;SLC16A6;SLC16A12;SLC16A4;SLC16A7;SLC3A2;SLC13A3;SLC36A4
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.6871730435158119,1.180031388248115,0.22077922077922077,0.9947223993114358,1.0,3/12,7.52%,OS9;RHBDD1;SELENOS
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.7183779161556635,1.1797883213170248,0.18666666666666668,0.9949332871109792,1.0,5/10,14.37%,UBAC2;VAPA;HSPA5;TAPT1;LRRK2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.6932745596109986,1.1793416732910629,0.2465753424657534,0.9963757604479495,1.0,3/13,14.47%,PELI1;SDCBP;SLC25A4
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.679140734121781,1.1783148404555515,0.24050632911392406,1.0,1.0,7/14,27.80%,UBA5;UFSP2;RUNX1;CBFB;STRN3;CNOT1;PAK1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.5765218585873448,1.178235163746459,0.21428571428571427,0.9996329761607595,1.0,8/70,7.22%,STX6;TBC1D20;COG2;FAM174B;COG7;CSNK1D;CSNK1A1;ATL2
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.7236472609683271,1.1782170836226242,0.2972972972972973,0.9983573940194647,1.0,5/10,18.08%,ATL1;ATL2;RAB18;RTN3;REEP3
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.7199853453891182,1.178158844232722,0.2876712328767123,0.9971297934166604,1.0,2/8,6.42%,BASP1;ROBO2
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.6999558414845525,-1.178104813444274,0.29411764705882354,1.0,1.0,3/5,17.07%,ST6GALNAC3;LARGE1;ST3GAL5
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.751886483815648,1.1778201387587925,0.20253164556962025,0.997305881991961,1.0,3/8,10.51%,CSF1;PRXL2A;CEBPB
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.569586217295953,1.1775851768083332,0.16842105263157894,0.9976139129262511,1.0,16/74,14.82%,NELL1;PCBP3;PRDM6;FUBP1;IGF2BP2;MTMR9;PRDM10;SCARB2;MTMR1;HIF1A;ADNP2;ROCK2;NFKBIZ;FUBP3;TRIM5;NOVA1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.6892100890021918,1.1775122593895437,0.2558139534883721,0.9966278386724374,1.0,6/13,22.14%,PDE4B;IL18;PDE4D;PRNP;ZFPM1;AXL
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.7561847805262029,-1.1773151609889583,0.2777777777777778,1.0,1.0,2/5,7.94%,ERCC6;APLF
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.8081810626561252,1.1770456383242183,0.22857142857142856,0.9979778427484849,1.0,1/6,0.79%,AKAP8
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.6449149938430225,1.1770231165320566,0.2289156626506024,0.9966277539714338,1.0,4/22,12.85%,PRKACA;HIF1A;PPARGC1A;PDK3
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.743342941697625,1.1770185515477818,0.2727272727272727,0.9952230215827338,1.0,6/9,21.99%,PRKCB;ELF1;RUNX1;CBFB;ELF2;CD81
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.6787745810351404,-1.1769819132407264,0.2413793103448276,0.9965752506453315,1.0,1/6,0.82%,CD4
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.6231553584122278,-1.1769022843845478,0.24,0.9917239324726912,1.0,2/7,5.10%,SLIT2;NBL1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.7441457988708331,1.17676979101826,0.2777777777777778,0.9952834424354512,1.0,4/8,12.08%,ENO1;PPARA;PPARGC1A;TMSB4X
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.5973630196115656,1.1766489397752085,0.21348314606741572,0.9946141797338933,1.0,4/44,2.17%,STC1;ADAMTS9;RHOB;RHOJ
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.7250877454491275,1.1763580613739897,0.25316455696202533,0.9948355620352939,1.0,3/8,20.64%,NFKBIA;PTPN2;ITGAV
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.7572238266057422,1.1763101913041454,0.2361111111111111,0.9936596589744601,1.0,3/6,17.00%,ATP6V1G1;NDUFS2;CPEB4
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.5902184194737159,1.1760143948646598,0.21052631578947367,0.9941287428168162,1.0,10/53,11.53%,SOD1;ETV5;DDX3X;PYROXD1;SOD2;SELENOS;ADNP2;PPARGC1A;GSR;VKORC1L1
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.6543856778017197,1.1760129912887807,0.21839080459770116,0.992725091788422,1.0,6/16,20.64%,ITGA5;CTR9;COL7A1;COL11A1;RTF1;ITGAV
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.7634513338013984,1.1758904870544498,0.25,0.992093212858915,1.0,2/7,13.07%,GMPS;AK3
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.7928284102427681,1.175881757023326,0.24193548387096775,0.990739847673696,1.0,2/5,10.51%,APOLD1;CEBPB
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.5430741495916234,1.1757178781905047,0.02,0.990257035109386,1.0,87/391,19.25%,SCML1;WWC1;TAF7;KLF2;ETV5;HDAC2;PRDM6;NRG1;KDM1A;TENM2;CBFA2T2;NEDD4L;CD38;GLIS3;BASP1;ENO1;ZNF608;SUFU;WWC2;HCFC2;CRY1;NIBAN2;SNX6;SAP130;SEMA4D;YAF2;BTRC;CTR9;NR4A3;TP63;PPARA;CTBP2;TGFB1;ESR2;APBB1;RPS27A;CXXC5;CLOCK;SDCBP;MTF2;ZBTB16;CEBPB;RCOR1;SIN3A;ZNF536;ZFPM2;BCL6;TBX3;CREM;DEAF1;SMURF2;RUNX1;FGFR2;MXD4;MDM2;MDM4;TCERG1;PHF21A;TSHZ3;EED;STAT3;RARB;MYT1L;MBD2;EZH1;HIVEP1;LCOR;WWP1;MZF1;ZBTB7A;TWIST1;ZBTB1;CBFB;CDKN1B;ZFPM1;PDCD4;ZHX3;ZMYM5;NFIX;PER1;RBPJ;SMAD2;RTF1;FOXP2;SMARCA4;LOXL3;MBTD1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.798456856891619,1.1756237659775741,0.2361111111111111,0.9895447979699395,1.0,2/5,12.26%,USP15;ANKRD17
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.7674971999347215,1.1753932268655278,0.2537313432835821,0.9895547889748321,1.0,2/5,7.52%,TMCO1;SELENOS
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.5430332201368214,-1.1753436544436884,0.3181818181818182,0.9911837258858892,1.0,3/10,17.08%,ACTN4;MYO1E;MYO1D
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.5403467260241864,1.1753084888236984,0.22916666666666666,0.988744873075875,1.0,22/89,20.92%,SOD1;MTCH2;GBE1;ATP1B3;ATL2;DNAJC15;RIOK3;BCL6;TANK;ABCA1;REEP5;ACADL;LPCAT3;RTN3;SUCLG1;SCARB1;CMPK1;PDCD4;LIFR;GPX3;ANGPTL4;YWHAG
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,0.6741181243308445,1.1752888415783176,0.2028985507246377,0.9874488854068235,1.0,3/15,11.50%,ARRDC2;CEBPB;OSTF1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.47604594997719013,-1.1752658228539956,0.26666666666666666,0.9865084512578616,1.0,2/21,4.68%,BCL2L11;RPS3
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.7182084107567132,1.1750564184763244,0.24691358024691357,0.987533506593819,1.0,2/13,8.18%,HDAC2;UGCG
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.6194471668671998,1.1749221847785065,0.17777777777777778,0.9871452284632283,1.0,12/39,13.17%,ATP6V1G1;ATP6V1H;RHEB;SLC38A9;SEC13;EIF2AK2;RNF152;ATP6V1E1;SZT2;EIF2AK4;CEBPB;SESN1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.7388751139206283,1.1748628154768157,0.3333333333333333,0.9861573201440813,1.0,3/8,19.38%,NEDD4L;STK39;CAMK2D
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.7013447024139089,1.1748096975162825,0.23529411764705882,0.985143621196863,1.0,4/13,13.01%,MMUT;GLUL;GLUD1;ASPA
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.7341644593501585,1.1745620477577932,0.26582278481012656,0.984974270553616,1.0,4/8,21.53%,KLF2;ABCA1;SMAD6;SMAD7
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.815596519819481,1.174523140361818,0.19402985074626866,0.9838653683068146,1.0,2/5,9.93%,MGST1;SLC16A12
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6863955023000274,1.1740606488663052,0.2676056338028169,0.9851063460181315,1.0,2/11,3.83%,GRIN1;ANK3
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.6048224476245154,-1.173582413458937,0.27586206896551724,0.9812076583210604,1.0,2/10,7.14%,TPM2;VIM
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.6048224476245154,-1.173582413458937,0.27586206896551724,0.9812076583210604,1.0,2/10,7.14%,TPM2;VIM
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.7840347953874305,1.1732110525357624,0.2153846153846154,0.9885169214210524,1.0,4/6,16.78%,GJA1;AGO2;SMURF2;ACVR1B
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.793567363435164,1.1726552910331238,0.30434782608695654,0.9902301796574569,1.0,1/6,0.67%,TBC1D20
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.6643180687739081,1.1724721616139506,0.2112676056338028,0.9899274527573062,1.0,5/17,15.22%,PDE7B;RIMS2;PDE7A;AKAP6;PDE4D
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.5759053052942866,1.1722460797155652,0.16666666666666666,0.989526561532278,1.0,10/68,13.92%,SRGN;SOD1;SYT1;HABP4;RIMS2;TGFB1;SNAP25;SYTL4;TMSB4X;CD9
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.6064549196762447,1.1722247587767611,0.2413793103448276,0.9882510879792991,1.0,11/42,10.94%,PHYHIPL;ELAVL3;KCNC2;GRIN1;NXPH1;LSAMP;CACNA1B;CTNNA2;SNAP25;TRPM3;GRIN2B
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.7543263473873477,1.1720477845231891,0.25925925925925924,0.9880793064599959,1.0,4/10,17.58%,CRY1;SELENOS;PPARGC1A;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.7209653352453413,1.171437033039393,0.2875,0.990091176200353,1.0,4/12,17.23%,IPO5;CAMK2N1;LATS2;CDKN1B
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.6782864690414595,1.171239528859236,0.2857142857142857,0.9897626040638716,1.0,6/17,12.83%,CD44;TGFB1;WNT2B;ZBTB16;RUNX1;CREB3L2
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.5891994533102693,1.171070137330625,0.20454545454545456,0.9893225708348116,1.0,9/35,14.98%,EPM2A;TSC2;BNIP3L;TBK1;WAC;SESN1;KDR;SLC25A4;C9ORF72
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.8116757803090047,1.1698885193116069,0.23880597014925373,0.9949994013578953,1.0,1/5,7.81%,TGFB1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.6088612641060044,1.1698354257114716,0.23529411764705882,0.993895019353735,1.0,5/41,10.88%,HS3ST5;CHST11;OGN;DSE;CHSY1
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.7677967300287185,1.169722585729768,0.2535211267605634,0.9929755212544861,1.0,3/6,16.63%,USP15;ANKRD17;ZDHHC5
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.8000579781459853,1.1695609889437526,0.2714285714285714,0.9924776167727826,1.0,1/5,3.03%,KCNQ1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.7393571381538986,1.1693923121181151,0.25675675675675674,0.9919950280398804,1.0,1/6,6.26%,CSNK1A1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.6376651886195044,1.169260194256145,0.3055555555555556,0.991304801771058,1.0,1/13,1.38%,PRKACA
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.660040113299919,1.1684942804837795,0.2891566265060241,0.9944004162857312,1.0,7/25,18.05%,MID1;EIF2AK2;EGFR;ULK4;MAP2K1;MAPK1;PER1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6447312869337488,1.1684138916038447,0.3058823529411765,0.9936115417394557,1.0,4/19,15.30%,LRRC7;PRKCI;LIN7A;ERBIN
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.67620164382844,1.168012109413812,0.2375,0.9946838862728069,1.0,1/11,1.12%,CHST11
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.6902541265969868,1.1679609039076881,0.23376623376623376,0.9937305182880514,1.0,5/13,19.46%,PLAA;FLT1;FGFR2;ARF4;ABL2
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.679531610762815,1.1674251128599837,0.2976190476190476,0.994387714399681,1.0,3/14,12.30%,TBK1;RPS27A;TANK
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.679531610762815,1.1674251128599837,0.2976190476190476,0.994387714399681,1.0,3/14,12.30%,TBK1;RPS27A;TANK
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.79301755949689,1.1670975186125245,0.2236842105263158,0.9950116390524443,1.0,2/6,16.47%,FGFR2;TWIST1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.5919870442100011,-1.1669852366034996,0.2962962962962963,0.9992947681249568,1.0,3/11,3.48%,SLIT2;BCL2L11;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.7333345883420384,1.166930341514556,0.2564102564102564,0.9946417390073689,1.0,4/7,21.99%,CD38;VAV3;IRS2;CD81
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7670226056678892,1.1666719481438645,0.24285714285714285,0.9933689847221957,1.0,4/6,12.08%,ENO1;PPARA;PPARGC1A;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.7670226056678892,1.1666719481438645,0.24285714285714285,0.9933689847221957,1.0,4/6,12.08%,ENO1;PPARA;PPARGC1A;TMSB4X
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.7378182410699217,1.1666561266834583,0.2777777777777778,0.992110748887854,1.0,3/7,16.28%,TAF1B;CCNH;POLR1C
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.74074102922843,1.166525117751656,0.2,0.9914589400559627,1.0,4/8,19.41%,GRIN1;RIMS2;NRXN1;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.7132072324805004,1.166207516968747,0.275,0.991972272852908,1.0,4/14,8.12%,NRG1;OLFM2;CDH2;CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6615823484010638,1.1659138306216883,0.26506024096385544,0.9923065350847239,1.0,9/17,26.40%,CRY1;PIAS2;CLOCK;ZBTB7A;PER1;SMARCA4;STRN3;CNOT1;NCOR2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.5985426364784386,1.1655938294384554,0.2247191011235955,0.9928173520955985,1.0,9/47,12.46%,TAF7;CD44;ARID3A;MGST1;CDH2;CSF1R;PTPRE;ELF1;RUNX1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.6377948544180382,-1.1651935304067633,0.36,1.0,1.0,2/10,2.95%,SCN1A;CACNA1D
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.6898606334817488,1.165181002563174,0.33766233766233766,0.9937766511964069,1.0,2/9,12.26%,USP15;ANKRD17
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.6711179413527314,-1.1650321166463518,0.32142857142857145,0.9958439941439654,1.0,2/5,7.64%,CAV2;PC
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.6337483961780266,1.1649142671181743,0.29545454545454547,0.9938076559354331,1.0,7/26,13.01%,BCKDHB;MCCC2;BLMH;GLUL;BCAT2;GLUD1;ASPA
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.6942854261227811,1.1642931728846873,0.275,0.9961362032462949,1.0,6/10,26.93%,KDM1A;LRRK2;FZD3;NF1;TAFA1;VEGFA
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.7033788129123645,1.1639161955446466,0.2962962962962963,0.9967613746109845,1.0,4/13,18.35%,LPIN1;LPCAT3;CSNK2A1;CHKA
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.7230338677027823,1.1639113387784552,0.3333333333333333,0.9954459186073866,1.0,1/8,5.07%,SMAP1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.5553820122804761,1.163850760296314,0.14,0.9943370824316108,1.0,30/155,15.01%,STX6;IPO9;ARL5A;TSC2;GGA3;NUP153;RAB28;AP2A1;COG7;SNX6;XPO4;SEC13;IPO5;NUP88;SYNDIG1;CSE1L;TGFB1;KIF13B;TRIM23;NUP133;RAB18;EIF4ENIF1;ARFGAP3;RAB7A;NSF;AKAP6;NAPG;STAT3;AP3D1;TBC1D15
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.5376056890878608,-1.1638049678442062,0.2857142857142857,0.9938849410547524,1.0,1/11,0.79%,NRP1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.7279601146106126,1.1637923438456312,0.2631578947368421,0.9932852876920074,1.0,3/8,16.25%,NIBAN2;EGFR;ZBTB7A
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.6608025844005876,1.1635264787799215,0.27631578947368424,0.9936408213300644,1.0,1/14,1.24%,GJA1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.6435893428433453,1.163381641134686,0.27631578947368424,0.9931592036075767,1.0,5/18,19.62%,PITRM1;SLC25A4;SPG7;ABCB10;BNIP3
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.7662294385305733,1.1632638275730003,0.24358974358974358,0.9924229437249669,1.0,3/5,21.72%,IRS1;PTH1R;IRS2
prerank,MSigDB_Hallmark_2020__UV Response Up,0.6031786937294092,1.1632134758281973,0.20652173913043478,0.991446503717146,1.0,25/54,23.79%,GRINA;RHOB;PRKACA;NFKBIA;PTPRD;RAB27A;AGO2;CDC5L;SOD2;MGAT1;DDX21;TMBIM6;PLCL1;SLC25A4;IGFBP2;CA2;DNAJA1;CHKA;JUNB;GPX3;CCK;SLC6A12;CCND3;OLFM1;SELENOW
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.7381108166392419,1.1630502926496438,0.23529411764705882,0.9911712000626475,1.0,2/7,12.08%,DDX3X;TMSB4X
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.6498519371002981,1.1628585005390897,0.3448275862068966,0.9911246957878607,1.0,2/19,6.87%,MICALL2;PRKCI
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.6805217456176088,1.1627134989484171,0.21176470588235294,0.9906629642130241,1.0,5/18,22.20%,RAD21;XRCC4;TNKS;RPA1;CTCF
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6251871873297887,1.1627048909989466,0.21839080459770116,0.9893862218177767,1.0,8/25,12.22%,CADM1;CDH18;CDH2;NECTIN2;CDH12;CADM2;CDH20;CDH10
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.7260300282563595,-1.1624389412336789,0.30434782608695654,0.9931675899714204,1.0,2/5,24.13%,TRIM25;ANXA11
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.5967448448189803,1.1623311415233475,0.2222222222222222,0.9899034995553337,1.0,11/42,11.36%,PHYHIPL;ELAVL3;KCNC2;NXPH1;LSAMP;GFAP;ADGRB3;SNAP25;PDE10A;ZNF536;CADM2
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.636882386773804,1.1618316201828092,0.24358974358974358,0.9914737245705966,1.0,5/18,19.89%,BTRC;RPS27A;MAPK1;SKP1;MAP3K8
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5729252358098397,1.1612749357935177,0.23076923076923078,0.9935996156019723,1.0,12/52,17.85%,TSC2;MYDGF;IL18;SEMA4D;EGFR;EPOR;FLT1;KDR;INSR;TWIST1;MAPK1;UNC5B
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.6658363922455333,1.1612250505542974,0.2976190476190476,0.9924721315957686,1.0,5/16,21.53%,TENM3;EPHA7;TGFB1;NF2;SMAD7
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.7802021191309163,1.1607787117210646,0.2465753424657534,0.9935941623885499,1.0,3/5,21.46%,TBX3;SMAD2;SMAD6
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.6360721701623875,1.1605324145465743,0.3333333333333333,0.9936379122590108,1.0,6/16,28.73%,CTR9;STAT3;ST18;IL6ST;PTPN11;PID1
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.7064396408388083,1.1604534385700471,0.2716049382716049,0.9927534437023332,1.0,3/14,12.83%,CD44;ZBTB16;CREB3L2
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.6644266362294223,1.1603985618570503,0.27848101265822783,0.9916726579040226,1.0,7/14,27.72%,CD38;TP53BP1;VAV3;IRS2;CD81;SH3KBP1;SHLD2
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.6902206775471139,1.1603049671131855,0.23529411764705882,0.9909120626096086,1.0,3/13,10.15%,WWC1;WWC2;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.6784576851409805,-1.1601592809245753,0.37142857142857144,0.9962921832884097,1.0,2/5,28.50%,PKM;DHX36
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5959005526163516,-1.1593418659614498,0.3225806451612903,0.9941274758284053,1.0,1/8,2.39%,ATP2B4
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.5578465889946733,1.1589670206012805,0.20224719101123595,0.9971003125315051,1.0,10/48,22.87%,PRKACA;CCP110;TUBA1A;CSNK1D;CEP70;CEP57;PAFAH1B1;CNTRL;YWHAG;CEP290
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7494683427391045,1.1587200320093807,0.3392857142857143,0.9960847097238931,1.0,2/5,19.41%,NRXN1;NLGN1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7494683427391045,1.1587200320093807,0.3392857142857143,0.9960847097238931,1.0,2/5,19.41%,NRXN1;NLGN1
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.745388264099788,1.1586360277316434,0.2702702702702703,0.9952697196580791,1.0,3/7,16.92%,DCUN1D4;HIF1A;DCUN1D1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.6047655148758608,1.1584860438469884,0.19767441860465115,0.9947590261479743,1.0,12/33,20.21%,CSF1;CD44;CD38;PTPN1;TNFRSF1B;TGFB1;STAT3;CD9;ACVR1B;PTPN2;MAP3K8;GRB2
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.7093420669198389,1.1584243150189328,0.24675324675324675,0.993869119220525,1.0,3/11,14.45%,ITGA5;PTRH2;PDK4
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.6443147716428355,-1.1579974958974324,0.25,0.9936047877024898,1.0,1/6,2.29%,ATM
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.6009634918064323,1.1579558451767322,0.23595505617977527,0.994907920392291,1.0,5/29,12.08%,NFKBIA;DDX3X;EIF2AK2;EGFR;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.7284792554321732,1.1575871311697468,0.3194444444444444,0.9956822877923797,1.0,3/7,15.34%,NOS1AP;HIF1A;SCARB1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.7325252452352774,1.1571907100499212,0.24358974358974358,0.996323952809531,1.0,3/11,16.47%,HDAC2;TBX3;TWIST1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.65281009646437,1.1569876561359258,0.2948717948717949,0.996115434894274,1.0,6/15,14.49%,WASF3;MICALL2;WASF1;DIAPH1;SPIRE1;WASHC5
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.7164032015782643,1.156924969706448,0.3013698630136986,0.9952425311691366,1.0,1/7,3.50%,RAB27A
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.675696623463103,-1.1569197209387112,0.4857142857142857,0.992303984703836,1.0,1/6,1.97%,PARP9
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.664941788647676,1.1568405658708825,0.275,0.9944630095321398,1.0,4/16,25.33%,MICALL2;ARIH2;UBE2D3;UBE2L3
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7184578605131785,1.1564601988637802,0.28205128205128205,0.9950639386189258,1.0,3/11,13.86%,PTPN1;PRLR;STAT3
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5821928891044965,1.1563519916928315,0.3,0.9918700133501747,1.0,7/42,7.04%,PRKACA;MUCL1;PSMB1;RAF1;PSMB2;BTRC;PSMA7
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.5821928891044965,1.1563519916928315,0.3,0.9918700133501747,1.0,7/42,7.04%,PRKACA;MUCL1;PSMB1;RAF1;PSMB2;BTRC;PSMA7
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.5821928891044965,1.1563519916928315,0.3,0.9918700133501747,1.0,7/42,7.04%,PRKACA;MUCL1;PSMB1;RAF1;PSMB2;BTRC;PSMA7
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.7227649079770521,1.1561553732133008,0.32,0.9916043283933194,1.0,4/9,19.81%,MIGA1;CHCHD3;SPG7;EEA1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.6414020991924066,1.1559208833965322,0.1927710843373494,0.9918044995467096,1.0,13/36,24.96%,NEDD4L;AMFR;ZNRF1;PELI1;RNF152;MARCHF6;RNF34;RBX1;UBE2B;UBR5;UBE2K;ARIH2;UBE2D3
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.7012134611243854,-1.1557340503107192,0.37142857142857144,0.9911076317319382,1.0,3/5,29.45%,PARN;DIS3L2;TENT4B
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.7405712993545353,1.1556944129020157,0.34285714285714286,0.9917976779426042,1.0,3/5,17.05%,BCL6;RUNX1;CBFB
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.753348500928912,1.1554025188412385,0.33766233766233766,0.9921388749504702,1.0,1/6,7.81%,TGFB1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.6619815284317502,1.1553859725517157,0.29213483146067415,0.9897717262034872,1.0,5/16,13.35%,CPSF2;SYMPK;GRSF1;CSTF3;PABPC1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.6619815284317502,1.1553859725517157,0.29213483146067415,0.9897717262034872,1.0,5/16,13.35%,CPSF2;SYMPK;GRSF1;CSTF3;PABPC1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.48826565485411344,-1.1550828141356906,0.17391304347826086,0.9885085793175991,1.0,4/18,8.53%,MRPL3;MRPL33;FASTKD2;MRPL1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.4438237683055551,-1.155077404091972,0.25,0.9837099939811059,1.0,4/27,2.34%,NTN4;NRP1;ITGA8;LAMC1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.7463646769154898,1.1546762681520248,0.25316455696202533,0.9926822120285422,1.0,1/9,2.05%,NRG1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.7368937127970181,1.154638405304017,0.35294117647058826,0.9916484126722798,1.0,3/6,15.34%,NOS1AP;HIF1A;SCARB1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7027346375416571,1.1545625141913154,0.328125,0.9906812562105699,1.0,4/5,27.01%,TSHZ3;NRXN1;NLGN1;PTK2B
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.5810628677485798,-1.1540605872426464,0.3076923076923077,0.9820302876414442,1.0,1/10,1.59%,BCL2L11
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.6182881348543511,1.1540247601025837,0.27058823529411763,0.9924411570196581,1.0,4/34,4.78%,ADAMTS9;KLF2;EPN1;NIBAN2
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.6850342531730393,1.1537621485030878,0.24675324675324675,0.9926891160105397,1.0,4/17,14.37%,TSC2;RUBCN;LZTS1;LRRK2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.7768969169812421,1.1537035078937254,0.234375,0.9918774090205951,1.0,2/6,8.28%,MINPP1;PPA1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.5558639854639223,1.1535448252552176,0.1414141414141414,0.9914627871725892,1.0,19/125,14.82%,SRSF12;HNRNPL;RBM17;STRAP;RAVER2;CDC5L;HNRNPF;CCAR1;CPSF2;CWC27;SYMPK;HNRNPC;ELAVL1;RBM4B;CSTF3;PABPC1;METTL14;SRSF10;NOVA1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.5637085304376961,1.153485036966258,0.22580645161290322,0.9904637324531458,1.0,10/51,12.59%,GRIN1;ACTR3;AP2A1;EPHA7;ANKS1B;EFNB2;SDCBP;GRIN2B;ROCK2;ARHGEF7
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.7683291722435255,1.1534817911029103,0.3055555555555556,0.9892764996471418,1.0,1/6,1.70%,GLRB
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.6304938118160102,1.15316713996928,0.26136363636363635,0.9896665160081304,1.0,6/23,10.52%,NUP153;SEC13;NUP88;SCARB2;HIF1A;NUP133
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.5638632524322884,1.1531368952264285,0.2631578947368421,0.988559318007029,1.0,25/60,24.86%,ARRDC2;ADAMTS4;PHYHIPL;GFAP;SEMA4D;KLHL2;KIF13B;MBP;MOBP;OMG;PDE8A;FGFR2;ASPA;SLC1A2;NRXN1;ST18;GRIA2;PLP1;MAPK4;ARSG;TF;MT3;PEX5L;GPM6B;KIF1B
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.6850210051665379,1.1529787765638195,0.36585365853658536,0.9881514099825021,1.0,2/14,6.87%,MICALL2;PRKCI
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.5932661004759238,-1.1528784964577126,0.25925925925925924,0.981131168359942,1.0,3/10,12.69%,FASTKD2;RPL6;RPL23A
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.7912571829988964,1.1526405893995166,0.28378378378378377,0.9890093639073511,1.0,3/5,20.71%,PTPN1;BRAP;UBASH3B
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.7706498889805565,1.15251660650498,0.3076923076923077,0.9884503171340028,1.0,2/5,13.07%,AK9;AK3
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.8112383882909399,1.1523149734881286,0.21428571428571427,0.9884730435635346,1.0,2/5,6.87%,SLC22A6;PRKCI
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7557151741312814,1.152088953361929,0.3333333333333333,0.9885839238351091,1.0,1/5,9.58%,F3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6906046213763074,1.1519275852926762,0.3291139240506329,0.9881155802595079,1.0,5/14,16.01%,RUBCN;TGFB1;IRS1;FLT1;AMBRA1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.6257920179412112,1.1518297083343492,0.2823529411764706,0.9874598400318226,1.0,6/16,28.55%,CP;TF;MT3;IREB2;CYBRD1;SLC40A1
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.7418898127107237,1.1516666318282638,0.2972972972972973,0.9858522677336239,1.0,3/6,21.72%,IRS1;INSR;IRS2
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7418898127107237,1.1516666318282638,0.2972972972972973,0.9858522677336239,1.0,3/6,21.72%,IRS1;INSR;IRS2
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.7042388422894725,1.151355731662045,0.3125,0.9862412176561179,1.0,2/8,15.83%,NIBAN2;CFL1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.6684835696567939,1.1513515693456986,0.30952380952380953,0.9850531457325864,1.0,3/14,13.60%,COG2;NSF;NAPG
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.6905822028918396,1.1511222217699266,0.32,0.9851672738369985,1.0,4/10,17.24%,CST3;CAMK2N1;LRRK2;PRNP
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5748353805994916,1.1509332120455937,0.18556701030927836,0.9849816557056948,1.0,12/61,15.83%,RANBP10;RHOB;WASF3;DPYSL2;DIAPH1;NECTIN2;PRKCI;CAPZB;RANBP9;MICAL3;PACSIN2;CFL1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.6623176629533126,1.150633715790206,0.34615384615384615,0.9852326788160571,1.0,1/10,3.50%,RAB27A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7086280647138099,1.1503860435858226,0.26666666666666666,0.9852590376171839,1.0,1/9,1.38%,PRKACA
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.6845243924447162,1.1503350381429844,0.25609756097560976,0.9843529323461359,1.0,3/11,13.67%,RNF10;TNFRSF1B;PTPRZ1
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.7677209804710534,1.1498661685243703,0.30666666666666664,0.9860069037838973,1.0,4/6,21.72%,PPARA;IRS1;TWIST1;IRS2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.720785251036142,1.1492372631515047,0.3076923076923077,0.9883637365096304,1.0,3/6,17.16%,ADAM17;OXSR1;STK39
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.7198105442828959,1.1487980349727749,0.36363636363636365,0.9894266248451679,1.0,1/7,1.44%,CAMKMT
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.7382770634649666,1.1486537094785982,0.2777777777777778,0.9890642047298446,1.0,2/5,18.13%,SGPL1;ACER3
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.7536174950868195,1.1484875560672216,0.2564102564102564,0.9888262300086349,1.0,3/8,16.47%,NIBAN2;TGFB1;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.7707276326695407,1.1482569877522333,0.32,0.9886752231913448,1.0,2/5,11.32%,PPARA;PAG1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.6724113158709957,-1.1481592079169454,0.3103448275862069,0.9922788532222494,1.0,1/5,0.34%,CAV2
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.6503383499436396,1.1475855687991365,0.30864197530864196,0.9911008233356858,1.0,3/15,9.46%,CSF1;ADAM17;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6911931763212983,1.1473898703335912,0.2702702702702703,0.9909474284073879,1.0,4/10,8.44%,SYT1;RIMS2;ANK3;GRIK2
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.5951238338098362,1.1472498274012675,0.26595744680851063,0.9903763166046428,1.0,8/47,13.38%,PRKACA;PCBP3;ZFP36L2;ALKBH5;PPARGC1A;DCP2;CSTF3;TCERG1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.6247522796779892,1.147218653654864,0.2727272727272727,0.9894749743453374,1.0,4/21,11.82%,GFAP;RAP1B;SNCAIP;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.7107654507342114,1.1470244714019981,0.28205128205128205,0.9893486298122147,1.0,2/10,9.30%,CTR9;DNMT1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.7043458768891921,-1.146665408519412,0.44,0.9924084199717623,1.0,4/5,19.49%,ST6GALNAC3;ST3GAL1;ST3GAL5;ST3GAL2
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.6597750090156967,1.1464692884904826,0.35064935064935066,0.9909256532127096,1.0,5/15,24.82%,RAB27A;SCARB1;PIP4P2;ITGAV;CAMK1D
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7465815716353578,1.1463328007052511,0.2537313432835821,0.9906510169193573,1.0,1/6,2.61%,PDK1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.5883133024882281,1.1463275294493172,0.2808988764044944,0.989472553403724,1.0,12/34,23.15%,GJA1;CDH18;CDH2;CDH12;CTNND2;CDH20;CDH10;CD9;JAM3;SMAD7;PKP2;PIP5K1C
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.776611583679827,1.1461080402310275,0.3709677419354839,0.9892979859551442,1.0,2/5,20.61%,SSH1;RYR3
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.5945831235227441,1.1455264260270654,0.29069767441860467,0.9915381484508934,1.0,8/23,25.10%,PTPRD;ANK3;UGCG;NRXN1;NLGN1;STX2;GAK;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.6414714975423264,1.1451643749041118,0.30864197530864196,0.9920070064528672,1.0,5/19,20.64%,FMN2;EGFR;MDM4;PRNP;ITGAV
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5410104898901029,-1.145008767781581,0.18181818181818182,0.9927140685479234,1.0,2/9,8.25%,ATM;PIK3R4
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.6902683101449116,1.1449162453128578,0.325,0.9920003342866693,1.0,2/11,12.72%,HDAC2;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.7063764071318324,1.1447251609847207,0.2876712328767123,0.9917749818933601,1.0,3/7,19.55%,KDM1A;FZD3;NAP1L1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.6333526725658818,1.1445781768898855,0.23170731707317074,0.9914894908905332,1.0,5/26,14.95%,LPIN1;MMUT;ACADVL;ECHDC1;ACADL
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.6572139848221198,1.1444342159281897,0.35,0.991265284561804,1.0,3/16,11.41%,CD44;GYPC;EPOR
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.7559034967748016,1.1442054609030323,0.3225806451612903,0.9912353143798097,1.0,1/5,11.82%,ROCK2
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.5796214643114168,1.1441217407246682,0.2727272727272727,0.9906370914754337,1.0,4/37,6.16%,LPIN1;HSPA4L;NAA11;PIAS2
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.7187406886029717,1.1438676893878714,0.33766233766233766,0.9906683267483241,1.0,2/8,8.42%,ESR2;ARID1A
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.6628274884049095,1.143381763308052,0.30985915492957744,0.9920626421583031,1.0,1/12,3.37%,DDX3X
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.6366308594680635,1.1433549636741185,0.2857142857142857,0.9909836046383289,1.0,10/18,32.19%,RBM4B;SAMD8;METAP1;MAPKAPK5;CYFIP1;PUM3;FOXO3;GRM5;APP;EIF4E
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.7202723543026571,1.1430641722357109,0.3150684931506849,0.9911587360579274,1.0,5/8,25.46%,KDM1A;PTPRZ1;LRRK2;NAP1L1;TAFA1
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.768671386201746,1.1427379921980247,0.33766233766233766,0.9915979052071187,1.0,1/5,6.99%,SLC39A11
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.7234807161515594,1.1424537048708412,0.28125,0.9918559422229146,1.0,3/5,26.93%,HIF1A;RBPJ;VEGFA
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.5808038747751145,1.1422777479705803,0.2717391304347826,0.9917296207773532,1.0,14/42,18.37%,TENM2;PTPRD;DDIT4;TENM3;SMARCA1;UGCG;WNT2B;ADNP2;ACSL4;RUNX1;MYT1L;FZD3;MAP2K1;THOC2
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.6742973693816954,1.1420395559667356,0.3670886075949367,0.9919509606137155,1.0,2/10,7.94%,DPM1;PIGL
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.7109942691322633,1.141972458494398,0.32894736842105265,0.9911069865913902,1.0,2/8,3.95%,NFKBIA;SUFU
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.6371063423000085,1.1419132602421154,0.35365853658536583,0.9902410962402983,1.0,3/16,7.81%,SUFU;IPO5;TGFB1
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.637650331431477,1.141889555292059,0.3170731707317073,0.9892340079053478,1.0,6/17,24.80%,DDIT4;TGFB1;MAPK1;SMAD7;UBE2K;SPRED1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.587748140308241,1.1418156145199327,0.25555555555555554,0.988503484319116,1.0,7/39,12.64%,OS9;AMFR;RHBDD1;UBE2J1;SELENOS;MARCHF6;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6532850777713263,1.14174569255413,0.34523809523809523,0.9876436843349161,1.0,5/12,19.41%,PTPRD;SEMA4D;SYNDIG1;NRXN1;NLGN1
prerank,MSigDB_Hallmark_2020__Complement,0.5380180175704236,1.1415490587100132,0.21978021978021978,0.987440065701775,1.0,19/65,23.12%,USP15;RAF1;CPM;CP;F3;C1R;CTSL;CEBPB;ZFPM2;LIPA;CFH;HSPA5;LGALS3;CA2;DGKH;GRB2;LAMP2;DOCK4;MT3
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.7711702225724874,1.1410350139006948,0.3108108108108108,0.9888526174160231,1.0,1/5,2.63%,HABP4
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.5604172261836601,1.140938639647997,0.20212765957446807,0.9882327447423311,1.0,2/46,0.61%,CD44;ADAMTS9
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.5498588176686272,1.1408053918295278,0.25806451612903225,0.9876617266525524,1.0,18/67,17.05%,CSF1;PURB;PRKACA;PTPRQ;RAF1;SMOC1;PRKCB;TGFB1;EIF2AK2;CCN2;CEBPB;BCL6;RUNX1;FGFR2;CEBPD;ST7;LGALS3;CBFB
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.6413823734156345,-1.1407416790363085,0.3076923076923077,1.0,1.0,1/7,0.42%,DNAI4
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.5423060250242624,1.1406890801703633,0.23232323232323232,0.9871512311422169,1.0,26/91,21.35%,TSC2;DHRS3;AMFR;PTPN1;SIK2;NCAM1;TGFB1;UGCG;GALNT11;ELF1;RGS5;RUNX1;FGFR2;TRIM5;DCDC2;LRRK2;IGFBP2;BRAP;CBFB;PRNP;PTPN2;LIFR;GIT2;UBASH3B;YWHAG;TMEM204
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.7260501797099999,1.140370395657157,0.30985915492957744,0.987611560617748,1.0,3/6,23.12%,UGCG;STAT3;MT3
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.7490461710021595,1.139834981213773,0.32432432432432434,0.9894881548674342,1.0,1/7,2.05%,NRG1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.6916960477162193,1.1396932701113673,0.3924050632911392,0.989012709443008,1.0,2/9,7.94%,DPM1;PIGL
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.6703534965704236,1.1396360252643674,0.3246753246753247,0.9881141510429144,1.0,1/9,10.99%,TRAF3IP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6552285866314382,1.1396292765511105,0.3291139240506329,0.987052891149795,1.0,8/19,22.99%,GJA1;NR4A3;SOD2;DNMT1;CDKN1B;PDCD4;LDLRAP1;JUN
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.6708985455235899,1.139429249229403,0.3333333333333333,0.987205004466817,1.0,6/11,26.93%,AGO2;SMURF2;POMZP3;ACVR1B;LHFPL2;VEGFA
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.5956872865529865,1.1394095497194419,0.2840909090909091,0.9861589882668554,1.0,11/39,22.76%,CHST11;OGN;PAPSS1;MGST1;DSE;CHSY1;PAPSS2;CHST15;SLC10A7;GCLC;METTL16
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.6180911805732627,-1.139277789206534,0.375,1.0,1.0,1/10,3.74%,RYR2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.7631713584028325,1.1391407578380006,0.3150684931506849,0.9863704286148018,1.0,1/6,0.38%,SOD1
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.6474520208920812,1.1389714204443864,0.2972972972972973,0.9861127471226613,1.0,5/18,20.81%,ENPEP;SGPL1;CYP3A5;SIAH1;LNPEP
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.6444164575837327,1.1389577510538802,0.3333333333333333,0.9850481941702475,1.0,3/16,12.00%,TSC2;TGFB1;DEAF1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.7465771714546009,1.1389280753577908,0.2647058823529412,0.9840094663324654,1.0,2/5,11.55%,CRACD;WASHC2C
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.785877434230709,1.1384742247108526,0.28378378378378377,0.9857985978040961,1.0,1/6,7.68%,TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.7746647733543588,1.1382889816596162,0.2876712328767123,0.9857293480864728,1.0,5/6,21.72%,PPARA;IRS1;TWIST1;ABHD5;IRS2
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.6582973864787788,1.1379831961796691,0.3375,0.9862310465053299,1.0,5/14,14.15%,PDE10A;XKR4;CREM;MCF2L2;MYT1L
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.7420419795249831,1.1376495832456435,0.296875,0.9866966905619731,1.0,2/5,8.41%,MTMR9;MTMR1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.6651920532604233,1.1372032668253498,0.31645569620253167,0.9877423772557717,1.0,3/12,16.47%,NIBAN2;TGFB1;TWIST1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6987309966202706,1.1371939843539967,0.2804878048780488,0.9867309061848463,1.0,5/9,26.39%,INSR;TDG;MYSM1;TRIP12;RAB14
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5957750507736834,1.13719206389902,0.27586206896551724,0.9856057854252284,1.0,8/36,18.70%,ADAM17;TGFB1;SDCBP;ACVR2A;RNF111;ACVR1B;RBPJ;SMAD2
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.6790514802479303,1.1369117765499335,0.32051282051282054,0.9858962838169125,1.0,4/10,19.84%,ADGRV1;AKAP6;LRRK2;PRKAR2A
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5776059935097515,1.1367619279688987,0.35294117647058826,0.9855035354058431,1.0,9/31,21.93%,ROBO1;CASP8AP2;F3;IFT57;SENP1;APAF1;TNFRSF10B;SLC22A2;COL4A3
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.691840868425547,1.136660057157077,0.3333333333333333,0.9849036697247705,1.0,5/10,25.20%,SLC7A2;SLC3A2;SLC1A2;SLC22A2;SLC1A1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.6659251931857532,1.136556452765397,0.3424657534246575,0.9843744237517993,1.0,1/12,1.24%,GJA1
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.7853588055867714,1.136342431562398,0.2698412698412698,0.9842383944874115,1.0,5/5,21.53%,NEDD4L;FHL1;LRRK2;CAMK2D;SMAD7
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.6435153451872703,1.136194326696235,0.3176470588235294,0.9837686848980707,1.0,3/17,3.83%,NKAIN3;SPTBN4;ANK3
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.6377159813765532,1.1361370126116204,0.26506024096385544,0.9829204121255473,1.0,5/14,20.64%,ITGA5;DUSP1;COL7A1;COL11A1;ITGAV
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.5994828260560816,1.1361360213008962,0.2840909090909091,0.9818097675920721,1.0,6/29,16.73%,KCNC2;ATL1;ATL2;ELAVL1;TP53BP1;ZBTB1
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.532910311198703,1.13596422705747,0.16161616161616163,0.9814936015586294,1.0,26/147,13.46%,CD44;TPT1;HDAC2;NFKBIA;MYDGF;FMN2;CD38;DDX3X;RHBDD1;NIBAN2;RAF1;SEMA4D;PRKCI;APIP;BNIP3L;EGFR;NAIP;RPS27A;WDR73;TMBIM6;PRLR;TBX3;NAA38;RAB7A;HSPA5;KDR
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.6947233906745568,1.1358629687830855,0.3037974683544304,0.9809832450060826,1.0,3/10,19.68%,BTRC;GOLGA2;SKP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.6996764121958688,1.1350288988016461,0.24050632911392406,0.9837951165703459,1.0,1/11,3.59%,DDIT4
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.5921609008517337,-1.1343885395976858,0.25,1.0,1.0,1/7,0.27%,A2M
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6078009770390868,1.133839776347862,0.2717391304347826,0.9888541675762653,1.0,9/25,12.80%,KCNC2;KCND2;KCNQ1;KCNH7;KCNQ3;ATP1B3;KCNQ5;ABCC9;NALCN
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.6713366462897334,-1.1338386894838688,0.4444444444444444,1.0,1.0,2/6,5.68%,LMCD1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.6713366462897334,-1.1338386894838688,0.4444444444444444,1.0,1.0,2/6,5.68%,LMCD1;SLC9A1
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.5992211819143727,1.1337848332165585,0.3372093023255814,0.9879487681682301,1.0,8/26,21.53%,USP15;TGFB1;HIVEP1;ACVR2A;PDCD4;SMAD2;SMAD6;SMAD7
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.6997383440435014,-1.1337626271457877,0.3076923076923077,1.0,1.0,1/5,0.26%,ZDHHC15
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.5504359578283701,1.1336476762113674,0.19387755102040816,0.9875932460336129,1.0,18/115,14.82%,SRSF12;HNRNPL;RBM17;RAVER2;CDC5L;HNRNPF;CCAR1;CPSF2;CWC27;SYMPK;HNRNPC;ELAVL1;RBM4B;CSTF3;PABPC1;METTL14;SRSF10;NOVA1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.6699810294470376,-1.1334515851482196,0.36,0.9986364647988327,1.0,1/5,7.62%,AKR1C3
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5546343963385403,1.1333473016144358,0.24210526315789474,0.9881961748910569,1.0,9/59,8.23%,PHYHIPL;CRMP1;LSAMP;DCLK1;PTPRD;CACNA1B;PCDH17;ADGRB3;SNAP25
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.6277295942665819,-1.1332055481875336,0.3225806451612903,0.9949733535181973,1.0,1/6,0.19%,WDFY4
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.6245464817442185,1.1331395473739863,0.28,0.9881941960563655,1.0,8/23,21.37%,ADGRV1;DHRS3;OPA3;SLC4A10;ATF6;COL11A1;COL18A1;PITPNA
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.7028956321697724,1.1330102518577458,0.3333333333333333,0.9876689653756954,1.0,3/8,24.80%,DDIT4;SMAD7;SPRED1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.6888038399189954,1.1329699868672924,0.3181818181818182,0.985645943076419,1.0,4/11,22.57%,ENO1;PGK1;TPI1;HK1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.6888038399189954,1.1329699868672924,0.3181818181818182,0.985645943076419,1.0,4/11,22.57%,ENO1;PGK1;TPI1;HK1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.5591787419417691,1.1328573094686398,0.2736842105263158,0.9851819953440033,1.0,16/75,15.80%,PHYHIPL;ELAVL3;CRMP1;LSAMP;DCLK1;CACNA1B;PCDH17;SCN3A;ADGRB3;SNAP25;ZNF536;CADM2;AKAP6;NOVA1;TSHZ1;NRXN1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.6865302965048679,1.1328395865419254,0.25301204819277107,0.9841302085871058,1.0,5/10,16.47%,NIBAN2;TGFB1;SIN3A;ZBTB7A;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7499006678650784,1.1325019870348059,0.34375,0.9847775423645657,1.0,3/5,19.41%,NR4A3;SGIP1;NLGN1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.6310901625527428,1.1323923917746637,0.345679012345679,0.9842483102015211,1.0,4/17,11.29%,RIPOR1;PTPN1;TGFB1;UHMK1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.628377227399512,1.132020247307708,0.3037974683544304,0.9847022010359383,1.0,8/24,21.00%,GRIN1;FARSB;APIP;SOD2;GRIN2B;GOLGA2;RYR3;ALDH1A2
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.6192352298162724,1.1319443001952942,0.30666666666666664,0.9840727576294817,1.0,9/21,27.38%,NRCAM;DIP2B;SIN3A;ABL1;MT3;OLFM1;DNM2;GOLGA4;ZFYVE27
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.5192605855346893,1.1317163887826263,0.20202020202020202,0.9841992464544203,1.0,37/204,14.52%,WWC1;GJA1;ADGRV1;NRG1;MYDGF;DDX3X;USP15;RHEB;NOS1AP;PELI1;NDFIP2;IL18;SEMA4D;SLC38A9;SEC13;PRKCB;TBK1;TGFB1;EIF2AK2;EGFR;DDX21;IRS1;VAPA;CXXC5;F3;IQCJ-SCHIP1;EPOR;ROCK2;ANKRD17;NDFIP1;FLT1;FGFR2;TRIM5;KDR;SIAH1;TNFRSF10B;INSR
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.7179684257374246,1.1316737955674023,0.36,0.9832792700520232,1.0,2/7,13.86%,IL18;STAT3
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.709596559491571,1.1316541951102757,0.2962962962962963,0.982260194871275,1.0,3/10,17.13%,TET3;CTR9;SETD3
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.5944413300948039,1.1315462714388356,0.26436781609195403,0.9816923481969961,1.0,5/40,5.49%,CDC42EP4;TENM2;CCP110;ACTR3;AKIRIN1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.6816972125678186,1.131389511829637,0.3888888888888889,0.9814396923792754,1.0,4/10,14.37%,GRIN1;GABRE;GRIN2B;LRRK2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.650688104404967,1.131277092789202,0.28,0.9810867953329457,1.0,8/17,22.02%,NRG1;TGFB1;ZFPM2;FGFR2;MYL3;RBPJ;SMAD7;PKP2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.601862257465297,1.1312746932856583,0.3655913978494624,0.9800186793555855,1.0,4/28,9.74%,MCC;RHOJ;HIF1A;GLUL
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.7449567564814485,1.1312277015635883,0.2923076923076923,0.9792546395030516,1.0,1/6,10.27%,DNAJC15
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.5376395822634481,1.1311032725660584,0.30434782608695654,0.9789053030977924,1.0,15/69,14.37%,PLAA;PANK2;PTPRD;EPHA7;MINPP1;TGFB1;PPA1;AGK;GK5;PLAAT3;FRA10AC1;STAT3;PGK1;PPP3CA;LRRK2
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.6521100158910366,1.1308171608549125,0.26436781609195403,0.9791700172714779,1.0,1/19,0.16%,STC1
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),0.8126616557739396,1.1306821635127537,0.24358974358974358,0.9787658467320235,1.0,2/5,12.95%,CTR9;WAC
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.5546220225669692,1.1303844506602934,0.18181818181818182,0.9794418046571098,1.0,14/81,11.47%,TP53TG5;GJA1;NRG3;DDX3X;ENO1;FHL1;ADAM17;TGFB1;ESR2;EGFR;APBB1;ADNP2;SDCBP;BCL6
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.659496208769958,1.1303011618963024,0.3424657534246575,0.9788381672971836,1.0,2/12,3.83%,GRIN1;ANK3
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.6560807703368503,1.1302001465708396,0.2898550724637681,0.9782358479227596,1.0,1/15,1.24%,GJA1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6409107698946526,1.1301771244537335,0.3333333333333333,0.9772577880834762,1.0,2/15,3.10%,KDM1A;SGCZ
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.6840807866927934,1.1300852768277934,0.35064935064935066,0.9767028134864076,1.0,7/11,23.15%,SYT1;RIMS2;SNAP25;SNAP23;STX2;DNAJC5;PIP5K1C
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.6443234558261702,1.1298356722144198,0.27380952380952384,0.9767355284002817,1.0,6/19,16.28%,TAF1B;CPSF2;SYMPK;CCNH;CSTF3;POLR1C
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.6324322226938378,1.1296697753743687,0.34210526315789475,0.9764365622411094,1.0,2/15,7.62%,TSC2;PPARA
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.652541504768207,1.129550269767158,0.2857142857142857,0.975950537026352,1.0,1/18,0.38%,SOD1
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.7686071082273498,1.129378134565287,0.3333333333333333,0.9747612912696854,1.0,2/5,7.11%,MTHFD2L;ALDH1L1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.7686071082273498,1.129378134565287,0.3333333333333333,0.9747612912696854,1.0,2/5,7.11%,MTHFD2L;ALDH1L1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.6285351627984123,1.128898706158411,0.34177215189873417,0.9760175756964748,1.0,4/16,20.77%,CCT4;TNKS;MAPK1;MAPKAPK5
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.5706791490578443,1.128870927199951,0.38202247191011235,0.9751273302943029,1.0,10/34,17.28%,PURB;CTR9;NR4A3;PRKCB;ZBTB16;SIN3A;RUNX1;LGALS3;CBFB;ZFPM1
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.7430546257000433,1.1285829571173804,0.2714285714285714,0.9755568528406223,1.0,3/6,13.86%,NR4A3;UGCG;STAT3
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.5704553506311254,1.1284673422792857,0.3146067415730337,0.9749542502468485,1.0,15/48,18.62%,FMN2;NEDD4L;GFAP;EGFR;SMURF2;RAB7A;NSF;MDM2;MDM4;TIPARP;WWP1;HECW1;CDKN1B;CSNK2A1;AREL1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.636943925518867,1.1282838159182698,0.34615384615384615,0.9748899067359403,1.0,1/13,1.38%,PRKACA
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.7484446121189207,1.1281753624792783,0.33783783783783783,0.9743987851652204,1.0,1/5,7.62%,PPARA
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.6457973892629401,1.1280385864501417,0.3048780487804878,0.974050872280526,1.0,4/15,5.28%,RIPOR1;ARL5A;COG7;CSNK1D
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.540329010031439,1.1280156177306182,0.1919191919191919,0.9731138613748809,1.0,39/155,27.05%,WWC1;SUFU;WWC2;HCFC2;YAF2;CTR9;CCAR1;ESR2;APBB1;CLOCK;HIF1A;MTF2;CEBPB;PPARGC1A;ZNF536;CREM;STAT3;INSR;PLAG1;SRSF10;MZF1;ACVR1B;ABL1;SP1;RALY;NCOA2;NLK;SP3;NSD2;ZNF138;DNM2;RFX3;YBX1;UBE2L3;RPS6KA5;SFPQ;ESRRG;SOX13;ZMIZ1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.5379551048359189,1.1279984852895,0.24742268041237114,0.9721352158492371,1.0,20/87,17.28%,SOD1;CADM1;PDE4B;CSF1R;IL18;ADAM17;TBK1;TGFB1;EIF2AK2;MBP;HIF1A;F3;CEBPB;ROCK2;RUNX1;STAT3;PDE4D;POLR1C;TWIST1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.5372548244384279,1.1276689932876736,0.19,0.9724775256209813,1.0,47/176,26.84%,WWC1;SUFU;WWC2;HCFC2;YAF2;CTR9;CCAR1;ESR2;APBB1;RBM4B;CLOCK;HIF1A;MTF2;CEBPB;PPARGC1A;ZNF536;CREM;ANKRD17;STAT3;INSR;PLAG1;SRSF10;MZF1;ACVR1B;RBBP6;ABL1;SP1;METAP1;MAPKAPK5;NCOA2;NLK;SP3;NSD2;ZNF138;DNM2;CYFIP1;RFX3;YBX1;PUM3;FOXO3;CCDC88A;UBE2L3;RPS6KA5;SFPQ;TOM1L1;ESRRG;SOX13
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.7590070344588122,1.1276390731154755,0.37662337662337664,0.9715887608256428,1.0,2/5,10.03%,NFKBIA;EIF2AK4
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.7526558911406922,1.1275556311303534,0.2676056338028169,0.9710499398065507,1.0,4/7,19.79%,PARP11;TIPARP;TNKS;PARP6
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.5994333525868807,1.127077000553881,0.2962962962962963,0.9726852128307668,1.0,3/27,15.30%,NFKBIA;TMSB4X;ERBIN
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.7568573762726225,1.1270213767971222,0.2972972972972973,0.9719293093696079,1.0,4/7,17.76%,NDFIP2;NDFIP1;CORO2B;DNAJA1
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.5470821154353686,1.126803790449499,0.2978723404255319,0.9718255105157747,1.0,4/66,1.35%,STC1;RHOB;GJA1;MCC
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.521975593746178,-1.1267827867071922,0.3076923076923077,1.0,1.0,5/21,8.49%,NSUN3;TARBP1;TFB1M;DIMT1;TRMT44
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.7617137220780141,1.1267348558627135,0.3108108108108108,0.9711912626459627,1.0,2/5,12.53%,PRKACA;ABCA1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.7319195142972682,1.1265105191622244,0.345679012345679,0.9713048394120031,1.0,3/5,21.99%,ADGRB3;CD9;CD81
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.6905753509737487,1.126320908491431,0.313953488372093,0.9712560700226563,1.0,2/8,20.64%,HIF1A;ITGAV
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7200758054903563,1.12614220769167,0.3287671232876712,0.9709806984343886,1.0,3/10,15.30%,LRRC7;PRKCI;ERBIN
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.5224016029171222,1.1256317635218154,0.11,0.9723343044728046,1.0,90/383,21.99%,WWC1;TAF7;KLF2;ETV5;KLF15;LPIN1;HDAC2;GRIN1;NFKBIA;MYDGF;KDM1A;GLIS3;EAPP;DDX3X;ACTR3;KANSL3;TET3;AGO2;SMARCA1;AKIRIN1;IL18;PRDM10;CDC5L;RNF10;NR4A3;TP63;PPARA;CTBP2;TBK1;TGFB1;EGFR;APBB1;MED14;RPS27A;CLOCK;HIF1A;MTF2;CEBPB;PPARGC1A;SIN3A;ZFPM2;PTOV1;SREBF1;TBX3;ELF1;FUBP3;RUNX1;FGFR2;SENP1;TCERG1;STAT3;RARB;PPP3CA;ATF6;PLAG1;TP53BP1;GLYR1;HIVEP1;ACVR2A;MZF1;TNKS;TEAD1;RNF111;TWIST1;BCLAF3;SETD3;ZFPM1;ARF4;CRLF3;ABL1;NFIX;ST18;PER1;SP1;RBPJ;SMAD2;JUNB;SMARCA4;SUPT16H;KLF6;PAXBP1;CCNK;NCOA2;ECD;SMAD7;MYSM1;SP3;TCF4;ELL;CD81
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.700098357732506,1.1255609953906331,0.32,0.9716274685118956,1.0,3/8,14.37%,SELENOS;TMBIM6;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.6378432495886626,1.1255283331070303,0.2716049382716049,0.9707499486582056,1.0,3/17,10.22%,CTR9;DNMT1;MTF2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.6510587736769684,1.1250488718821856,0.2962962962962963,0.9718307593835651,1.0,4/15,12.26%,DDX3X;ADAM17;EGFR;ANKRD17
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.7398707667642344,1.1245890843410462,0.2361111111111111,0.9731884888505021,1.0,4/6,17.24%,RHBDD1;RUNX1;LRRK2;PRNP
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.7093621056870945,1.1245842454923618,0.32894736842105265,0.9722048274568307,1.0,2/7,13.12%,NEDD4L;MDM2
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.6432671809494477,1.1244951924416047,0.3333333333333333,0.9715768632137384,1.0,6/18,22.02%,TGFB1;FGFR2;MYL3;RBPJ;SMAD7;PKP2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.5248758883406868,-1.1232943661122274,0.3333333333333333,1.0,1.0,3/16,1.65%,PGR;MECOM;DKK3
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.6297444511139101,1.1232796552401358,0.35714285714285715,0.9769876165360472,1.0,4/16,22.49%,PRKACA;PDK3;SELENOT;TRA2B
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.5497295907381068,1.1229924230392203,0.23232323232323232,0.9774145849519912,1.0,29/105,25.33%,OS9;NEDD4L;AMFR;NDFIP2;RC3H2;BTRC;RNF168;RPS27A;RNF34;SMURF2;NDFIP1;MDM2;SIAH1;RNF19A;RBX1;PSMD14;RNF111;RBBP6;FBXO11;AREL1;ANAPC4;UBE2B;UBE4B;RCHY1;UBE2K;ARIH2;UBE3B;TRIP12;UBE2L3
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.6756657164650799,1.1228586649613048,0.3157894736842105,0.9770929084407226,1.0,1/9,2.45%,FMN2
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.6520588564395071,1.1226370618965613,0.3194444444444444,0.9771240468571928,1.0,5/19,8.52%,NEDD4L;PTPRD;SEMA4D;ADGRB3;LZTS1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.46487595562238443,-1.1223921420182654,0.2727272727272727,1.0,1.0,2/26,1.09%,SH3RF3;TNFRSF19
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.6422366492525124,1.1222488242528148,0.30120481927710846,0.9780078975128309,1.0,7/17,15.93%,SLC23A2;SLC38A4;SLC38A9;SLC16A7;SLC13A3;SLC36A4;SLC38A10
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.6143791726662338,1.122163091989151,0.32926829268292684,0.9774523419805133,1.0,3/23,5.53%,GJA1;GRIN1;SNX6
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.7319895017342735,-1.1221227416026633,0.41379310344827586,1.0,1.0,3/5,21.14%,MYO1E;PODXL;IQGAP1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.7319895017342735,-1.1221227416026633,0.41379310344827586,1.0,1.0,3/5,21.14%,MYO1E;PODXL;IQGAP1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.6519467202446418,1.1217218314049353,0.23529411764705882,0.9782808130796692,1.0,4/21,10.12%,KDM1A;RHBDD1;EIF2AK4;GNB1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.5449835446321224,1.1216858684761204,0.25,0.9774392232253669,1.0,21/75,21.53%,TAF7;TSC2;DDIT4;SEMA4D;ERRFI1;TGFB1;TRAF3IP1;SNX25;CAMK2N1;LRRK2;C9ORF72;PDE4D;TWIST1;PRNP;PRR5L;PPM1E;NF1;UBASH3B;YWHAG;SMAD6;SMAD7
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.607791435872296,1.1216050694940514,0.3522727272727273,0.9768435401912064,1.0,7/25,23.55%,PELI1;RNF152;RNF168;TRIM5;HECTD1;UBE2B;ARIH2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.8105030513778264,1.1215690554101596,0.26153846153846155,0.9759733917726283,1.0,2/5,14.95%,ACADVL;ACADL
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.7200467622376915,1.1201716720605506,0.3283582089552239,0.981482099800047,1.0,2/6,14.55%,NECTIN2;TP53BP1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.6677520735899019,1.1199612761072846,0.3373493975903614,0.9813920088827726,1.0,8/12,29.84%,PDE4D;GNAI1;MGRN1;PRKAR2A;UBE2B;PEX5L;PRKAR1A;PRKAR1B
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.5580236046086714,1.1199475035171647,0.25274725274725274,0.9804564194507737,1.0,16/55,19.89%,NFKBIA;PSMB1;PELI1;PSMB2;BTRC;PSMA7;RPS27A;HIF1A;TANK;PSMA4;USP10;RBX1;PSMD14;ST18;SKP1;MAP3K8
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.6516392177975442,1.1197963051153246,0.325,0.9802830999632852,1.0,3/15,7.52%,OS9;SEC13;SELENOS
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.6329339759878381,1.119572586237067,0.25316455696202533,0.9803422211615329,1.0,2/19,1.03%,SOD1;RHOB
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.5934365692248031,1.1195677190344435,0.32558139534883723,0.9793473989052256,1.0,13/29,25.36%,PELI1;SCD;ADAM17;PPARA;TGFB1;MAPKAPK2;STAT3;ERBIN;GPX3;SMAD6;TAB2;FOXO3;STRN3
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.7879445301949266,1.1191115500062045,0.38028169014084506,0.9805127328461991,1.0,1/5,1.06%,LPIN1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.6970676173062536,1.1190598763598054,0.3424657534246575,0.9798037349688631,1.0,5/8,23.52%,NRCAM;SIN3A;ABL1;OLFM1;DNM2
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.5308779687003411,-1.1185730954814048,0.30434782608695654,1.0,1.0,2/15,3.02%,SERPINI1;SERPINH1
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.7987909182935938,1.1184150735162002,0.2727272727272727,0.9819221947776994,1.0,1/5,2.09%,RAD21
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.6706204002258399,1.11816168288425,0.4,0.9820947611671047,1.0,4/11,16.01%,TGFB1;IRS1;FLT1;AMBRA1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6948624534202894,1.117702853193916,0.4,0.9829274567294051,1.0,4/9,19.41%,NRXN3;NCAM2;NRXN1;NLGN1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.5796899301226881,1.1175177290369342,0.3522727272727273,0.9828577512869692,1.0,8/25,15.83%,WASF3;MICALL2;WASF1;DIAPH1;SPIRE1;MICAL3;WASHC5;CFL1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.664671427570815,1.117267025865438,0.3048780487804878,0.9830288225573648,1.0,4/11,19.38%,PRKACA;AKAP6;PDE4D;CAMK2D
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.6280563886199124,1.1172638594918207,0.36904761904761907,0.9820185154427119,1.0,1/15,0.38%,SOD1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.6458979073621096,1.1163981389845008,0.325,0.9841344480031848,1.0,3/15,12.00%,TSC2;TGFB1;DEAF1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.6458979073621096,1.1163981389845008,0.325,0.9841344480031848,1.0,3/15,12.00%,TSC2;TGFB1;DEAF1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.63509475541339,1.1162681697732046,0.2564102564102564,0.9836470854495181,1.0,7/15,15.93%,SLC38A4;SLC6A17;SLC7A2;SLC38A9;SLC3A2;SLC36A4;SLC38A10
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.5317880714827483,-1.1160790079851226,0.2916666666666667,1.0,1.0,3/13,9.50%,CDK6;RBL1;AKT3
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.7119498368403872,1.1158385988822654,0.33766233766233766,0.9844618172808758,1.0,3/6,27.94%,STAT3;CANX;IL6ST
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.639843459669909,1.115639617350146,0.34177215189873417,0.9843286530920908,1.0,2/14,10.97%,DDX52;RIOK3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.6557705631365248,1.1155323771128705,0.2972972972972973,0.983915298184961,1.0,6/17,23.80%,DNMT1;MTF2;EED;JARID2;CREBZF;RBBP7
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.5569814017272772,1.1153745937794322,0.32978723404255317,0.9838452248930623,1.0,13/53,23.00%,STC1;RHOB;ROBO1;FRMD5;TCAF1;NF2;SCAI;NAV3;NF1;KANK1;SMAD7;TP53INP1;TMEFF2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5049666212867433,-1.1151711328232898,0.2857142857142857,1.0,1.0,3/13,13.94%,ATM;UBB;DDX5
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.6008375796405897,1.1150140445413637,0.34444444444444444,0.9846771653656595,1.0,7/22,20.34%,NUP153;SEC13;NUP88;HIF1A;NUP133;ZBTB7A;NUP205
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.5510892583082372,-1.1150116895606639,0.3181818181818182,1.0,1.0,3/8,5.92%,WDR75;SHQ1;DIMT1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.533641244208171,1.1149603301769566,0.3125,0.9840058239561219,1.0,22/75,25.97%,RHOB;RIPOR1;CDC42EP4;RRAS2;WASF1;RAP1B;DNMT1;GNB1;SHC2;ROCK2;BRAP;CFL1;GRB2;GPSM2;NF1;MAPKAPK5;JUN;KRAS;CYFIP1;ARHGAP5;USP8;RASSF1
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.6357543076409926,1.1147889681203451,0.3924050632911392,0.9839358724283174,1.0,4/13,13.92%,TNFRSF1B;TGFB1;EPOR;CD9
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.44723431340174824,-1.1146846674744384,0.25,1.0,1.0,6/30,5.29%,NRP1;SYNPO2;LMOD1;EVL;BAIAP2L2;NCK1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.7689512975627752,1.1144031651279116,0.4142857142857143,0.9844861467316155,1.0,2/5,17.16%,NEDD4L;STK39
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.6244489205491844,1.114323691714733,0.3595505617977528,0.9837963954733853,1.0,8/19,25.01%,CTR9;WAC;RBX1;MGRN1;UBE2B;RAD18;UBE2D3;MARCHF7
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.3860944142349212,-1.114134141112757,0.2,1.0,1.0,22/73,10.86%,SLIT2;FAM13C;DKK3;PRRX1;LMOD1;COL14A1;SLIT3;KCNJ8;PDZRN3;COL5A2;LAMB2;PTPN21;PAMR1;EML1;PRKG1;EDNRA;SEMA6D;COL1A2;ZNF423;TNS2;MAGI1;CXCL12
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.584689005632613,1.1139825625550326,0.3488372093023256,0.9843353812943667,1.0,8/27,21.53%,USP15;TGFB1;HIVEP1;ACVR2A;PDCD4;SMAD2;SMAD6;SMAD7
prerank,MSigDB_Hallmark_2020__DNA Repair,0.5773078241240455,1.113943017801387,0.3023255813953488,0.9834823274194735,1.0,10/42,16.28%,RNMT;DUT;PDE4B;DGUOK;GUK1;SDCBP;AK3;CSTF3;RBX1;POLR1C
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6786596923042576,-1.1134897230428469,0.42857142857142855,1.0,1.0,2/6,19.17%,ZNHIT6;RPL35
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.5490115476028709,-1.1134451779158259,0.4166666666666667,0.9999350543730832,1.0,3/9,4.72%,IQGAP2;LMOD1;ARPC5
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.6154877030101176,-1.1132545726345813,0.4230769230769231,0.996165334382194,1.0,3/8,9.98%,NTN4;LAMB2;FLRT2
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.6285712479643463,1.1131513713850136,0.3170731707317073,0.9862849750999289,1.0,1/13,2.15%,NFKBIA
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.688170179901715,1.113040231864605,0.379746835443038,0.9848779894926684,1.0,4/8,21.72%,IRS1;STAT3;SMARCA4;IRS2
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.688170179901715,1.113040231864605,0.379746835443038,0.9848779894926684,1.0,4/8,21.72%,IRS1;STAT3;SMARCA4;IRS2
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7149674682513102,1.1129799063621726,0.36,0.9841714954705262,1.0,4/9,14.45%,SCD;IRS1;PDK3;PDK4
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.6298792722582073,1.112914377763415,0.38461538461538464,0.9834869285974459,1.0,3/14,8.84%,GLRB;RHBDD1;MARCHF6
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.6455193067996914,1.1127482817812893,0.325,0.9832645881793586,1.0,3/12,14.98%,ENO1;SCARB2;C9ORF72
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.5448800434470368,1.1127027074281794,0.25773195876288657,0.9824595420085793,1.0,7/53,8.68%,GPR161;MID1;GLRB;TENM3;CDH2;SMARCA1;NXN
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.630542361004835,1.112394051840678,0.3,0.9829949961522504,1.0,3/15,12.91%,CSNK1D;TTC8;IFT57
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.5849462434199575,1.1121523114624714,0.26666666666666666,0.9830290746613837,1.0,16/43,20.64%,SYT1;TSC2;PTPN1;RIMS2;NSF;RAB12;LRRK2;PACSIN2;SCARB1;MAP2K1;MAPK1;RUFY1;ABL1;RAB8B;ABL2;ITGAV
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.5857789424244099,1.1121493971108347,0.2857142857142857,0.982043087625615,1.0,7/24,20.34%,NUP153;SEC13;NUP88;HIF1A;NUP133;ZBTB7A;NUP205
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.6291790451483612,1.1120253063050867,0.29411764705882354,0.9815991333407817,1.0,4/16,14.52%,PRKCI;NR4A3;IRS1;INSR
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.6472960517238134,1.111788504248083,0.3972602739726027,0.9816650454265132,1.0,4/15,17.76%,PTPN1;NDFIP2;NDFIP1;DNAJA1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.6572862824150605,-1.1113390437668722,0.3333333333333333,0.9977838827838829,1.0,1/5,0.79%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7488303401832958,1.1108028990847667,0.37142857142857144,0.985056210303458,1.0,2/5,19.41%,BTRC;NLGN1
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.5806610545353408,1.1104084601353352,0.31521739130434784,0.9857890451115575,1.0,5/26,13.35%,VAPB;DDX3X;PPARA;EIF2AK2;PABPC1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.7029346713887644,1.110338301369121,0.34146341463414637,0.9850995468484345,1.0,3/10,17.23%,IPO5;LATS2;CDKN1B
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7489001631965546,1.1097838267799403,0.35526315789473684,0.9865000481969758,1.0,2/5,9.43%,RHEB;CLOCK
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.6463023866120462,1.1092768549703136,0.3793103448275862,0.9878065999938145,1.0,6/18,18.98%,SOD1;HIF1A;AP3D1;PAFAH1B1;SYBU;DST
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.6469894334235023,1.1092112893290917,0.3375,0.9871171524171661,1.0,1/15,0.34%,HS3ST5
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.63925026366962,1.1089796235817142,0.32142857142857145,0.9874298387515416,1.0,7/18,28.65%,UBA5;ZFPM1;PTPN2;ABCB10;RPS14;VEGFA;SH2B3
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.6527829794359928,1.108678575521148,0.33783783783783783,0.9877116080169933,1.0,2/10,19.38%,TMCO1;CAMK2D
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7709193882241293,1.108598180904374,0.30158730158730157,0.9871050159066214,1.0,3/6,14.97%,AGO2;SOAT1;NECAB1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.5143939670640795,1.1084890186314893,0.29896907216494845,0.9866911207740079,1.0,39/145,23.87%,CSF1;KLF2;GJA1;PTPN1;DDX3X;RAB27A;RIMS2;ANK3;AGO2;FUBP1;NOS1AP;ROBO1;TGFB1;DNMT1;HIF1A;F3;PPARGC1A;ROCK2;FUBP3;NSF;CAMK2N1;STAT3;INSR;TTN;TWIST1;MAP2K1;MAPK1;SP1;RBPJ;C1QTNF1;TBC1D5;UBR5;SLC22A2;CTCF;LEF1;MT3;OLFM1;KRAS;SLC38A2
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.6519265562506824,1.1084332435480733,0.33766233766233766,0.9858652291481795,1.0,2/13,12.85%,PRKACA;PDK3
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.5546971872864358,1.108212915850463,0.2857142857142857,0.985795375778225,1.0,11/53,17.00%,DDX3X;AGO2;IGF2BP2;GIGYF2;EIF2AK2;CNOT8;EIF2AK4;EIF4ENIF1;ROCK2;METTL14;CPEB4
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.576083129571122,1.1078666214002573,0.3333333333333333,0.9863888803657452,1.0,8/34,16.25%,NUP153;SEC13;NUP88;PPARA;HIF1A;NUP133;INSR;ZBTB7A
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.6838153544820799,1.1078459273313856,0.3611111111111111,0.9854352277136813,1.0,4/9,23.52%,RAB27A;SYNDIG1;NLGN1;DNM2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.6901607713856488,1.107821567099591,0.3561643835616438,0.9846238615626814,1.0,2/7,12.59%,TGFB1;ARHGEF7
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.6358113877924891,1.1075693428393383,0.379746835443038,0.9847759263830128,1.0,2/18,7.09%,DDX3X;DHX29
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.7673729151783052,1.1072773162420733,0.3142857142857143,0.9852279685928461,1.0,1/5,5.49%,AKIRIN1
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.6842208861860153,1.1072234640535503,0.359375,0.9845091940886372,1.0,2/11,10.27%,PITRM1;DNAJC15
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.6902736083753139,1.1071608661594265,0.35802469135802467,0.9838817377536037,1.0,3/7,27.94%,STAT3;CANX;IL6ST
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.5433646184512474,1.1068107280240354,0.3409090909090909,0.9846227395782184,1.0,9/46,13.86%,CD44;CSF1R;IL18;TBK1;TGFB1;NAIP;CEBPB;MAPKAPK2;STAT3
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5975734049300295,1.1063943810298043,0.3488372093023256,0.9857311774392183,1.0,8/35,19.51%,RIPOR1;WIPI1;PPARA;SREBF1;LRRK2;PDK4;WDR45B;MAP1LC3B
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.6279035881165728,1.1062416795386765,0.32954545454545453,0.9854728955864738,1.0,5/20,16.73%,SOD1;NRG1;TBX3;FGFR2;ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.7733594018336192,1.1060746422684846,0.3194444444444444,0.9852151191776679,1.0,4/5,21.72%,PPARA;IRS1;TWIST1;IRS2
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.7175488317217467,1.1058885356827122,0.3561643835616438,0.9850075504055973,1.0,2/8,5.68%,CSF1;CSF1R
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.7326353227649125,1.1055008753700435,0.3246753246753247,0.984762290651841,1.0,4/6,26.10%,AP2A1;AP2B1;CLTC;AP2M1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.7326353227649125,1.1055008753700435,0.3246753246753247,0.984762290651841,1.0,4/6,26.10%,AP2A1;AP2B1;CLTC;AP2M1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6765514842062722,1.1054542447204674,0.39473684210526316,0.9840106283901553,1.0,1/9,1.12%,CHST11
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.58752010350484,1.1053956931190603,0.36046511627906974,0.9833792541396411,1.0,3/30,11.76%,WWC1;ADAM17;GALNT11
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.6777964201547035,1.1053312484013205,0.36666666666666664,0.9827590006288289,1.0,6/10,28.38%,INTS2;INTS8;INTS6L;INTS4;INTS6;INTS7
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.7355588634109121,1.1050578952062562,0.375,0.9828317466718515,1.0,4/6,22.57%,MTCH2;LRRK2;DNAJA1;HK1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.6569389588286602,1.10475386285183,0.43373493975903615,0.9832795321717562,1.0,2/15,6.87%,MICALL2;PRKCI
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.6574277499345802,1.1046674822836628,0.38095238095238093,0.9827104981973773,1.0,8/14,25.38%,TGFB1;HIF1A;STAT3;TEAD1;SMARCA4;JUN;FOXO3;ETS1
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.6786217921602893,1.104325802757439,0.34285714285714286,0.9832068035975121,1.0,5/6,30.54%,KDR;ZFPM1;SH2B3;KITLG;KMT2A
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.5178573627283131,1.1042633502937549,0.28,0.9825897192232885,1.0,41/165,20.81%,NEDD4L;PSMB1;AMFR;ZNRF1;UBE2J1;PELI1;PSMB2;RC3H2;BTRC;PSMA7;RNF152;RNF168;MARCHF6;RPS27A;BLMH;RNF34;SMURF2;PSMA4;MDM2;TRIM5;SIAH1;FBXL13;RNF19A;HECTD1;RBX1;PSMD14;WWP1;TNKS;HECW1;RBBP6;CBFB;FBXO11;HECTD2;AREL1;ANAPC4;SKP1;UBE2B;UBR5;MARCHF1;UBE4B;LNPEP
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.45582575334839276,-1.1039291734065497,0.2631578947368421,1.0,1.0,4/26,2.98%,NRP1;SYNPO2;ARHGEF10L;EVL
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.5833539565021493,1.1038189382130215,0.3409090909090909,0.9836359404795868,1.0,13/29,25.20%,SYT1;LIN7A;SNAP25;SYN3;GLUL;CASK;SLC1A2;NRXN1;SLC22A2;DNAJC5;SLC6A16;SLC38A2;SLC1A1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.6172751646355732,1.1037380338060458,0.3698630136986301,0.9831080632349082,1.0,5/16,11.24%,TSC2;PTPN1;PRKCB;IRS1;PTPRE
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5570985702749649,1.1037317860169993,0.3,0.9821787492200337,1.0,10/45,13.46%,RHOB;MYDGF;ITGA5;AGO2;PRKCB;HIF1A;F3;FLT1;RUNX1;KDR
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.5541268754076675,-1.1035497823362714,0.23333333333333334,1.0,1.0,1/9,0.88%,EDN3
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.7022321412768113,1.1033396230805612,0.375,0.9830360160307167,1.0,6/8,26.97%,SYNDIG1;SNAP25;NLGN1;DNAJC5;PIP5K1C;PCLO
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.6097835780490525,1.1032225596655716,0.3372093023255814,0.9826082132323846,1.0,6/26,14.74%,ANK3;UGCG;SYTL4;EHD2;NSF;PACSIN2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.6145582793482303,1.1031939953559273,0.4069767441860465,0.9817505771726927,1.0,7/16,25.86%,DDX3X;ADAM17;EGFR;ANKRD17;STXBP4;CCND3;RGCC
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.5008152924537279,-1.1031467411386904,0.29411764705882354,1.0,1.0,8/15,16.49%,MYLK;ANXA1;ITGB1;ACTG1;ST3GAL4;THBS1;PTK2;SMOC2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5273468615016922,1.1030398623717204,0.3404255319148936,0.9813052765865046,1.0,11/43,21.93%,DDX3X;ROBO1;CASP8AP2;F3;IFT57;SENP1;APAF1;TNFRSF10B;ST18;SLC22A2;COL4A3
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.6415490964815462,1.1030159966812882,0.4189189189189189,0.9804016956173052,1.0,6/12,25.20%,SLC7A2;SLC3A2;SLC1A2;SLC36A4;SLC38A2;SLC1A1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7226473238117228,1.10300087540985,0.32098765432098764,0.9795388868646014,1.0,5/6,24.21%,NFKBIA;PPARA;ABCA1;ITGAV;ABCA5
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6800805435028614,1.1028716452342815,0.3253012048192771,0.9791164878468617,1.0,3/8,16.71%,TGFB1;EGFR;MAP2K1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.5926657939433169,1.1026940000537913,0.37362637362637363,0.9788507504657458,1.0,8/25,19.46%,CSF1R;EGFR;FLT1;FGFR2;KDR;INSR;ABL1;ABL2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.6168007377008089,1.1026611446178105,0.3333333333333333,0.9780113657467593,1.0,3/19,15.83%,CD44;CAPZB;CFL1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.6677213001581852,1.1025071028423492,0.4074074074074074,0.9776110828494746,1.0,1/13,1.78%,ATP6V1H
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.61809870204027,1.1020942954635773,0.33766233766233766,0.978551940248005,1.0,6/18,23.24%,GGA3;ROCK2;RTN3;PRNP;SP1;RTN1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.5130631532659039,1.1020843358624144,0.28,0.9776570218772053,1.0,43/188,20.34%,OS9;UBA5;NEDD4L;AMFR;HIF3A;NUP153;PIAS2;BTRC;CTR9;NUP88;SELENOS;DCUN1D4;KLHL2;RNF152;UBR1;RNF168;MARCHF6;RPS27A;TRIM23;HIF1A;RNF34;UHRF2;NUP133;SMURF2;WAC;MDM2;TRIM5;RBX1;BRAP;WWP1;MGRN1;ZSWIM8;RNF111;HECW1;DCUN1D1;FBXO11;AREL1;UVSSA;RTF1;SKP1;UBA2;UBE2B;NUP205
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7181100643784956,1.1019446112691003,0.36904761904761907,0.9772873045741045,1.0,3/7,20.26%,GRIK2;GRIA2;NAPB
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.5895278291990756,1.101832102680045,0.32142857142857145,0.9768504956816884,1.0,6/29,9.56%,PHYHIPL;ELAVL3;CACNA1B;SCN3A;SNAP25;CTNND2
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.6354166306222555,1.101478081905012,0.3780487804878049,0.9777691441494372,1.0,5/22,17.58%,UBA5;ZBTB16;RUNX1;ZFPM1;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.6568547749073268,1.1013869910889913,0.36486486486486486,0.977236040636379,1.0,3/10,18.51%,ROCK2;RANBP9;SP1
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.6906034155753107,1.1013447294701393,0.3939393939393939,0.976462511586012,1.0,3/7,25.51%,SLC35D1;UGP2;PGM3
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.5456784312133315,1.1011211874092315,0.3118279569892473,0.9765588027730501,1.0,23/62,30.90%,CSF1R;TBK1;EIF2AK2;MAPKAPK2;AKAP6;STAT3;PTPN9;PTPN2;LIFR;IFITM3;ALDH1A2;LDLRAP1;LEF1;IL1RAPL1;SETD2;TIMP3;IL6ST;PTPN11;MCL1;PID1;PTPN14;NFAT5;APP
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.6002131675618837,1.1009671731761326,0.38823529411764707,0.975527816984239,1.0,4/18,10.52%,NUP153;SEC13;NUP88;NUP133
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.6002131675618837,1.1009671731761326,0.38823529411764707,0.975527816984239,1.0,4/18,10.52%,NUP153;SEC13;NUP88;NUP133
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.654973543007126,1.1008985705515113,0.31645569620253167,0.9749416298507981,1.0,6/10,20.64%,NFKBIA;PPARA;ABCA1;PTPN2;ABHD5;ITGAV
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.5584121893688541,1.1008533405988625,0.31521739130434784,0.974241208228999,1.0,10/46,14.93%,CSNK1G2;DDX3X;CSNK1A1;BTRC;NXN;WNT2B;RPS27A;LRRK2;FZD3;RBX1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.6239185764462706,1.1006473341907097,0.38666666666666666,0.9743967591694804,1.0,5/15,11.24%,TSC2;PTPN1;PRKCB;IRS1;PTPRE
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.7160390581306016,1.1000591978781078,0.4,0.9758279849802266,1.0,1/8,2.63%,HABP4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.6190580357240589,1.099946351117827,0.32926829268292684,0.9754162495668258,1.0,1/18,3.59%,DDIT4
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.7230755085732257,1.0996644709690055,0.3968253968253968,0.9758479493691747,1.0,3/5,26.93%,NEXMIF;RGCC;VEGFA
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.6099971762975809,1.0994433272315602,0.325,0.9760396701523166,1.0,3/21,7.81%,RHBDD1;ADAM17;TGFB1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.6968139259382434,1.0990174431568551,0.37662337662337664,0.9771581255538282,1.0,3/6,24.24%,DDX3X;DCP1A;YBX1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.7244170509680852,1.0990123141857333,0.375,0.9762597035991533,1.0,2/6,13.23%,SLC23A2;SLC1A2
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.6001738965430504,1.098999883290355,0.39285714285714285,0.9753820467361615,1.0,4/19,10.52%,NUP153;SEC13;NUP88;NUP133
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.6191178679259091,-1.0989198598579917,0.4166666666666667,1.0,1.0,1/8,0.45%,PGR
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.6734123478790381,1.0988764744497046,0.323943661971831,0.9748682056617364,1.0,2/7,19.65%,UBN1;SUPT16H
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.5583937724350018,-1.0988346352871383,0.36363636363636365,1.0,1.0,2/12,4.20%,EDN3;CDC27
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6427064544920906,1.0986904621972613,0.35064935064935066,0.974783811608108,1.0,7/13,27.57%,BTRC;DCUN1D4;DCUN1D1;GOLGA2;SKP1;UBE2L3;DCUN1D2
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.6631775396043122,1.0985761303780535,0.3493975903614458,0.9742714915040076,1.0,3/13,7.14%,CRMP1;CACNA1B;STMN1
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.5675990559620188,1.098449079701565,0.37037037037037035,0.9739121943819705,1.0,7/27,15.80%,SYT1;RIMS2;GRIK2;EIF2AK4;GRIN2B;TSHZ3;NRXN1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.6300686955422093,1.0980355300134477,0.3333333333333333,0.9750538116916962,1.0,8/20,22.57%,ENO1;PDHX;NR4A3;PGK1;GLO1;ME2;TPI1;HK1
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.6159052083416673,1.0979900687563,0.33766233766233766,0.9744667826183129,1.0,8/17,19.54%,CD44;RAB27A;GRSF1;EPOR;ELF1;ADGRE2;SNAP23;SLC25A37
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5731818125672365,1.0979686945809375,0.3614457831325301,0.973587044811341,1.0,2/20,3.10%,SOD1;SGCZ
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6905397425281925,1.0974704160896167,0.3815789473684211,0.9736866160082717,1.0,3/11,16.44%,ADAM17;SDCBP;RNF111
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6905397425281925,1.0974704160896167,0.3815789473684211,0.9736866160082717,1.0,3/11,16.44%,ADAM17;SDCBP;RNF111
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.5835686787025363,-1.0973883661038615,0.3448275862068966,1.0,1.0,1/5,11.63%,CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.7218527792661524,1.0973731267911002,0.410958904109589,0.9731408441836122,1.0,2/6,21.53%,ABL1;SMAD7
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5937924820592774,1.0968287975788518,0.3793103448275862,0.9745128755547604,1.0,7/22,18.74%,OLFM2;RIMS2;ARFGAP3;ABCA1;RAB12;CANX;RAB8B
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.6985644697600282,1.0967804007356214,0.34210526315789475,0.9737503780623046,1.0,2/7,17.28%,MDM4;ZFPM1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.7301964588839688,1.0965616545111165,0.43478260869565216,0.9738186773476839,1.0,3/6,26.05%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.6823886898461026,1.0962662054987629,0.3625,0.9741410844507175,1.0,3/10,13.31%,CPSF2;SYMPK;CSTF3
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.5458046849685563,1.0961991541360188,0.37209302325581395,0.9734751207257977,1.0,10/39,13.86%,IPO9;TSC2;NUP153;SEC13;IPO5;NUP88;CSE1L;NUP133;EIF4ENIF1;STAT3
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.5456965077610076,1.096178405244095,0.34444444444444444,0.9726976038257389,1.0,6/38,11.57%,PANK2;OPA3;SCD;PPARA;SIN3A;SREBF1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.5867173422646538,1.0960682411153264,0.34831460674157305,0.9723816328698283,1.0,4/32,14.26%,HNRNPL;HNRNPF;HNRNPC;METTL14
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.6971331982415451,1.0957239242412682,0.38961038961038963,0.9729574721294143,1.0,5/10,20.71%,NOS1AP;DIAPH1;PRNP;CAMK2D;UBASH3B
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.5232946491679505,1.0955666754052704,0.2727272727272727,0.9726980802565295,1.0,36/180,18.69%,OS9;PLAA;NEDD4L;PSMB1;AMFR;ZNRF1;PELI1;PSMB2;NDFIP2;RC3H2;BTRC;PSMA7;RNF168;MARCHF6;CLOCK;RNF34;TRIM9;OTUD7A;SMURF2;NDFIP1;PSMA4;MDM2;MVB12B;SIAH1;RNF19A;RBX1;PSMD14;WWP1;ZSWIM8;RNF111;HECW1;RBBP6;FBXO11;APPBP2;AREL1;ANAPC4
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.6183630106749182,-1.0952392555220962,0.4,1.0,1.0,4/7,16.79%,RIPOR2;DOCK8;CXCL12;LRCH1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),0.7149715267514406,1.0951847777322457,0.323943661971831,0.9734504848387965,1.0,2/6,19.51%,AMBRA1;MAP1LC3B
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.5244278926170505,-1.0951212316249883,0.3793103448275862,1.0,1.0,1/11,0.27%,A2M
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7157142191190168,1.0949210660439246,0.4189189189189189,0.9736963108631619,1.0,3/6,19.68%,BTRC;GOLGA2;SKP1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.5898251058906712,1.0948525133888587,0.3563218390804598,0.9731098154240525,1.0,7/28,18.86%,NFKBIA;MGAT1;CEBPD;SUSD6;LGALS3;TULP4;JUNB
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.7077527259277603,1.0945598477042506,0.4230769230769231,0.9733835176037011,1.0,3/7,18.70%,TGFB1;GRAMD1A;SMAD2
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.6815753254425845,1.0942755170335456,0.35714285714285715,0.9737313551695337,1.0,3/8,23.12%,MBD2;CHD1;MT3
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.6138892570658205,1.0939209153969256,0.3698630136986301,0.9743022626260798,1.0,1/14,1.38%,PRKACA
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.6495485060128501,1.0938783797639533,0.37142857142857144,0.9735683588347668,1.0,3/9,25.67%,PPARGC1A;GLYR1;RPS6KA5
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6440931118452381,1.0937413990957947,0.37142857142857144,0.9733010025303772,1.0,3/11,27.01%,PRLR;CRLF3;PTK2B
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.6367598647588476,-1.0936808873185135,0.4230769230769231,1.0,1.0,2/5,2.90%,NRP1;RALBP1
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.6165145853374465,1.0935312727856437,0.39473684210526316,0.9733780717043887,1.0,4/12,19.27%,PPARA;SREBF1;SCARB1;ELOVL5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.7333643392704159,1.0934537268642988,0.3972602739726027,0.9728513387663822,1.0,3/5,18.40%,HOMER2;PRNP;NAV3
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5705571820699857,1.0933577517508957,0.34444444444444444,0.9723441242678836,1.0,12/38,17.28%,ZFP36L2;CSF1R;KIRREL3;TGFB1;WNT2B;ZBTB16;FLT1;RUNX1;FGFR2;KDR;MELK;ZFPM1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.5882878868597694,1.0931929766900252,0.3626373626373626,0.9722457217959547,1.0,7/23,20.34%,NUP153;SEC13;NUP88;HIF1A;NUP133;ZBTB7A;NUP205
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6013901733957995,1.0927143413811835,0.2839506172839506,0.9734534015140122,1.0,7/19,24.38%,AGO2;GNB1;PPP3CA;FZD3;NLK;LEF1;GNAO1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.5539988596806036,-1.0926479233303483,0.3448275862068966,1.0,1.0,5/9,15.64%,MYLK;ANXA1;ITGB1;ACTG1;PTK2
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.7134112489263131,1.0926364391102508,0.379746835443038,0.9728544908022497,1.0,2/7,17.48%,CTNNA2;PAFAH1B1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.6508983669941959,1.0924217142419501,0.38666666666666666,0.9728668313338038,1.0,2/9,10.07%,SCD;ACSL4
prerank,PanglaoDB_Augmented_2021__T Cells,-0.47764789194175594,-1.0922429141534582,0.2857142857142857,1.0,1.0,5/19,8.29%,CD4;DKK3;CLEC2D;NOTCH3;SEMA6D
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6719362954166486,1.0922346074217009,0.3950617283950617,0.9728052575544015,1.0,3/9,14.45%,PANK2;PPARA;PDK4
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.6649559000137157,1.0919505946713528,0.4050632911392405,0.9730483229952086,1.0,2/10,7.51%,SOD1;SOD2
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.7261905589524104,1.0917999792458113,0.379746835443038,0.971023167293083,1.0,3/6,12.46%,HDAC2;TGFB1;RUNX1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.7261905589524104,1.0917999792458113,0.379746835443038,0.971023167293083,1.0,3/6,12.46%,HDAC2;TGFB1;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.7261905589524104,1.0917999792458113,0.379746835443038,0.971023167293083,1.0,3/6,12.46%,HDAC2;TGFB1;RUNX1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.6435190276327991,1.0917552176105478,0.3793103448275862,0.9703658813605395,1.0,3/16,17.45%,NAA11;CLOCK;NAA15
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.4592037052098464,-1.0915413383082941,0.35714285714285715,1.0,1.0,5/17,13.28%,OSBPL6;CYP27A1;AKR1C3;FAXDC2;HSD11B1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.5211685956374419,-1.0914884383063082,0.2857142857142857,1.0,1.0,2/14,3.40%,SMARCAL1;THOC1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.6647039503494553,1.091431003452074,0.42168674698795183,0.9708764588469221,1.0,4/9,26.05%,CCT4;CORO2B;CCT3;CCT8
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.6846811461043948,1.0913672994433568,0.410958904109589,0.9702204917594245,1.0,4/7,23.60%,TTC23;DCDC2;ARMC9;EVC
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.6744416674855467,-1.091280913806519,0.42424242424242425,0.9996879619163551,1.0,3/5,13.33%,ITGA8;ITGB1;ITGA3
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.6381703423829994,1.0912008405954317,0.35714285714285715,0.9701067292499361,1.0,4/13,25.68%,MYO16;IRS1;NF1;PLEKHA1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.5699035929114152,-1.091059436277889,0.32,0.9961990279176003,1.0,4/11,5.84%,NTN4;MYH11;TNXB;LAMB2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.5786422682460757,1.0910179772836222,0.40963855421686746,0.9700298181032125,1.0,4/24,13.80%,CCP110;YAF2;APAF1;EED
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.7356009097466969,1.0909632757562768,0.4305555555555556,0.9684954978853897,1.0,3/6,26.05%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.7356009097466969,1.0909632757562768,0.4305555555555556,0.9684954978853897,1.0,3/6,26.05%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.5827287214014139,1.0909494489579998,0.3695652173913043,0.9677349740444773,1.0,12/34,21.56%,TBK1;OXSR1;ROCK2;LRRK2;TNKS;MAP2K1;ACVR1B;MAPK1;STK39;CSNK2A1;CAMK2D;NLK
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.6467194184296312,1.090869523699098,0.40540540540540543,0.9672770626997894,1.0,6/14,21.14%,ENO1;CRY1;PPARGC1A;PGK1;CHST15;TPI1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.6126210092808708,1.0907160410957388,0.3764705882352941,0.96716655221193,1.0,7/21,21.46%,DDX3X;RAF1;RIOK3;TRAF3IP1;HSPA5;JAM3;SMAD6
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.7016401864935073,1.0905373957654718,0.3918918918918919,0.9670562397715402,1.0,2/9,9.72%,ELAVL1;WDR43
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.6618700172095151,1.0901525397289846,0.375,0.9678747514671886,1.0,5/11,28.38%,INTS2;INTS8;INTS4;INTS6;INTS7
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.5349633763862462,-1.0900570659253477,0.30434782608695654,0.9949079245283019,1.0,3/8,12.64%,OSBPL6;NUS1;ABCA8
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6350406159365557,1.089893296378048,0.43037974683544306,0.9680186920135386,1.0,1/12,1.38%,PRKACA
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.7385708036429439,1.0895696335042555,0.3835616438356164,0.9676157374735356,1.0,2/5,20.29%,GNAI1;GPSM2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.7385708036429439,1.0895696335042555,0.3835616438356164,0.9676157374735356,1.0,2/5,20.29%,GNAI1;GPSM2
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.5989076394228636,-1.0891389782116248,0.3333333333333333,0.9940742689618883,1.0,2/7,12.54%,COL5A2;SKI
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.6093891662161147,1.0891152235925943,0.367816091954023,0.9688844142460262,1.0,5/21,19.02%,MICOS10;AGK;CHCHD3;SPG7;DNAJC11
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6844295590577063,1.0887064802005773,0.4230769230769231,0.9696885853847539,1.0,3/10,18.59%,TGFB1;GALNT11;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.5497885727436024,1.088680079532308,0.2717391304347826,0.968924715843928,1.0,10/55,11.47%,TP53TG5;GJA1;DDX3X;ENO1;FHL1;TGFB1;ESR2;APBB1;DIP2B;BCL6
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.5313741635236356,1.0879676957913378,0.31958762886597936,0.9711659701589997,1.0,16/90,18.11%,HNRNPL;PRKACA;RBMS2;HNRNPF;ALKBH5;ADARB2;HNRNPC;PPARGC1A;TUT7;CSTF3;TCERG1;NOVA1;RBM39;SF3B1;HNRNPUL1;DHX15
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.7545504748857202,1.0878891421142092,0.36231884057971014,0.970573894769858,1.0,1/5,2.68%,NEDD4L
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.6726053229815481,1.0878167564665446,0.43283582089552236,0.9700370595070514,1.0,4/10,22.57%,ENO1;PGK1;TPI1;HK1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.5499019936682663,1.087785083459129,0.3655913978494624,0.9693026621221961,1.0,15/52,25.94%,ACADVL;BCKDHB;PPARA;GLUL;ACSL4;ACADL;SUCLG1;CA2;ELOVL5;METAP1;HSPH1;SERINC1;XIST;HSDL2;ALDH3A2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.4120298405664541,-1.087773626783579,0.2,0.994026654687032,1.0,6/38,7.17%,NTN4;NRP1;ITGA8;LAMC1;LAMB2;TBCD
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),-0.640395033580693,-1.0876456731054258,0.3611111111111111,0.9906891959558078,1.0,1/5,2.81%,MAPK14
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.5288028645961829,1.0869595009589264,0.35106382978723405,0.9718241264883858,1.0,15/60,15.80%,PHYHIPL;ELAVL3;CRMP1;LSAMP;DCLK1;PTPRD;CACNA1B;ATL1;ADGRB3;SNAP25;ZNF536;CADM2;LRFN5;NOVA1;NRXN1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.6649813111148134,1.0867243041626893,0.3493975903614458,0.9719541590693295,1.0,5/11,28.67%,PLAA;MVB12B;UBAP1;TOM1L1;RNF115
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.6783075953568498,1.0866774434404525,0.32857142857142857,0.971346007082144,1.0,1/7,6.42%,ROBO2
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.5411740062621453,1.0865764704209155,0.3711340206185567,0.9709007772862931,1.0,16/79,12.80%,KCNC2;ATP6V1H;KCND2;KCNQ1;KCNH7;KCNQ3;TMEM165;SCN3A;SLC6A17;TMCO1;ATP1B3;SLC39A11;KCNQ5;TRPM3;ABCC9;NALCN
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.6986872778703233,1.086364462079288,0.4155844155844156,0.9710761986578922,1.0,2/6,17.16%,NEDD4L;STK39
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.5617530275894413,-1.0862850033502176,0.4,0.9907657533374365,1.0,2/10,0.88%,SLIT2;EDN3
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.7105213895899924,1.085680416790413,0.3972602739726027,0.973010530931614,1.0,1/6,7.51%,SOD2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5974497580792228,1.0855772626119597,0.36585365853658536,0.9725291403578866,1.0,5/17,17.05%,UBA5;KDM1A;UFSP2;RUNX1;CBFB
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.6757025132451617,1.085559270516592,0.35714285714285715,0.971779804078232,1.0,3/7,23.61%,CAMKK2;SLC25A4;VPS13D
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.5742317143914577,1.0854162474686726,0.3888888888888889,0.9715509979424891,1.0,6/32,12.64%,OS9;AMFR;UBE2J1;SELENOS;MARCHF6;HSPA5
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.6951980549076835,1.0851289847912096,0.39705882352941174,0.9718860687133061,1.0,2/5,15.34%,SREBF1;SCARB1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5565127682742121,1.0850549445324342,0.34375,0.971282251793127,1.0,11/43,17.23%,SOD1;CAMKK2;EPHA7;CSF1R;EGFR;FLT1;FGFR2;KDR;INSR;TTN;CDKN1B
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.6273017626523049,1.0848703465735567,0.3176470588235294,0.9711348401419363,1.0,8/16,17.63%,PRKACA;KCNQ1;PDE4B;NR4A3;GNB1;LRRK2;MAPK1;ABL1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.5149152270097408,1.084847436123072,0.3163265306122449,0.9703810929935991,1.0,34/123,23.84%,SYT1;VAPB;TOR1AIP2;EPN1;DNAJC6;SGCZ;ACTR3;ANK3;AP2A1;PRKCI;SCARB2;EGFR;VAPA;RPS27A;SGIP1;NAPG;AP3D1;PACSIN2;LPCAT3;AP2B1;REPS1;REEP3;SNAP23;GRB2;EPS15;LDLRAP1;AGFG1;GAK;MITD1;TF;PIP5K1C;USO1;DNM2;GAPVD1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5320736533064464,1.0846392974203583,0.375,0.9704664593019409,1.0,9/54,14.52%,LPIN1;PRKACA;PRKCI;NR4A3;SELENOS;IRS1;DENND4C;RAB12;INSR
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.7175735399863004,1.084614948062448,0.39436619718309857,0.9696789979570068,1.0,1/8,0.96%,TEFM
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6879594873383097,1.083963311922748,0.4090909090909091,0.971579835159984,1.0,2/6,19.38%,NOS1AP;CAMK2D
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.6393845468222419,1.0838712979340974,0.4125,0.9711039031540091,1.0,5/11,24.37%,ACADVL;PDK4;ACADL;ELOVL5;WDTC1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.7304784773735739,1.0837361527753329,0.38461538461538464,0.9707709072306644,1.0,3/5,19.62%,SLC25A4;SPG7;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.661983556666435,-1.0835961780344538,0.5,0.9943995560488346,1.0,2/5,16.79%,RIPOR2;LRCH1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.5706539914012061,1.0833528396406436,0.36470588235294116,0.9714057363773969,1.0,4/19,16.15%,PARVB;WASF1;ARHGEF7;ARHGEF4
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.6519683834199705,1.083248531971338,0.44,0.9702537505010094,1.0,3/11,9.83%,BCKDHB;MCCC2;BCAT2
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.6519683834199705,1.083248531971338,0.44,0.9702537505010094,1.0,3/11,9.83%,BCKDHB;MCCC2;BCAT2
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.7085932431426314,1.0831180629225874,0.3611111111111111,0.9699049524823831,1.0,2/6,14.55%,TGFB1;TP53BP1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.5483083740883001,1.0828764992839697,0.34065934065934067,0.970034279402289,1.0,13/46,19.89%,NFKBIA;PSMB1;PELI1;PSMB2;BTRC;PSMA7;RPS27A;PSMA4;RBX1;PSMD14;ST18;SKP1;MAP3K8
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.6256446284276747,1.0826176829154737,0.4155844155844156,0.9703312513373968,1.0,3/15,12.09%,ZFP36L2;EGFR;PDE8A
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.5770324625109695,1.0818931707763153,0.35365853658536583,0.972393223653258,1.0,3/23,7.81%,XPO4;IPO5;TGFB1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.6375635883640957,1.0817688189775694,0.4166666666666667,0.972061419964855,1.0,3/12,17.16%,DDX3X;OXSR1;STK39
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.5477341439942859,1.0817586414422018,0.33695652173913043,0.9712455158884014,1.0,14/51,18.62%,NFKBIA;SNX6;IL18;SELENOS;PPARA;TNFRSF1B;BCL6;NFKBIZ;TMSB4X;LRFN5;LPCAT3;PDCD4;PTPN2;AREL1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5523131669405402,1.08163568850317,0.38095238095238093,0.9709857176462681,1.0,11/41,17.69%,NELL1;PRKACA;SUFU;SMOC1;SEMA4D;TP63;FGFR2;ACVR2A;TMEM64;TWIST1;ZHX3
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.7177814875822655,1.0813815454758455,0.42857142857142855,0.9711838146774339,1.0,3/5,17.24%,IL18;TGFB1;PRNP
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.667896966453236,1.0809279682186577,0.3698630136986301,0.9722780912600361,1.0,5/12,14.32%,SLC7A2;TRPM3;SLC3A2;ABCC9;SLC36A4
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.5381772065608699,1.0809092145625987,0.3958333333333333,0.9714999457610095,1.0,13/52,22.78%,SRGN;SOD1;HABP4;TGFB1;SYTL4;TMSB4X;CD9;TTN;SCCPDH;PROS1;LAMP2;TF;LHFPL2
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.6358901529001739,1.080881062762233,0.3880597014925373,0.9707670143694556,1.0,4/12,22.57%,ENO1;PGK1;TPI1;HK1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.7121761821295867,1.0808255936974165,0.39473684210526316,0.9701756138515076,1.0,3/6,17.63%,EGFR;KDR;ABL1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.6034352349055513,1.08073898726065,0.3780487804878049,0.969646546153907,1.0,3/19,12.59%,ACTR3;AKIRIN1;ARHGEF7
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.6502605009799216,1.0806939685829242,0.3670886075949367,0.9690046181297425,1.0,2/15,2.39%,CD44;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.5111822405612617,1.0806578632628512,0.3404255319148936,0.9682763531639816,1.0,8/74,7.81%,RIPOR1;MICALL2;ANK3;TMEM30A;XPO4;IPO5;TP63;TGFB1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.511059527658955,1.0806215423953525,0.32653061224489793,0.9675580760864029,1.0,36/156,20.74%,OS9;PLAA;NEDD4L;PSMB1;AMFR;ZNRF1;UBE2J1;PELI1;PSMB2;BTRC;PSMA7;SELENOS;UBR1;MARCHF6;RPS27A;CLOCK;RNF34;TRIM9;SMURF2;PSMA4;HSPA5;MDM2;SIAH1;FBXL13;RBX1;PSMD14;WWP1;ZSWIM8;HECW1;APPBP2;AREL1;ANAPC4;ECPAS;SKP1;UBE2B;UBE4B
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.5240228453062321,1.0806141564692195,0.27,0.9667275541326806,1.0,49/159,23.56%,ARRDC2;STX6;ATP6V1G1;ARL5A;ATP6V1H;OLFM2;ANK3;GGA3;RAB28;AP2A1;COG7;SNX6;SEC13;PRKCB;SYNDIG1;ATP6V1E1;TRIM23;RAB18;ARFGAP3;RAB7A;ABCA1;NSF;NAPG;RAB12;AP3D1;TBC1D15;CANX;PREPL;ARF4;ARF1;RUFY1;RAB8B;SNX4;CMTM6;TBC1D8;TBC1D5;STX2;NAPB;SLC10A7;STX12;LAMP2;TF;RABGAP1L;CEP290;USP6NL;USO1;BLZF1;DNM2;TBC1D4
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.6942192471894673,1.0805914121033064,0.35526315789473684,0.9660205589805728,1.0,2/7,4.81%,CRMP1;DPYSL2
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7180283437132652,1.0801723644542842,0.410958904109589,0.9670401701943411,1.0,4/6,20.37%,ELF1;RUNX1;CBFB;ELF2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.6135190984494342,1.0800873291965125,0.4457831325301205,0.9665169577343605,1.0,6/15,21.94%,NEDD4L;FHL1;TCAF1;STK39;AHCYL1;FGF12
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.54005878907563,1.0800364626984011,0.3723404255319149,0.9659163475649769,1.0,22/75,17.63%,SIK2;CAMKK2;CSF1R;STK4;EIF2AK2;STK33;EGFR;OXSR1;EIF2AK4;UHMK1;FLT1;FGFR2;MAPKAPK2;KDR;SLK;MELK;LRRK2;INSR;MAK;ACVR1B;STK39;ABL1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.6516669555523041,1.0795614673134193,0.4266666666666667,0.9670725017944497,1.0,4/11,27.94%,EIF2AK4;RIOK3;CD81;IL6ST
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.6849046157723303,1.079307959678037,0.4492753623188406,0.9672540343649488,1.0,2/8,5.68%,CSF1;CSF1R
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.5433395989340594,1.0792410465532305,0.40229885057471265,0.9667063943195859,1.0,12/46,15.80%,NRCAM;DNER;PTPRD;ANK3;CDH2;ZC4H2;KIRREL3;CTNND2;FARP1;LRFN5;LRRK2;NRXN1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.7184154863904948,1.078745834201617,0.4430379746835443,0.9679976307665835,1.0,1/5,5.23%,MGST1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.5852743398366363,1.0784942243070745,0.42105263157894735,0.9683858032001289,1.0,2/20,11.82%,RHOB;ROCK2
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.5155378226066899,1.0784777984795353,0.3125,0.9676049189927777,1.0,11/66,14.34%,PPME1;AKAP8;PRKACA;CCP110;TUBA1A;CSNK1D;BTRC;CCNH;CEP70;CEP57;MELK
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.6943531205578859,1.0784706838817362,0.4189189189189189,0.9668080679696014,1.0,1/9,3.37%,DDX3X
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.6980874344193462,1.0783876123447935,0.35135135135135137,0.9663236137951049,1.0,4/7,17.48%,GNPAT;NCEH1;PLAAT3;PAFAH1B1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.4325376498392901,-1.0783317114502693,0.3333333333333333,1.0,1.0,3/23,6.62%,PRPF6;SNRNP200;GCFC2
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.7104964685759925,1.0781306678315865,0.4246575342465753,0.9664442741725806,1.0,1/5,24.75%,USP25
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.6952372050702427,1.077998041295987,0.43209876543209874,0.9660989571081314,1.0,3/8,26.00%,SGIP1;EPS15;CLTC
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.6647452829944032,1.0776964923304524,0.4264705882352941,0.9663833474875304,1.0,1/9,7.81%,TGFB1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6461207009274833,1.0776880586781947,0.4868421052631579,0.9656081260752315,1.0,3/10,20.34%,NUP153;NUP133;NUP205
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.49893508925348884,1.0775339081368898,0.31313131313131315,0.9652902034397401,1.0,23/175,12.19%,HNRNPL;TAF1B;RBMS2;DARS1;RPS21;NUP153;AGO2;FARSB;HNRNPF;SEC13;NUP88;PWP1;ALKBH5;ADARB2;CPSF2;SYMPK;RPS27A;RPL21;RPL28;NUP133;RPL41;FYTTD1;FUBP3
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6014756166728034,1.0775305909070274,0.35365853658536583,0.9645000241601946,1.0,4/18,14.50%,SMOC1;RAB18;SMCHD1;ATF6
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.5560311338420354,1.0775091592499328,0.38636363636363635,0.9637798916153274,1.0,11/48,13.28%,PHYHIPL;EBF4;KCNQ1;ANK3;SLC22A23;MYRIP;MCF2L;CP;SHC2;FGFR2;ARFGEF3
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.7090904971048932,1.0770059057301833,0.3783783783783784,0.9650347766273907,1.0,2/6,12.27%,NDFIP2;NDFIP1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.6279101944323684,1.0765295029278734,0.41025641025641024,0.9660989061992358,1.0,4/8,25.68%,CSF1R;CYFIP1;PIP5K1A;PLEKHA1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.6180577952679732,1.0760624975749449,0.38095238095238093,0.9672469156868189,1.0,6/12,26.93%,TENM3;C12ORF57;FBN1;NF1;CEP290;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5230413587501348,1.075861984728668,0.3877551020408163,0.9672716223633655,1.0,19/77,19.54%,KLF2;DDX3X;NOS1AP;EGFR;IRS1;ELAVL1;HIF1A;PPARGC1A;SREBF1;METTL14;INSR;SCARB1;ATAD5;PTH1R;PTPN2;ABCB10;SP1;ELOVL5;SLC25A37
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.6728793837924433,1.075187194701272,0.4142857142857143,0.9693062138053302,1.0,2/8,7.31%,MUCL1;TP63
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.44495949130930096,-1.0751705825143612,0.3181818181818182,1.0,1.0,3/18,1.51%,PPIP5K2;AGPAT5;TPK1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.7109283753325117,1.0750754204428996,0.38028169014084506,0.9681481139124474,1.0,2/5,17.81%,SLC1A2;STEAP4
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.7109283753325117,1.0750754204428996,0.38028169014084506,0.9681481139124474,1.0,2/5,17.81%,SLC1A2;STEAP4
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.6996884427618305,1.0749357515586195,0.35526315789473684,0.9678648529599826,1.0,2/8,12.46%,TGFB1;RUNX1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.6089315295287453,1.0748327719654955,0.4235294117647059,0.967420107058287,1.0,10/21,27.03%,DNAJC6;AP2A1;SGIP1;CANX;AP2B1;GAK;PIP5K1C;CLTC;AP2M1;GPR107
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.56034449488204,1.0748042293182374,0.38095238095238093,0.9666354236484705,1.0,8/27,21.83%,NRCAM;ZC4H2;EIF2AK4;SIN3A;LRRK2;NLGN1;YWHAG;TCF4
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.5251185325892015,1.0746521749757982,0.358695652173913,0.9663966893342348,1.0,19/71,21.72%,PTPN1;PPARA;TNFRSF1B;RNF152;IRS1;HIF1A;CNOT8;GRSF1;TRIM5;LRRK2;ATF6;INSR;ZSWIM8;TWIST1;PRR5L;ABHD5;BNIP3;TP53INP1;IRS2
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.5704793820025146,-1.0746516971538358,0.35294117647058826,1.0,1.0,2/11,3.06%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.5731175257569558,-1.0742029183465902,0.4,1.0,1.0,3/7,11.63%,HSPA1A;TPR;CHMP4B
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.6281451240681056,-1.0741880594360165,0.43333333333333335,1.0,1.0,1/6,0.34%,CAV2
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.5532903562630364,1.073872971213232,0.3793103448275862,0.9688112338706061,1.0,8/35,18.19%,RIPOR1;TGFB1;APBB1;CNST;SYTL4;EXOC1;TTN;PRR5L
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.6938339743897347,1.0738032140538025,0.4142857142857143,0.9682737306687089,1.0,3/7,26.93%,TGFB1;TJP1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.7193952906703546,1.073565570778721,0.4594594594594595,0.9683483057507041,1.0,2/5,12.64%,PTPN1;HSPA5
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.6709946636950003,1.0733225893859477,0.4342105263157895,0.968465164159971,1.0,5/7,30.24%,MTMR9;MTMR1;MTMR2;SMG7;MTMR4
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.6480737808785335,1.0732027082339741,0.4246575342465753,0.9680225123500353,1.0,4/13,14.05%,ENO1;CRY1;PPARGC1A;PGK1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.6271770877966655,1.0729929111962087,0.4444444444444444,0.9680801754830279,1.0,6/13,23.12%,ACADVL;NR4A3;PPARGC1A;NDUFS1;COX10;MT3
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.638110684715107,-1.0726521462501049,0.36666666666666664,1.0,1.0,1/5,0.88%,EDN3
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.5884952471586126,-1.0726224932709525,0.32142857142857145,1.0,1.0,1/7,0.79%,NRP1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.7075596916872773,1.0725224359719157,0.3972602739726027,0.9683304676441101,1.0,3/7,4.97%,PRKACA;KCNQ1;PDE4B
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.7075596916872773,1.0725224359719157,0.3972602739726027,0.9683304676441101,1.0,3/7,4.97%,PRKACA;KCNQ1;PDE4B
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.5120393815279233,-1.0724637946825497,0.35294117647058826,0.9984345054472036,1.0,1/11,0.82%,CD4
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.6025964178870538,1.0722371163166675,0.4230769230769231,0.9685144261541744,1.0,5/14,22.06%,NR4A3;MTFR1;PPARGC1A;NDUFS1;COX10
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.6419716472217453,1.072222233024133,0.43023255813953487,0.9677781942447518,1.0,4/10,15.83%,STMN1;NCKAP5;MICAL3;CFL1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6210030044201578,1.0720674507249086,0.4155844155844156,0.9674479344046645,1.0,4/10,26.72%,PITPNC1;SCARB1;PITPNA;OSBPL5
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.7047392555322516,1.0718456467576194,0.38961038961038963,0.9675731895628826,1.0,2/6,19.57%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.5585461006587535,-1.0717694265465836,0.4,0.9963885485583599,1.0,1/9,0.79%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.4955710435039166,1.071510069163554,0.28,0.9679760430346736,1.0,36/185,18.59%,SOD1;CSF1;TAF1B;GJA1;CADM1;HABP4;DDX3X;RAB27A;RIMS2;ANK3;AGO2;FUBP1;NOS1AP;ROBO1;TGFB1;EIF2AK2;EGFR;DDX21;DNMT1;ELAVL1;HIF1A;F3;PPARGC1A;ROCK2;FUBP3;CAMK2N1;STAT3;METTL14;TTN;POLR1C;TWIST1;MAP2K1;MAPK1;SF3B1;SP1;RBPJ
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.528094003586745,1.0714048384231638,0.4,0.9676716732247498,1.0,15/78,16.65%,ATP6V1G1;ATP6V1H;ACADVL;PDHX;NDUFV1;COX6C;ATP6V1E1;GLUD1;NDUFB2;SLC25A3;NDUFS2;PDK4;SLC25A4;SUCLG1;COX4I1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.7124946238128623,1.0711334022628018,0.45714285714285713,0.967947712837621,1.0,3/6,24.37%,ACADVL;ACADL;WDTC1
prerank,PanglaoDB_Augmented_2021__NK Cells,0.6638262534945547,1.0709579048450981,0.4358974358974359,0.9678538065847818,1.0,3/10,10.88%,TGFB1;ZBTB16;CHSY1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.6346663752500921,-1.0708296759031073,0.46153846153846156,0.9954874637644308,1.0,5/6,33.65%,ZCCHC17;NRDE2;TENT2;SLIRP;NAF1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.666633546606176,1.0707125257918522,0.4,0.9680201629901876,1.0,2/8,10.57%,SEMA4D;SEMA3B
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.6483473785825812,1.0705951701192955,0.4,0.9676916095393295,1.0,1/8,3.59%,DDIT4
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.6423490366823015,1.0705363882614771,0.4383561643835616,0.9670369041958148,1.0,1/12,4.14%,WASF1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.665957846943184,1.0703428786170923,0.5070422535211268,0.9670696045374945,1.0,1/8,7.81%,TGFB1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.6355897563361343,1.0701382884424526,0.37662337662337664,0.9671273400066858,1.0,2/9,11.42%,ARID1A;KDM3A
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.7038072036625728,1.0696323655841717,0.4,0.9683631904871529,1.0,5/6,28.38%,INTS2;INTS8;INTS6L;INTS6;INTS7
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.6444517483832296,1.0696280012200368,0.3972602739726027,0.9675764960548257,1.0,4/11,22.76%,GIGYF2;ROCK2;METTL14;METTL16
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.5437162507875014,1.0693076186780226,0.41379310344827586,0.9680424506591992,1.0,13/55,19.46%,TSC2;NRG3;GFAP;PTPN1;SEMA4D;RAP1B;SNCAIP;ROCK2;PACSIN2;RUFY1;ABL1;CAMK2D;ABL2
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.4993345161422986,1.06923559750736,0.32323232323232326,0.9675323819660563,1.0,27/153,13.46%,CSF1;S1PR3;GJA1;HDAC2;NRG1;KDM1A;EAPP;CSF1R;IL18;ADAM17;PRKCI;NR4A3;CCAR1;TGFB1;EGFR;EFNB2;IRS1;CNOT8;SDCBP;CDC123;PRLR;ZFPM2;TBX3;FLT1;FGFR2;MDM2;KDR
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.6806524972946915,1.0691690872045674,0.38271604938271603,0.967023148766268,1.0,1/5,8.66%,RNF168
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.5541514464749898,1.069045483939816,0.4,0.9666978309907633,1.0,15/37,23.87%,ARRDC2;SLC38A4;SLC7A2;TMEM30A;SCARB2;SLC3A2;RAB7A;ATP11B;RUFY1;SNX4;CMTM6;SLC6A12;SLC22A2;CEP290;SLC38A2
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5255816508312524,1.069044886392818,0.3854166666666667,0.9659073994036899,1.0,17/68,16.22%,KCNQ1;IL18;SSH1;DIAPH1;NR4A3;TGFB1;EGFR;RAP1B;GNB1;RIOK3;ROCK2;AKAP6;LRRK2;TIPARP;GNAI1;LCOR;GABRB1
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.5049279558918125,1.068679043329293,0.3838383838383838,0.9663312726878567,1.0,26/74,22.99%,HSPA4L;CCP110;PITPNC1;DDIT4;SLC35D1;TP63;TGFB1;KIF13B;ZBTB16;SLC3A2;PTPRE;MXD4;MDM2;SESN1;APAF1;ELP1;WWP1;DRAM1;ACVR1B;SP1;CCNK;CD81;RPL18;RCHY1;CCND3;JUN
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6448605637405679,1.0679662097838265,0.44871794871794873,0.9685890916423026,1.0,5/10,19.41%,CDH18;CDH12;CDH20;CDH10;NLGN1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.60644082482066,1.0676512337729824,0.3974358974358974,0.9680131469137996,1.0,8/17,22.06%,NDUFB9;NDUFV1;COX6C;NDUFB2;NDUFS2;COX4I1;NDUFS1;COX10
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.60644082482066,1.0676512337729824,0.3974358974358974,0.9680131469137996,1.0,8/17,22.06%,NDUFB9;NDUFV1;COX6C;NDUFB2;NDUFS2;COX4I1;NDUFS1;COX10
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.5716477577596089,1.0675235697976637,0.4470588235294118,0.9678045499162106,1.0,4/20,10.52%,NUP153;SEC13;NUP88;NUP133
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.6554341983098027,1.0673889237419965,0.4166666666666667,0.9675218217931396,1.0,5/8,29.48%,PRLR;CYP3A5;ITIH2;UPB1;SPTLC3
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.6193208989066341,1.0673386838601657,0.42857142857142855,0.9669667165831856,1.0,3/11,19.41%,LRRC7;NRXN1;NLGN1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.6879062492220483,1.0670825242288764,0.4473684210526316,0.9669329603910276,1.0,1/7,5.41%,ZFP36L2
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.6259961496446802,1.067050772533212,0.43209876543209874,0.9662389101723964,1.0,3/15,13.41%,KCNQ1;RAP1B;AKAP6
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.715094313027183,1.0670294214349074,0.39705882352941174,0.9655459857448742,1.0,1/5,18.27%,GLRX3
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.6782884349342655,1.0665079408570513,0.3972602739726027,0.9668567430220442,1.0,4/12,17.42%,OGN;SOD2;CDKN1B;PDCD4
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.6841438039137248,1.0661912636488584,0.40625,0.9672513692896265,1.0,3/5,15.17%,TMEM30A;SCARB2;ATP11B
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.610917501766697,1.0660644229787832,0.41975308641975306,0.9669048687573226,1.0,3/14,16.27%,KCNQ1;MYL3;TTN
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6523359442856184,-1.0660443661919041,0.45714285714285713,1.0,1.0,1/6,1.59%,BCL2L11
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.501037538351949,-1.0659311762658417,0.44,1.0,1.0,1/13,3.18%,CD58
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.7406455306798626,1.0656654436879829,0.5072463768115942,0.967553668954587,1.0,3/7,17.10%,LRRK2;MAP2K1;MAPK1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.692745918695485,1.0656523254947463,0.38571428571428573,0.9668214093120349,1.0,1/6,1.38%,PRKACA
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.6083997960142004,1.0655544092768798,0.4375,0.9664432638837864,1.0,4/14,11.66%,AKIRIN1;TGFB1;SRA1;TBX3
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.5775706404692991,1.0654876722852082,0.40963855421686746,0.965893505133517,1.0,10/26,32.13%,ADAM17;TGFB1;EGFR;ERBIN;GRB2;RPS6KA5;PTK2B;PTPN11;PLCG1;NCK2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.5589056899529762,-1.0650745730311888,0.41379310344827586,1.0,1.0,2/7,13.49%,ST6GAL1;ST3GAL1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.5097107636743861,1.0650215946697386,0.3917525773195876,0.9669753374614799,1.0,19/81,20.92%,PRKACA;CCP110;PSMB1;TUBA1A;CSNK1D;PSMB2;ZFP36L2;BTRC;PSMA7;RPS27A;PSMA4;CEP70;CEP57;PSMD14;PAFAH1B1;ANAPC4;SKP1;CNTRL;YWHAG
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.574882817649327,1.0648324888428513,0.35802469135802467,0.9669664369963533,1.0,3/19,10.94%,GRIN1;DDX3X;GRIN2B
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.36839404233181117,-1.0646743681520683,0.3333333333333333,0.9980348500485976,1.0,6/48,7.19%,NRP1;PHLDB2;ARHGEF10L;EVL;SLC9A1;WASF2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.7081071109509569,1.0646653943628492,0.4,0.966892100349111,1.0,1/5,9.46%,HIF1A
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.49899297673240417,1.0646443386749458,0.32,0.9662374769394151,1.0,44/197,19.63%,CSNK1G2;PRKACA;PANK2;PDK1;DCLK1;SIK2;CAMKK2;DGKI;EPHA7;CSNK1D;CSNK1A1;MAPK6;STK4;PRKCI;PRKCB;TBK1;TGFB1;EIF2AK2;AGK;NRBP1;OXSR1;EIF2AK4;ROCK2;GK5;PDK3;MAPKAPK2;STAT3;PGK1;MELK;LRRK2;PDK4;INSR;ACVR2A;LATS2;MAK;MAP2K1;ACVR1B;MAPK1;STK39;ABL1;CSNK2A1;DGKH;CAMK2D;CDK17
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.7232741479501307,1.0645779826660824,0.4444444444444444,0.9656655868356985,1.0,1/5,5.68%,CSF1R
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.5282423552649128,1.0645043466052668,0.3617021276595745,0.9650946146936251,1.0,11/53,14.50%,OS9;UBA5;RHBDD1;TMCO1;SELENOS;MARCHF6;CEBPB;HSPA5;CREB3L2;TNFRSF10B;ATF6
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.5490397108074814,1.0642502549129655,0.3956043956043956,0.9653400652745133,1.0,8/27,23.60%,SUFU;BTRC;TTC23;FGFR2;DCDC2;MGRN1;ARMC9;EVC
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.6812303585881101,1.0641121309517085,0.42424242424242425,0.965112507464307,1.0,4/9,21.96%,EAPP;TCERG1;SUPT16H;ELL
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.5536929598306602,1.0639647855407346,0.391304347826087,0.9647631838710207,1.0,7/41,19.57%,CSF1;EIF2AK2;LPAR6;ELF1;TRIM5;IFIT3;IFITM3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6183271545604327,1.0638808522103387,0.4155844155844156,0.9642273027522936,1.0,2/10,28.97%,CPEB4;CPEB2
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.719143613296736,1.0637906856019452,0.425,0.9637816972956568,1.0,4/8,21.72%,IRS1;PPARGC1A;PTPN2;IRS2
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5316197398354139,1.0637616683636475,0.358695652173913,0.963085006121469,1.0,20/55,16.97%,ELAVL3;PCBP3;LSAMP;CACNA1B;NCAM1;ARHGEF9;LIN7A;ADGRB3;CTNNA2;SNAP25;RNF152;TRPM3;ZNF536;CADM2;CDH20;SGIP1;SLC1A2;CNTNAP2;NRXN1;UNC79
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.70979103821694,1.0636206282556142,0.45588235294117646,0.9628682721102383,1.0,2/7,10.54%,HDAC2;RCOR1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.5510555886040555,1.0633249039241814,0.40229885057471265,0.9632600997907613,1.0,7/32,16.81%,TPT1;CACNA1B;NDFIP2;SLC3A2;NDFIP1;TRPC4;MAGT1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.6198036363751753,1.0632164024484885,0.40789473684210525,0.962865303781346,1.0,4/12,27.98%,PTPN1;PTPN2;UBE2K;PTPN11
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.5325914062516488,1.063055739271815,0.3956043956043956,0.9626006825670093,1.0,17/63,20.92%,PRKACA;CCP110;PSMB1;TUBA1A;FHL1;CSNK1D;PSMB2;PSMA7;PSMA4;CEP70;CEP57;RBX1;PSMD14;PAFAH1B1;SKP1;CNTRL;YWHAG
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.6597838526809279,1.0629207205811615,0.4177215189873418,0.9623607529661699,1.0,4/13,12.40%,ATP6V1G1;ATP6V1H;ATP6V1E1;RAB7A
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.657832242189091,1.0622478337334418,0.42857142857142855,0.9640289725152109,1.0,3/8,14.45%,IRS1;PDK3;PDK4
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.5701635395867024,-1.062076974243637,0.4230769230769231,1.0,1.0,1/7,2.29%,ATM
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.6928184847280605,1.0619929661638523,0.43209876543209874,0.9643698581224359,1.0,2/8,18.25%,TTN;CSNK2A1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.4999608297817508,1.0617469324397593,0.422680412371134,0.9644035072980027,1.0,28/119,16.62%,CSNK1G2;MCC;PSMB1;AMFR;DDX3X;UBAC2;CSNK1D;PSMB2;CSNK1A1;BTRC;STK4;PSMA7;TGFB1;EGFR;CTNND2;SMURF2;PSMA4;FGFR2;BICC1;LRRK2;RBX1;IGFBP2;PSMD14;LATS2;TMEM64;TNKS;LGR4;HECW1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.7378826874124671,1.061151926080969,0.5538461538461539,0.9660742026273242,1.0,3/5,26.05%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.6756034728927067,1.0610940655991976,0.4473684210526316,0.9655584944868011,1.0,4/5,32.45%,LANCL1;P4HB;UBQLN1;FYN
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.5364026001508267,1.061090574107376,0.4175824175824176,0.9648101019684623,1.0,12/40,20.44%,RHOB;MYDGF;AGO2;PRKCB;HIF1A;F3;FLT1;RUNX1;KDR;TWIST1;SP1;ANGPTL4
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.6198445478946182,1.0607486027999111,0.45454545454545453,0.9653340651045621,1.0,3/13,10.57%,SEMA4D;DIP2B;SEMA3B
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.4417926113988887,-1.0606719771730704,0.35,1.0,1.0,3/13,7.57%,WNT5B;ATM;EPHA3
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.6773982283740775,1.0605844526115376,0.39436619718309857,0.965358780031297,1.0,2/6,23.31%,SENP1;SENP2
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.5845029366787082,1.060326365839838,0.39285714285714285,0.9655200114609219,1.0,4/23,7.81%,CD44;CEMIP2;OGN;TGFB1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.5033522467686341,1.0603197318893904,0.28,0.9647900647175826,1.0,31/193,14.74%,TBC1D20;RANBP10;VAPB;WASF3;TOR1AIP2;COG2;FAM174B;DPYSL2;COG7;CSNK1D;ATL1;DIAPH1;NECTIN2;CSNK1A1;PRKCI;ATL2;AGTPBP1;VAPA;WDR73;MTFR1;PPARGC1A;RAB18;RAB7A;ARHGEF7;CAPZB;RANBP9;PLAAT3;MICAL3;REEP5;LRRK2;PACSIN2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5043085036389858,1.0602896626165812,0.35,0.9641655294319317,1.0,36/199,14.52%,CSF1;COL4A6;ATP6V1G1;TSC2;GRIN1;ATP6V1H;NRG1;MPZL1;DDIT4;ACTR3;AP2A1;EPHA7;CSF1R;HNRNPF;GIGYF2;NR4A3;STMN1;ANKS1B;EGFR;ATP6V1E1;EFNB2;IRS1;SDCBP;SHC2;GRIN2B;PRLR;ROCK2;FLT1;ARHGEF7;FGFR2;MAPKAPK2;KDR;CEP57;STAT3;PDK4;INSR
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.5423273329778979,1.0598850385519984,0.4166666666666667,0.9649123193374609,1.0,14/52,22.26%,HDAC2;HCFC2;SMARCA1;ARID1A;HNRNPC;MBD2;EZH1;ZBTB7A;ZBTB1;SMARCA4;KDM6A;JARID2;MYSM1;NUDT5
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.5556601367313712,1.0597741967299883,0.41379310344827586,0.9645849443484349,1.0,7/28,23.03%,TGFB1;HIF1A;ROCK2;FGFR2;RBPJ;LOXL3;LEF1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.6336157936747701,1.0594531074785425,0.4819277108433735,0.9652022118736906,1.0,3/10,9.96%,TGFB1;PTBP2;TMBIM6
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.5793943270299149,-1.0593606624362737,0.43478260869565216,1.0,1.0,1/9,1.17%,SPRY1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.6585324389654637,1.0589831235890408,0.44285714285714284,0.9662502274714496,1.0,2/8,7.49%,CD38;PRKCB
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.5300079011780242,1.0589499013504755,0.36585365853658536,0.965666940711515,1.0,12/37,18.08%,VAPB;TOR1AIP2;ATL1;ATL2;VAPA;RAB18;REEP5;LRRK2;LPCAT3;RTN3;PRNP;REEP3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.6621555726548041,1.0588895670245166,0.3888888888888889,0.9650845696293826,1.0,1/9,12.46%,RUNX1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.6864476565869244,1.0588003338861696,0.41975308641975306,0.9646466796739867,1.0,1/9,4.38%,OGN
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.5956406411746373,1.0587854400220502,0.3977272727272727,0.9639066264327257,1.0,4/24,8.50%,ATP6V1G1;ATP6V1H;ATP6V1E1;CP
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.49639947178239713,1.058547545091246,0.33,0.9640835331573372,1.0,33/198,14.52%,CSF1;S1PR3;HDAC2;GRIN1;NRG1;EAPP;DDX3X;RAB27A;CSF1R;RNF10;ADAM17;CCAR1;FRMD5;TNFRSF1B;TGFB1;EGFR;EFNB2;IRS1;CNOT8;ADNP2;SDCBP;CDC123;CCN2;PRLR;TBX3;ANKRD17;FLT1;FGFR2;MDM2;AKAP6;KDR;PPP3CA;INSR
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.5392809290752539,1.0583758180527938,0.3516483516483517,0.9639498300869279,1.0,16/60,16.47%,FMN2;PSMB1;KCND2;HIF3A;PSMB2;PSMA7;BNIP3L;RPS27A;HIF1A;PSMA4;MDM2;MDM4;PGK1;RBX1;PSMD14;TWIST1
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.7295749279309452,1.0577203877113568,0.39705882352941174,0.9649224428810868,1.0,1/5,9.03%,RPS27A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.7295749279309452,1.0577203877113568,0.39705882352941174,0.9649224428810868,1.0,1/5,9.03%,RPS27A
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.6942744303306762,1.0575351608383676,0.44,0.96491541596219,1.0,1/5,9.46%,HIF1A
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5463970633955784,1.0574766793839383,0.37362637362637363,0.9643531300885063,1.0,13/38,21.53%,STRAP;SNX6;ADAM17;PPARA;TGFB1;RPS27A;SMURF2;SNX25;ZBTB7A;FBN1;SMAD2;SMAD6;SMAD7
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.6822086889509615,1.0574706788095871,0.3880597014925373,0.9636252695940783,1.0,1/6,15.83%,CFL1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.5565614021572876,1.0574026700989898,0.4111111111111111,0.9631123847714776,1.0,10/40,15.29%,KLF2;PSMB1;HIF3A;PSMB2;PSMA7;RPS27A;HIF1A;PSMA4;RBX1;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.6243843431204626,1.0572864141318448,0.4230769230769231,0.9628298015481823,1.0,6/12,27.01%,TGFB1;IRS1;FLT1;AMBRA1;CD81;PTK2B
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.6511198264078267,1.0572129042261034,0.4533333333333333,0.9623578717001178,1.0,2/9,13.23%,GJA1;SLC1A2
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.6336546288498306,1.0569751629707225,0.3918918918918919,0.9624634927528364,1.0,4/11,17.55%,DDX3X;HIF1A;RIOK3;ARF1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.4946174601033817,1.056787216771256,0.32,0.962355771970351,1.0,52/230,19.63%,CSNK1G2;PRKACA;PDK1;DCLK1;SIK2;CAMKK2;USP15;CRY1;CSNK1D;CSF1R;CSNK1A1;MAPK6;STK4;PRKCI;PRKCB;TBK1;TGFB1;EIF2AK2;STK33;EGFR;NRBP1;OXSR1;EIF2AK4;CCNH;UHMK1;ROCK2;FLT1;FGFR2;PDK3;MAPKAPK2;KDR;SLK;MAP2K6;MELK;LRRK2;PDK4;INSR;ACVR2A;LATS2;MAK;TNKS;MAP2K1;ACVR1B;MAPK1;STK39;ABL1;CSNK2A1;SMAD2;CAMK2D;ABL2;RPS6KA2;CDK17
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.6641619388062323,1.0566585518552645,0.4430379746835443,0.9620352058813708,1.0,2/8,13.92%,FRMD5;CD9
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.5785229497759664,1.0566114322326001,0.425,0.9613840409643696,1.0,1/17,0.38%,SOD1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.6175143226743068,1.0563574449524347,0.4657534246575342,0.9615609832360946,1.0,2/13,8.04%,CSNK1D;NUDCD3
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.7025415307393654,1.0562137759395007,0.5066666666666667,0.9613834552132334,1.0,3/6,18.70%,ACVR2A;ACVR1B;SMAD2
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),0.7224188830170623,1.0560879039203968,0.4714285714285714,0.9611196874107962,1.0,2/5,17.63%,ZFP36L2;ABL1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.620407873504723,1.0555411018434335,0.4810126582278481,0.9623730883214313,1.0,3/13,18.70%,BASP1;HES4;SMAD2
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3724681997856501,-1.0553276651183632,0.3,1.0,1.0,2/40,1.17%,SPRY3;SPRY1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.4534827882544221,-1.055005231645195,0.42105263157894735,1.0,1.0,4/19,5.71%,ATP10A;ANO6;ATP8A1;ABCA4
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.6322351657783989,1.0549185782698864,0.4268292682926829,0.963632406274608,1.0,3/13,11.15%,SLC22A6;ENPEP;SLC13A3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.5964542577092007,1.0548162878133553,0.42857142857142855,0.9632733528930012,1.0,9/20,27.72%,KDM1A;FMN2;SPIRE1;TWIST1;UBR5;TRIP12;SPIDR;SETD2;SHLD2
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5594724916342005,1.053836328208494,0.42857142857142855,0.9657061379906619,1.0,7/39,14.52%,LPIN1;PRKCI;SELENOS;IRS1;DENND4C;RAB12;INSR
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.6424215587228891,-1.0532690077274551,0.45,1.0,1.0,3/6,7.31%,SLC9A1;SLC6A1;HCN2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.607641227588773,1.0531523403972465,0.39759036144578314,0.9673595445139529,1.0,2/14,7.81%,LZTFL1;TGFB1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.6942866237131051,1.0527434902642503,0.40625,0.9681022859449455,1.0,2/6,13.46%,F3;KDR
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.536687648669452,-1.052585330888478,0.3333333333333333,1.0,1.0,3/8,14.76%,NBL1;GLI2;BMPR1B
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.5201372471843565,1.0525548895275174,0.41414141414141414,0.9679990445686988,1.0,21/83,23.12%,MTMR9;CCT4;COG7;ATP1B3;STK4;PPARGC1A;CCNH;TBRG1;MDM4;NAPG;PPIB;ZSWIM7;NAA15;STXBP4;CCT3;UBE2B;STX12;SMAD7;NLK;LAMP2;MT3
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.48435175623621635,1.0523540848887196,0.41237113402061853,0.9680601101047617,1.0,11/74,14.52%,TSC2;NRG1;MYDGF;IL18;PPARA;TGFB1;EGFR;IRS1;F3;FGFR2;INSR
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.5029348074205117,1.0521721088882614,0.37755102040816324,0.9679101962455026,1.0,24/120,14.52%,CSF1;PLAA;RIPOR1;AGO2;CSF1R;SEMA4D;ADAM17;CCAR1;SOD2;TGFB1;EGFR;HIF1A;F3;SDCBP;SEMA3B;ROCK2;SMURF2;FLT1;ARHGEF7;HSPA5;KDR;STAT3;PPP3CA;INSR
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5881118936697922,1.0520025505174986,0.5116279069767442,0.9678697766567678,1.0,8/23,25.57%,RC3H2;CNOT8;TUT7;DCP2;DCP1A;DIS3;PATL1;CNOT1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.6327619312114091,1.0517676308046677,0.5,0.9679230022383762,1.0,3/12,15.66%,SUFU;SIN3A;LATS2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.5128304733473047,1.05163696745421,0.45263157894736844,0.9676176856290744,1.0,11/62,11.93%,PHYHIPL;SLC23A2;CDC42EP4;SMARCA1;SCARB2;EGFR;SLC2A12;SHC2;PRLR;SLC4A10;FARP1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5029674211634754,1.051561307718688,0.3939393939393939,0.9671726767830143,1.0,15/78,14.05%,RHOB;RHOJ;MYDGF;CEMIP2;AGO2;NIBAN2;PRKCB;HIF1A;F3;GLUL;ROCK2;FLT1;RUNX1;KDR;PGK1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.5680337361748183,1.0512157066425996,0.4578313253012048,0.967069950081902,1.0,3/17,13.80%,YAF2;APAF1;EED
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.5680337361748183,1.0512157066425996,0.4578313253012048,0.967069950081902,1.0,3/17,13.80%,YAF2;APAF1;EED
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.609275979069583,1.0510086852468328,0.4225352112676056,0.9670381264714778,1.0,3/10,15.06%,SOD1;SREBF1;LPCAT3
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.6660614208390374,1.0509775319218615,0.4782608695652174,0.9664241354975299,1.0,2/6,21.46%,ZFPM1;SMAD6
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.6932234830026819,1.0508984864764968,0.3968253968253968,0.966005005148876,1.0,3/5,18.75%,SREBF1;SCARB1;ABHD5
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5752503747342798,1.0502848419252584,0.42528735632183906,0.9675087730433586,1.0,3/19,8.25%,DDX3X;EIF2AK2;EGFR
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.5794925517047931,1.049883035546104,0.45348837209302323,0.9682512264037869,1.0,5/15,25.39%,CP;TRPC4;TF;MT3;IREB2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.5639343363814621,1.049646521348653,0.3563218390804598,0.9684894985762147,1.0,2/30,6.62%,CCP110;DCDC1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.5643929309627376,1.0491656094640334,0.45348837209302323,0.9696090117020106,1.0,6/25,5.15%,DPP10;NEDD4L;KCNQ1;DPP6;NOS1AP;FHL1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.5634714211573227,1.048860710931108,0.4942528735632184,0.9699772572732752,1.0,5/26,17.42%,NFKBIA;IL18;RIOK3;NFKBIZ;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.6615731063179756,1.0485939581479289,0.4805194805194805,0.9701982328692323,1.0,1/7,7.62%,PPARA
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.4998036031883981,1.0485517357459044,0.4329896907216495,0.9696164340872755,1.0,21/89,16.47%,WWC1;EPM2A;TSC2;DDX3X;DDIT4;WWC2;PPARA;UBR1;DUSP1;PDE10A;TNFAIP8L1;RNF34;RIOK3;OTUD7A;TMSB4X;TANK;MDM2;USP10;PDE4D;MGRN1;TWIST1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.5086845626817745,1.0484773364764959,0.46236559139784944,0.9692051355173265,1.0,16/59,20.34%,AMFR;NUP153;SEC13;NUP88;CEBPB;NUP133;ROCK2;CORO2B;DNAJC7;MAPKAPK2;MAPK1;RPA1;ABL1;HSPH1;CAMK2D;NUP205
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.5615174255476466,1.048330591967752,0.41379310344827586,0.9689793577981651,1.0,7/34,16.14%,WWC1;SLC7A2;EFNB2;SHC2;ARFGEF3;CKB;TEAD1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.395098054118589,-1.04832428360509,0.4444444444444444,1.0,1.0,6/37,10.99%,NRP1;PHLDB2;SLC9A1;EPHA3;CORO1C;ACTG1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.557146546856203,1.0479633276943792,0.45569620253164556,0.9696315209975976,1.0,7/16,31.78%,DUSP1;ULK4;PER1;VEGFA;CYLD;PHLPP1;DLG1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.7089252823936849,1.0473924058258652,0.4852941176470588,0.9707134727754723,1.0,4/5,28.02%,TCAF1;PRNP;GOPC;GRM5
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.6364276022454425,1.0472793697512013,0.4177215189873418,0.9703717679340222,1.0,2/10,7.52%,OS9;SELENOS
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.686779316439926,1.0467560311026662,0.4492753623188406,0.9718816507365248,1.0,3/5,27.72%,SMCHD1;TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.6022049935392538,1.0465952034240573,0.3717948717948718,0.9717237799762986,1.0,2/15,2.17%,PARVB;RHOJ
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.49576020420107103,1.046383712538799,0.3434343434343434,0.9716505086373075,1.0,50/244,19.25%,SCML1;TAF7;HDAC2;NRG1;KDM1A;CBFA2T2;CD38;DDX3X;BASP1;ENO1;CRY1;NIBAN2;IGF2BP2;SNX6;YAF2;GIGYF2;BTRC;TP63;SELENOS;CTBP2;TGFB1;EIF2AK2;CLOCK;CNOT8;ZBTB16;RCOR1;SIN3A;ZFPM2;EIF4ENIF1;BCL6;TBX3;DEAF1;SMURF2;MDM2;TSHZ3;EED;MBD2;WWP1;ZBTB7A;TWIST1;CDKN1B;PDCD4;ZHX3;PER1;RBPJ;SMAD2;FOXP2;SMARCA4;LOXL3;MBTD1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.6573761335055033,1.0463212763885228,0.4861111111111111,0.9711175419161978,1.0,3/6,30.90%,PRNP;ARF1;APP
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.6105803534523809,1.0462536716261985,0.45348837209302323,0.9705470895579495,1.0,3/17,8.49%,ATP6V1G1;ATP6V1H;ATP6V1E1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.6690458630366627,1.0462085284101625,0.4444444444444444,0.970000451361066,1.0,4/6,26.93%,AGTPBP1;STAT3;CEP290;VEGFA
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.6385430871183305,1.046120036912541,0.5205479452054794,0.9695310966194598,1.0,7/10,31.99%,DCUN1D4;DCUN1D1;ABL1;SMAD7;UBE2L3;DCUN1D2;RPS2
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6189655375629277,1.0459443414668037,0.43478260869565216,0.9695055903229381,1.0,5/10,28.73%,GBE1;PHKB;MT3;UGP2;PID1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.6626525369299935,1.0459367906330117,0.4084507042253521,0.9688159065911359,1.0,6/6,33.80%,DCUN1D4;RBX1;DCUN1D1;DCUN1D2;UBA3;NAE1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.677335515178309,1.0458475132264802,0.4146341463414634,0.9683561257286799,1.0,6/8,30.67%,INTS2;INTS8;INTS6L;INTS6;INTS7;SSB
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.6123920420864641,1.0457973809498453,0.49382716049382713,0.9677979323676199,1.0,3/17,13.44%,AGO2;CNOT8;MOV10L1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.6567631340310001,1.0455186783644304,0.4583333333333333,0.9679413858999468,1.0,2/6,31.81%,MTMR2;RDX
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.694860932439142,1.045257806687481,0.37142857142857144,0.9681759663453614,1.0,1/5,5.41%,ZFP36L2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5275650191485532,1.0450602435862886,0.3829787234042553,0.9680983452879317,1.0,7/39,13.55%,MUCL1;DPM1;TET3;C1GALT1;GALNT15;GALNT11;GALNT7
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.5394222512158695,1.0447927364508114,0.41379310344827586,0.968294455643779,1.0,9/38,16.19%,DDX3X;RAF1;RUBCN;CRACD;RIOK3;TRAF3IP1;WASHC2C;HSPA5;LGALS3
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.5661862299236096,1.0447627868326694,0.4939759036144578,0.967670039944913,1.0,4/18,12.26%,ADAM17;NAIP;CEBPB;ANKRD17
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7370940459468609,1.0447151163959598,0.515625,0.9670996797943944,1.0,2/5,13.99%,PAPSS1;PAPSS2
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.6408367542981834,1.04462795162941,0.4810126582278481,0.9667045890505037,1.0,5/10,20.53%,STMN1;HEG1;SCAI;ABL2;KANK1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.5557945113545733,1.0444310888138209,0.43820224719101125,0.9667799090667192,1.0,11/39,17.98%,NFKBIA;PSMB1;PSMB2;ADAM17;PSMA7;TNFRSF1B;TMSB4X;PSMA4;PSMD14;MAP3K14;ST18
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.5276037863784234,1.0440701268945487,0.42696629213483145,0.9674078824780048,1.0,13/52,26.72%,DNAJC6;AP2A1;EXOC1;ARF1;SORCS1;SNAP23;STXBP6;EPS15;GOPC;DNM2;CLTC;RAB14;OSBPL5
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.6535116832255287,1.0435453648390145,0.4605263157894737,0.9685797091860738,1.0,2/9,14.71%,MDM4;HECTD1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.627485539424506,1.0432269746172362,0.44,0.9688954149428212,1.0,4/12,19.38%,KCNQ1;MYL3;TTN;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.4538402453960611,-1.0431017294130205,0.46153846153846156,1.0,1.0,1/10,1.76%,JPH2
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.45659431163099456,-1.0425726056760303,0.3684210526315789,1.0,1.0,3/12,7.57%,WNT5B;ATM;EPHA3
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.589179878745041,-1.0425504263320597,0.375,1.0,1.0,1/8,1.04%,PRPSAP1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.5443588247253323,1.0424898119701806,0.4367816091954023,0.9709710257843359,1.0,9/36,22.51%,DDX3X;CSF1R;CCNH;MTCP1;MAP2K1;CDKN1B;ABL1;CCNK;CCND3
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6988827586333456,1.0423784629247972,0.4444444444444444,0.9699302503094053,1.0,3/7,25.10%,PTPRD;NLGN1;IL1RAPL1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6988827586333456,1.0423784629247972,0.4444444444444444,0.9699302503094053,1.0,3/7,25.10%,PTPRD;NLGN1;IL1RAPL1
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.5850665608478343,1.042151991359514,0.5176470588235295,0.9699274038167273,1.0,5/23,14.87%,HDAC2;SMARCA1;ARID1A;HNRNPC;MBD2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.4877736394645005,1.0410943190234099,0.38,0.973050701795656,1.0,70/399,18.59%,NELL1;WWC1;CSF1;HNRNPL;GJA1;PCBP3;PRDM6;ZC3H7B;DDX3X;RAB27A;RIMS2;ANK3;SUFU;WWC2;HCFC2;AGO2;FUBP1;NOS1AP;IGF2BP2;NDFIP2;PRDM10;HNRNPF;YAF2;ROBO1;CTR9;CCAR1;TGFB1;ESR2;APBB1;ZC3H7A;PTBP2;DNMT1;CLOCK;HIF1A;F3;ADNP2;MTF2;CEBPB;PPARGC1A;GRSF1;ZNF536;BCL6;PTRH2;CREM;ROCK2;NFKBIZ;FUBP3;NDFIP1;RUNX1;TRIM5;KDR;CAMK2N1;STAT3;INSR;PLAG1;SRSF10;NOVA1;TIPARP;MZF1;TTN;TWIST1;MAP2K1;ACVR1B;TDG;MAPK1;ABL1;AFF4;PER1;SP1;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4952794174290153,1.041066091342381,0.45454545454545453,0.972405729935796,1.0,43/200,19.25%,SCML1;TAF7;HDAC2;NRG1;KDM1A;CBFA2T2;CD38;BASP1;ENO1;CRY1;NIBAN2;SNX6;YAF2;BTRC;TP63;CTBP2;TGFB1;CLOCK;ZBTB16;RCOR1;SIN3A;ZFPM2;BCL6;TBX3;DEAF1;SMURF2;MDM2;TSHZ3;EED;MBD2;WWP1;ZBTB7A;TWIST1;CDKN1B;PDCD4;ZHX3;PER1;RBPJ;SMAD2;FOXP2;SMARCA4;LOXL3;MBTD1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.632443134365861,1.0408953306413902,0.47435897435897434,0.9722280591131359,1.0,4/12,25.22%,STMN1;ABL1;MAP1B;CAMSAP1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.7171243090558878,1.040364204498479,0.4375,0.9732682697328032,1.0,2/5,17.55%,WASHC5;ARF1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.6021896052126394,1.040117288544065,0.39759036144578314,0.9732855002923979,1.0,7/12,36.56%,RAP1B;PDE4D;TJP1;RAP1A;RDX;RAB1A;RAPGEF2
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.5488399779693068,1.0401154001217503,0.4166666666666667,0.972604733767874,1.0,6/30,17.29%,RAD21;MORF4L1;FAN1;PSMD14;ZSWIM7;RPA1
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.603382455167716,-1.0400154277028724,0.5,1.0,1.0,1/7,0.43%,FGF13
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.5294773636247238,1.0398507023789025,0.4782608695652174,0.9727874180567612,1.0,16/47,28.78%,DDX3X;GGA3;IGF2BP2;GIGYF2;EIF2AK2;CNOT8;EIF4ENIF1;RTN3;PRNP;RTN1;YBX1;EIF2AK3;CNOT1;RNF139;LSM14A;RPL13A
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.5775525885631724,-1.0397085078310884,0.46875,1.0,1.0,1/5,0.79%,NRP1
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.6032753871072272,1.0396161711926921,0.5194805194805194,0.9727899768522972,1.0,4/13,22.47%,RPS27A;RNF34;MAP2K6;TAB2
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.6796532884136051,1.0396079881386386,0.5,0.9720961021386635,1.0,1/8,7.19%,ADGRB3
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6754238739775128,1.0395032058235183,0.45161290322580644,0.9709656482211798,1.0,1/5,8.85%,IRS1
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.6754238739775128,1.0395032058235183,0.45161290322580644,0.9709656482211798,1.0,1/5,8.85%,IRS1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6935548013227758,1.0393729475382545,0.5070422535211268,0.9707229625358498,1.0,3/5,23.68%,GBE1;PHKB;UGP2
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.6810244951794802,1.039235014853757,0.44285714285714284,0.9705030327147695,1.0,3/5,28.15%,PRKCB;VMP1;ZDHHC17
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.5666663102517084,1.0388229272259264,0.4714285714285714,0.9712384363232128,1.0,3/19,5.28%,FSIP2;IFT140;CSNK1D
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.5422269931238266,1.0387639471437287,0.4166666666666667,0.9707127734650671,1.0,7/25,18.59%,TGFB1;FGFR2;KDR;RARB;TEAD1;ZFPM1;RBPJ
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.53183659931154,1.0387532767601215,0.4444444444444444,0.9700314289333344,1.0,14/36,25.47%,PHYHIPL;ELAVL3;CACNA1B;CTNND2;ZNF536;CADM2;PTPRZ1;PURG;GRIA2;ERC2;MAPK4;PCDH19;MAP1B;LRRC4C
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.5572579714644218,1.0386071968600494,0.4625,0.9697679815583827,1.0,5/25,15.37%,CRY1;IRS1;ROCK2;STAT3;GNAI1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.6166347909840322,-1.0385939252542415,0.45714285714285713,1.0,1.0,3/5,15.09%,DOCK8;CXCL12;JAM2
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.6328159865536047,-1.0382922589909336,0.5,1.0,1.0,1/6,0.79%,NRP1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.598191311248831,1.0382523330422446,0.5308641975308642,0.9702785953199704,1.0,3/17,13.41%,KCNQ1;RAP1B;AKAP6
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.4950414174402761,1.0377237209883876,0.42105263157894735,0.9713905964334502,1.0,24/104,18.62%,PLAA;NEDD4L;PSMB1;RHBDD1;ZNRF1;PELI1;PSMB2;BTRC;PSMA7;MARCHF6;CLOCK;RNF34;TRIM9;SMURF2;PSMA4;MDM2;SIAH1;RBX1;PSMD14;WWP1;ZSWIM8;HECW1;APPBP2;AREL1
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6576681196487683,1.0374768196007196,0.49333333333333335,0.9715947177985362,1.0,1/9,7.68%,TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.4535318105772274,-1.03743937509778,0.39285714285714285,1.0,1.0,1/16,0.43%,FGF13
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.5165881236809498,-1.037398693616363,0.4117647058823529,1.0,1.0,4/13,10.99%,SYNPO2;SLC9A1;CDC42;ACTG1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.6056234559590802,1.0371488963021789,0.4852941176470588,0.9719841136563832,1.0,2/7,19.41%,NRXN1;NLGN1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.5896089102180865,1.0366575998073373,0.4642857142857143,0.9732036997859174,1.0,5/21,19.62%,WIPI1;AMBRA1;WDR45B;MAP1LC3B;BNIP3
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.523546868002378,1.0366082220767883,0.4731182795698925,0.9726055488230175,1.0,13/44,26.05%,HNRNPL;NUP153;DDX21;ZDHHC5;DHX15;ABCB10;NUP205;EIF3B;DCAF1;NUP160;YBX1;CNOT1;CCT8
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.591171555874856,1.0362329259129979,0.4473684210526316,0.9731192711950043,1.0,4/15,22.47%,RPS27A;CTSL;MAPKAPK2;TAB2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.592992495428509,1.0361245661968363,0.5,0.9728329065136484,1.0,4/12,25.02%,SCD;ACSL4;ELOVL5;SCD5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.5861192153214253,1.036087822026321,0.5176470588235295,0.9722954975299929,1.0,7/27,16.63%,DPP10;PRKCI;EGFR;CNST;PTPN9;LGALS3;ZDHHC5
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.5795766179499082,1.0359777207347427,0.4457831325301205,0.9719879761533536,1.0,6/20,22.28%,CTNNA2;CTNND2;FARP1;DCDC2;BTBD3;TMEM106B
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.5069949561683429,1.0356314780494402,0.425531914893617,0.9725671212053656,1.0,12/65,14.08%,GJA1;PELI1;NDFIP2;PRKCB;TBK1;DDX21;VAPA;CXXC5;ANKRD17;NDFIP1;TRIM5;TNFRSF10B
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.506888312374022,1.035177673709652,0.4444444444444444,0.9733520602511695,1.0,16/64,22.38%,CSNK1G2;LPIN1;VAPB;MGST1;SGPL1;VAPA;SAMD8;LPCAT3;TYW1B;ACER3;CSNK2A1;CHKA;ELOVL5;CERS6;SPTLC1;SGPP1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.5150426719476583,1.0350365682052283,0.4,0.9731698074197958,1.0,4/28,16.47%,SELENOS;MAPKAPK2;STAT3;TWIST1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.6309178021662041,1.0349110512175301,0.4625,0.9729214967322267,1.0,3/12,17.24%,ANK3;TCAF1;PRNP
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.626262694644273,1.0348785910727816,0.5068493150684932,0.9723127207279764,1.0,4/11,21.53%,PRKACA;MYL3;C12ORF57;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.6067047643341743,1.034729932667219,0.48,0.971311050455909,1.0,2/12,7.81%,IPO5;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.6067047643341743,1.034729932667219,0.48,0.971311050455909,1.0,2/12,7.81%,IPO5;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.5620436526218412,1.0346859436818507,0.4588235294117647,0.9707488445425285,1.0,2/20,7.44%,SOD1;XRCC4
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.5029656628383334,1.0346806918265814,0.40860215053763443,0.9700846553836981,1.0,17/86,14.73%,RHOB;TSC2;NFKBIA;DDIT4;RAF1;STK4;TP63;RNF152;ZBTB16;IFT57;MDM2;APAF1;SIAH1;TNFRSF10B;MELK;PAWR;YARS1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.5009822338821728,1.0343503127406568,0.425531914893617,0.9705880409091417,1.0,18/69,19.99%,PSMB1;IGF2BP2;PSMB2;ZFP36L2;RC3H2;PSMA7;RPS27A;ELAVL1;CNOT8;DCP2;PSMA4;MAPKAPK2;PABPC1;PSMD14;DCP1A;PRR5L;DIS3;CARHSP1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.6009315735714942,1.0340429814642018,0.5263157894736842,0.9708267514815209,1.0,3/18,14.37%,CCP110;NBDY;LRRK2
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.6063107682841049,1.0337840721101508,0.4567901234567901,0.9711457110956093,1.0,5/12,26.97%,HEG1;JAM3;NLGN1;TJP1;PCLO
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.6937979779532022,1.0337338910959506,0.4473684210526316,0.9706002907205673,1.0,1/5,7.81%,TGFB1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.602850053358411,1.0336904101919542,0.46153846153846156,0.970004442458736,1.0,4/12,25.49%,CSNK1D;RANBP9;GOLGA2;SLAIN2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.641203872992416,1.033669729922998,0.4868421052631579,0.9693948292455735,1.0,2/8,18.88%,DGKI;DGKH
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.6735326000545261,1.032880970353066,0.42424242424242425,0.9705800400328084,1.0,2/5,10.33%,KLF9;CTSL
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.6735326000545261,1.032880970353066,0.42424242424242425,0.9705800400328084,1.0,2/5,10.33%,KLF9;CTSL
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.48043164598156884,-1.0327809182683694,0.42857142857142855,1.0,1.0,3/15,8.95%,GLB1;ST6GALNAC3;GALC
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.49317949562243285,1.0326018506586896,0.43956043956043955,0.9707664919419753,1.0,11/46,17.58%,PRKACA;ADAM17;SELENOS;PPARA;TNFRSF1B;GNB1;LRFN5;LPCAT3;ADORA2B;PTH1R;PTPN2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5550985698147959,1.0324278857523295,0.4482758620689655,0.9706246322813354,1.0,8/27,22.51%,ADAM17;IPO5;EGFR;CCNH;LATS2;CDKN1B;CCNK;CCND3
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.5392705086118699,1.032164959531209,0.43529411764705883,0.9701304185953468,1.0,11/31,26.53%,CTR9;CCNH;MLLT1;AFF4;RTF1;SUPT16H;CCNK;ELL;POLR2F;ELOB;SETD2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.5392705086118699,1.032164959531209,0.43529411764705883,0.9701304185953468,1.0,11/31,26.53%,CTR9;CCNH;MLLT1;AFF4;RTF1;SUPT16H;CCNK;ELL;POLR2F;ELOB;SETD2
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.6472776211309533,1.0321309677363026,0.5308641975308642,0.969567413070189,1.0,2/7,17.24%,EIF2AK4;PRNP
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.7025757614007543,1.031847853359556,0.4090909090909091,0.9698120746596394,1.0,1/5,7.68%,TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.6700838726815395,1.0317705130107253,0.4444444444444444,0.9693517945357395,1.0,3/5,29.90%,PPARA;ITGAV;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.7048612574272695,1.0317480564860917,0.43243243243243246,0.9687252224819756,1.0,2/5,19.57%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5878809369677204,1.0309183180311958,0.4647887323943662,0.970892132118951,1.0,3/10,28.63%,IPO5;KPNA4;RANBP2
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.47719527104351656,1.030390984421658,0.42424242424242425,0.9720049485652028,1.0,29/161,17.10%,SLC2A3;CD44;PSMB1;DDX3X;RAB27A;MGST1;LRRC7;TMEM30A;DIAPH1;ADAM17;ATP11A;TNFRSF1B;CRISPLD2;SNAP25;VAPA;RAP1B;SDCBP;RAB18;OSTF1;RAB7A;CST3;APAF1;ATP11B;PSMD14;PDXK;LGALS3;MANBA;MAGT1;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.6222695501972492,1.03023225574652,0.5064935064935064,0.9718920887393012,1.0,2/9,6.24%,CSF1;ADAM17
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.6513124626461086,1.0297477686507912,0.47297297297297297,0.9727999457527683,1.0,1/9,3.96%,RPS21
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.6140535802883698,1.0296934377281206,0.4936708860759494,0.9722888748794108,1.0,1/11,1.06%,LPIN1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.6837967043786326,1.0292257588635876,0.5,0.9734336734514744,1.0,2/5,21.72%,PRKCB;IRS2
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.5298516724237116,1.0291706808452954,0.43333333333333335,0.9729373235709246,1.0,8/36,18.59%,NIBAN2;PRKCI;TP63;EGFR;GALNT11;STAT3;ZBTB7A;RBPJ
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.6243166535031,1.0290774895323354,0.4936708860759494,0.9725571572605386,1.0,2/11,10.97%,DDX52;RIOK3
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.45545419996580194,-1.0288336290784073,0.0,1.0,1.0,17/100,9.11%,TAGLN;TPM2;FGF1;ITGA8;DKK3;PRRX1;ACTA2;LMOD1;MYL9;COL14A1;COL5A2;PAMR1;COL15A1;MYLK;EDNRA;SPARC;COL1A2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.6679449393378439,1.02830083606962,0.5285714285714286,0.9742546784986762,1.0,3/6,24.37%,ACADVL;ACADL;WDTC1
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.6600268960681069,1.0282884968303232,0.4605263157894737,0.9735786218475964,1.0,1/6,1.24%,GJA1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.49793767772156894,1.028191086219036,0.42105263157894735,0.9731339901359652,1.0,15/62,22.99%,USP15;TGFB1;RPS27A;SMURF2;HIVEP1;ZFYVE9;ACVR2A;RNF111;ACVR1B;PDCD4;SMAD2;SMAD6;SMAD7;NLK;JUN
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.5391021049457637,-1.028012996067433,0.4444444444444444,1.0,1.0,4/9,13.09%,RYR2;SLC8B1;PKD2;ITPR1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.605686220074603,1.0278722087719894,0.4166666666666667,0.9734600675949358,1.0,7/10,30.90%,EGFR;VAPA;PRNP;TRAM1;ALDH3A2;TRAM2;APP
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.483325783582341,1.0278220448917297,0.43,0.9729370375287353,1.0,51/207,23.52%,KLF2;HDAC2;CD38;CAMKK2;NIBAN2;SMARCA1;RNF10;YAF2;BTRC;TP63;PPARA;TGFB1;ESR2;EGFR;ARID1A;APBB1;MED14;CLOCK;HIF1A;ZBTB16;CEBPB;PPARGC1A;KDM3A;ELF1;DEAF1;FUBP3;RUNX1;CREB3L2;WAC;STAT3;TP53BP1;TEAD1;RNF111;MAP2K1;SETD3;CRLF3;NAA15;SP1;SMAD2;SMARCA4;KLF6;ELF2;SP3;TP53INP1;TCF4;CTCF;CEP290;JUN;LEF1;MT3;DNM2
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.6172750570269837,1.02771374894851,0.4634146341463415,0.9726159781153134,1.0,3/15,7.81%,XPO4;CSE1L;TGFB1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.6657311039220424,1.0273075571546226,0.4852941176470588,0.9733439091101196,1.0,1/6,11.28%,ABCC9
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.5893537398298869,-1.027253782033525,0.5,1.0,1.0,1/6,0.79%,NRP1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.536943330381936,1.0269597174692884,0.4523809523809524,0.9739846923809036,1.0,2/21,3.29%,KDM1A;PTPN1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.5942647582074433,1.0267462089399635,0.47560975609756095,0.9741512442604561,1.0,5/19,19.62%,WIPI1;AMBRA1;WDR45B;MAP1LC3B;BNIP3
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.6485482982014256,1.0265986650406673,0.4657534246575342,0.9739950654565547,1.0,1/7,6.24%,ADAM17
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.6136582311297417,1.0264167627828586,0.4782608695652174,0.9739823372131164,1.0,2/10,13.46%,PPARA;KDR
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4479954257558189,-1.0262922795525364,0.3888888888888889,1.0,1.0,5/40,5.10%,SPRY3;SLIT2;SPRY1;ATP2B4;NBL1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.6090361037537667,1.0262220977471723,0.44594594594594594,0.973847966558682,1.0,5/11,19.70%,NDUFB9;NDUFV1;NDUFB2;NDUFS2;NDUFS1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.633260643200427,1.0261172292096121,0.47435897435897434,0.9734777868101524,1.0,3/11,17.24%,ANK3;TCAF1;PRNP
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.6089422911854123,1.0261038728135312,0.4375,0.9728294165169354,1.0,6/19,20.36%,DDIT4;EPHA7;EFNB2;GRIN2B;PRNP;NF1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.5100166506291861,1.02534355476677,0.5053763440860215,0.9744172190813001,1.0,12/69,12.32%,ANKH;ETV5;TOR1AIP2;EMP1;ADAM17;TNFRSF1B;SNAP25;PTBP2;GLRX;SEMA3B;GYPC;CFH
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5253014531074117,1.02514302930025,0.4891304347826087,0.9744541940596021,1.0,16/40,30.83%,CSNK1D;CSNK1A1;MDM2;RNF19A;LRRK2;HECTD1;RBX1;SMAD7;RCHY1;ZER1;ELOB;ARIH2;RNF180;UBQLN1;BBS7;RNF144A
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.5496013725177419,1.0250609965442163,0.4457831325301205,0.9740632333684046,1.0,4/22,10.57%,PDLIM1;SEMA4D;SGPL1;SEMA3B
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.4714536665076078,1.0249279298380658,0.4,0.9738866126062593,1.0,77/297,23.52%,SOD1;CD44;TPT1;RHOB;HDAC2;NFKBIA;MYDGF;FMN2;CD38;DDX3X;RHBDD1;MTCH2;NIBAN2;RAF1;SEMA4D;ARHGEF9;STK4;PRKCI;CCAR1;APIP;TP63;MCF2L;BNIP3L;EGFR;NAIP;APBB1;RPS27A;WDR73;TMBIM6;SRA1;PRLR;BCL6;MADD;TBX3;NAA38;ARHGEF7;HSPA5;IFT57;APAF1;KDR;SLK;SIAH1;TNFRSF10B;MELK;ATF6;PAWR;LATS2;CFL1;NF2;ARHGEF4;ANKRD13C;ZBTB7A;ARF4;NAA15;ABL1;FBXO11;DNAJA1;VAV3;IFIT3;AREL1;GLO1;RPS6KA2;BNIP3;NF1;ANGPTL4;LANCL1;SMAD6;TP53INP1;GCLC;AXL;SPTLC1;JUN;LEF1;MT3;OLFM1;ARHGEF12;DNM2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.6431037347803541,1.0244872294615537,0.4266666666666667,0.9747998147741807,1.0,1/6,8.57%,DUSP1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5318779830747171,1.0243807692758493,0.449438202247191,0.9744378986939064,1.0,8/35,17.24%,PRKACA;CAMKK2;EGFR;MCTP2;KDR;PPP3CA;LRRK2;PRNP
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.48071701911623577,1.024357320016793,0.46464646464646464,0.9738204766299332,1.0,28/177,14.52%,STC1;CSF1;RHOB;RIPOR1;CSF1R;SEMA4D;ADAM17;ROBO1;CCAR1;FRMD5;SOD2;TGFB1;CTNNA2;EGFR;F3;ULK4;SDCBP;SEMA3B;ROCK2;TCAF1;TMSB4X;FLT1;HSPA5;KDR;SLK;STAT3;PPP3CA;INSR
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.5101826935266573,1.0242655721698768,0.4639175257731959,0.9734455377868915,1.0,23/89,22.09%,CSNK1G2;PRKACA;CSNK1D;CSNK1A1;STK4;PRKCI;PRKCB;TBK1;UHMK1;ROCK2;PDK3;MAPKAPK2;LRRK2;LATS2;TNKS;MAPK1;STK39;CSNK2A1;CAMK2D;RPS6KA2;MAPKAPK5;NLK;MARK3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.4712568357006594,1.0241791465132812,0.4536082474226804,0.9729574983342729,1.0,18/82,14.52%,WWC1;CD44;MID1;MYDGF;CSF1R;ROBO1;TGFB1;EIF2AK2;EGFR;CCN2;ROCK2;PDE8A;FLT1;FGFR2;TRIM5;KDR;LRRK2;INSR
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.6233829365731489,1.023866860696375,0.5068493150684932,0.9733075342233007,1.0,3/8,9.26%,ANK3;ATP1B3;GLRX
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.4000892554433083,-1.023403132316291,0.4666666666666667,1.0,1.0,6/38,4.41%,ZBTB7C;EDN3;TNFRSF19;WNK2;PDZRN3;TMEM132C
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5276202723334946,1.0231341850827982,0.47058823529411764,0.9748910224421721,1.0,7/28,19.49%,CAMKMT;CRY1;ROCK2;RGS5;MGRN1;METAP1;GIT2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.5004908555180319,-1.0229975628627113,0.41379310344827586,1.0,1.0,2/7,8.82%,PGS1;TAMM41
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.5119207994569887,-1.0224024510078173,0.35714285714285715,1.0,1.0,2/11,3.18%,CTNNA3;CD58
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.4821685704349611,1.0222699563950983,0.47959183673469385,0.9769116772688041,1.0,6/81,6.00%,GPR161;ADAMTS9;GJA1;TENM3;PAPPA;TACC2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.5622291752361581,-1.022238677011504,0.38461538461538464,1.0,1.0,1/6,4.75%,SNAP29
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.594337370449711,1.0222128022410653,0.47560975609756095,0.976387174834825,1.0,6/16,17.24%,CACNA1B;IRS1;STAT3;ERBIN;GNAI1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.5840024907459171,1.0221093586109853,0.4878048780487805,0.9760473993838611,1.0,3/12,20.89%,RUBCN;LGALS3;MTMR2
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.5139346521511828,-1.0220144163351872,0.391304347826087,1.0,1.0,2/12,3.02%,SERPINI1;SERPINH1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.6884977297363825,1.0218850627337939,0.5857142857142857,0.9761536253107753,1.0,3/6,26.05%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.621284953411806,1.0217905573593147,0.4935064935064935,0.9758356853123225,1.0,3/12,16.04%,HNRNPC;DCP2;TNKS
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.5745090568849931,-1.0217811909112677,0.4482758620689655,1.0,1.0,3/7,8.74%,SERPINI1;NFASC;NTF3
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.5768574494072636,1.0217302709783944,0.5,0.9754051938759508,1.0,2/16,10.99%,TBK1;TRAF3IP1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.6076902476570061,1.021661897647729,0.5064935064935064,0.9749682427664079,1.0,9/14,31.94%,MTHFD2L;ALDH1L1;ME2;GCLC;MTHFD1L;ASS1;SLC19A1;MTHFR;DLST
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5157702175676256,1.0216552560410492,0.4731182795698925,0.9742991728143594,1.0,15/37,27.57%,KDM1A;CRY1;NDFIP2;DCUN1D4;NDFIP1;LRRK2;RBX1;DCUN1D1;SMAD7;RCHY1;SENP2;MARCHF7;UBE2L3;UBQLN1;DCUN1D2
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.616500037261216,1.0215823926332248,0.4657534246575342,0.973814262120543,1.0,2/9,11.92%,GRIK2;SLC4A10
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.6404815304077847,1.021314683993843,0.48148148148148145,0.9741258256978478,1.0,3/9,5.68%,CSF1;AKIRIN1;CSF1R
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.4872235087488813,1.021264201498025,0.5252525252525253,0.9736698566345878,1.0,32/150,18.91%,RNMT;TAF7;GLIS3;INTS2;TBPL1;CTR9;NR4A3;PKNOX1;ELL2;PPARA;ESR2;CPSF2;DDX21;SYMPK;NRBP1;CCN2;PPARGC1A;CCNH;DEAF1;INTS8;CSTF3;CEBPD;RARB;TEAD1;ZBTB1;CBFB;MLLT1;NFIX;AFF4;SP1;RBPJ;RTF1
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6946703429304159,1.0210179822359886,0.4857142857142857,0.973833401171899,1.0,1/5,3.03%,KCNQ1
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.48486704439820716,-1.020675160570047,0.41935483870967744,1.0,1.0,4/9,3.74%,JPH2;GRIN2A;ATP2B4;RYR2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.545777046342186,1.0205333564120616,0.47191011235955055,0.9748119561119567,1.0,6/29,16.67%,ADAMTS9;MARCHF6;DENND3;SIAH1;RAB12;MANBA
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.5273282938705683,-1.020221041870926,0.3888888888888889,1.0,1.0,3/11,3.32%,NRP1;SLIT2;NR4A1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5290962129191271,1.02021749140588,0.4606741573033708,0.9751149469543077,1.0,8/31,24.00%,DCLK1;WASF1;MYO16;CNTNAP2;LRRK2;GPM6A;DNM2;TAOK3
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.6149430176760695,1.0199407087631533,0.5058823529411764,0.9752982101885173,1.0,6/10,32.90%,EPHA7;PRNP;NF1;FOXO3;MCL1;SRPK2
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.5853940811021936,1.01988343425085,0.4935064935064935,0.9748149514515853,1.0,4/13,17.58%,TGFB1;EFNB2;ZSWIM8;PTPN2
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.6317009200146935,1.019822571267457,0.5256410256410257,0.973675338423045,1.0,2/9,6.75%,NEDD4L;ATP1B3
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.6317009200146935,1.019822571267457,0.5256410256410257,0.973675338423045,1.0,2/9,6.75%,NEDD4L;ATP1B3
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6355330985643317,1.0197714956311252,0.5492957746478874,0.9731941943784573,1.0,3/8,14.37%,GRIN1;GRIN2B;LRRK2
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.49886716770254763,1.0195950112536591,0.5108695652173914,0.9730843976512364,1.0,8/43,14.39%,TPT1;CACNA1B;TMEM165;TMCO1;TRPM3;SLC3A2;NALCN;TRPC4
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.3896923389646947,-1.0195872669246326,0.5263157894736842,1.0,1.0,2/28,1.46%,NET1;ARHGEF3
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.6152169982005744,1.0195502195099844,0.48717948717948717,0.9725134607502904,1.0,4/13,15.72%,TGFB1;EGFR;STAT3;LCOR
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.5017306788452836,1.019462457437981,0.45977011494252873,0.9721737952414559,1.0,13/47,22.38%,CSNK1G2;VAPB;SGPL1;UGCG;AGK;VAPA;SAMD8;ACER3;ELOVL5;SERINC1;CERS6;SPTLC1;SGPP1
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.6476000817938732,1.0191453424522245,0.5,0.9705551038756393,1.0,1/7,3.50%,RAB27A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6476000817938732,1.0191453424522245,0.5,0.9705551038756393,1.0,1/7,3.50%,RAB27A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.6476000817938732,1.0191453424522245,0.5,0.9705551038756393,1.0,1/7,3.50%,RAB27A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6476000817938732,1.0191453424522245,0.5,0.9705551038756393,1.0,1/7,3.50%,RAB27A
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.4926254168953981,1.0191025961466627,0.4489795918367347,0.9700091245591688,1.0,22/81,25.22%,ADGRV1;MICALL2;DCLK1;STMN1;MYO16;VAPA;CTNND2;OMG;UHMK1;GRM7;CNTNAP2;LRRK2;NLGN1;GPM6A;PLP1;PTPRM;DNM2;TAOK3;CNTN4;GPM6B;ATXN10;CAMSAP1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.7019830842118725,1.018986433238963,0.5362318840579711,0.9696795217734235,1.0,1/5,12.67%,CST3
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.5038807399665649,1.0187677443963412,0.4631578947368421,0.969739627827508,1.0,8/47,11.60%,KCNC2;SLC2A1;TGFB1;SNAP25;APBB1;CLOCK;SYTL4;EXOC1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.63466122470152,1.018542119953493,0.47368421052631576,0.9697510277234671,1.0,2/7,20.13%,DUSP1;PPM1E
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.5387151553394809,1.0182857259088096,0.4444444444444444,0.969866535318331,1.0,4/26,10.52%,NUP153;PIAS2;NUP88;NUP133
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.6034232798597191,1.0182680788946803,0.49382716049382713,0.969239646044282,1.0,5/13,26.53%,MTF2;FGFR2;GPM6A;JARID2;SETD2
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.46771964079020345,1.0182544253240293,0.5,0.968634407686583,1.0,27/143,21.06%,PRKACA;IFT52;CCP110;TUBA1A;ACTR3;LZTFL1;IFT140;CSNK1D;NUDCD3;TRAF3IP1;EHD2;EXOC1;GALNT11;TTC8;IFT57;CEP70;CEP57;DCDC2;MAK;ARF4;PAFAH1B1;RAB8B;WDR19;ASAP1;CNTRL;YWHAG;SEPTIN7
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.5705009145912028,1.0180073510936805,0.5,0.9687989314262968,1.0,5/13,29.90%,NFKBIA;LPCAT3;ABCA5;EEPD1;NR1H3
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.6303167555077613,1.0179215645901978,0.5362318840579711,0.9684371098203137,1.0,3/9,14.37%,GRIN1;GRIN2B;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.6069233108310625,1.0179066756278352,0.5205479452054794,0.9678128987657164,1.0,3/11,14.85%,DIP2B;PPARGC1A;GLYR1
prerank,PanglaoDB_Augmented_2021__Neurons,0.5014153426170028,1.017905671939874,0.5,0.9671549702145503,1.0,28/104,21.54%,PHYHIPL;ELAVL3;ATP6V1H;NXPH1;DNER;CACNA1B;SLC6A17;ADGRB3;CTNNA2;SNAP25;ACSL4;CADM2;SGIP1;NAPG;CAMK2N1;SLC36A4;CNTNAP2;GNAI1;NRXN1;UNC79;IFIT3;DLGAP1;GRIA3;GRIA2;ERC2;VSNL1;CCK;NBEA
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.4925632898724534,1.0175494624607546,0.40816326530612246,0.9676240277223774,1.0,26/114,19.62%,ATP6V1G1;PRKACA;ATP6V1H;GFAP;RHEB;MTMR9;SNX6;RUBCN;SLC38A9;RNF152;ATP6V1E1;WDR41;SREBF1;EXOC1;WDR6;TRIM5;STAT3;LRRK2;ATF6;USP10;C9ORF72;DRAM1;ABL1;GOLGA2;ABL2;BNIP3
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.6129052525123503,1.0174310312846877,0.5714285714285714,0.9672639862862028,1.0,5/10,23.03%,CHD1;SP1;SMARCA4;JUN;LEF1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.6665361706505055,1.0173039098933796,0.5441176470588235,0.96702861837601,1.0,2/7,12.82%,MORF4L1;EP400
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.4785002177671365,-1.0172632746215713,0.36363636363636365,1.0,1.0,1/10,0.80%,SLIT2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.5968030639716017,1.017027750357262,0.47435897435897434,0.967241711421839,1.0,3/14,14.50%,SMOC1;RAB18;ATF6
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.45486633260961057,-1.016620147156614,0.4,1.0,1.0,6/19,7.31%,ATP2B4;ATP1B2;KCNJ8;SLC9A1;SLC6A1;HCN2
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6600479368442922,1.0164619643802697,0.4864864864864865,0.9685155477525136,1.0,4/9,26.97%,PTPRD;NLGN1;IL1RAPL1;PCLO
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.6833833859684528,1.0163068773867479,0.5492957746478874,0.9683142363093665,1.0,2/6,19.27%,FADS2;ELOVL5
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.5804229649811038,1.016050325093772,0.5,0.9685053855034985,1.0,3/17,9.80%,WWC1;WWC2;DIP2B
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.6974406610095779,1.0158143958209966,0.5,0.9686206419393981,1.0,2/5,27.01%,PRLR;PTK2B
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.48302341822313255,1.0157178431029004,0.4895833333333333,0.9682959860001145,1.0,18/79,16.62%,MCC;TSC2;PSMB1;AMFR;UBAC2;PSMB2;CSNK1A1;STK4;PSMA7;NXN;PSMA4;BICC1;RBX1;IGFBP2;PSMD14;LATS2;TMEM64;HECW1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.501906536147726,-1.0156479411529744,0.5416666666666666,1.0,1.0,3/13,8.53%,MRPL3;MRPL33;MRPL1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6465354574321114,1.015594089549677,0.4868421052631579,0.9680335675078875,1.0,1/7,16.15%,ARHGEF4
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.5320071006060987,1.0152775363097484,0.48863636363636365,0.9682381140136591,1.0,8/34,19.76%,TBC1D20;CCP110;IFT140;TAPT1;DCDC2;TBC1D15;TBC1D8;TBC1D5
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.6781771848379121,1.0151569647219838,0.49333333333333335,0.967845799798326,1.0,2/5,15.72%,EGFR;LCOR
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.6594862745980787,1.01486332726396,0.5068493150684932,0.9680433444865676,1.0,1/5,0.66%,SYT1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.5851208072743387,1.0148357358565054,0.4567901234567901,0.9674941843749183,1.0,6/13,20.36%,TENM3;AGTPBP1;STAT3;C12ORF57;FBN1;NF1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.4699913863483946,1.0147170845204005,0.47474747474747475,0.9672400318759611,1.0,28/159,17.10%,SLC2A3;CD44;PSMB1;DDX3X;RAB27A;MGST1;LRRC7;TMEM30A;DIAPH1;ATP11A;TNFRSF1B;CRISPLD2;SNAP25;VAPA;RAP1B;SDCBP;RAB18;OSTF1;RAB7A;CST3;APAF1;ATP11B;PSMD14;PDXK;LGALS3;MANBA;MAGT1;MAPK1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.5049592035394787,1.0146851680071305,0.46808510638297873,0.9667058283054408,1.0,10/53,12.64%,NRG1;GFAP;DDX3X;RAF1;TGFB1;EIF2AK2;RIOK3;TRAF3IP1;ABCA1;HSPA5
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.6662828816525227,1.0144863330320095,0.5757575757575758,0.9666165693461121,1.0,1/6,10.97%,RIOK3
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.6308740667563482,1.014409628096088,0.4788732394366197,0.966233754661922,1.0,6/11,20.42%,NEDD4L;FHL1;SLC4A10;AP3D1;CAMK2D;UNC80
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.49529755365801353,1.0142057869964114,0.45263157894736844,0.9662473085685325,1.0,19/88,14.52%,CSF1;RIPOR1;CSF1R;SEMA4D;ADAM17;CCAR1;SOD2;TGFB1;EGFR;F3;SDCBP;SEMA3B;ROCK2;FLT1;HSPA5;KDR;STAT3;PPP3CA;INSR
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.6123757434300836,1.0140516929336667,0.5147058823529411,0.9659607421049469,1.0,1/10,6.51%,PPP2R1B
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5793819114159069,1.0140005787434132,0.4868421052631579,0.9654428180595263,1.0,4/12,26.93%,HIF1A;RBPJ;MT3;VEGFA
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.6047427339901241,-1.0139849744763247,0.5333333333333333,1.0,1.0,2/5,3.48%,SLIT2;SLIT3
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.6815770961415614,1.0138211033705917,0.5189873417721519,0.9653342698766911,1.0,2/5,19.23%,RAP1B;JAM3
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.4697767492061402,1.0136408603035019,0.46464646464646464,0.9652258670060152,1.0,28/160,17.10%,SLC2A3;CD44;PSMB1;DDX3X;RAB27A;MGST1;LRRC7;TMEM30A;DIAPH1;ATP11A;TNFRSF1B;CRISPLD2;SNAP25;VAPA;RAP1B;SDCBP;RAB18;OSTF1;RAB7A;CST3;APAF1;ATP11B;PSMD14;PDXK;LGALS3;MANBA;MAGT1;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.46940602540708415,1.0136028520009879,0.55,0.9646754625510111,1.0,52/222,22.20%,TP53TG5;RHOB;GJA1;TSC2;DDX3X;ENO1;NIBAN2;RAF1;FHL1;SEMA4D;SOD2;BNIP3L;CTBP2;TNFRSF1B;TGFB1;ESR2;MYO16;EIF2AK2;APBB1;DUSP1;ADNP2;TMBIM6;CCN2;BCL6;TBRG1;PDE8A;CASK;WDR6;MDM4;CAMK2N1;CD9;LPCAT3;PIP4P2;NF2;MAP2K1;ACVR1B;CDKN1B;CRLF3;PDCD4;PTPN2;ST18;IFIT3;SMARCA4;RPS6KA2;BNIP3;DCBLD2;COL18A1;ALDH1A2;SMAD6;TP53INP1;COL4A3;CTCF
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.6896813288772106,1.0136028030160091,0.5,0.9640306260118727,1.0,2/5,18.22%,MAPKAPK2;PTGR1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.6684499808631323,1.0130577906087779,0.5416666666666666,0.9650170112042482,1.0,1/5,10.22%,MTF2
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4394439787483474,-1.0129914593072553,0.42105263157894735,1.0,1.0,5/15,13.81%,ATM;TOPBP1;FOXN3;BABAM2;MRE11
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.6043015331905726,1.0129073073215766,0.5394736842105263,0.9649023209492213,1.0,4/13,15.06%,SELENOS;TMBIM6;LRRK2;LPCAT3
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5911572989430425,1.01219066501099,0.4722222222222222,0.966429536887212,1.0,1/8,7.17%,SLC2A1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.5924504896318012,1.0121634895455915,0.5128205128205128,0.9659276217360622,1.0,5/17,15.08%,IL18;TGFB1;STAT3;LRRK2;TIPARP
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.6138605940689846,1.011774587968242,0.47297297297297297,0.9665171607542747,1.0,7/10,33.57%,CORO2B;DNAJA1;CEP290;GAPVD1;SPIDR;CEP120;KIAA0586
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.48334118340486676,-1.0116034126961955,0.4358974358974359,1.0,1.0,2/11,7.91%,PLA2G4C;MGLL
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.5469142972809916,-1.01137535203707,0.4074074074074074,1.0,1.0,2/11,1.46%,NET1;ARHGEF3
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.6424783311647879,1.0112889200412942,0.5131578947368421,0.9672074730751846,1.0,6/11,32.10%,CCP110;TAPT1;SEPTIN7;CCDC88A;SEPTIN9;CEP120
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.48887732968719777,1.011216707387645,0.5102040816326531,0.9667601705551494,1.0,25/105,17.42%,PLAA;KCNC2;KCNQ1;CAMKK2;PDE4B;SSH1;SLC38A9;CTR9;IPO5;NR4A3;SELENOS;TNFRSF1B;EGFR;IRS1;RAP1B;ADNP2;GNB1;ROCK2;PDK3;AKAP6;PDK4;LCOR;CPEB4;MAPK1;PDCD4
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.589719992350174,1.011166200841589,0.5064935064935064,0.9662458473475578,1.0,5/12,22.10%,ST13;HSPA5;DNAJC7;DNAJC18;GAK
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.5594916550314614,1.0111645508931415,0.5416666666666666,0.9656038235287222,1.0,1/13,1.38%,PRKACA
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.6223635470686139,1.0111262225345579,0.5063291139240507,0.9651044563219715,1.0,4/16,12.40%,ATP6V1G1;ATP6V1H;ATP6V1E1;RAB7A
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.6229644893241832,1.011089515148571,0.5507246376811594,0.9645720113944849,1.0,2/10,11.82%,S1PR3;ROCK2
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.6359276975296926,1.0110568440444245,0.49333333333333335,0.9640132981660736,1.0,3/7,29.96%,FADS2;ELOVL5;HSD17B4
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.6871317829760057,1.0106408794808304,0.4935064935064935,0.9647222849681492,1.0,4/5,30.51%,GABRE;PRNP;GRM5;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.6112378810401202,1.010543627767453,0.4875,0.9643527833731369,1.0,2/12,7.81%,LZTFL1;TGFB1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.5107843454657234,1.0104193805523312,0.4725274725274725,0.9641452962910895,1.0,14/58,17.98%,NFKBIA;PSMB1;PSMB2;ZFP36L2;ADAM17;PSMA7;TNFRSF1B;TMSB4X;TANK;PSMA4;PSMD14;ERBIN;MAP3K14;ST18
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5318742044596599,-1.0103258312097376,0.4117647058823529,1.0,1.0,2/8,7.96%,ERCC6;FUS
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.5001188121585075,1.0102679669654469,0.45454545454545453,0.9639582609880776,1.0,21/90,19.52%,CSNK1G2;PRKACA;NAA11;CSNK1D;CSNK1A1;STK4;PRKCI;PRKCB;TBK1;UHMK1;ROCK2;PDK3;MAPKAPK2;LRRK2;LATS2;TNKS;MAPK1;STK39;CSNK2A1;CAMK2D;RPS6KA2
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.6577351090443301,1.0095899679263238,0.5061728395061729,0.9653845920628606,1.0,1/6,1.59%,NAXD
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.647430168057709,1.009293067666938,0.5373134328358209,0.9657880716232128,1.0,3/7,20.77%,TNKS;MAPK1;MAPKAPK5
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.5151435585983184,1.0092622695319924,0.5104166666666666,0.9652378496847569,1.0,9/51,16.86%,HNRNPL;HABP4;HNRNPF;PTBP2;TMBIM6;GRSF1;SRSF10;KHDRBS3;RBM39
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6328434430416672,1.0091440539914187,0.5540540540540541,0.964936550704506,1.0,2/8,14.02%,FGFR2;RARB
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.5606530253623938,-1.0091319941361145,0.48148148148148145,1.0,1.0,1/6,1.97%,PARP9
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.5676352378505947,1.0089274742074075,0.5135135135135135,0.9648434607731989,1.0,6/14,26.47%,ENO1;PGK1;MANBA;TPI1;HK1;MAN2C1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.6832342529416748,1.0088798737526676,0.5211267605633803,0.9643418428400478,1.0,2/7,17.29%,TDG;RPA1
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.6918433677249357,1.0087506674271878,0.5432098765432098,0.9640752026901775,1.0,2/5,18.70%,TGFB1;SMAD2
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.4369042021432012,-1.0086778120733872,0.4166666666666667,1.0,1.0,1/23,0.11%,TAGLN
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.6108221208848081,1.0084439592958752,0.5,0.9643508338595252,1.0,1/11,2.09%,RAD21
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.5615017779346112,1.0080117416758303,0.45121951219512196,0.9650339472276391,1.0,5/20,21.72%,NEDD4L;DDX3X;SLC4A10;ABHD5;IRS2
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.5371845174275871,-1.0080061698003935,0.38095238095238093,1.0,1.0,3/9,3.32%,NRP1;SLIT2;NR4A1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.3344215300665543,-1.0079937306405422,0.5,1.0,1.0,9/61,5.17%,TAGLN;FGF1;FAM13C;RCAN2;LAMC1;LMOD1;PDZRN3;TMEM132C;SCN7A
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.42255602690053834,-1.0079731042482916,0.38461538461538464,1.0,1.0,2/32,0.80%,FGF13;SLIT2
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5412397165227791,1.0078337444104593,0.47674418604651164,0.9649477807030641,1.0,8/35,21.72%,CSF1R;MYO16;IRS1;EXOC1;PLCL1;NF1;GAB2;IRS2
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.46762042806468906,1.0075066908443757,0.48,0.9652222960014196,1.0,106/484,21.99%,TAF7;KLF2;ETV5;KLF15;LPIN1;HDAC2;GRIN1;NFKBIA;MYDGF;KDM1A;CD38;GLIS3;DDX3X;ACTR3;KANSL3;TET3;CAMKK2;AGO2;NIBAN2;SMARCA1;AKIRIN1;IL18;PRDM10;CDC5L;RNF10;YAF2;BTRC;NR4A3;TP63;PPARA;CTBP2;TBK1;TGFB1;ESR2;EGFR;ARID1A;APBB1;MED14;RPS27A;CLOCK;HIF1A;WDR43;MTF2;ZBTB16;CEBPB;PPARGC1A;SIN3A;ZFPM2;KDM3A;PTOV1;SREBF1;TBX3;ELF1;DEAF1;FUBP3;RUNX1;FGFR2;CREB3L2;WAC;SENP1;TCERG1;STAT3;RARB;PPP3CA;ATF6;PLAG1;TP53BP1;GLYR1;HIVEP1;ACVR2A;MZF1;TNKS;TEAD1;RNF111;TWIST1;BCLAF3;MAP2K1;SETD3;ZFPM1;ARF4;CRLF3;NAA15;ABL1;HMGN1;NFIX;ST18;PER1;SP1;RBPJ;SMAD2;JUNB;SMARCA4;SUPT16H;KLF6;ELF2;PAXBP1;CCNK;NCOA2;ECD;SMAD7;MYSM1;SP3;TP53INP1;TCF4;ELL;CD81
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.5142857618827933,1.0071755005538086,0.5058823529411764,0.9657900549569625,1.0,8/33,17.58%,SELENOS;PPARA;CTNNA2;TRAF3IP1;CASK;LRFN5;LPCAT3;PTPN2
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.60822053557801,1.0071263862144622,0.55,0.9652901188148594,1.0,4/9,26.93%,TENM3;C12ORF57;NF1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.6814812044013637,1.0071120783527692,0.5352112676056338,0.9647108690484668,1.0,1/5,10.36%,ZBTB16
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.6594925632371016,1.007104080847898,0.5616438356164384,0.9634747798793261,1.0,3/5,28.09%,SLC25A4;SLC25A17;SLC19A1
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.6594925632371016,1.007104080847898,0.5616438356164384,0.9634747798793261,1.0,3/5,28.09%,SLC25A4;SLC25A17;SLC19A1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.46486933004092096,1.0070639786216231,0.46,0.9629311088884712,1.0,148/774,19.07%,WWC1;TAF7;PURB;KLF2;ETV5;KLF15;LPIN1;HDAC2;PRDM6;GRIN1;RAD21;NFKBIA;MYDGF;KDM1A;TENM2;NEDD4L;EBF4;HIF3A;GLIS3;DDX3X;ACTR3;ENO1;ZNF608;SUFU;HDX;KANSL3;TET3;WWC2;HCFC2;ARID3A;AGO2;CRY1;SMARCA1;AKIRIN1;CSF1R;IL18;PRDM10;CDC5L;RNF10;SAP130;SEMA4D;PIAS2;CTR9;NR4A3;KLF9;PKNOX1;CHD2;TP63;PHF20L1;HIVEP2;PRKCB;SOD2;PPARA;CTBP2;TBK1;TGFB1;ESR2;EGFR;ARID1A;APBB1;MED14;RPS27A;CXXC5;CLOCK;HIF1A;SDCBP;SRA1;MTF2;ZBTB16;CEBPB;RCOR1;ZBTB40;PPARGC1A;TSHZ2;SIN3A;CCNH;ZNF536;ZFPM2;KDM3A;BCL6;PTOV1;SREBF1;TBX3;CREM;ELF1;DEAF1;SMURF2;FUBP3;RUNX1;FGFR2;CREB3L2;MXD4;MDM2;SENP1;MDM4;CEBPD;TCERG1;PHF21A;TSHZ3;EED;STAT3;RARB;MYT1L;PPP3CA;ATF6;PLAG1;TP53BP1;GLYR1;MBD2;EZH1;HIVEP1;ZNF397;ZNF213;ACVR2A;TSHZ1;LCOR;MZF1;TNKS;TEAD1;ZBTB7A;RNF111;TWIST1;BCLAF3;PURG;ZBTB1;CBFB;SETD3;ZFPM1;ARF4;CHD1;CRLF3;ZNF780B;ABL1;ZHX3;ZMYM5;PHF20;NFIX;ST18;PER1;HES4;SP1;RBPJ;ZNF595;SMAD2;JUNB;RTF1;FOXP2;SMARCA4
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.5251016776675289,1.0069919536235017,0.48863636363636365,0.9618259706364862,1.0,10/38,14.52%,SLC2A3;SLC6A17;SLC7A2;SLC2A1;SLC16A12;SLC16A7;SLC13A3;ABCC9;SLC1A2;INSR
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.5251016776675289,1.0069919536235017,0.48863636363636365,0.9618259706364862,1.0,10/38,14.52%,SLC2A3;SLC6A17;SLC7A2;SLC2A1;SLC16A12;SLC16A7;SLC13A3;ABCC9;SLC1A2;INSR
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.5045600609249452,1.0069560729855938,0.4835164835164835,0.9612977164641955,1.0,10/40,12.27%,TAF7;GRIN1;NEDD4L;SCN3A;SLC6A17;NDFIP2;TRPM3;SLC3A2;ABCC9;NDFIP1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.49587556945158395,1.006918772070712,0.5164835164835165,0.9607767851100767,1.0,6/37,13.12%,RHBDD1;MARCHF6;RPS27A;CTSL;OTUD7A;MDM2
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5687058794438177,1.0066992784301583,0.4691358024691358,0.9609062059789906,1.0,5/16,19.55%,PTPRD;SYNDIG1;NRXN1;NLGN1;NAP1L1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.6204124204936595,1.0062472410900734,0.5128205128205128,0.9617178330141903,1.0,1/11,2.68%,NEDD4L
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.4694489055875184,1.0061962880208015,0.48484848484848486,0.9612903351784874,1.0,33/128,17.10%,PPP1CC;GRIN1;NRG1;SPTBN4;PSMB1;CAMKK2;RAF1;PSMB2;ZFP36L2;LRRC7;IL18;NCAM1;BTRC;PSMA7;TGFB1;EGFR;IRS1;MBP;RPS27A;SHC2;GRIN2B;PSMA4;FGFR2;RANBP9;MAPKAPK2;KDR;RGL3;LRRK2;RBX1;PSMD14;BRAP;MAP2K1;MAPK1
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.5660811344386617,-1.0061170654367804,0.4827586206896552,1.0,1.0,1/7,1.14%,PLA2G4C
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.5521213056639517,1.006054447988391,0.5529411764705883,0.9610486521828766,1.0,4/21,12.37%,ZFP36L2;NBDY;TUT7;DCP2
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.659340306156077,1.0060352512405208,0.5285714285714286,0.9604766797011581,1.0,3/5,29.45%,BNIP3L;BNIP3;PISD
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.6411120590506117,1.0057418103499136,0.5180722891566265,0.9605992673206579,1.0,4/11,25.84%,CTR9;WAC;UBE2B;USP22
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.6737816003871483,1.005509346740098,0.5,0.9607084887589475,1.0,1/5,7.44%,XRCC4
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.6018066675028542,1.0051528584954197,0.524390243902439,0.9611013341747584,1.0,2/9,21.50%,CTR9;VIRMA
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5370908631704846,1.0050895015465713,0.4883720930232558,0.960662709712615,1.0,6/26,18.59%,ROBO2;ROBO1;PRKCI;TP63;STAT3;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.6304559244571122,1.0050569645598992,0.5294117647058824,0.9601851098891298,1.0,2/8,18.51%,ROCK2;SP1
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6405619359666126,1.0050405102281075,0.5375,0.9596027466259083,1.0,3/8,5.68%,CSF1;AKIRIN1;CSF1R
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.49164754442198255,1.0046971084730796,0.4897959183673469,0.9599821264214246,1.0,30/123,19.52%,RHOB;PRKACA;TSC2;TGFB1;APBB1;DUSP1;UHRF2;SDCBP;CDC123;SRA1;UHMK1;MADD;TBX3;TBRG1;ANKRD17;FGFR2;WDR6;MDM2;CAMK2N1;STAT3;MAP2K6;NF2;MAP2K1;CDKN1B;CRLF3;PDCD4;ABL1;CSNK2A1;JUNB;RPS6KA2
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.6187434912662033,1.0045787080931377,0.569620253164557,0.9597032294052719,1.0,5/8,24.21%,SOAT1;ABCA1;SCARB1;STX12;ABCA5
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.6068278749032243,-1.0044176215650016,0.4375,1.0,1.0,1/5,3.95%,SNAPC3
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4877643592125534,1.004416399131306,0.4782608695652174,0.9596219012006301,1.0,6/43,14.52%,CSF1;NFKBIA;PPARA;TGFB1;NSF;INSR
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.4708392411548445,1.0042968015280445,0.47,0.9592844729648654,1.0,56/246,20.81%,OS9;NEDD4L;PSMB1;AMFR;HIF3A;ZNRF1;UBE2J1;PELI1;PSMB2;RNF10;RC3H2;BTRC;CTR9;PSMA7;SELENOS;KLHL2;RNF152;UBR1;RNF168;MARCHF6;RPS27A;TRIM23;HIF1A;BLMH;RNF34;UHRF2;SMURF2;PSMA4;WAC;MDM2;TRIM5;SIAH1;FBXL13;RNF19A;RBX1;PSMD14;BRAP;WWP1;TNKS;MGRN1;ZSWIM8;RNF111;HECW1;RBBP6;CBFB;FBXO11;HECTD2;AREL1;UVSSA;RTF1;SKP1;UBE2B;UBR5;MARCHF1;UBE4B;LNPEP
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.6269440995795885,1.004086004165622,0.5324675324675324,0.9592166503487805,1.0,4/11,12.40%,GGA3;SCARB2;SZT2;RAB7A
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.49612926258144313,1.0039028630441136,0.5106382978723404,0.9590439410840714,1.0,13/56,22.44%,PRKACA;KDM1A;AMFR;STK4;SYMPK;TMBIM6;PSME3IP1;LRRK2;ZFPM1;GOLGA2;LDLRAP1;MARK3;MITD1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.4943141817881869,1.0037987151650634,0.4791666666666667,0.958805887976296,1.0,15/64,16.54%,CSNK1G2;PSMB1;DDX3X;CSNK1D;PSMB2;PSMA7;TGFB1;EGFR;SMURF2;PSMA4;FGFR2;LRRK2;PSMD14;TNKS;LGR4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.5150829705189225,1.003750475191043,0.5061728395061729,0.958266729841614,1.0,11/39,19.62%,DDIT4;BNIP3L;EIF2AK2;SERINC3;ABCC9;TRIM5;NCBP3;MAP3K14;IFIT3;IFITM3;BNIP3
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.5330490830012451,-1.0037280047517896,0.34615384615384615,1.0,1.0,1/13,0.19%,WDFY4
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.6935499898750153,1.003230357277463,0.5277777777777778,0.9589593297467375,1.0,2/6,16.47%,FGFR2;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6271011664788663,1.0031915399420832,0.49333333333333335,0.9584665747509785,1.0,2/8,8.25%,ADAM17;EGFR
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.5010107552364127,-1.0030461881823611,0.42105263157894735,1.0,1.0,1/16,0.34%,CAV2
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.517987373384643,1.0029906418538743,0.5061728395061729,0.9583341419193214,1.0,11/38,19.62%,DDIT4;BNIP3L;EIF2AK2;SERINC3;ABCC9;TRIM5;NCBP3;MAP3K14;IFIT3;IFITM3;BNIP3
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.4761382619948872,1.0028922148380153,0.46,0.9579927405558287,1.0,37/151,23.56%,STX6;GJA1;ARL5A;WIPI1;GGA3;RAB28;AP2A1;COG7;SNX6;SEC13;SYNDIG1;EGFR;TRIM23;RAB18;ARFGAP3;NSF;NAPG;CNTNAP2;LRRK2;AP3D1;TBC1D15;CNTLN;WDR45B;ARF4;ARF1;JAM3;TBC1D8;TBC1D5;STX2;NAPB;SEPTIN7;TM9SF2;STX12;RABGAP1L;USP6NL;USO1;TBC1D4
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.50960918640001,1.0026759391999849,0.49473684210526314,0.9579391588242413,1.0,16/45,30.83%,CSNK1D;CSNK1A1;MDM2;RNF19A;LRRK2;HECTD1;RBX1;SMAD7;RCHY1;ZER1;ELOB;ARIH2;RNF180;PSMC6;BBS7;RNF144A
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.48359330881871687,1.0025792786859582,0.44329896907216493,0.9576310852177348,1.0,18/78,16.60%,PSMB1;IGF2BP2;PSMB2;ZFP36L2;RC3H2;GIGYF2;PSMA7;RPS27A;ELAVL1;EIF4ENIF1;ROCK2;DCP2;PSMA4;MAPKAPK2;PABPC1;METTL14;PSMD14;DCP1A
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.653018763672122,1.0023113794895075,0.5428571428571428,0.9579822307968437,1.0,1/7,10.67%,PPARGC1A
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.517032338305234,-1.0021435246716812,0.4666666666666667,1.0,1.0,1/10,0.40%,IL34
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.6572914100305032,1.0020118562771196,0.5205479452054794,0.9582155872826303,1.0,2/5,31.81%,MTMR2;RDX
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.6563312307085146,1.0017990867090956,0.5616438356164384,0.9582336612661211,1.0,1/5,9.27%,SNCAIP
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.6022577207819528,1.001735872328032,0.5342465753424658,0.9577829574482888,1.0,1/9,3.03%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.48282713066012,1.0016166477065935,0.5306122448979592,0.9575410324588862,1.0,18/89,18.05%,GJA1;PELI1;NDFIP2;PRKCB;TBK1;DDX21;VAPA;CXXC5;RIOK3;OTUD7A;ANKRD17;NDFIP1;TANK;TRIM5;TNFRSF10B;USP10;MAP3K14;PER1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.6652294850052896,1.001314586238968,0.5230769230769231,0.9577610699092315,1.0,4/6,29.31%,ASPA;ASS1;MTHFR;MSRA
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.6327274568042428,1.001269918318702,0.569620253164557,0.9572725440283549,1.0,8/9,36.77%,CDKN1B;ABL1;SMAD7;IRS2;HNRNPU;TERF1;POT1;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5165015404063233,1.00116884506261,0.5263157894736842,0.956972963765118,1.0,10/55,16.25%,NFKBIA;IL18;PRKCI;PRKCB;EIF2AK2;RPS27A;CLOCK;TRIM5;STAT3;ZBTB7A
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.5161145999412395,1.0011111534206334,0.5172413793103449,0.956518012879435,1.0,10/33,22.57%,CRY1;IRS1;HIF1A;PPARGC1A;STAT3;PDK4;INSR;PTPN2;SELENOT;HK1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.5215107200987924,1.0010814108908732,0.5783132530120482,0.9559793298935665,1.0,15/42,21.77%,SLC22A6;ATP5MK;ALDH1L1;ACOT11;PPARA;PPARGC1A;SLC16A7;LARP1B;CYP3A5;INSR;ABO;CPEB4;MAP7;ADGRF5;SLC22A2
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.46983159422841925,1.0010366384241485,0.5,0.9554413335654234,1.0,30/139,22.20%,NELL1;MCC;TSC2;OGN;NIBAN2;RAF1;SOD2;CTBP2;TGFB1;MYO16;EIF2AK2;TBX3;TBRG1;WDR6;MDM4;CAMK2N1;NF2;MAP2K1;CDKN1B;PTPN2;ST18;IFIT3;RPS6KA2;NF1;COL18A1;ALDH1A2;SMAD6;TP53INP1;COL4A3;CTCF
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.5397530286759782,1.0008175619842148,0.5454545454545454,0.9554157298320216,1.0,10/30,27.30%,WIPI1;ATG16L2;RAB7A;AMBRA1;WDR45B;MAP1LC3B;STX12;TP53INP1;VMP1;UBQLN1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.5963213293219469,1.0007403718944232,0.5714285714285714,0.955111811786226,1.0,2/8,26.08%,CRLF3;MGAT5
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.6031421741447274,1.0005053604076166,0.4868421052631579,0.9551576099741238,1.0,5/9,21.99%,NECTIN2;LGALS3;PRNP;PTPN2;CD81
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.48269206494862094,1.0000080636192519,0.4583333333333333,0.9561278382873303,1.0,19/54,27.29%,RRAS2;RHEB;ARHGAP31;DNMT1;GNB1;SHC2;RAB18;BRAP;GRB2;NF1;MAPKAPK5;JUN;KRAS;ARHGAP32;CCDC88A;USP8;RASSF1;TIAM2;ABR
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3046345460945011,-1.0,1.0,1.0,1.0,23/156,9.40%,COL24A1;FAT1;FGF13;TPM2;MYH11;LMOD1;EVL;SERPINH1;COL14A1;COL5A2;TNXB;CKAP5;MTM1;COL13A1;COL15A1;VIM;CEP126;BMP1;HOOK3;SHROOM4;COL1A2;CORO1C;LTBP3
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.6533711860714371,0.9998838200097362,0.5569620253164557,0.9559209597741708,1.0,2/6,23.12%,SLC39A11;MT3
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.624908302108829,0.9997948894507189,0.5,0.9555852090824568,1.0,1/6,21.62%,KDM2A
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.4802910735851903,0.9994132323302582,0.5368421052631579,0.9561661603659696,1.0,23/64,20.08%,FMN2;LSAMP;PTPRD;RAB27A;SCN3A;ROBO2;ADGRB3;TRPM3;ZNF536;CADM2;TBRG1;SGIP1;PDZRN4;NOVA1;FGF14;NRXN1;CPEB4;INTS6L;COL11A1;GRIA3;JAM3;GRIA2;KCNT2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6075937399765354,0.9993736318340144,0.56,0.9556565690015568,1.0,4/11,23.24%,GGA3;RTN3;PRNP;RTN1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7202302246990542,0.9989131371172454,0.5416666666666666,0.956533184318966,1.0,2/5,17.58%,PPARGC1A;PTPN2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.6824849700033537,0.9984263306320498,0.5294117647058824,0.9573636065812625,1.0,3/5,21.53%,RC3H2;NFKBIZ;SMAD7
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.574497122636816,0.9984060907560304,0.5263157894736842,0.9568542249180386,1.0,5/15,10.72%,SLC16A6;SLCO1A2;SLC16A12;SLC16A4;SLC16A7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.5543284105507729,0.9983906843410026,0.5393258426966292,0.9562940297115043,1.0,8/28,20.29%,DPP10;PRKCI;EGFR;PTPN9;GNAI1;LGALS3;ZDHHC5;GPSM2
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.632221961965706,0.9978496399136713,0.52,0.9574958625039813,1.0,3/10,9.46%,HDAC2;ADAM17;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.635149004198604,0.9977280886230411,0.5507246376811594,0.9572635995276203,1.0,4/7,32.11%,PRKAR2A;PRKAR1A;PRKAR1B;PKIG
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.7000429438957666,0.9975293611472841,0.5151515151515151,0.9571600309731044,1.0,3/5,19.97%,GRIN1;CPEB4;GRIA2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.6084195879643308,0.9974596343580215,0.5526315789473685,0.9568576968714728,1.0,4/10,23.24%,GGA3;RTN3;PRNP;RTN1
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.6946655460168101,0.9973820029984746,0.5967741935483871,0.9564788004780715,1.0,3/5,25.01%,LRRK2;RBX1;MARCHF7
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.6017967599470875,0.9973702295286911,0.5185185185185185,0.9559145518523607,1.0,4/15,16.51%,AP2A1;TGFB1;SNX25;AP2B1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.643715145596893,0.9973302141682036,0.5769230769230769,0.9554534760527525,1.0,3/7,19.33%,NAA11;NAA15;METAP1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.5615486212862879,0.9972003675132081,0.5581395348837209,0.955268174415408,1.0,4/17,18.88%,DGKI;GK5;PLAAT3;DGKH
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.4538682157341871,-0.9971639307836666,0.375,1.0,1.0,2/19,3.06%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.5536977726203686,0.9970549685950253,0.5394736842105263,0.9550319392107517,1.0,4/18,14.52%,PRKCI;SELENOS;IRS1;INSR
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.5285533685669762,-0.9970120180590375,0.4583333333333333,1.0,1.0,1/8,2.29%,ATM
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.5152229029797429,0.9967325611683906,0.5054945054945055,0.9553073458812738,1.0,8/40,20.36%,SOD1;ARHGAP15;SCARB2;TBC1D15;TDG;PAFAH1B1;VAV3;NF1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.6138460977583392,0.9967203795306961,0.5584415584415584,0.9547392174350937,1.0,3/9,17.24%,PRKACA;KDR;PRNP
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.641208872869798,0.996486388794124,0.5342465753424658,0.9547335754830701,1.0,2/9,10.03%,AGO2;EIF2AK4
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.5878880347515644,0.9964193890328052,0.5,0.9542558367696788,1.0,4/17,12.40%,ATP6V1G1;ATP6V1H;ATP6V1E1;RAB7A
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.6597869654893771,0.9963660739639822,0.5405405405405406,0.9538424549193294,1.0,1/8,10.20%,SRA1
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.4869295555220691,0.9962073963176451,0.4895833333333333,0.9536462318463766,1.0,15/70,18.00%,CNTN3;PHYHIPL;PTPRD;PCDH17;SNAP25;SHC2;PPARGC1A;THSD7A;ABCC9;PDZRN4;NOVA1;FGF14;NRXN1;SYBU;LIFR
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.5536683449975988,0.9958809207270352,0.5542168674698795,0.9539660460752761,1.0,1/17,0.27%,WWC1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.5297046633195956,0.995751877483589,0.5056179775280899,0.9537954464958404,1.0,10/39,17.63%,PSMB1;PSMB2;ZFP36L2;PSMA7;EIF2AK2;PSMA4;RUNX1;PSMD14;CBFB;ABL1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.6233775805013042,0.9953204340872279,0.49382716049382713,0.954394600012446,1.0,5/10,27.94%,TGFB1;HIF1A;SARS1;EIF2AK3;IL6ST
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.5866586630549171,0.9950318854982968,0.5301204819277109,0.9546370765702188,1.0,3/11,15.50%,USP15;BRCC3;USP3
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5089172952947473,0.9949915411958695,0.46511627906976744,0.9541487831573157,1.0,7/29,20.02%,S1PR3;GRIN1;LPAR6;ABL1;C1QTNF1;ABL2;SELENOT
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.6693261762709668,0.9947820415535581,0.5394736842105263,0.9541689331525431,1.0,2/5,18.70%,NR4A3;SMAD2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6113144895536846,0.9947499204683653,0.5641025641025641,0.9536751970436518,1.0,1/11,6.24%,ADAM17
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.48416562831798104,0.9946377037090309,0.5106382978723404,0.9534546968851687,1.0,16/68,16.62%,MCC;PSMB1;AMFR;UBAC2;PSMB2;CSNK1A1;STK4;PSMA7;PSMA4;BICC1;RBX1;IGFBP2;PSMD14;LATS2;TMEM64;HECW1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.5208496526697796,0.994322674775366,0.5,0.9538047166472099,1.0,9/34,21.53%,PRKACA;KCNQ1;ATP1B3;ABCC9;PDE4D;CAMK2D;RYR3;AHCYL1;SMAD7
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.5590054014058972,0.993607704301671,0.5064935064935064,0.9552117632273468,1.0,4/14,12.64%,PTPN1;RHBDD1;TMBIM6;HSPA5
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.49185599167341765,0.9931629430397398,0.4838709677419355,0.9559209597741706,1.0,18/61,19.52%,CD44;HSPA4L;AMFR;FKBP5;HOMER2;COX6C;SEMA3B;PRLR;FARP1;PLAAT3;CD9;PAPSS2;SCARB1;CKB;CA2;PDCD4;ELOVL5;RPS6KA2
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.6174228750061443,0.9931170591982084,0.575,0.9554150208730517,1.0,6/10,33.04%,RAB8B;PEX3;SLC25A17;ALDH3A2;ATAD1;ABCD3
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.38344536359894243,-0.9930876368733537,0.5882352941176471,1.0,1.0,2/21,1.01%,WDFY4;PPP1R14A
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.5227827617456855,0.9927788695878629,0.5116279069767442,0.9558324754940124,1.0,8/27,20.36%,NRG1;RAF1;SYTL4;PPP3CA;SCARB1;DST;DCBLD2;NF1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.5308794836836537,0.9927693112682678,0.5466666666666666,0.9552577398668345,1.0,6/23,17.58%,SELENOS;PPARA;TRAF3IP1;LRFN5;LPCAT3;PTPN2
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.4818333445801767,0.9926602852347063,0.48936170212765956,0.9549425285845766,1.0,19/64,25.22%,MICALL2;TENM2;TENM3;STMN1;UGCG;VAPA;UHMK1;RUNX1;MYT1L;CNTNAP2;THOC2;NLGN1;GPM6A;PLP1;PTPRM;CNTN4;GPM6B;ATXN10;CAMSAP1
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4948149435966353,0.992567710789844,0.5,0.9546529425567944,1.0,19/56,30.83%,CSNK1D;CSNK1A1;SDCBP;WAC;MDM2;RNF19A;LRRK2;HECTD1;RBX1;SMAD7;RCHY1;ZER1;ELOB;ARIH2;RNF180;RAD23B;EIF3H;BBS7;RNF144A
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.6686779621477013,0.9925072380385426,0.5070422535211268,0.954225013683371,1.0,1/5,14.37%,LRRK2
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.6452892876635756,0.9924969566811527,0.5866666666666667,0.9536526983810502,1.0,2/7,18.59%,GALNT11;RBPJ
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.6105025427250002,0.9921931050801834,0.5443037974683544,0.9538870853916726,1.0,4/10,18.90%,KCNQ1;EGFR;FGFR2;MAP7
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5735290468263623,0.9921664450234371,0.5432098765432098,0.9533849097242117,1.0,2/15,7.94%,DPM1;PIGL
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.506405225595204,-0.9921414842419142,0.5217391304347826,1.0,1.0,3/12,8.53%,MRPL3;MRPL33;MRPL1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.582003342115784,0.991987527469395,0.5068493150684932,0.9526526820272638,1.0,4/14,10.33%,CD44;ADAMTS4;MMP16;CTSL
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.582003342115784,0.991987527469395,0.5068493150684932,0.9526526820272638,1.0,4/14,10.33%,CD44;ADAMTS4;MMP16;CTSL
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.47624291219264525,-0.9918829400100598,0.44,1.0,1.0,3/10,12.27%,VPS35;PTTG1IP;APOE
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.556266352822661,-0.9917312432115615,0.4,1.0,1.0,1/5,0.69%,CDK6
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.6548478701932356,0.9916188638114525,0.4857142857142857,0.9531006707138197,1.0,3/5,22.06%,COX6C;COX4I1;COX10
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.5575204826951371,0.9911124349229172,0.5411764705882353,0.9538243114909782,1.0,8/26,23.12%,DDIT4;EFNB2;GRIN2B;LRRK2;CDKN1B;PRNP;BNIP3;MT3
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.4846958052717483,0.9909540825651069,0.5268817204301075,0.9536624934641789,1.0,21/78,17.42%,ADGRV1;NFKBIA;SUFU;ZFP36L2;SEMA4D;CTR9;PPARA;TGFB1;EGFR;EIF2AK4;SRA1;ZBTB16;ZFPM2;TBX3;ANKRD26;ABCA1;METTL14;TMEM64;TWIST1;ZFPM1;PDCD4
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.6624525804032038,0.9908464971419567,0.56,0.9533190551233176,1.0,1/5,11.23%,ZFPM2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.6026396895209248,0.9908143522483401,0.5396825396825397,0.9527943321806198,1.0,2/8,19.27%,ACSL4;ELOVL5
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.6805203568769168,0.9907506840214838,0.5362318840579711,0.9523391366621357,1.0,1/5,7.62%,PPARA
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.5989501436493826,0.9907122705931947,0.5609756097560976,0.9506643883061897,1.0,6/10,31.26%,C1R;CFH;PROS1;CD81;C1S;CD55
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.5989501436493826,0.9907122705931947,0.5609756097560976,0.9506643883061897,1.0,6/10,31.26%,C1R;CFH;PROS1;CD81;C1S;CD55
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.5989501436493826,0.9907122705931947,0.5609756097560976,0.9506643883061897,1.0,6/10,31.26%,C1R;CFH;PROS1;CD81;C1S;CD55
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),-0.5409385184082882,-0.9905033766353956,0.5,1.0,1.0,1/6,1.12%,GALNT16
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.502860148885558,0.9904201346583693,0.5238095238095238,0.9509112323332506,1.0,7/29,19.84%,PRKACA;ADAM17;SELENOS;GNB1;ADORA2B;PTH1R;PRKAR2A
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.6084807447719991,0.9900859946638149,0.4931506849315068,0.9512202003818407,1.0,2/9,19.20%,PLAAT3;PEX3
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.6445796822963206,0.9900277372794217,0.5333333333333333,0.9508612293318209,1.0,2/5,19.68%,RBX1;SKP1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.5469026715412763,0.9898702784004192,0.569620253164557,0.9507832758649785,1.0,8/23,19.97%,GRIN1;LRRC7;GRIN2B;CNIH3;DLGAP1;GRIA3;NLGN1;GRIA2
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.5952507060331024,0.9896919618484465,0.5714285714285714,0.9506742617653977,1.0,4/11,10.94%,SOD1;GRIN1;TGFB1;GRIN2B
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.5719904358310455,0.9891650106302609,0.5256410256410257,0.9516800888174001,1.0,5/15,26.93%,TGFB1;KDR;ADM;SPRED1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.6302971611833894,0.9890480062023682,0.5540540540540541,0.9513341622836531,1.0,6/9,35.93%,HNRNPC;DCP2;HNRNPU;XRN1;TERF1;POT1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.5388425032540998,-0.9889998584437991,0.5151515151515151,1.0,1.0,3/7,21.09%,EXT2;CSGALNACT2;B3GNT2
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.5911122291551579,0.9888673454352704,0.5529411764705883,0.9511752528816749,1.0,2/13,6.22%,HS3ST5;NECTIN2
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.48458676128124395,0.9887384493909253,0.5625,0.9510041057504662,1.0,13/84,9.79%,HDAC2;CSMD3;CRMP1;CBFA2T2;TENM3;CDH2;LRRC7;PRKCI;SCARB2;CTNNA2;EFNB2;KIF13B;ULK4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.5307008602250513,0.9881540547134663,0.5531914893617021,0.9519948491763123,1.0,10/30,19.52%,RHOB;IPO5;TGFB1;DUSP1;HECA;CAMK2N1;LATS2;CDKN1B;PDCD4;RPS6KA2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.6047517910955351,0.9879609284223565,0.48,0.9520344965157951,1.0,3/9,17.16%,ADAM17;OXSR1;STK39
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.6222017368394936,0.9877280098016258,0.5641025641025641,0.9520740954753638,1.0,6/9,33.04%,RAB8B;PEX3;SLC25A17;ALDH3A2;ATAD1;ABCD3
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.6581788408418963,0.9875942224242301,0.575,0.9518780143553024,1.0,2/6,12.59%,STMN1;ARHGEF7
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.45506112991513303,-0.987512379376765,0.46153846153846156,1.0,1.0,2/14,2.01%,ZBTB7C;KCNMA1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6442250462761135,0.9871267686888541,0.5526315789473685,0.9524815926739681,1.0,3/7,16.12%,CRY1;STMN1;MGRN1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5610593411206278,0.9870850073836432,0.5512820512820513,0.9520006111623517,1.0,6/16,20.71%,PRKACA;DIAPH1;AKAP6;PDE4D;CAMK2D;UBASH3B
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.559933166089011,0.9869668918622013,0.5411764705882353,0.9517430376555271,1.0,4/22,8.18%,ERRFI1;STMN1;TP63;UGCG
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.5972766812864765,-0.9868244043259548,0.5625,1.0,1.0,3/8,20.40%,CDC42;OPHN1;RAP2A
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.5967255204776145,0.9868041149953295,0.5074626865671642,0.9515538207411909,1.0,2/10,19.27%,ACSL4;ELOVL5
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.6335425191817229,0.9865162112015741,0.5384615384615384,0.9516801153170468,1.0,2/9,9.46%,TGFB1;HIF1A
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5583085012057104,-0.9864613372129606,0.5666666666666667,1.0,1.0,2/7,4.72%,IQGAP2;ARPC5
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.4767139488064038,0.9864062515119237,0.5555555555555556,0.9513490671768176,1.0,5/56,6.14%,TBC1D20;MMUT;RGS7;MTMR9;SEMA4D
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.5017927388952601,0.986251308377636,0.5543478260869565,0.9512160044631092,1.0,16/41,30.83%,CSNK1D;CSNK1A1;MDM2;RNF19A;LRRK2;HECTD1;RBX1;SMAD7;RCHY1;ZER1;ELOB;ARIH2;RNF180;RNF139;BBS7;RNF144A
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.5694416285848108,0.9860944194283214,0.5064935064935064,0.9510460788209741,1.0,5/15,17.16%,ANK3;ATP1B3;GLRX;TCAF1;STK39
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.4664353719064687,0.9858805217766108,0.5353535353535354,0.9509133612338782,1.0,27/151,16.71%,SRGN;DDX3X;AGO2;IGF2BP2;ZFP36L2;NDFIP2;ROBO1;GIGYF2;TGFB1;EIF2AK2;PTBP2;DNMT1;HIF1A;CNOT8;TMBIM6;MTF2;EIF4ENIF1;PTRH2;ROCK2;NDFIP1;DCP2;RUNX1;KDR;EED;TIPARP;LGR4;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5962689147344703,0.9856992744917226,0.527027027027027,0.9508116207951072,1.0,4/13,19.38%,NR4A3;ROCK2;AKAP6;CAMK2D
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.6500894795577252,0.9856055803156069,0.5833333333333334,0.9505067393555883,1.0,2/5,19.87%,TNFRSF1B;RALY
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.6311022734271774,0.9855445957964463,0.5441176470588235,0.9501037343157543,1.0,1/6,9.16%,RAP1B
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.6231908915473171,0.9851311230936646,0.5540540540540541,0.9504886818560041,1.0,1/8,10.67%,PPARGC1A
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.3744115661912702,-0.984804703847499,0.38461538461538464,1.0,1.0,4/35,8.25%,CAV2;TTL;KLHL13;PIK3R4
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.5130634758301816,0.9845835765173133,0.5164835164835165,0.9515617791901586,1.0,13/41,23.80%,TAF1B;DDX21;DNMT1;MTF2;EED;POLR1C;TDG;SF3B1;JARID2;CREBZF;CTCF;POLR2F;RBBP7
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.6187404889384996,0.9845032644580359,0.5333333333333333,0.9512203135427172,1.0,4/8,19.27%,NR4A3;PPARA;PPARGC1A;ELOVL5
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.549135930957614,0.9839919395155632,0.5578947368421052,0.9521320090072584,1.0,10/27,21.78%,STX6;MICALL2;VPS50;EHD2;WASHC2C;RAB7A;SNX4;CMTM6;EPS15;VPS39
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.4952639147295988,0.9839280083237913,0.5888888888888889,0.9517046903089437,1.0,23/50,29.60%,CSF1R;IL18;ROBO2;TBK1;TGFB1;AKAP6;STAT3;PTPN9;LRRK2;TIPARP;ACVR2A;ACVR1B;PTPN2;NCOA2;LDLRAP1;LEF1;IL1RAPL1;SLC1A1;PTPN11;PID1;PTPN14;ARL6IP5;NFAT5
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.5954760548825533,-0.983873806986582,0.4074074074074074,1.0,1.0,2/5,16.57%,ANXA1;PIK3CD
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.6059129422566338,0.983850258973196,0.5263157894736842,0.9512962876257882,1.0,3/9,20.44%,IL18;SCARB1;ANGPTL4
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.5384656824337286,0.9833344181176771,0.5058823529411764,0.9520162642297121,1.0,8/21,19.97%,GRIN1;HOMER2;GRIK2;GRIN2B;GRM7;CPEB4;GRIA3;GRIA2
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.6098105994215072,-0.9832042104657182,0.5185185185185185,1.0,1.0,1/6,0.88%,EDN3
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.6130527390442471,0.983053161418009,0.6049382716049383,0.9522085264133456,1.0,1/10,0.58%,STX6
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.48600627639398863,0.9829124368534876,0.5617977528089888,0.9520393331681987,1.0,13/67,21.70%,TAF7;HDAC2;TP63;RNF34;MDM2;MDM4;MAP2K6;RPA1;PHF20;CSNK2A1;SUPT16H;MAPKAPK5;TP53INP1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.5898452790713842,0.9828452592680743,0.5783132530120482,0.9517173746334479,1.0,5/11,26.93%,CSF1R;ADAM17;TWIST1;ETS1;VEGFA
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.46482281728095515,0.9828274166249915,0.5376344086021505,0.9511756605534293,1.0,6/86,7.30%,SOD1;TBC1D20;MMUT;RGS7;SEMA4D;ARHGAP15
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.6322029848167243,0.9828124865957998,0.582089552238806,0.9506529317762337,1.0,3/7,16.19%,CEBPB;PAG1;LGALS3
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.48590877199336635,0.9825597755328918,0.550561797752809,0.9507599271819455,1.0,14/55,22.47%,TSC2;PDLIM1;TGFB1;NXN;ZFPM2;HEG1;CDKN1B;ZFPM1;FBN1;KDM6A;NF1;FGF12;PKP2;TAB2
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.6155456619071531,0.9825065242650514,0.5555555555555556,0.9502869079883187,1.0,2/11,14.37%,SUFU;LRRK2
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.4928934187378773,0.9820384423860179,0.5106382978723404,0.9510284365145318,1.0,17/59,19.60%,PLAA;PDE4B;MGST1;CTR9;SELENOS;TNFRSF1B;EGFR;IRS1;ADNP2;ROCK2;PDK3;PDK4;GNAI1;LCOR;PDCD4;ABL2;TFPI
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.577324864544633,0.9818863760486545,0.55,0.950897241275434,1.0,4/13,21.72%,PRKCI;IRS1;INSR;IRS2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.5960265671922125,0.9810987559680117,0.5529411764705883,0.952411338311262,1.0,7/13,34.66%,RAB8B;PEX3;SLC25A17;ALDH3A2;ATAD1;ABCD3;ZFAND6
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.5753253817913323,0.9805808180598411,0.5609756097560976,0.9532111570789261,1.0,5/15,19.62%,HABP4;CASP8AP2;TNFRSF10B;MAP3K14;BNIP3
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5999736249625378,0.9802472028878946,0.5875,0.9534988113473776,1.0,4/11,32.07%,CTNNA2;ABL1;IL1RAPL1;NEDD4
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.5230799342185775,0.9802026612119756,0.5862068965517241,0.9530258515024328,1.0,11/29,31.78%,CLIP4;WDR73;SLK;DST;CAMSAP1;CCDC88A;SLAIN2;KATNAL1;RAB11A;CLIP1;DLG1
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.6689929052074512,0.9799243083419379,0.6029411764705882,0.9531856236351266,1.0,2/5,24.59%,EIF2AK4;CNTN4
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.48510548658376923,0.9798333598000232,0.5176470588235295,0.9529381870089181,1.0,8/40,19.84%,PRKACA;ADAM17;GNB1;TRAF3IP1;LGALS3;ADORA2B;PTH1R;PRKAR2A
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5315998324576309,0.9798040275230717,0.5227272727272727,0.9524906940245842,1.0,6/30,21.72%,CSF1R;IRS1;EXOC1;PLCL1;GAB2;IRS2
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.5518022536171162,0.9796904082955973,0.5432098765432098,0.9522257643716009,1.0,4/20,9.43%,KCNC2;SLC2A1;SNAP25;CLOCK
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.4704854855646563,0.979583788257916,0.5057471264367817,0.9519672147014552,1.0,12/47,29.87%,PPP1CC;SEC13;STMN1;NUP133;TNKS;PAFAH1B1;GPSM2;NUP160;CENPP;SETD2;RANBP2;CLIP1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.6722371849881643,0.979534054507252,0.5789473684210527,0.9515392816497781,1.0,2/5,21.99%,SZT2;CD81
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.574028479837036,0.9793587187590475,0.5662650602409639,0.9513541304579002,1.0,4/18,22.31%,UBA5;GOLGA2;GFM2;MCTS1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.5235555649027885,0.9793226699171135,0.48314606741573035,0.9509028589911617,1.0,10/26,25.86%,ADAM17;EGFR;TBX3;ANKRD17;FGFR2;MDM2;CDKN1B;CCND3;USP22;RGCC
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.6317405736002961,0.9789038992502146,0.578125,0.9509632398168326,1.0,2/6,31.97%,ELOVL5;ELOVL6
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.6317405736002961,0.9789038992502146,0.578125,0.9509632398168326,1.0,2/6,31.97%,ELOVL5;ELOVL6
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.5647753869077385,-0.9787049034694117,0.5172413793103449,1.0,1.0,2/6,16.28%,CHMP4B;PPP2R2D
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.6061656672449542,0.9781874308592055,0.5875,0.9522834304269814,1.0,2/7,22.63%,HIF1A;TF
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.48856690462779984,0.978088247014312,0.5714285714285714,0.9519957271476154,1.0,10/45,19.07%,HDAC2;RPS27A;MTF2;NUP133;EZH1;RBX1;ZBTB7A;ABL1;HMGN1;SMARCA4
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.6518744558442517,0.9780174091130855,0.6,0.9515876606446938,1.0,4/5,33.97%,GLUD1;IREB2;ASS1;ACO1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.62379292888858,-0.9777747298383754,0.5483870967741935,1.0,1.0,1/5,1.75%,ERCC6
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5920575339490314,0.977676966620328,0.5657894736842105,0.9518857819512427,1.0,1/9,6.54%,ROBO1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.6170142894389941,0.9775580755333826,0.4861111111111111,0.9515747136870893,1.0,4/6,33.33%,CCDC91;GAK;AP1G1;LAMP1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.6568274392655675,0.9773643000141493,0.5466666666666666,0.9515351169114377,1.0,2/6,10.75%,WNT2B;CSDE1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.6258900597777017,0.9772830218125298,0.5569620253164557,0.9512065617827673,1.0,2/6,15.83%,MICAL3;CFL1
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.5793740275818949,0.977119831410646,0.5866666666666667,0.9510769690111203,1.0,2/11,8.25%,NOS1AP;EGFR
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.6410236426503859,0.9769575851378839,0.5903614457831325,0.9509535433343613,1.0,3/7,21.98%,GLUL;GLUD1;GCLC
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6276906121173257,0.9769359427677857,0.5405405405405406,0.9504275756559575,1.0,2/7,8.25%,ADAM17;EGFR
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.5953370999747029,-0.9769313561784756,0.4594594594594595,1.0,1.0,1/5,2.10%,FOXQ1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4588970114543775,0.9767537437362105,0.5959595959595959,0.9504128002681139,1.0,21/120,15.80%,DOK6;NRCAM;NRXN3;SPTBN4;ANK3;EPHA7;NIBAN2;ATL1;SEMA4D;NCAM1;ROBO2;ROBO1;CTNNA2;APBB1;EFNB2;SEMA3B;FGFR2;RANBP9;SIAH1;C9ORF72;NRXN1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.6280837662436618,0.9765446269952022,0.5921052631578947,0.9504040454957886,1.0,2/7,16.27%,CDH2;TTN
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.6500524394727938,0.9765029594056577,0.5277777777777778,0.9499273299567204,1.0,2/6,7.49%,NECTIN2;PRKCB
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.5729663746568004,0.976303997763521,0.5595238095238095,0.9498049460060453,1.0,5/15,17.00%,SLC38A9;IPO5;UBR1;SESN1;CPEB4
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.5025617536363685,0.9759002962335094,0.5806451612903226,0.9503418877349668,1.0,12/40,16.96%,CSF1R;SEMA4D;SLC2A1;EFNB2;HIF1A;ABCA1;CST3;CEBPD;LRRK2;ZBTB7A;CA2;PTH1R
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.4074919220152394,-0.9755873259310334,0.5,1.0,1.0,6/18,8.28%,GPC6;CYP4V2;ABCA4;ALDH1A1;AKR1C3;GPC3
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.3825378931316245,-0.9753907988031268,0.4,1.0,1.0,3/20,4.86%,CD4;HDAC9;GPR89B
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5539726838004303,0.9753718401122449,0.5833333333333334,0.9512375387873816,1.0,9/20,25.38%,PPARA;TGFB1;HIF1A;STAT3;TEAD1;SMARCA4;JUN;FOXO3;ETS1
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.5712763355737458,0.9750002160489625,0.5733333333333334,0.951563512598012,1.0,4/13,12.58%,SYT1;RIMS2;GRIK2;NSF
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.48183814317145945,0.9746216864505844,0.5483870967741935,0.9519130308439536,1.0,23/68,26.60%,SOD1;ATP6V1H;COG2;EGFR;ARFGAP3;ABCA1;SEC24D;NAPG;AP2B1;MAPK1;ARF1;SNAP23;DST;BNIP3;STX12;LAMP2;USO1;KIF1B;CLTC;AP2M1;TOM1L1;RAB14;GOLGA4
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.6026318512156761,0.9745866521242675,0.5769230769230769,0.9514550451247699,1.0,3/10,5.68%,CSF1;AKIRIN1;CSF1R
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.6537979308768389,0.9745479522036803,0.5797101449275363,0.9510394222580102,1.0,2/5,28.97%,CPEB4;CPEB2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.619962530581016,0.9745301559018827,0.5352112676056338,0.9505526301503717,1.0,4/8,19.38%,NEDD4L;HECW1;STK39;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.462251126060366,-0.9745265428766187,0.6086956521739131,1.0,1.0,2/17,3.48%,SLIT2;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.6132887544762985,0.9742727713678596,0.6,0.9506930432276084,1.0,2/8,12.98%,ZBTB16;TAPT1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.6609154376287405,0.9741851434317992,0.53125,0.950409816286111,1.0,2/5,24.86%,ERC2;KIF1B
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.6132695167882999,0.9739107868145402,0.5921052631578947,0.9505978360239629,1.0,1/6,7.19%,ADGRB3
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.474192717356295,0.9738707251272196,0.5959595959595959,0.9501184007567328,1.0,28/97,30.67%,DDX52;INTS2;AGO2;NOP58;RPL21;WDR43;RPL28;RPL41;TUT7;INTS8;RPLP2;SMAD2;DIS3;RPL9;RPL18;TEX10;SARS1;RPS14;INTS4;NOL8;RPL27A;INTS6;INTS7;RPL13A;RCL1;RPL32;RPL31;SSB
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.4446054392204989,0.9738424594305947,0.5408163265306123,0.9496395268891135,1.0,26/144,17.63%,CSF1;CD44;MYDGF;DDX3X;ITGA5;CAMKK2;RAF1;CSNK1D;CSF1R;SEMA4D;ADAM17;STK4;TBK1;TGFB1;EGFR;SDCBP;ROCK2;PDE8A;KDR;LRRK2;INSR;MTCP1;ACVR2A;MAPK1;PRNP;ABL1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.5030277908142369,0.9738096446000348,0.6067415730337079,0.9491790648784116,1.0,8/48,14.52%,CSF1;EPHA7;CSF1R;EGFR;FLT1;FGFR2;KDR;INSR
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.48403488542551276,0.9730027392233599,0.5567010309278351,0.9509314258358199,1.0,23/91,22.49%,HDAC2;DUT;ETF1;CCT4;PSMB2;PSMA7;PWP1;DDX21;HNRNPC;PSMA4;SLC25A3;PABPC1;PGK1;PSMD14;CANX;DHX15;CCT3;GLO1;NAP1L1;UBA2;EIF3B;RPL18;TRA2B
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4708058871284112,0.9729272420186812,0.4895833333333333,0.950589617514963,1.0,12/61,14.23%,PPP1CC;PTPRD;PTPN1;SSH1;PPP2R1B;BTRC;DUSP1;PTPRE;PTPRZ1;FRA10AC1;PTPN9;PPP3CA
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.6234474428847514,0.9726118262163653,0.475,0.950830333764238,1.0,4/7,35.93%,SIN3A;MIER1;TERF1;POT1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.6049203383243986,0.9724747433823798,0.5352112676056338,0.9505839689105808,1.0,1/6,13.46%,KDR
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.6305101110659032,0.9723924396725939,0.5466666666666666,0.9502192290811112,1.0,5/7,33.85%,ROCK2;DLGAP1;APP;AKAP9;TMEM108
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.5098800266974779,-0.9722200126683874,0.43243243243243246,1.0,1.0,2/8,2.39%,DDI2;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.5852981067859587,0.9715879032124874,0.6,0.951817633031638,1.0,5/12,13.41%,KCNQ1;ANK3;NOS1AP;GNB1;AKAP6
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.5553829182660969,0.9714574104243501,0.5662650602409639,0.9515592711217271,1.0,1/18,0.61%,ADAMTS9
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.5857234024325885,0.9710267873267924,0.5764705882352941,0.9521007822065779,1.0,4/12,29.15%,RAB27A;VTA1;STAM2;RAB11A
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.6104983045465405,0.9708556503244011,0.5657894736842105,0.9519905389651521,1.0,1/11,4.09%,NUP153
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.49592792646711853,0.970808535963403,0.5625,0.9515787148737818,1.0,14/86,16.25%,NFKBIA;KDM1A;IL18;PRKCI;PRKCB;ESR2;EIF2AK2;RPS27A;CLOCK;PPARGC1A;TRIM5;STAT3;TP53BP1;ZBTB7A
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.5757642283221156,0.9707956470638747,0.5487804878048781,0.9510491211370238,1.0,1/15,6.05%,SMOC1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6214087571260111,0.9707604335116059,0.5211267605633803,0.9505969597200427,1.0,1/6,5.74%,IL18
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.6181662796462294,0.9707383373575885,0.5384615384615384,0.9500862678754824,1.0,3/8,20.44%,IL18;SCARB1;ANGPTL4
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.39478264519894707,-0.9705280687341379,0.5263157894736842,1.0,1.0,3/25,2.98%,NRP1;ARHGEF10L;EVL
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.5518818576098397,-0.9705159341008424,0.46153846153846156,1.0,1.0,3/6,29.23%,PTEN;SYNJ1;INPP5B
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.5518818576098397,-0.9705159341008424,0.46153846153846156,1.0,1.0,3/6,29.23%,PTEN;SYNJ1;INPP5B
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.5518818576098397,-0.9705159341008424,0.46153846153846156,1.0,1.0,3/6,29.23%,PTEN;SYNJ1;INPP5B
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5019198764599111,0.9704676030926285,0.6144578313253012,0.9502313053785576,1.0,7/44,7.81%,CD44;PTPN1;ITGA5;CSF1R;IL18;SEMA4D;TGFB1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.4555223848782794,0.970145019076027,0.5670103092783505,0.9505708319756617,1.0,26/119,18.19%,SOD1;AKAP8;MYDGF;SPTBN4;CAMKK2;EPHA7;CSNK1D;CSF1R;SEMA4D;ADAM17;STK4;TGFB1;EGFR;CEBPB;TRAF3IP1;ROCK2;PDE8A;KDR;LRRK2;INSR;C9ORF72;ACVR2A;TTN;PRNP;ABL1;PRR5L
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.4825729642911451,0.9700248693194282,0.5384615384615384,0.9503793889928711,1.0,12/55,16.51%,PSMB1;AGO2;AP2A1;PSMB2;PSMA7;GNB1;SMURF2;PSMA4;PPP3CA;FZD3;PSMD14;AP2B1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5986184405207605,0.9697616516972741,0.5974025974025974,0.9504179508713511,1.0,5/12,29.74%,TUBA1A;TUBA1B;KIF1B;CCDC88A;KIF5C
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.4655166117896971,0.969619880227231,0.5684210526315789,0.9503210334923068,1.0,10/65,14.34%,PPME1;PRKACA;CCP110;TUBA1A;CSNK1D;BTRC;CCNH;CEP70;CEP57;MELK
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.5630297117514219,0.9692922604279967,0.5352112676056338,0.9505243659988499,1.0,3/13,16.47%,MBP;STAT3;TWIST1
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.5340600973026979,0.9690893560345608,0.5569620253164557,0.950580422066512,1.0,5/17,15.24%,SRGN;CSF1R;TNFRSF1B;PTPRE;ADGRE2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5572671085043542,-0.9689055947810526,0.5405405405405406,1.0,1.0,2/5,12.67%,ZDHHC21;TRAF6
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.3713438159871736,-0.96876921000142,0.6,1.0,1.0,3/43,1.57%,SH3RF3;TNFRSF19;MECOM
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.5176696212463265,0.9687658066049665,0.573170731707317,0.9507833695709816,1.0,4/24,11.07%,HDAC2;RCOR1;MORF4L1;SIN3A
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.5104790288053351,-0.9687165306903185,0.5161290322580645,1.0,1.0,2/10,8.63%,SNAPC3;GTF3C3
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.620463595418899,0.9686283496708539,0.6,0.9505689679704277,1.0,3/9,17.42%,SOD2;CDKN1B;PDCD4
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.5213818338914034,0.9685576934840917,0.5777777777777777,0.9502138988625419,1.0,10/33,27.30%,WIPI1;ATG16L2;RAB7A;AMBRA1;WDR45B;MAP1LC3B;STX12;TP53INP1;VMP1;UBQLN1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.5993044004711827,0.9680808637079416,0.5789473684210527,0.9508802843714992,1.0,1/11,1.89%,DPM1
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.6234559470506763,0.9679602587520156,0.581081081081081,0.950642739058345,1.0,3/8,14.66%,FKBP5;CWC27;PPIB
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.5464692976108008,-0.9679153460386861,0.5263157894736842,1.0,1.0,3/6,0.82%,IL34;CDK6;CD4
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.39384873453948616,-0.9674896944588988,0.6190476190476191,1.0,1.0,3/24,3.74%,EDN3;RCAN2;RYR2
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.4172509858498132,-0.9673904839646565,0.5294117647058824,1.0,1.0,5/19,13.81%,ATM;TOPBP1;FOXN3;BABAM2;MRE11
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.3491877562477614,-0.9672797632014172,0.7142857142857143,1.0,1.0,14/71,10.86%,DKK3;LMOD1;MYL9;ARHGEF10L;CDH6;SORBS2;IGFBP7;LAMB2;PAMR1;EDNRA;SHROOM4;COL1A2;TNS2;CXCL12
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.5159489573394234,0.9669488235979099,0.5393258426966292,0.952492093740276,1.0,10/33,17.63%,PSMB1;PSMB2;PSMA7;EIF2AK2;PSMA4;RUNX1;METTL14;PSMD14;CBFB;ABL1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.5968606461907241,0.9661579507583468,0.5555555555555556,0.9539819839083675,1.0,3/10,20.89%,MAP2K1;MAPK1;MTMR2
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.6308546107410737,0.9651718237219233,0.5652173913043478,0.9559268143348573,1.0,1/6,5.77%,RUBCN
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.5630004251083116,0.9649653158396708,0.5277777777777778,0.9559385133505446,1.0,3/7,26.72%,PLAAT3;LPCAT3;OSBPL5
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.47074092037358045,0.9647540608291414,0.5851063829787234,0.9559268076016075,1.0,15/67,22.47%,TSC2;PDLIM1;SGCZ;TGFB1;ZFPM2;HEG1;INSR;CDKN1B;ZFPM1;FBN1;KDM6A;NF1;FGF12;PKP2;TAB2
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.44195790843667226,0.964525333428912,0.59,0.9558742040412398,1.0,64/266,23.36%,CSF1;S1PR3;HDAC2;TSC2;NRG1;EAPP;NIBAN2;RAF1;CSF1R;ADAM17;NR4A3;CCAR1;SOD2;CTBP2;TGFB1;MYO16;EIF2AK2;EGFR;EFNB2;IRS1;CNOT8;SDCBP;CDC123;PRLR;BCL6;TBX3;TBRG1;FLT1;RUNX1;FGFR2;WDR6;MDM2;MDM4;KDR;CAMK2N1;STAT3;INSR;NF2;MAP2K1;CDKN1B;PTPN2;ST18;LIFR;IFIT3;ACER3;CSNK2A1;JUNB;TBC1D8;RPS6KA2;NAP1L1;GAB2;ITGAV;COL18A1;ALDH1A2;SMAD6;TP53INP1;IRS2;COL4A3;CD81;CTCF;MCTS1;JUN;LEF1;KRAS
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.6262834160952775,0.9642456910479298,0.6027397260273972,0.9559910530900524,1.0,1/8,4.09%,NUP153
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.4997402027445836,-0.9638878046464753,0.47368421052631576,1.0,1.0,1/14,0.79%,NRP1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.5336611391292216,0.9636745992194511,0.547945205479452,0.9567732722306712,1.0,3/15,18.19%,TGFB1;ARHGEF7;PRR5L
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.39409936886187513,-0.9636729071577979,0.42105263157894735,1.0,1.0,3/27,4.67%,CDK6;CUL2;CACUL1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.5616795711334348,0.9636299289590828,0.5733333333333334,0.9563410370992994,1.0,6/15,19.97%,GRIN1;LRRC7;GRIN2B;GRIA3;NLGN1;GRIA2
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.5590639278056083,0.9635594439865798,0.5647058823529412,0.9558976355266651,1.0,3/16,14.98%,DDX3X;CSDE1;C9ORF72
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.4837117742672535,0.9629996138900466,0.5520833333333334,0.9565736644470642,1.0,15/66,22.26%,HDAC2;HCFC2;SMARCA1;ARID1A;MTF2;EZH1;ZBTB7A;ZBTB1;CHD1;HMGN1;SMARCA4;KDM6A;JARID2;MYSM1;NUDT5
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.44712756427604683,0.962672342854439,0.71,0.9568412122152782,1.0,158/738,22.35%,SCML1;WWC1;TAF7;PURB;KLF2;ETV5;KLF15;HDAC2;NRG1;RAD21;KDM1A;CBFA2T2;EBF4;HIF3A;CD38;GLIS3;BASP1;ENO1;ZNF608;SUFU;HDX;WWC2;CAMKK2;HCFC2;ARID3A;CRY1;NIBAN2;SMARCA1;SNX6;CDC5L;RNF10;PIAS2;YAF2;BTRC;CTR9;NR4A3;KLF9;PKNOX1;CCAR1;CHD2;TP63;PHF20L1;HIVEP2;PRKCB;SOD2;PPARA;CTBP2;TGFB1;ESR2;EGFR;ARID1A;APBB1;MED14;CLOCK;HIF1A;SRA1;MTF2;ZBTB16;CEBPB;RCOR1;ZBTB40;PPARGC1A;TSHZ2;SIN3A;CCNH;ZNF536;ZFPM2;KDM3A;BCL6;SREBF1;TBX3;CREM;ELF1;DEAF1;SMURF2;FUBP3;RUNX1;CREB3L2;WAC;MXD4;MDM2;MDM4;CEBPD;TSHZ3;EED;STAT3;MYT1L;ATF6;INSR;PLAG1;TP53BP1;SRSF10;MBD2;HIVEP1;ZNF397;ZNF213;TSHZ1;LCOR;WWP1;MZF1;TEAD1;ZBTB7A;RNF111;TWIST1;PURG;MAP2K1;ZBTB1;ACVR1B;CBFB;SETD3;CDKN1B;CHD1;CRLF3;PDCD4;NAA15;ZNF780B;ABL1;ZHX3;PHF20;NFIX;ST18;PER1;HES4;SP1;RBPJ;ZNF595;SMAD2;JUNB;FOXP2;SMARCA4;LOXL3;MBTD1;CAMK2D;KLF3;CDK17;ZNF814;KLF6;ZNF483;ELF2;ZNF83;JARID2;CCNK;NCOA2;KLF13;CREBZF;SMAD6;SMAD7;NLK;KDM2A;SP3;TP53INP1;TCF4;GCLC;NSD2;CTCF;MXI1;ZNF138;TRPS1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.6008240037602836,0.9623097834611163,0.5802469135802469,0.9570677063493059,1.0,3/10,5.68%,CSF1;AKIRIN1;CSF1R
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.5579846038840973,-0.962270951453403,0.43333333333333335,1.0,1.0,2/6,13.12%,RYR2;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.3628287320561446,-0.9622208880603118,0.5,1.0,1.0,4/41,3.91%,SLIT2;NIBAN1;ATP2B4;YWHAB
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.5504999829446525,0.9621542808610969,0.5802469135802469,0.9569739668200294,1.0,5/18,15.93%,SLC38A4;SLC38A9;SLC3A2;SLC36A4;SLC38A10
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.4396499697230784,-0.961977871570323,0.4666666666666667,0.9993103970441262,1.0,3/16,8.95%,GLB1;ST6GALNAC3;GALC
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.5996095776301038,-0.9619724011361344,0.5625,0.993727657395835,1.0,1/7,0.82%,CD4
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.5996095776301038,-0.9619724011361344,0.5625,0.993727657395835,1.0,1/7,0.82%,CD4
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5600914786198904,0.9617597138945585,0.5128205128205128,0.9574385161316096,1.0,3/10,21.53%,DDIT4;PDE4D;SMAD7
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.6346685061709798,0.9616914481689796,0.6338028169014085,0.9570541183587056,1.0,2/5,35.27%,DGKH;PLPP1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.43721890652593715,-0.9616646709035173,0.5,0.9917933162648568,1.0,4/22,9.82%,MRPL3;MRPL33;MRPL1;EEF2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.5512702568763536,-0.9611690754179271,0.6129032258064516,0.9902334531296795,1.0,2/6,20.08%,LIN7C;PHACTR4
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6250108972222894,0.9608082992173751,0.5538461538461539,0.9585170244485761,1.0,1/5,12.64%,HSPA5
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.6013614188025764,0.9606901050929179,0.573170731707317,0.9582833652355771,1.0,6/9,24.29%,PPARA;IRS1;PPM1K;IRS2;LDLRAP1;ADM
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.5931387637456599,0.9606261192598844,0.5882352941176471,0.957893342232954,1.0,4/10,22.57%,HSPA5;TAPT1;SKP1;HK1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.420830527289039,-0.9603331631799776,0.6,0.9893040446199909,1.0,4/33,3.32%,CAV2;NRP1;PGF;NR4A1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.4281856892069852,-0.9602716595464034,0.5,0.9867778588554152,1.0,2/15,0.69%,TWIST2;CDK6
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5939422526130949,0.9602121609040575,0.5866666666666667,0.9585473711061883,1.0,3/8,26.93%,CSF1R;AXL;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5144399273599283,0.9599209742541083,0.6588235294117647,0.9587255045067324,1.0,6/29,20.64%,DDX3X;RNF34;TNFRSF10B;LGALS3;UNC5B;ITGAV
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.5758504338606449,0.9597959097031531,0.5529411764705883,0.9585965006759765,1.0,2/16,3.10%,KDM1A;SGCZ
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.4752177077314722,0.9594881713273384,0.5268817204301075,0.9588380704422957,1.0,16/59,22.14%,EPHA7;CCT4;CSF1R;DCUN1D4;TGFB1;EGFR;FLT1;FGFR2;KDR;INSR;TNKS;DCUN1D1;MAPK1;SERINC1;MAPKAPK5;AXL
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.48643546297153256,0.9594804501505214,0.6041666666666666,0.9583042255466091,1.0,13/62,22.70%,STX6;AP2A1;SNX6;VPS50;WASHC2C;RAB7A;CCDC91;PREPL;TBC1D5;EEA1;EPS15;GAK;DENND2A
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.6534321304172819,0.9591785205126813,0.6081081081081081,0.9584994361090037,1.0,3/6,24.13%,FGFR2;TWIST1;MTHFD1L
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.5426645293878918,0.9591719564210205,0.5569620253164557,0.957972168313338,1.0,4/18,21.72%,DDX3X;ABCA1;ABHD5;IRS2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.4633735322371611,0.9590105219040074,0.5591397849462365,0.9578959314914177,1.0,9/59,14.52%,NRG1;MYDGF;IL18;TGFB1;EGFR;IRS1;F3;FGFR2;INSR
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.5111603006528442,0.9587615706795781,0.6136363636363636,0.9579294395843562,1.0,7/26,26.93%,SGIP1;INSR;TBC1D5;LDLRAP1;TF;ATAD1;VEGFA
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5699089708784597,0.958599226119853,0.589041095890411,0.9577494855236091,1.0,3/15,6.75%,NEDD4L;FHL1;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.6358446268141988,0.9584621624741223,0.6231884057971014,0.957471731341325,1.0,4/8,26.40%,PIAS2;ZBTB7A;SMARCA4;NCOR2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5957487028254389,0.9582769909908936,0.5714285714285714,0.9573556190411453,1.0,5/10,22.33%,NEDD4L;HECW1;STK39;CAMK2D;GOPC
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.5568202754709111,0.9580960978984655,0.5921052631578947,0.9572914640296479,1.0,3/10,27.98%,NEXMIF;JAM3;PTPN11
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.5354672379607851,0.9580800729838579,0.6049382716049383,0.9567899892924426,1.0,6/20,21.86%,RNF168;RPS27A;FAN1;WDR48;RPA1;ERCC6L2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.48052135026342546,0.9579511378425439,0.5108695652173914,0.9566111886370097,1.0,8/35,14.37%,CSF1;BNIP3L;TNFRSF1B;ADNP2;CCN2;PPARGC1A;PDE8A;LRRK2
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.6303827747832764,0.9578653955449289,0.6,0.9562831250825298,1.0,2/8,12.64%,EIF2AK4;HSPA5
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.5337935040417453,0.957721158175561,0.5517241379310345,0.9561852485357385,1.0,3/18,4.81%,NRCAM;CRMP1;DPYSL2
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.49285032800458617,0.9575233327972928,0.5568181818181818,0.9560932246851673,1.0,7/25,20.02%,CRY1;IRS1;STAT3;PDK4;INSR;PTPN2;SELENOT
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.49091592509860166,0.9574101113072239,0.6195652173913043,0.9557545310013366,1.0,11/41,19.62%,RRAS2;BNIP3L;TNFRSF1B;TBK1;ADNP2;CCN2;PDE8A;LRRK2;CDKN1B;ACER3;BNIP3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.4905873545992844,0.9573517575921272,0.5978260869565217,0.9553818052565317,1.0,10/49,17.24%,DPP10;ANK3;PRKCI;TP63;EGFR;TCAF1;PTPN9;LGALS3;ZDHHC5;PRNP
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4939215895151695,0.957249008794997,0.5222222222222223,0.9551012189717547,1.0,9/38,15.29%,PSMB1;HIF3A;PSMB2;PSMA7;RPS27A;HIF1A;PSMA4;RBX1;PSMD14
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.552347431493823,0.9572116690656898,0.547945205479452,0.9546719890266085,1.0,4/11,21.93%,ADAM17;FLT1;SP1;COL4A3
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.5106325510119525,0.9571715679112985,0.5444444444444444,0.9542432424485178,1.0,7/29,30.88%,RAD21;TTN;CSNK2A1;PDS5B;RAB11A;ZNF207;SMC1A
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.5566394759394867,0.956685288572754,0.56,0.954816464119072,1.0,5/14,22.10%,ST13;HSPA5;DNAJC7;DNAJC18;GAK
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.3675663232363639,-0.9566731880140378,0.4444444444444444,0.9928457077513683,1.0,10/49,10.52%,COL24A1;SERPINH1;COL14A1;COL5A2;COL13A1;COL15A1;BMP1;COL1A2;COL10A1;COL8A1
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.5261065790508928,0.9556527819274129,0.6111111111111112,0.9566473434822058,1.0,8/27,15.29%,PANK2;PSMB1;PSMB2;PSMA7;PPARA;PSMA4;PDK4;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.6271695340778879,0.9553313262750236,0.5466666666666666,0.9568470071321379,1.0,1/8,2.97%,PTPRD
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.6371386288851755,0.9553097005728799,0.6486486486486487,0.9563608708063402,1.0,1/7,6.53%,SEC11A
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.44295453676668184,0.9550772396901621,0.72,0.9563606238040763,1.0,83/455,18.25%,HS3ST5;CSF1;CSNK1G2;PPP1CC;PRKACA;PDK1;PSMB1;DCLK1;PTPRD;HIF3A;PTPN1;SIK2;WIPI1;RHBDD1;CAMKK2;COG7;CSNK1D;CDH2;PSMB2;SSH1;MGAT4A;CSNK1A1;PPP2R1B;BTRC;MAPK6;STK4;TRIOBP;PRKCI;PSMA7;PRKCB;MGAT1;TBK1;TGFB1;EIF2AK2;KLHL2;UGCG;CP;DUSP1;NRBP1;GLRX;HIF1A;OXSR1;EIF2AK4;ZBTB16;PTAR1;PTPRE;ROCK2;PSMA4;CST3;PDK3;MAPKAPK2;PTPRZ1;FBXL13;PTPN9;PPP3CA;MELK;LRRK2;PDK4;INSR;RBX1;TIPARP;PSMD14;ACVR2A;LATS2;MAK;TNKS;WDR45B;DCAF5;MANBA;MAP2K1;TULP4;ACVR1B;DCUN1D1;MAPK1;SETD3;STK39;ARF4;ABL1;FBXO11;FBN1;ATG4B;GOLGA2;CSNK2A1
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.5050807969401557,0.9549955981970538,0.5476190476190477,0.9560465075755594,1.0,6/21,22.49%,PRKACA;SELENOS;PDK3;SELENOT;IRS2;TRA2B
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6096966658638328,0.954822489632638,0.5540540540540541,0.9558924421860818,1.0,3/7,21.99%,ABCA1;CD9;CD81
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.5462219216683697,-0.9547504705237287,0.5625,0.9947689641894494,1.0,4/6,15.09%,ANO6;HMGB1;CXCL12;JAM2
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.6113367463479753,0.9547262838919548,0.5945945945945946,0.955641644065812,1.0,3/6,30.54%,SETD3;SETD2;KMT2A
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.5008077311426442,0.9545817915684439,0.6382978723404256,0.9554310068416921,1.0,8/43,16.60%,DDIT4;WIPI1;SEC11A;CEBPB;DCP2;HSPA5;ATF6;DCP1A
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.5842818543358008,0.9544136361702679,0.6086956521739131,0.9553174024266208,1.0,1/7,10.38%,XKR4
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.522791045679148,0.9540420976659655,0.5135135135135135,0.9555226072090481,1.0,3/12,16.54%,RAF1;ADORA2B;LGR4
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.3548374614910445,-0.9540386691641055,0.5,0.9941704390207879,1.0,5/32,5.29%,SLIT2;LMOD1;EVL;BAIAP2L2;NCK1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.45668800286919153,-0.9539518190135043,0.6,0.9916585656842384,1.0,1/10,0.79%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5906048566807457,0.9536409721880589,0.5753424657534246,0.9558185835468639,1.0,1/6,5.84%,TMEM30A
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.5384959162389072,0.9534639517986359,0.625,0.9556708466583802,1.0,8/17,30.90%,TTC8;C12ORF57;MAGT1;DGCR2;NF1;CYFIP1;GRM5;APP
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.6473486560411725,0.9531140336126818,0.5571428571428572,0.9560459464680674,1.0,1/5,10.03%,EIF2AK4
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.5839333701355767,0.9528732020997019,0.6025641025641025,0.9560345205995476,1.0,2/11,16.52%,WIPI1;WDR45B
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.5726266333017447,-0.9524758920901567,0.6333333333333333,0.9931615708336701,1.0,1/5,0.40%,IL34
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.3856076110969032,-0.9523843863272791,0.5,0.990666090472284,1.0,3/45,4.06%,SPRY3;SPRY1;MAPKAP1
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.559512924622154,0.9523201694625364,0.6153846153846154,0.9568346142819337,1.0,1/16,0.34%,HS3ST5
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.5639330745654616,0.9520146124586497,0.6301369863013698,0.9570269427763659,1.0,4/12,27.01%,RAP1B;ROCK2;KANK1;PTK2B
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5771369717429636,0.9516195922169024,0.5822784810126582,0.9573777761518242,1.0,4/8,19.38%,PRKACA;AKAP6;PDE4D;CAMK2D
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6437536264514048,0.9515902078855925,0.59375,0.9569180681065377,1.0,1/5,11.82%,ROCK2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5408339045335698,0.9514782639297404,0.6043956043956044,0.9566570501687275,1.0,9/24,21.59%,EPN1;SNX6;ERRFI1;EGFR;RAB7A;ARHGEF7;PTPN2;GRB2;EPS15
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.47927603053095397,0.951409362356488,0.6082474226804123,0.9563510500720837,1.0,13/71,16.28%,TAF7;TAF1B;TBPL1;NR4A3;PPARA;ESR2;NRBP1;CCN2;PPARGC1A;CCNH;RARB;TEAD1;POLR1C
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.5001376953539344,0.9513877421338501,0.6526315789473685,0.9558644004198188,1.0,5/44,12.40%,STX6;SNX6;VPS50;WASHC2C;RAB7A
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.6083567283899398,0.9513398882928865,0.6197183098591549,0.955412208538971,1.0,3/7,17.55%,INSR;PRNP;ARF1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5436436105043904,0.9506391036050957,0.6417910447761194,0.9565311220889202,1.0,4/13,28.65%,NF2;CRLF3;NLK;SH2B3
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.4848290511903731,0.950252061188036,0.5888888888888889,0.9568695741446862,1.0,3/38,3.29%,PARVB;MICALL2;PTPN1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.585270169883245,0.9496786756920745,0.618421052631579,0.957709911436912,1.0,4/11,25.79%,OTUD7A;MINDY2;USP25;USP8
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.5659252995019639,0.9493737399410059,0.5822784810126582,0.9579232487530583,1.0,5/13,13.41%,KCNQ1;NOS1AP;FHL1;GNB1;AKAP6
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.5445771309867355,0.9489643161712402,0.5324675324675324,0.9584351171316934,1.0,4/13,12.64%,PTPN1;RHBDD1;TMBIM6;HSPA5
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.4990192045837248,0.9487325497062347,0.5617977528089888,0.9584618942520285,1.0,9/45,17.29%,TEFM;PSMB1;PSMB2;PSMA7;DDX21;RPS27A;PSMA4;PSMD14;RPA1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5150734910928425,0.9486928296537338,0.6329113924050633,0.9580156476764113,1.0,5/16,25.30%,PARVB;ARHGEF7;ARHGEF4;CYFIP1;CCDC88A
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.45280396564730807,0.9485497849187509,0.6185567010309279,0.9578737943362265,1.0,11/104,10.68%,DARS1;RPS21;ETF1;AGO2;RARS1;FARSB;PPA1;RPS27A;RPL21;RPL28;RPL41
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.6235987102091882,0.9483802906496775,0.6111111111111112,0.9577827197869112,1.0,3/7,14.66%,FKBP5;CWC27;PPIB
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.5728448017382491,0.9483638237720169,0.5952380952380952,0.9572869948071921,1.0,2/18,3.85%,MID1;TENM3
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.2959820075204482,-0.9479474721018918,0.6,0.999007370397154,1.0,10/69,7.44%,DNAI4;VAMP4;SHQ1;TIAM1;ARL6;NCK1;HSPA1A;TBCD;OTUD6B;TPR
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.6062415504408558,0.9479033283717012,0.6463414634146342,0.9578480838437754,1.0,3/7,25.10%,RAB7A;STXBP6;IL1RAPL1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),0.4974332900017947,0.9477866273816993,0.6125,0.957571868301102,1.0,12/31,34.25%,DDX3X;TBK1;RIOK3;POLR1C;POLR2F;SETD2;PTPN11;IRF1;PRKDC;STAT6;XRCC5;NFKB1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.5922493094500884,0.9475743383370933,0.5833333333333334,0.9574979981336686,1.0,4/8,28.55%,CYP3A5;ABO;TFPI;SLC40A1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.4295703628264824,-0.9472388385755168,0.46153846153846156,0.9981526917753333,1.0,7/18,18.66%,MYL9;ACTB;ACTG1;ILK;ACTN1;FLNA;STXBP3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.6011014316969802,0.9472003201894078,0.6133333333333333,0.9577831944542299,1.0,2/6,5.68%,CSF1;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.543980476067893,0.9468214061897487,0.6296296296296297,0.9581577731110418,1.0,5/16,21.99%,CD38;IL18;VAV3;IRS2;CD81
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.6032370373594517,0.9466258628876794,0.5945945945945946,0.9581677466264622,1.0,3/8,24.06%,NIBAN2;NAP1L1;RFX3
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4796973044043555,0.9464492490381273,0.5903614457831325,0.9581385100370267,1.0,12/29,30.22%,PRKACA;ADAM17;GNB1;ADORA2B;PTH1R;PRKAR2A;CD81;ADM;PRKAR1A;ADCY5;PRKAR1B;PLCG1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.5101187503023413,0.9459335535232324,0.6067415730337079,0.9588200982720632,1.0,9/31,17.63%,PSMB1;PSMB2;PSMA7;EIF2AK2;PSMA4;RUNX1;PSMD14;CBFB;ABL1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.6078047839837625,0.945547670555946,0.5571428571428572,0.9592660007002818,1.0,3/5,30.04%,BNIP3;PID1;ZDHHC6
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.5691999573118673,0.9452645077347791,0.5774647887323944,0.9593480213367639,1.0,1/9,1.68%,ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.4647123199611574,0.9448848080121982,0.5876288659793815,0.9597819685607265,1.0,20/74,20.53%,CSNK1G2;PSMB1;DDX3X;CSNK1D;PSMB2;PSMA7;TGFB1;EGFR;SMURF2;PSMA4;FGFR2;LRRK2;PSMD14;TNKS;LGR4;CSNK2A1;SMARCA4;UBE2B;UBR5;KANK1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.46163991557002304,-0.9440164941931104,0.5,1.0,1.0,2/9,9.24%,ANO6;ANO10
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.6440755711185264,0.9439600288163875,0.6935483870967742,0.9613602613901875,1.0,1/5,15.06%,LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.3515851512778734,-0.9438663864782789,0.6666666666666666,1.0,1.0,5/35,3.32%,NRP1;FGF1;PGF;LAMC1;NR4A1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.5136840943331202,0.9438455794232146,0.5882352941176471,0.9610000642968748,1.0,6/23,17.76%,NEDD4L;LZTFL1;SIN3A;ROCK2;LATS2;DNAJA1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.480992046398226,0.9437365383372579,0.6304347826086957,0.9607072028355625,1.0,15/54,21.53%,STRAP;SNX6;ADAM17;PPARA;TGFB1;RPS27A;SDCBP;SMURF2;SNX25;LATS2;ZBTB7A;RNF111;SMAD2;SMAD6;SMAD7
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5426692654603972,0.9435696401969469,0.575,0.9604704156297589,1.0,1/10,1.38%,PRKACA
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.4846286743887329,-0.9433081274560331,0.5454545454545454,1.0,1.0,2/9,3.45%,MAPK14;HDAC9
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.5619070672869553,0.9430849660005192,0.6447368421052632,0.9611143047727689,1.0,4/13,27.01%,RAP1B;ROCK2;KANK1;PTK2B
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.3489665640547935,-0.9430210940164994,0.5555555555555556,0.9983558672182424,1.0,6/21,8.28%,GPC6;CYP4V2;ABCA4;ALDH1A1;AKR1C3;GPC3
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.6197094254413242,0.942471533325097,0.625,0.9618967188443259,1.0,2/7,11.29%,TGFB1;UHMK1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.6249349416223099,0.9423741013297845,0.6075949367088608,0.9616095739474417,1.0,2/7,23.03%,SMAD2;LEF1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.45536008819882695,0.9421880528086993,0.6153846153846154,0.9614896366255952,1.0,8/48,13.46%,CD44;CSF1R;TGFB1;EGFR;CCN2;PDE8A;FGFR2;KDR
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.46563312161379633,-0.9413010081928953,0.5185185185185185,0.9996343575920933,1.0,4/13,12.03%,MAPKAP1;LARP1;TIPRL;RPTOR
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.48465986223950447,0.9412215435125219,0.6136363636363636,0.96320465425496,1.0,7/33,23.03%,CSF1R;MED14;CEBPB;TWIST1;CBFB;JUN;LEF1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.46200024091227115,0.9411835064860413,0.6145833333333334,0.9627227691844927,1.0,10/60,22.99%,USP15;ZFP36L2;TGFB1;RPS27A;ZFYVE9;SMAD2;SMAD6;SMAD7;NLK;JUN
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6111021516335122,0.9409624388097318,0.6376811594202898,0.9626135284003597,1.0,4/8,19.38%,NEDD4L;HECW1;STK39;CAMK2D
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.581846828516451,0.9406418548100712,0.6025641025641025,0.9628263629723909,1.0,1/7,5.84%,TMEM30A
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.6379395334828954,0.9404459792064596,0.6216216216216216,0.9627227328045659,1.0,2/5,11.07%,CRY1;SIN3A
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.49784813533886274,0.9402831349893415,0.6219512195121951,0.9625859461639278,1.0,3/29,7.73%,CHST11;COG7;MGAT1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.5268619557031656,0.9398628157830924,0.6375,0.9630921680873935,1.0,6/19,21.72%,ENO1;CRY1;PPARGC1A;PGK1;TPI1;IRS2
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.5751709569923227,0.939497726960836,0.6388888888888888,0.9634759833518602,1.0,3/12,6.75%,KCNE4;KCNQ1;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.4594901427105298,-0.9393100754661091,0.5882352941176471,1.0,1.0,1/16,0.43%,FGF13
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.5514881691904444,0.9390146812356684,0.6172839506172839,0.9640088489217753,1.0,7/16,26.72%,SOAT1;ABCA1;SCARB1;STX12;LDLRAP1;ABCA5;OSBPL5
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5065595656247487,0.938711677834724,0.6744186046511628,0.9642921565661181,1.0,6/34,12.26%,DDX3X;FHL1;ADAM17;MYO16;EGFR;ANKRD17
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.5851227836122657,0.9384884986942486,0.6075949367088608,0.9642710150149872,1.0,3/8,20.89%,INSR;PRNP;MTMR2
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.6116146814191218,0.9383418042060593,0.6351351351351351,0.9641006719646528,1.0,1/6,3.16%,GFAP
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.4881325993700067,0.9383171530423354,0.5813953488372093,0.9636377509538286,1.0,6/31,16.22%,GLRB;GRIN1;TRPM3;SLC1A2;ATP11B;GABRB1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.33654971059233557,-0.9381527702804765,0.4444444444444444,1.0,1.0,12/42,12.96%,DERL1;PARP9;ZNF618;CAPRIN2;TIAM1;TCF7L2;HMGB1;PKD1;APOE;ADD1;SKI;FLOT1
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.5647725369263588,-0.9375285812117455,0.5333333333333333,1.0,1.0,1/6,0.96%,CSRP2
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.5429668521532319,0.9371370242041787,0.5529411764705883,0.9658087692721466,1.0,5/14,20.89%,CTNND2;INSR;PRNP;ARF1;MTMR2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5751757477093389,0.9367871793787675,0.6301369863013698,0.9661289565392867,1.0,3/10,23.45%,TGFB1;MAPK1;UBE2K
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.4916418546818356,-0.9366790353644764,0.5294117647058824,0.9991282208109012,1.0,1/10,2.29%,ATM
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.47086774602717246,0.9366403434642085,0.6170212765957447,0.965974519967485,1.0,11/44,24.17%,NUP153;PIAS2;NUP88;NUP133;SENP1;METTL21A;LOXL3;UBA2;NUP205;SENP2;NUP160
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6253761437525621,0.9365920738065096,0.5915492957746479,0.96552812250776,1.0,2/5,12.14%,HOMER2;GRM7
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.5814954267161851,-0.936484205408423,0.5517241379310345,0.9971634983685631,1.0,1/5,3.06%,ZDHHC21
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.5762642527219237,0.9362299996395324,0.6153846153846154,0.9659746454406369,1.0,2/10,13.46%,TMSB4X;KDR
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.5497936333609553,0.9361754372831234,0.6025641025641025,0.9655397430611887,1.0,5/14,22.51%,CCNH;CAMK2N1;CDKN1B;CCNK;CCND3
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6136960324188948,0.9360956651882825,0.6428571428571429,0.9651768491447392,1.0,1/8,1.89%,DPM1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.5188212683879788,0.9355220145376533,0.6049382716049383,0.9659143339034281,1.0,10/24,30.90%,NFKBIA;IL18;NFKBIZ;PDCD4;SNX4;CD81;ETS1;IL6ST;CCN4;APP
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5938834123906067,0.9353617600233959,0.6164383561643836,0.9653101853811117,1.0,2/9,14.37%,AK3;LRRK2
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.5938834123906067,0.9353617600233959,0.6164383561643836,0.9653101853811117,1.0,2/9,14.37%,AK3;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4776099001357258,0.9351507782395263,0.5869565217391305,0.96532707969107,1.0,16/55,24.96%,STRAP;SNX6;ADAM17;PPARA;TGFB1;RPS27A;SMURF2;SNX25;ACVR2A;ZBTB7A;SMAD2;SMAD6;SMAD7;SPART;SPRED1;UBE2D3
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6143735112115771,0.9351287882748864,0.569620253164557,0.9648500305251817,1.0,3/6,20.89%,INSR;PRNP;MTMR2
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.4665299064070331,0.93511572662037,0.6333333333333333,0.9643405853867242,1.0,19/40,20.87%,KCNC2;KCNQ1;DPP6;PRKCB;CTNNA2;MOBP;XKR4;OTUD7A;SLC4A10;ASPA;SLC1A2;MCF2L2;MYT1L;NRXN1;ST18;GRIA2;NAPB;UNC80;CCK
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.5895779310933728,0.9349692964904605,0.6521739130434783,0.96414965370444,1.0,4/8,31.68%,TNFRSF1B;SMAD7;CD55;MALT1
prerank,PanglaoDB_Augmented_2021__Basophils,0.479592038220667,0.9348116297052337,0.6111111111111112,0.9640191988294843,1.0,7/31,18.94%,CD44;CSF1R;SNCAIP;FADS2;PDK3;ADORA2B;CABLES1
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.6341857493673948,0.9347881911983529,0.6164383561643836,0.9635438815308686,1.0,1/5,0.96%,TEFM
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.5937374290246231,0.9346281932147831,0.6753246753246753,0.9633153739042974,1.0,2/10,15.43%,MTMR9;PPP6R2
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.5933105729668289,0.9345792065543636,0.5789473684210527,0.9628847093409278,1.0,3/7,29.27%,CTR9;JARID2;MTHFR
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.507084888588634,0.9341473543735759,0.5238095238095238,0.9634222384106964,1.0,1/21,0.32%,SRGN
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.5232855607968232,-0.9341327173814719,0.46153846153846156,0.9996769743404715,1.0,1/5,0.79%,NRP1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.5138298734153909,0.933593363773534,0.654320987654321,0.964035692331962,1.0,6/25,12.56%,GNPAT;SCD;PDSS2;PRLR;SREBF1;AGPAT4
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.4697545073052376,-0.9335759902326044,0.5,0.9982352775151353,1.0,2/9,3.55%,KCNMA1;ATP1B2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5806935151799495,0.9335500684957527,0.6533333333333333,0.963583488664195,1.0,4/10,31.25%,LPAR6;PTH1R;GRM5;TACR1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.5497477669104203,0.9331613384906522,0.5833333333333334,0.9638031782613619,1.0,2/16,13.86%,CTR9;STAT3
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.36536437361406077,-0.9330936269901436,0.5,0.9966545853771825,1.0,6/36,5.29%,SYNPO2;LMOD1;EVL;BAIAP2L2;RPS3;NCK1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6509897541139301,0.9328089136837239,0.618421052631579,0.963940797065674,1.0,1/5,9.16%,RAP1B
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.6029641060669567,0.9324822971335244,0.6,0.9641818704698404,1.0,3/5,32.27%,STRN3;CNOT1;CNOT2
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.6255488075393824,0.9320399268860385,0.6891891891891891,0.9648368721261729,1.0,5/6,37.34%,ABCA1;LDLRAP1;NPC1;LRP6;RELCH
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.6182414049428114,0.9320185238878773,0.6285714285714286,0.9643691096596951,1.0,2/6,23.05%,NR4A3;DOCK4
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.6416610972316974,0.9317087754440462,0.6086956521739131,0.9645061308159261,1.0,2/5,16.19%,FLT1;LGALS3
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.6185464075869053,0.9317032165312523,0.5846153846153846,0.9634800116235627,1.0,2/5,27.16%,PHKB;PYGB
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.6185464075869053,0.9317032165312523,0.5846153846153846,0.9634800116235627,1.0,2/5,27.16%,PHKB;PYGB
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5990529712309534,0.9314655533222364,0.6133333333333333,0.9634161836476746,1.0,5/8,38.13%,CDK17;CDK14;BRD4;BACH1;TFDP2
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.5846545601449127,0.9314390797675822,0.6515151515151515,0.9629341323911719,1.0,2/6,30.46%,MTHFD1L;QDPR
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.47212237324595874,0.9311304523066977,0.6483516483516484,0.9630715539059118,1.0,8/55,7.54%,CBFA2T2;PTPRD;TENM3;LRRC7;ROBO2;ROBO1;PRKCI;SCARB2
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.4698280056527636,-0.9310655714832983,0.4090909090909091,0.998784394654088,1.0,2/8,3.77%,CA5B;CYB5R4
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.4133048067602026,-0.9304429807305765,0.6875,0.9976234816396543,1.0,3/16,5.71%,ATP10A;ATP8A1;ABCA4
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.6288202032017034,0.9302771400321904,0.6268656716417911,0.9644677904903787,1.0,3/7,23.12%,PLAAT3;ACADL;MT3
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.43652861505536666,0.9302198659735392,0.6451612903225806,0.9640618809691837,1.0,19/68,25.30%,DPP10;SPTBN4;DPP6;ANK3;ATP1B3;DENND4C;EHD2;ROCK2;RAB12;RAB8B;MAP7;CD81;PKP2;GAK;TSPAN5;NECTIN3;KCNIP4;PIP5K1A;CCDC88A
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6057072857054642,0.9301381754926626,0.6666666666666666,0.9637593988922211,1.0,3/7,22.14%,IL18;ZBTB1;AXL
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.4414795311649379,-0.9300767290820506,0.5,0.9958385821823108,1.0,1/12,0.82%,CD4
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.6079015589651168,0.9295322324214172,0.5857142857142857,0.9645462341932897,1.0,2/6,26.76%,PRLR;FDFT1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.4898758903733342,0.9289264822089748,0.631578947368421,0.9652943265369622,1.0,6/27,13.59%,FMN2;EGFR;RNF168;SPIRE1;SMCHD1;BRCC3
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.5619270239862955,0.9284279086279178,0.6486486486486487,0.9659550287075176,1.0,3/11,19.38%,NR4A3;ROCK2;CAMK2D
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.45875633431558693,0.9283927097527496,0.5681818181818182,0.9655169522064895,1.0,12/35,19.97%,PRKACA;GRIN1;ANK3;LRRC7;GRIN2B;PDE4D;FGF14;CNIH3;GRIA3;CAMK2D;NLGN1;GRIA2
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.6443050048023699,0.9283828847931106,0.6133333333333333,0.9650198714853471,1.0,3/5,21.98%,GLUL;GLUD1;GCLC
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.590123541905351,0.9282857916113666,0.6363636363636364,0.9646962307549813,1.0,5/8,38.50%,GNAI1;GPSM2;CLTC;MAP9;RNF4
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.5278290161026788,0.9281291267081744,0.5903614457831325,0.9645997599140398,1.0,5/15,17.58%,CD44;KIF13B;EIF2AK4;PPP3CA;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.6008243040929653,0.927989619960012,0.6538461538461539,0.9644170273910823,1.0,2/7,22.60%,GPR137C;SIK3
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.622518514767046,0.9277759166598954,0.6575342465753424,0.9642830427791369,1.0,1/5,1.64%,TSC2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.49670453090988653,0.9274722932560131,0.5882352941176471,0.9644134098071366,1.0,7/33,19.23%,SEMA4D;TGFB1;DUSP1;NEXMIF;CORO2B;NF2;JAM3
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.5288951312000676,-0.9273901645818178,0.5172413793103449,0.9993799146102788,1.0,2/6,12.03%,LARP1;RPTOR
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.5241320938770256,0.9273609635313858,0.625,0.9641663964599745,1.0,9/21,35.69%,SMAP1;SGIP1;ARF1;LDLRAP1;TF;LRPAP1;BMP2K;SNAP91;HNRNPK
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.535559203168698,0.9266579440409054,0.6216216216216216,0.9651423393897348,1.0,4/13,29.34%,RPS27A;MAP2K6;TAB2;CYLD
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.5092809070814484,0.9261254857379209,0.6363636363636364,0.9658265417323412,1.0,3/27,10.03%,KDM1A;RHBDD1;EIF2AK4
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.5604914479040358,0.9259252651590492,0.6265060240963856,0.9657621138630315,1.0,2/12,3.03%,NEDD4L;KCNQ1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.5538585476765248,0.9258610599426864,0.6712328767123288,0.9654127320774742,1.0,3/13,17.79%,PHF20L1;MORF4L1;PHF20
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.5277620231990638,0.9257272930673783,0.5569620253164557,0.9652249675862862,1.0,4/11,25.10%,TNFRSF1B;GRM7;STXBP6;IL1RAPL1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5437973982929365,0.9255365528738179,0.6794871794871795,0.9651126107737865,1.0,3/12,22.99%,MED14;TWIST1;JUN
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.5731539191122328,0.925422880415288,0.6710526315789473,0.9648822489621052,1.0,2/8,21.99%,ANKRD17;CD81
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.48731145525897085,0.9246846666482464,0.6629213483146067,0.9660044689158969,1.0,9/34,16.51%,PSMB1;AP2A1;PSMB2;PSMA7;SMURF2;PSMA4;FZD3;PSMD14;AP2B1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.5571591382671264,0.9246187770002334,0.6329113924050633,0.965591517558043,1.0,2/14,13.86%,CTR9;STAT3
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4806088760997669,0.9245630814597543,0.5930232558139535,0.9652486915231084,1.0,4/23,23.45%,ADAM17;MADD;PTPN2;UBE2K
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.6380320897321676,-0.9244539321412146,0.6538461538461539,1.0,1.0,2/5,0.80%,NRP1;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.5369716966352662,-0.9243364342837997,0.4864864864864865,1.0,1.0,1/5,2.87%,SMARCAL1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.43518561093271496,0.9242996489691694,0.6122448979591837,0.9653241461316113,1.0,16/93,20.18%,COL4A6;MID1;GJA1;TENM3;WWC2;SMARCA1;NXN;STAT3;CD9;PAWR;TEAD1;LGR4;LIFR;SMAD2;BNIP3;DCBLD2
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.45284051239053663,0.9239557351548685,0.6666666666666666,0.9655280441401576,1.0,10/72,7.75%,PHYHIPL;GJA1;FAT3;CRMP1;DCLK1;PTPRD;GFAP;PCDH17;ADGRB3;SYNDIG1
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5116742919944899,0.923758395227606,0.6190476190476191,0.9654427032648664,1.0,5/18,18.05%,RIOK3;OTUD7A;TANK;USP10;PER1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.35859163125688626,-0.9234768755930328,0.6923076923076923,1.0,1.0,3/34,5.26%,ZDHHC15;ZDHHC21;ARL6
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.4902812793251945,0.9233252208895967,0.6206896551724138,0.9660261378608072,1.0,10/35,28.38%,INTS2;ELL2;INTS8;SP1;CCNK;ELL;POLR2F;INTS4;INTS6;INTS7
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.46908538756352947,0.9228524245216349,0.6111111111111112,0.9665554922315551,1.0,6/37,15.99%,CSF1;NEXMIF;ROCK2;CASK;SLK;NF2
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5660383942128088,0.9227236516514636,0.6352941176470588,0.9663361493997332,1.0,3/14,13.83%,TGFB1;SNX25;SIAH1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.4889925020677408,0.9226096505274256,0.6404494382022472,0.9660422621765713,1.0,8/30,16.27%,MYRIP;TGFB1;APBB1;ACSL4;SYTL4;EXOC1;GLUD1;TTN
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.5872441864007087,0.9218118098301099,0.6231884057971014,0.9672380560757359,1.0,2/5,22.14%,SELENOS;AXL
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5239642252652479,0.9216883498641775,0.618421052631579,0.967056048536694,1.0,4/13,29.34%,RPS27A;MAP2K6;TAB2;CYLD
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.5542331050322854,0.9216128992279989,0.6323529411764706,0.9666609257058737,1.0,4/9,39.61%,ELOVL5;ELOVL6;ABCD3;ACSL1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.5028337620554848,0.9214991992014347,0.6455696202531646,0.9658665948504521,1.0,9/23,36.40%,SEC13;NUP133;REEP3;NUP205;NUP160;PPP2R2A;IST1;RANGAP1;ANKLE2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.5028337620554848,0.9214991992014347,0.6455696202531646,0.9658665948504521,1.0,9/23,36.40%,SEC13;NUP133;REEP3;NUP205;NUP160;PPP2R2A;IST1;RANGAP1;ANKLE2
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.505224678766563,0.921344698813197,0.6263736263736264,0.9656590651291166,1.0,11/30,24.16%,SCD;ERRFI1;SEMA3B;FADS2;PDK3;CD9;GNAI1;LGALS3;CHKA;TP53INP1;ALCAM
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.6142405120689773,0.9213144757682332,0.6438356164383562,0.9652069639538136,1.0,2/5,7.81%,CSF1;TGFB1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.5336217915375007,0.9211130153174464,0.6666666666666666,0.9651276453288373,1.0,1/14,3.59%,DDIT4
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.6211065194581955,0.9207107116767628,0.6027397260273972,0.9655321591561803,1.0,4/5,20.07%,SNAP25;AP3D1;SNAP23;STX2
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.4309432601250817,0.9205303921501994,0.73,0.9654049351471053,1.0,13/132,12.19%,TAF1B;DUT;DARS1;RPS21;AGO2;FARSB;PWP1;RPS27A;RPL21;RPL28;RPL41;TBRG1;FUBP3
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.43748226665363005,0.9203856451774075,0.7032967032967034,0.9652512921241693,1.0,19/70,25.17%,DPP10;SPTBN4;DPP6;ANK3;ATP1B3;LIN7A;DENND4C;EHD2;ROCK2;RAB12;RAB8B;MAP7;WDR19;CD81;PKP2;GAK;TSPAN5;KCNIP4;PIP5K1A
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.4874388590726788,0.9203822587445265,0.6385542168674698,0.9647475075249395,1.0,8/26,23.03%,KANSL3;APBB1;MORF4L1;EP400;PHF20;PER1;JADE2;LEF1
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.5522711143430081,-0.92035449902422,0.5,1.0,1.0,2/5,24.16%,CLU;HSP90AA1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4505976135529322,0.9200370908539114,0.6421052631578947,0.9649657063108413,1.0,19/49,37.38%,USP15;TGFB1;RPS27A;ZFYVE9;SMAD2;SMAD6;SMAD7;NLK;JUN;ZMIZ1;FOS;PXN;USP9X;USP9Y;SMURF1;TGFBR1;PTPRK;BMPR1A;APPL2
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.5378799704891359,-0.9198565078465873,0.5925925925925926,1.0,1.0,1/6,2.28%,MYH11
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.5525677171649469,0.919612051846549,0.6323529411764706,0.9648661915554553,1.0,4/10,23.12%,EGFR;MAPK1;JUN;MT3
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.5525677171649469,0.919612051846549,0.6323529411764706,0.9648661915554553,1.0,4/10,23.12%,EGFR;MAPK1;JUN;MT3
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.5195992418235101,0.9187439350222011,0.65,0.9660850351387907,1.0,6/20,23.20%,NEXMIF;CORO2B;CASK;NF2;KANK1;SPOCK1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.6160478576868891,0.9187086345995944,0.6708860759493671,0.9656509470595215,1.0,2/5,23.87%,CORO2B;SLC38A2
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.651554753287268,0.918657092102082,0.6666666666666666,0.9652384748303086,1.0,3/5,29.36%,PDCD4;DNAJA1;AIDA
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.4659077802985979,-0.9186136435995675,0.5882352941176471,1.0,1.0,4/11,21.99%,MRPL1;ZNHIT6;RPL35;RPL10A
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.5055679303706608,0.9182373128899113,0.6046511627906976,0.9655033320598878,1.0,7/28,25.57%,CCP110;SDCBP;TAPT1;ASAP1;GPSM2;CCDC88A;CNOT1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.4950535190390652,0.9179065570397238,0.6627906976744186,0.9658524825514946,1.0,9/29,19.68%,PSMB1;PSMB2;BTRC;PSMA7;PSMA4;TNFRSF10B;PSMD14;MAP3K14;SKP1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.6054284364007217,0.9179057691062608,0.6625,0.9648548005197238,1.0,3/7,35.93%,POLR2F;TERF1;POT1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.6054284364007217,0.9179057691062608,0.6625,0.9648548005197238,1.0,3/7,35.93%,POLR2F;TERF1;POT1
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.5805161217516244,0.9178594437982109,0.6086956521739131,0.9644438116883759,1.0,2/8,22.31%,DHX29;MCTS1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.5867027147135484,0.9175410516948815,0.6447368421052632,0.9645712553843813,1.0,3/6,26.53%,METTL21A;SETD3;SETD2
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.5627290845035497,0.9174703599374114,0.6794871794871795,0.9642135580211116,1.0,3/11,12.40%,GGA3;SCARB2;RAB7A
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.46242821047743893,0.9174254662954667,0.6477272727272727,0.9638509622240667,1.0,11/44,20.34%,NUP153;SEC13;NUP88;NUP133;DNAJC7;MAPKAPK2;MAPK1;RPA1;HSPH1;CAMK2D;NUP205
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.4355039520228057,0.9172020314431534,0.76,0.9638731874219499,1.0,23/139,17.77%,CSF1;PSMB1;HIF3A;RHBDD1;CDH2;PSMB2;MGAT4A;BTRC;PSMA7;KLHL2;CP;HIF1A;ZBTB16;PSMA4;CST3;FBXL13;RBX1;PSMD14;DCAF5;TULP4;DCUN1D1;FBXO11;FBN1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.5044422325455651,0.9161451554933513,0.654320987654321,0.9656271304815381,1.0,6/18,16.47%,ROBO2;ROBO1;TNFRSF1B;TGFB1;ROCK2;TWIST1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.5539450147810554,0.9161183006966045,0.5769230769230769,0.965159147605694,1.0,2/10,23.52%,MTFR1;DNM2
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5017920109495164,0.9160131647933368,0.6333333333333333,0.9643875531338728,1.0,7/20,24.21%,IL18;SOAT1;ABCA1;SCARB1;RALY;LDLRAP1;ABCA5
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5017920109495164,0.9160131647933368,0.6333333333333333,0.9643875531338728,1.0,7/20,24.21%,IL18;SOAT1;ABCA1;SCARB1;RALY;LDLRAP1;ABCA5
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.43486083199316466,0.9158504294839735,0.65625,0.9642623660742926,1.0,10/73,16.78%,CD44;ZFP36L2;TGFB1;EGFR;PDE8A;FLT1;MAPKAPK2;KDR;ACVR2A;ACVR1B
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.46129847191185525,0.9155858399401537,0.7176470588235294,0.9643315606021579,1.0,2/43,1.68%,SYT1;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.5983614173687186,0.9155641589567769,0.5694444444444444,0.963881195682968,1.0,1/5,6.24%,ADAM17
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.48956041472323997,0.9154172929074533,0.6547619047619048,0.9636987723302431,1.0,3/24,9.46%,ADAMTS9;MGAT4A;HIF1A
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.5462578089708368,-0.9153433424503075,0.6071428571428571,1.0,1.0,2/5,12.27%,PPARD;APOE
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.468604465987192,0.9151889878321742,0.6404494382022472,0.9636475856499501,1.0,12/56,13.67%,PHYHIPL;DHRS3;DCLK1;PTPRD;GFAP;CHL1;PCDH17;SYNDIG1;SHC2;ZNF536;KDR;PTPRZ1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.43351994654594883,0.9150607613190039,0.6767676767676768,0.9633397287737007,1.0,20/125,15.50%,NFKBIA;CCP110;PSMB1;USP15;PSMB2;PSMA7;DESI2;RPS27A;HIF1A;OTUD7A;SMURF2;PSMA4;MDM2;SENP1;MDM4;BRCC3;WDR48;USP10;PSMD14;USP3
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.4238958819064073,0.9145876917312193,0.68,0.9638019611790622,1.0,28/181,17.77%,CSF1;PCMT1;DARS1;RPS21;PAPPA;AGO2;CDH2;FARSB;MGAT4A;ADAM17;SEC11A;CP;RPS27A;RPL21;RPL28;RPL41;GALNT11;CST3;DENND3;RAB12;IGFBP2;SPG7;RPLP2;ADORA2B;MANBA;ABL1;FBXO11;FBN1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.45948466977187175,0.9143396144267671,0.6041666666666666,0.96387117898934,1.0,9/41,17.26%,TENM2;ARPP21;VPS50;ZBTB16;SLC16A7;EFHD1;PLAG1;IGFBP2;SIDT1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.48911493684805574,0.9143030443161091,0.5977011494252874,0.9634381343823238,1.0,5/25,10.70%,HABP4;TGFB1;EGFR;WDR43;GRSF1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.5267841474556173,0.9142112244610726,0.5945945945945946,0.9631362467866325,1.0,5/13,29.08%,C9ORF72;ABL1;MAP1B;CAMSAP1;AKAP13
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.46326649863425345,0.9140939614487079,0.6222222222222222,0.9628398952377568,1.0,7/29,27.53%,MICALL2;TP63;YWHAG;ARIH2;UBE2D3;UBE2L3;PPP3CC
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.5006861093429812,0.9139459398237016,0.6219512195121951,0.962580409793907,1.0,7/18,35.79%,SCD;ELOVL5;SCD5;ELOVL6;ABCD3;ABHD3;GPX4
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.4839484379437745,0.9137970007032616,0.6428571428571429,0.9624517011820386,1.0,10/32,18.62%,NEDD4L;SMURF2;RAB7A;NSF;TIPARP;WWP1;HECW1;CDKN1B;CSNK2A1;AREL1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.4664106757686301,0.9135871250420432,0.6588235294117647,0.9624274794123836,1.0,8/34,12.99%,KCNC2;MYRIP;SLC2A1;SNAP25;IRS1;CLOCK;ACSL4;GLUD1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.605094166957125,0.9135295237473147,0.5921052631578947,0.9620382281092232,1.0,1/5,17.58%,PTPN2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.49746553502870966,-0.9133631887588853,0.5526315789473685,1.0,1.0,1/5,1.59%,BCL2L11
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.6133908633566356,0.9128236535873202,0.6710526315789473,0.9629576855977808,1.0,3/5,24.21%,ABCA1;SCARB1;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4963024102864799,0.9126241273523343,0.6436781609195402,0.9628967738063561,1.0,7/27,15.29%,PSMB1;FHL1;PSMB2;PSMA7;PSMA4;RBX1;PSMD14
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.5907685214178192,0.9123777559200479,0.6338028169014085,0.9629556865810196,1.0,2/5,8.25%,NOS1AP;EGFR
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.4916657415226336,0.9121422380384695,0.6781609195402298,0.9629208600926461,1.0,10/34,28.38%,INTS2;ELL2;INTS8;SP1;CCNK;ELL;POLR2F;INTS4;INTS6;INTS7
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.5671586328392086,0.9119695156511706,0.6142857142857143,0.9627872364618887,1.0,3/6,32.55%,CNIH3;NLGN1;SHISA6
prerank,PanglaoDB_Augmented_2021__B Cells,-0.3760238381081572,-0.9117797882424011,0.5882352941176471,1.0,1.0,1/22,0.19%,WDFY4
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.49150592868764426,0.9117704701122658,0.6813186813186813,0.9626745457221902,1.0,5/30,20.64%,DDX3X;TMBIM6;LGALS3;CSNK2A1;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5415389779483818,0.9113903046410161,0.5789473684210527,0.9630140577100678,1.0,2/9,9.26%,ANK3;GLRX
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.5176762642427362,0.9109781437148299,0.6282051282051282,0.9633324478840405,1.0,1/13,4.14%,WASF1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.48507936682801156,0.9109667071621671,0.6136363636363636,0.9628666563637129,1.0,3/26,15.29%,PRKACA;PSME3IP1;PSMD14
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.4864675917922192,0.9098334435799467,0.7093023255813954,0.9646116219953047,1.0,9/36,16.51%,PSMB1;AP2A1;PSMB2;PSMA7;SMURF2;PSMA4;FZD3;PSMD14;AP2B1
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.37103577522468567,-0.909690738784396,0.6086956521739131,1.0,1.0,4/22,9.38%,VIT;FBLN2;TBCD;CORO1C
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.5120520525080348,0.9093047000826178,0.6410256410256411,0.9652139299257181,1.0,4/18,14.00%,EGFR;CREM;MOV10L1;CCDC91
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.6509724867965357,0.9089137803414334,0.7164179104477612,0.9655927477398734,1.0,2/5,17.58%,FRMD5;PTPN2
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.6270307919185327,0.9086910972798263,0.7222222222222222,0.9654634880792184,1.0,3/6,35.93%,TDG;TERF1;POT1
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.4105756974244852,-0.9086416272721133,0.56,1.0,1.0,4/9,10.96%,SETDB2;TPR;ATF7IP;SETDB1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.5101456022919166,0.908492010779743,0.64,0.9653757831510592,1.0,4/15,10.57%,SEMA4D;ROBO2;ROBO1;SEMA3B
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.6121831079587343,0.9084105715079898,0.6567164179104478,0.9650604563632088,1.0,4/5,37.78%,STK39;NR1H3;KMT2A;SGK1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.446209431530906,0.9075948407475007,0.6086956521739131,0.9661317126507006,1.0,10/55,12.45%,OPA3;PSMB1;PSMB2;SCD;PSMA7;PPARA;SIN3A;SREBF1;ROCK2;PSMA4
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),0.6194340769615295,0.9075822320015048,0.6986301369863014,0.9656457124774732,1.0,1/5,11.02%,SAMD8
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.40512010758481737,-0.9075120578364094,0.5,1.0,1.0,8/21,18.66%,MYL9;ACTB;ACTG1;ILK;ACTN1;MEGF10;FLNA;STXBP3
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.4423763480570676,-0.9067900049063309,0.6111111111111112,1.0,1.0,1/11,0.91%,TARBP1
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.6288572218730837,0.9066897015927361,0.6973684210526315,0.9669791182562497,1.0,3/5,35.93%,TDG;TERF1;POT1
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.304552664988305,-0.9066357764355053,0.8,1.0,1.0,13/51,9.64%,ARHGEF10L;CDC42BPB;GPRC5C;LAMB2;PTPN21;FKBP9;DAG1;BCAM;SUN1;NFE2L1;ARHGEF17;ADCY6;PLXNB2
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.576084417109892,0.9065605164386363,0.6746987951807228,0.966720429895562,1.0,2/10,18.25%,TTN;CSNK2A1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.5994272635486461,0.9064010266979535,0.625,0.9665652465170931,1.0,3/5,35.19%,SMCHD1;HNRNPU;MACROH2A1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.4492524341145881,0.9063684189768467,0.6421052631578947,0.9661212886787852,1.0,5/50,2.97%,CNTN3;PHYHIPL;RHOJ;LSAMP;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.4928603061078277,-0.9063286801067957,0.5172413793103449,1.0,1.0,3/9,16.19%,CAPRIN2;APOE;PSEN1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.47313603919496244,0.9059752026419969,0.6395348837209303,0.9663481758020903,1.0,6/33,13.46%,RHOJ;ADAM17;TGFB1;HIF1A;TMSB4X;KDR
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.583162769943857,0.905636674597592,0.5857142857142857,0.9665902957391261,1.0,4/5,41.10%,GRAMD1A;INSIG2;LRP6;RORA
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.43814168785846647,0.905549291388026,0.6736842105263158,0.9663015496443176,1.0,16/67,17.10%,WWC1;MYDGF;EPHA7;STK4;APIP;EGFR;DUSP1;ULK4;ROCK2;FLT1;FGFR2;TRIM5;KDR;INSR;MAP2K1;MAPK1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.6038385997914077,0.9055323605322112,0.6666666666666666,0.9653646831848091,1.0,2/5,22.62%,ABO;FUT8
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.6038385997914077,0.9055323605322112,0.6666666666666666,0.9653646831848091,1.0,2/5,22.62%,ABO;FUT8
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.4969468924227193,0.9047346690933243,0.6555555555555556,0.9664915512158346,1.0,10/29,26.10%,TGFB1;SNX25;CD9;GRB2;CD81;LDLRAP1;DNM2;ADM;CLTC;AP2M1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.44725825240563966,0.9045921504467594,0.6236559139784946,0.9662651338327816,1.0,8/51,11.77%,NUP153;SEC13;NUP88;ALKBH5;CPSF2;SYMPK;NUP133;FYTTD1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.4332100096347692,-0.9040882291613495,0.42857142857142855,1.0,1.0,5/12,24.25%,ACTN4;MYO1E;MYO1D;SYNE2;MYO1B
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.3101498860539449,-0.9040229904353866,0.5454545454545454,1.0,1.0,6/38,7.44%,POLDIP3;THOC1;CKAP5;RFTN1;CASC3;TPR
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.5487717009683304,0.9037567311421084,0.6619718309859155,0.9674212398854165,1.0,4/10,29.93%,CSNK2A1;IHO1;RAD18;ZNF207
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.5512885657682126,0.903719140797603,0.6666666666666666,0.9670250921351838,1.0,1/11,1.33%,HDAC2
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.5181108376464307,0.9032556752269086,0.6438356164383562,0.9674609638424596,1.0,1/11,5.28%,CSNK1D
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.4944657551963198,0.9031623220281292,0.6666666666666666,0.9671472896150036,1.0,10/25,35.19%,ARID1A;SMARCA4;NAP1L1;SUPT16H;CTCF;ARID2;SETD2;MCM3AP;ANP32B;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.5923457705957944,0.9030992807643732,0.647887323943662,0.9668082903693389,1.0,4/6,36.56%,KDR;RAP1A;EMP2;RAPGEF2
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.4549875396421867,0.9022463455083507,0.6373626373626373,0.9674069707705463,1.0,8/48,11.77%,NUP153;SEC13;NUP88;ALKBH5;CPSF2;SYMPK;NUP133;FYTTD1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.4549875396421867,0.9022463455083507,0.6373626373626373,0.9674069707705463,1.0,8/48,11.77%,NUP153;SEC13;NUP88;ALKBH5;CPSF2;SYMPK;NUP133;FYTTD1
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.4139593837967894,-0.9018446452268085,0.6363636363636364,1.0,1.0,4/11,12.86%,TNIP1;MAP3K1;TRAF6;UBB
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.4555635772406287,-0.9011735813663652,0.5714285714285714,1.0,1.0,3/9,10.96%,MECOM;SETDB2;SETDB1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5208937546497283,0.900895535192991,0.6363636363636364,0.9695006044428146,1.0,3/16,13.86%,CSF1R;IL18;STAT3
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.5976258693839256,0.9008834404109645,0.6721311475409836,0.9690331544595268,1.0,1/6,14.57%,FZD3
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.4715860967288288,0.9005953987803306,0.686046511627907,0.9690981740833143,1.0,7/37,20.21%,NRG1;ADAM17;TGFB1;EGFR;ERBIN;MAPK1;GRB2
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.44276852156581165,0.9004843507134979,0.6526315789473685,0.9688256831060601,1.0,15/57,22.99%,PSMB1;PSMB2;BTRC;NR4A3;PSMA7;PSMA4;PPP3CA;PSMD14;MAPK1;VAV3;SKP1;GRB2;GAB2;TAB2;JUN
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.567664987939556,0.9003140652267883,0.6805555555555556,0.9686454502576397,1.0,4/7,28.65%,OXSR1;STK39;PTK2B;SH2B3
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.49331641381238245,0.900260985799254,0.6266666666666667,0.9682713069787934,1.0,5/21,8.52%,CSMD3;NEDD4L;SEMA4D;ADGRB3;LZTS1
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.5823683203065473,0.9001508474747723,0.7142857142857143,0.9680251670053539,1.0,4/8,27.05%,BCL6;ZBTB1;LEF1;ZMIZ1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.6048708235636839,0.8998453312818284,0.7101449275362319,0.9681619649011485,1.0,1/5,0.42%,CSF1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.5016150795822635,-0.8995966524811776,0.5714285714285714,1.0,1.0,2/7,3.55%,KCNMA1;ATP1B2
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.35962519489009726,-0.8995685610620219,0.6153846153846154,1.0,1.0,6/28,12.74%,A2M;SORBS2;C2ORF72;FAXDC2;ABCA8;C7
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.43220445554376,0.8994953118830519,0.723404255319149,0.9683394254747305,1.0,8/78,10.68%,DARS1;RPS21;AGO2;FARSB;RPS27A;RPL21;RPL28;RPL41
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.570180277207491,0.8992748612369659,0.6923076923076923,0.968333200679893,1.0,3/8,15.34%,PPARA;ABCA1;SCARB1
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.5992307757975086,0.8985897518220087,0.6857142857142857,0.9692797238796577,1.0,1/6,12.72%,FGFR2
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.566857562344373,0.8981768219797016,0.7012987012987013,0.9694920044145258,1.0,1/6,17.28%,ZFPM1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.4146595194275422,0.8980753605889323,0.7311827956989247,0.9691849153317043,1.0,26/93,25.17%,ARL5A;DPP10;SPTBN4;DPP6;ANK3;LRRC7;ATP1B3;LIN7A;DENND4C;EHD2;ROCK2;RAB12;AP3D1;NRXN1;RAB8B;MAP7;WDR19;NLGN1;TM9SF2;CD81;PKP2;GAK;TSPAN5;SH3PXD2B;KCNIP4;PIP5K1A
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.3220963784064659,-0.8979874273797219,0.5833333333333334,1.0,1.0,4/31,4.40%,DAPK2;ATM;FBXL2;PIP4K2B
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.4806583903167707,0.8975001709885776,0.6770833333333334,0.969702264682094,1.0,12/33,28.67%,EPN1;ERRFI1;EGFR;ARHGEF7;MVB12B;PTPN2;GRB2;EPS15;CCDC88A;SH3KBP1;STAM2;RNF115
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.5300886496249233,-0.8973796205780012,0.5714285714285714,1.0,1.0,1/5,0.79%,NRP1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.41719255754081574,-0.8971490675860554,0.56,1.0,1.0,4/19,13.60%,PER2;HOOK3;SNW1;HEYL
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.567989044254876,0.8970119569227838,0.6290322580645161,0.9701936732533522,1.0,4/6,40.46%,TRIM5;CD55;PRKCA;SASH1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.49295580174149395,0.8968519146797728,0.6973684210526315,0.9699629260881204,1.0,2/17,5.68%,RHOB;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.39791649573141186,-0.8968512061423692,0.631578947368421,1.0,1.0,3/15,6.46%,RPS3;CKAP5;HSPA1A
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.5876228259361542,0.8967711164172489,0.6266666666666667,0.9696257377061893,1.0,3/6,33.30%,AHCYL1;VMP1;PDZD8
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.49232281949518186,0.8967560797826397,0.7045454545454546,0.969167036319198,1.0,9/35,30.75%,COG7;ARFGAP3;NSF;ARF4;ATP9B;GOLPH3;RAB6A;COG3;SURF4
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.5193852534002307,-0.8963922380473578,0.6129032258064516,1.0,1.0,2/6,10.25%,TPR;IWS1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.5193852534002307,-0.8963922380473578,0.6129032258064516,1.0,1.0,2/6,10.25%,TPR;IWS1
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.5355865988719892,0.8962166524130297,0.6103896103896104,0.9696171348199861,1.0,2/8,13.31%,ZC3H12B;CSTF3
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.45217679888396217,0.8959511084528993,0.6666666666666666,0.9697015999169332,1.0,11/46,18.62%,NEDD4L;TNFRSF1B;SMURF2;RAB7A;NSF;TIPARP;WWP1;HECW1;CDKN1B;CSNK2A1;AREL1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.47668920197493525,-0.8959097981676655,0.48,1.0,1.0,3/9,8.28%,WNT5B;TIAM1;GPC3
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.48358054095767955,-0.8956392679176517,0.6451612903225806,1.0,1.0,4/9,8.12%,ACTA2;MYH11;MYLK;EDNRA
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.5708350005416941,0.8954141837796257,0.6805555555555556,0.9701560526606491,1.0,1/8,5.58%,SCD
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.4571083385013999,-0.895244546353034,0.6,0.9996601963712048,1.0,1/8,3.06%,ZDHHC21
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.4217552031314578,0.89522082306571,0.74,0.9700425539545958,1.0,19/121,15.50%,NFKBIA;CCP110;PSMB1;USP15;PSMB2;PSMA7;DESI2;RPS27A;HIF1A;OTUD7A;SMURF2;PSMA4;MDM2;MDM4;BRCC3;WDR48;USP10;PSMD14;USP3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.49109523375081454,0.8951801422350667,0.6823529411764706,0.9696354314569527,1.0,7/26,15.29%,PSMB1;FHL1;PSMB2;PSMA7;PSMA4;RBX1;PSMD14
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.5683627958862285,0.8951158003733418,0.6857142857142857,0.969269209516948,1.0,5/10,37.62%,SIAH1;BNIP3;APP;NAE1;TNFRSF21
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.4700284815134806,0.8947365881665514,0.6588235294117647,0.9694447066010807,1.0,10/27,25.26%,ZC3H7B;ZC3H7A;RBM4B;PER1;METAP1;MAPKAPK5;METTL16;CYFIP1;PUM3;FOXO3
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.4889764174472243,0.894723392530706,0.6704545454545454,0.9689929768770001,1.0,6/26,15.29%,PSMB1;PSMB2;PSMA7;RPS27A;PSMA4;PSMD14
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.3451489001244442,-0.8944224761153775,0.5714285714285714,0.9995062484685127,1.0,4/37,2.90%,NET1;NRP1;ARHGEF3;RALBP1
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.5501289372524516,0.8943053881536478,0.6521739130434783,0.9692796327188599,1.0,1/9,1.65%,KCNC2
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.5029945330824134,0.893798568566838,0.6341463414634146,0.9698691146923963,1.0,6/21,29.85%,ACOT11;AK3;LRRK2;ACBD6;BPNT2;ACSF2
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.5836832721885848,0.8937811074764572,0.7285714285714285,0.9693926004209068,1.0,4/6,38.68%,AP3D1;DNM2;SNAP91;DNM3
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.3972227138524706,-0.893679762750538,0.6842105263157895,0.9991967783646083,1.0,2/16,5.36%,FGF13;CKAP5
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.5714129887281689,0.8924452740693477,0.6521739130434783,0.9714399764644489,1.0,3/6,28.15%,PRKCB;VMP1;ZDHHC17
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.5321540262670956,0.8923160758095522,0.6962025316455697,0.9712052836307423,1.0,3/13,7.68%,ROBO2;ROBO1;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),0.5191813057272128,0.8922946709205218,0.6829268292682927,0.9707943594478688,1.0,7/16,35.93%,SMCHD1;TP53BP1;POLR2F;SHLD2;ZRANB3;TERF1;POT1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.48667655227932294,0.8922591924553636,0.6794871794871795,0.9703838425238485,1.0,3/23,2.66%,ADGRV1;DHRS3;OPA3
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.5726152299273886,0.8920552846570979,0.6521739130434783,0.9701802425301206,1.0,2/6,27.72%,TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.5059324334587384,0.8919646887630777,0.72,0.9699063633251115,1.0,5/18,21.00%,APIP;SOD2;GOLGA2;RYR3;ALDH1A2
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.4440808434085664,0.8916131236706251,0.7368421052631579,0.9700353032746842,1.0,10/59,18.35%,CDC42EP4;FKBP5;SMARCA1;SLC7A2;ERRFI1;EGFR;PRLR;TEAD1;LGR4;CHKA
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.5893883494579691,0.891569356076855,0.7638888888888888,0.9696662087538138,1.0,1/7,1.11%,MMUT
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.5655088795296452,-0.8914698943956423,0.7,1.0,1.0,4/6,13.25%,VIT;PKD2;PKD1;GLI2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.56556946048629,0.89125273849462,0.6486486486486487,0.9697599518033789,1.0,4/7,37.47%,TNKS;XRCC5;POT1;ATR
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.509236527322249,0.8912095231791825,0.6329113924050633,0.9693913580436319,1.0,5/17,25.79%,RAB27A;WASHC5;EEA1;WASHC4;USP8
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.3899467409770104,-0.8911409934302088,0.5,1.0,1.0,4/29,6.71%,ZDHHC15;ZDHHC21;ARL6;RFTN1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.5671272596792982,0.890935787283111,0.6666666666666666,0.96892129208086,1.0,4/6,32.98%,PPP3CA;PPP3CC;NFAT5;PPP3CB
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.5671272596792982,0.890935787283111,0.6666666666666666,0.96892129208086,1.0,4/6,32.98%,PPP3CA;PPP3CC;NFAT5;PPP3CB
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.4415672893726416,0.8907974506250985,0.6923076923076923,0.9686740645603339,1.0,5/48,13.30%,DDX3X;TBK1;SERINC3;ANKRD17;TRIM5
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.5040518338244359,0.8905319094740597,0.7411764705882353,0.9686276601815933,1.0,1/21,1.40%,TRMT9B
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.464321122390844,0.8902250782467136,0.6111111111111112,0.9687216378739749,1.0,7/37,19.33%,CAMKMT;EFNB2;BCL6;TMSB4X;TRIM5;AREL1;METAP1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.463523641683373,0.8901502951828966,0.7526881720430108,0.968369673667048,1.0,11/65,14.52%,LPIN1;ATP6V1G1;ATP6V1H;PRKCI;SELENOS;ATP6V1E1;IRS1;DENND4C;RAB12;PDK4;INSR
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4680002860820636,0.8899525518652276,0.6941176470588235,0.9683184806285914,1.0,7/36,19.76%,TBC1D20;IFT140;CAPZB;DCDC2;TBC1D15;TBC1D8;TBC1D5
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.579771230504696,0.8897724427534957,0.7014925373134329,0.9682373103040136,1.0,5/10,18.05%,PPARA;HIF1A;STAT3;PDCD4;PER1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.5723243461147164,0.8894723853984149,0.7361111111111112,0.9683362972492338,1.0,2/6,31.78%,RAB11A;DLG1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.5540851646506395,0.889459600632324,0.7073170731707317,0.9678952202119369,1.0,2/10,13.12%,KDM1A;MDM2
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.5769562510809343,-0.8881007047719619,0.6764705882352942,1.0,1.0,2/5,6.46%,NCK1;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.585841429336089,0.8880891852235699,0.7,0.9701380915142382,1.0,1/7,27.30%,UBQLN1
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.43128251840775417,-0.8880819502632725,0.5652173913043478,1.0,1.0,2/9,11.63%,NSFL1C;CHMP4B
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.4213508241679297,0.8880337065781267,0.7755102040816326,0.96974151580652,1.0,32/161,20.63%,CSF1;PRKACA;ZFP36L2;CSF1R;IL18;TNFRSF1B;TBK1;TGFB1;DUSP1;RPS27A;HIF1A;F3;OXSR1;PRLR;BCL6;TANK;CEBPD;AKAP6;PTPRZ1;STAT3;PTPN9;USP10;ERBIN;TWIST1;STK39;CDKN1B;PTPN2;LIFR;JUNB;ABL2;GRB2;GAB2
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.5802295305239794,0.8878706025184402,0.6521739130434783,0.9695999381935256,1.0,2/5,19.41%,NRXN1;NLGN1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.53728348304517,-0.8878036887025185,0.6451612903225806,1.0,1.0,1/5,9.79%,EXT2
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.4699643862318678,0.8876015750849968,0.6511627906976745,0.9695882363533235,1.0,5/25,12.64%,HSPA4L;PTPN1;RHBDD1;TMBIM6;HSPA5
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.41713376333991586,0.887577339048977,0.7070707070707071,0.9691576017828768,1.0,25/110,25.76%,IFT52;CCP110;ACTR3;LZTFL1;IFT140;NUDCD3;TRAF3IP1;EHD2;EXOC1;GALNT11;TTC8;DCDC2;MAK;ARF4;RAB8B;WDR19;ASAP1;RTTN;SEPTIN7;ARMC9;CEP290;ARMC2;RFX3;ATP6V1D;RAB3IP
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.443279014051704,0.8874970424173327,0.6947368421052632,0.9688071491828911,1.0,13/64,15.29%,PSMB1;CD38;PDE4B;PSMB2;RC3H2;BTRC;PSMA7;PRKCB;PAG1;NFKBIZ;PSMA4;PDE4D;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.5231994132886408,0.8873691010677754,0.6266666666666667,0.9685417432402854,1.0,1/7,6.40%,XPO4
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.4838017670512124,0.8870528790774839,0.6666666666666666,0.9686301846128962,1.0,10/24,32.07%,CD9;GRB2;CD81;LDLRAP1;DNM2;ADM;CLTC;AP2M1;RAB31;NEDD4
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.33774052773124674,-0.8867191781647025,0.7692307692307693,1.0,1.0,3/34,4.67%,CDK6;CUL2;CACUL1
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.4306813825095985,0.8866996746757253,0.7422680412371134,0.9688131150621552,1.0,16/99,15.37%,ADAMTS9;LSAMP;NCEH1;DGKI;NIBAN2;SMARCA1;ATL2;GRIK2;DUSP1;C1R;CFH;ABCA1;KDR;PAPSS2;PDK4;GNAI1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5368515880408098,0.8861916645824884,0.6567164179104478,0.9692595537552808,1.0,4/12,17.58%,SEMA4D;SH3BP5;NF2;PTPN2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.31183173793625785,-0.8861199576330986,0.6,0.999881490199056,1.0,5/41,7.19%,NRP1;PGF;MAPK14;NCK1;WASF2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.5852699397573866,0.8859268988995244,0.6712328767123288,0.9692182216294283,1.0,4/6,38.10%,NBDY;CNOT1;CNOT2;ATXN2
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.4455908647648023,0.8858821554312618,0.6555555555555556,0.9688439152836904,1.0,8/50,11.77%,NUP153;SEC13;NUP88;ALKBH5;CPSF2;SYMPK;NUP133;FYTTD1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.4212820936084265,0.8855500505333606,0.7525773195876289,0.968927025073097,1.0,15/109,16.60%,RPS21;ETF1;RC3H2;RPS27A;RPL21;CNOT8;NBDY;RPL28;RPL41;CSDE1;TUT7;DCP2;PABPC1;RPLP2;DCP1A
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5540189045811983,0.8853324593170907,0.6615384615384615,0.9688809503462421,1.0,4/9,26.08%,ROCK2;LGALS3;BOD1L1;MGAT5
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.4662248624594908,0.8850154656572307,0.6704545454545454,0.9689540347581639,1.0,5/31,9.59%,CDH2;ROBO2;ROBO1;KIF13B;OMG
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.49570621629340006,-0.8843454097800131,0.56,1.0,1.0,3/9,11.90%,SLC8B1;MCU;AFG3L2
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.4528229157899153,0.8838297467068333,0.6867469879518072,0.9709617088662065,1.0,4/31,6.54%,KDM1A;PTPRD;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.49930969397907343,-0.8837264658064923,0.5333333333333333,1.0,1.0,3/5,12.96%,MAPK14;RIPOR2;FLOT1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.588314919163923,0.8836810775118162,0.6301369863013698,0.9703127024807372,1.0,1/6,7.25%,ACOT11
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.588314919163923,0.8836810775118162,0.6301369863013698,0.9703127024807372,1.0,1/6,7.25%,ACOT11
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5711331101759329,0.8835186290982222,0.6578947368421053,0.9701372760863236,1.0,1/5,17.58%,PTPN2
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.5972699841931992,0.8834404594097585,0.6865671641791045,0.9698035882272502,1.0,2/5,17.24%,INSR;PRNP
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.5297792689079786,0.8832181720464146,0.6987951807228916,0.9696978607008742,1.0,5/16,20.90%,MBP;SBF2;ACER3;NF1;PLP1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.4150567127746633,0.8832002114924022,0.7157894736842105,0.9692460025427755,1.0,17/77,16.78%,GJA1;BASP1;AGO2;NIBAN2;CCN2;ZBTB16;CEBPB;SPIRE1;SMURF2;ARHGEF7;TAPT1;KDR;INSR;TP53BP1;NRXN1;CFL1;ACVR1B
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.5721167948837935,0.8830454217479201,0.6351351351351351,0.9690714358496333,1.0,4/7,29.02%,IMMP1L;SPG7;PMPCB;MIPEP
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.5651364276428578,0.8830334015042652,0.6865671641791045,0.9686252625861314,1.0,2/6,12.08%,SIN3A;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.38206818672207005,-0.8827096487076415,0.6428571428571429,1.0,1.0,6/26,10.86%,VIT;ATM;FBLN2;ZFHX3;MAGI1;CXCL12
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.5745569097447476,0.8823156114474583,0.6617647058823529,0.9694784759955346,1.0,2/9,18.70%,MDM4;SMAD2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.4376038295221946,0.8822633261626227,0.7419354838709677,0.9691312700837953,1.0,11/58,22.54%,PLAA;WIPI1;LIX1L;AMBRA1;VTA1;ATG4B;CSNK2A1;MAP1LC3B;TBC1D5;VPS39;LAMP2
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.49053650330227605,0.8822579428014913,0.7023809523809523,0.9686610462749239,1.0,5/19,17.00%,SIK2;SZT2;HSPA5;SESN1;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.41396258741681513,0.8821918884528909,0.7346938775510204,0.9683145735550098,1.0,31/112,23.60%,KLF2;GRIN1;ITGA5;RIMS2;ROBO1;PRKCI;TP63;PRKCB;CTBP2;IRS1;HIF1A;F3;TTC23;FGFR2;DCDC2;STAT3;LRRK2;NRXN1;ZDHHC5;CSNK2A1;RBPJ;SMARCA4;LOXL3;NLGN1;KANK1;ITGAV;ARMC9;AXL;MT3;TSPAN5;EVC
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.5784558357700466,0.8813564005158802,0.6621621621621622,0.9693338831740198,1.0,1/6,2.68%,NEDD4L
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.5391622306458719,0.8811338682029628,0.6933333333333334,0.9692534793454892,1.0,3/12,29.93%,NCKAP5;CLIP1;ZNF207
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5184613642579691,0.8810922820910753,0.6506024096385542,0.968862901365467,1.0,3/13,5.68%,CSF1;AKIRIN1;CSF1R
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.49134354890965454,-0.8807637986354717,0.5384615384615384,1.0,1.0,3/9,13.09%,RYR2;PKD2;ITPR1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.48357386734041247,0.8799325533662811,0.675,0.9705105136699229,1.0,2/15,13.67%,TNFRSF1B;PTPRZ1
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.53266065504462,0.8793600235999706,0.6746987951807228,0.9710544808205293,1.0,2/12,13.12%,KDM1A;MDM2
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.4616439669003446,0.8791823888728886,0.7692307692307693,0.9709045556239583,1.0,7/39,16.63%,DPP10;PRKCI;TGFB1;EGFR;PTPN9;LGALS3;ZDHHC5
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.29626075361914195,-0.8791180483475755,0.8571428571428571,1.0,1.0,8/57,6.98%,FAT1;TNFRSF19;FOXQ1;CDC42BPB;PPARD;DZIP1;PTPN21;C2ORF72
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.5120214793014584,0.8789909916504429,0.6463414634146342,0.9707646055816737,1.0,2/13,3.32%,DPP10;DPP6
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.4787974941193295,0.8785390696877143,0.686046511627907,0.971194668603125,1.0,2/25,5.68%,CSF1;CSF1R
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4713339732710281,0.8782378096335073,0.6962025316455697,0.971314963127942,1.0,10/30,23.28%,PHF20L1;APBB1;MORF4L1;EP400;BRD1;PHF20;PER1;JADE2;LEF1;YEATS2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.42695722439989925,0.8782127090016729,0.75,0.9709050777514081,1.0,20/56,29.15%,MICALL2;CSF1R;STMN1;VAPA;UHMK1;CNTNAP2;NLGN1;GPM6A;PLP1;PTPRM;CYFIP1;ARMC2;CNTN4;GPM6B;ATXN10;CAMSAP1;PLEKHA1;ZFYVE27;HDGFL3;RAB11A
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.4912273504699226,0.8781491845498458,0.7529411764705882,0.9705593610220596,1.0,6/20,16.88%,SLC22A6;MGST1;SLCO1A2;SLC4A10;SLC25A4;CA2
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.425703978701492,0.8774565187120866,0.71875,0.9714201809002,1.0,11/52,13.52%,RHOB;NRG1;RAF1;CSF1R;DIAPH1;FRMD5;TGFB1;EGFR;ROCK2;TMSB4X;SLK
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.4137930625849665,-0.877406650006606,0.6666666666666666,1.0,1.0,1/10,1.43%,PHLDB2
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.529048707454354,-0.8769306906275857,0.6666666666666666,1.0,1.0,2/6,11.79%,ACACA;ACAT1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.423978125932231,0.8768650288460064,0.6979166666666666,0.9720057205533497,1.0,14/54,23.31%,TSC2;BTRC;NXN;CTNND2;RUNX1;FGFR2;DCDC2;LRRK2;CBFB;CSNK2A1;SMARCA4;KANK1;NLK;SENP2
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.41005574570055625,0.8767255141919363,0.7446808510638298,0.9718020309400168,1.0,18/89,15.59%,MYDGF;DDX3X;CAMKK2;NOS1AP;CSNK1D;CSF1R;SEMA4D;ADAM17;STK4;TGFB1;EGFR;SYMPK;ROCK2;PDE8A;KDR;LRRK2;INSR;ACVR2A
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.46591352895717186,0.8761275002198378,0.6813186813186813,0.9725532931332138,1.0,7/28,20.77%,CCT4;HNRNPC;DCP2;TNKS;MAPK1;CCT3;MAPKAPK5
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5121836587595193,0.8759253594647649,0.7045454545454546,0.9724474125886475,1.0,4/12,23.10%,PDE4DIP;MAP2K1;MAPK1;USP6NL
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.4722280836030472,0.8756574860950256,0.6590909090909091,0.9724981610302711,1.0,12/25,26.93%,CDH2;TGFB1;EFNB2;FLT1;KDR;RBPJ;NF1;SMAD7;ADM;SLC1A1;COL4A1;VEGFA
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.5086249953918626,0.8756110159692216,0.6790123456790124,0.9720990615330328,1.0,2/15,4.97%,STC1;PDE4B
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.4130241006983048,0.875293898519932,0.84,0.9722085698579443,1.0,33/217,18.25%,WWC1;TAF7;RHOB;HDAC2;NFKBIA;RHOJ;DDIT4;WWC2;ARHGAP31;ARHGEF9;STK4;ARHGAP15;TP63;FAM13A;MCF2L;EGFR;RNF34;ULK4;TMSB4X;ARHGEF7;MDM2;MDM4;AKAP6;MAP2K6;LRRK2;GNAI1;NF2;ARHGEF4;MAPK1;RPA1;PHF20;VAV3;CSNK2A1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.45813488128156377,0.8750258507893404,0.6989247311827957,0.9721274804301004,1.0,12/33,26.72%,ANK3;GGA3;EXOC1;NSF;PREPL;STXBP6;GOPC;BLZF1;VAMP5;GOLGA4;GGA2;OSBPL5
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.445599144966643,0.8748158428324567,0.7444444444444445,0.9721245821349765,1.0,7/47,14.26%,HABP4;DDX3X;AGO2;ELAVL1;CDC123;UHMK1;METTL14
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5109525197621548,0.8744243356824238,0.65,0.9722973571534033,1.0,5/13,27.57%,HIF1A;DCUN1D1;ZMIZ1;UBQLN1;DCUN1D2
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.5535570431332111,0.8744055014667567,0.6756756756756757,0.9718505370721066,1.0,2/9,13.57%,ENO1;MYL3
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.5346909474110697,0.8740366361828682,0.6351351351351351,0.9720622782795679,1.0,6/9,35.76%,CNOT8;PRR5L;CNOT1;ZC3HAV1;PNPT1;RC3H1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.5570269270499849,-0.873807281889916,0.6451612903225806,1.0,1.0,1/5,0.19%,WDFY4
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.529813708312439,0.8734276537643672,0.6447368421052632,0.9726100344269174,1.0,4/14,28.46%,CRY1;ABL1;WRNIP1;MCL1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.5527006289746658,0.873301426226606,0.6619718309859155,0.9723828740769582,1.0,2/6,17.28%,TTN;ZFPM1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.5653633555667754,0.8730376797295332,0.7261904761904762,0.9719681313375181,1.0,1/8,9.16%,RAP1B
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5653633555667754,0.8730376797295332,0.7261904761904762,0.9719681313375181,1.0,1/8,9.16%,RAP1B
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.516101970964477,0.8728792763338281,0.7397260273972602,0.9718631889129303,1.0,2/12,11.29%,XPO4;UHMK1
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.5517069396849767,0.8727825611154862,0.7428571428571429,0.971583348063868,1.0,1/7,17.28%,ZFPM1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.5711509238371771,0.8726177053737603,0.7066666666666667,0.9714398197304521,1.0,4/7,29.13%,WNT2B;CSDE1;LHFPL2;KITLG
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.578351241816804,0.8725824574551823,0.6857142857142857,0.9710147553348311,1.0,4/6,39.25%,PHKB;PYGB;RB1CC1;AGL
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.4865990890844478,0.8722102472712449,0.6410256410256411,0.9712405482017709,1.0,4/12,26.72%,PLAAT3;LPCAT3;SERINC1;OSBPL5
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.4227306732279816,0.8710063096607126,0.7096774193548387,0.9728731474947072,1.0,16/71,21.38%,PPP1CC;PTPRD;PTPN1;SSH1;PPP2R1B;BTRC;DUSP1;PTPRE;PTPRZ1;PTPN9;PPP3CA;PTPN2;PPM1E;UBASH3B;MTMR2;PTPRM
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5202188283638117,0.870556177171457,0.7236842105263158,0.9731754305727609,1.0,2/13,14.45%,PPARA;PDK4
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.4063582558729519,0.8700578447432014,0.7551020408163265,0.9734919670109583,1.0,25/97,21.56%,TSC2;PTPN1;DDIT4;SUFU;CRY1;NIBAN2;BTRC;PRKCB;EGFR;NXN;IRS1;TMBIM6;PTPRE;SIAH1;LRRK2;BRAP;MGRN1;ZBTB7A;LGR4;PTPN2;CSNK2A1;KANK1;UBASH3B;MTMR2;NLK
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.40474521103246563,-0.8700374678565773,0.5238095238095238,1.0,1.0,3/11,12.45%,BAIAP2L2;PLS3;ADD1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.41332536430102323,0.8699266632495063,0.7474747474747475,0.9732510423520558,1.0,22/76,32.35%,RPS21;ETF1;RPS27A;RPL21;RPL28;RPL41;PABPC1;RPLP2;DCP1A;RPL9;RPL18;UPF3A;RPS14;RPL27A;SMG7;RPL13A;UPF2;PPP2R2A;RPL32;RPL31;RPS2;RPL34
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.5623626646168085,0.8697615961327086,0.704225352112676,0.9730636152837987,1.0,1/7,12.08%,TMSB4X
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.459471350730125,0.8692974676351606,0.7176470588235294,0.9733942737218589,1.0,4/25,7.11%,SLC22A6;TACC2;DCDC1;ALDH1L1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.48308327582738,0.8690746735902619,0.6666666666666666,0.9732601743005115,1.0,9/24,21.67%,NRCAM;DNER;CDH2;KIRREL3;FARP1;NRXN1;NLGN1;GPM6A;GABRB3
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.5477274027289578,0.8688620408502856,0.7532467532467533,0.9732084084604077,1.0,3/9,13.41%,ANK3;TMSB4X;AKAP6
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5201439851562791,0.8687849528821159,0.7317073170731707,0.972924690947243,1.0,2/10,14.08%,CEBPB;TNFRSF10B
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.4382986155851604,0.8685681183586572,0.6395348837209303,0.9728344852210268,1.0,4/24,6.19%,WASF3;MICALL2;WASF1;DIAPH1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5342131273172382,0.8684794734881118,0.6962025316455697,0.9725705297429598,1.0,1/9,8.74%,MED14
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.45461355075515625,0.8681059144705149,0.7411764705882353,0.9726205453542465,1.0,7/42,19.76%,TBC1D20;IFT140;DCDC2;C9ORF72;TBC1D15;TBC1D8;TBC1D5
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5106491354503293,0.8679475093772545,0.6823529411764706,0.9724003594198396,1.0,4/13,16.88%,TMEM165;SLC4A10;LRRK2;CA2
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.5185661833893703,-0.8674211256482109,0.5333333333333333,1.0,1.0,1/6,0.38%,EYS
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.47540430628191466,0.8672232900437478,0.7,0.9732411987071572,1.0,4/26,12.26%,DDX3X;ADAM17;EGFR;ANKRD17
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.5592452555293497,0.867026310906884,0.6753246753246753,0.9731606959499912,1.0,3/7,40.36%,TGFBR1;BMPR1A;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.45889446334630435,0.8670086269770925,0.7261904761904762,0.9727093354800124,1.0,3/24,13.57%,TOR1AIP2;ATP1B3;MYL3
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.545441766099178,0.8667880752005243,0.717948717948718,0.9725713802634675,1.0,3/7,13.27%,HNRNPC;ELAVL1;MAPKAPK2
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.5962769204885718,0.8667807590927917,0.6805555555555556,0.9721159131511384,1.0,3/5,32.34%,TCF4;SETD2;MCM3AP
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.44121307469303106,-0.8663984831412749,0.6666666666666666,1.0,1.0,2/9,7.23%,YWHAB;TIPRL
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.4818474539665244,0.8659206338705863,0.6746987951807228,0.9731136443603787,1.0,4/16,12.56%,GNPAT;AGK;SAMD8;AGPAT4
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.5066837045225857,0.8654009328623776,0.7215189873417721,0.9735526793028257,1.0,3/12,23.52%,MTFR1;WASHC5;DNM2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5241152865049412,0.8653441024635893,0.7294117647058823,0.9731742892476316,1.0,1/10,11.89%,SPIRE1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.4822912099259322,0.8651669398956433,0.6904761904761905,0.9730460475720125,1.0,5/22,18.35%,LPIN1;PLAAT3;LPCAT3;CSNK2A1;CHKA
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.47329047865353635,0.8650756192035636,0.7701149425287356,0.9727450764792552,1.0,13/36,24.21%,ARRDC2;SLC22A6;SLCO1A2;RAB7A;ABCA1;RUFY1;CHKA;SNX4;CMTM6;PEX3;SLC22A2;CEP290;ABCA5
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.4358229122338468,0.8646694847341994,0.7261904761904762,0.9730778755774533,1.0,4/36,10.35%,MID1;EIF2AK2;SDCBP;CCN2
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.45222085784473687,0.8637989468718612,0.6966292134831461,0.9740579386426278,1.0,10/34,24.80%,CD44;ZFP36L2;HNRNPF;FGFR2;CEP57;MAPK1;GRB2;POLR2F;HNRNPM;SPRED1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.48180520703061164,0.8635480678100331,0.6883116883116883,0.9739726737065278,1.0,4/17,10.57%,EPHA7;SEMA4D;ROBO1;SEMA3B
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.4593343453330834,0.8630327534511738,0.7303370786516854,0.9743667243788731,1.0,5/23,15.67%,BASP1;MBP;HSPA5;GLUD1;CKB
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.48291149556305446,0.8629336532122038,0.7471264367816092,0.9741041608009332,1.0,6/18,24.09%,ADAM17;PRKCB;ZBTB7A;PTPN2;KLF6;DCAF1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.46207425175383937,-0.8628188847934658,0.6521739130434783,1.0,1.0,4/7,20.44%,ACTB;STX8;APPL1;ZDHHC2
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.505339628814017,-0.8626815956355404,0.625,1.0,1.0,3/8,20.40%,CDC42;OPHN1;RAP2A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5239293873047497,0.8626035503431981,0.6885245901639344,0.9742344473284451,1.0,4/10,26.93%,NEXMIF;RGCC;TJP1;VEGFA
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.5577286067933311,0.8624825743814639,0.6962025316455697,0.973924337249367,1.0,3/7,38.39%,AHCYL1;PAPOLA;NCBP1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.45945587689380357,0.862058794083616,0.7840909090909091,0.9741933025332095,1.0,5/27,13.12%,RHOB;KDM1A;CLOCK;TANK;MDM2
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.4322788259113199,0.8618404375817958,0.776595744680851,0.9741273388257771,1.0,10/60,15.67%,NRG1;SPTBN4;DNER;HOMER2;IFT140;SGPL1;TRAF3IP1;ARFGEF3;DCDC2;CKB
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4709755332659492,0.8617880563816532,0.6956521739130435,0.9737747067032437,1.0,6/26,17.23%,ARID3A;CNOT8;WAC;MDM2;MDM4;CDKN1B
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.4314994630609555,-0.8615640701993863,0.5,1.0,1.0,2/9,11.63%,CENATAC;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.46408234525841263,0.8608243247143388,0.7023809523809523,0.9750225653533404,1.0,3/25,7.81%,CCT4;IPO5;TGFB1
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.5670645354581405,0.8605013173979648,0.7536231884057971,0.9751090845236083,1.0,3/5,41.40%,SARS1;SSB;AARS1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.5406376379065123,0.8598581420565272,0.6857142857142857,0.9751197036521149,1.0,2/10,14.52%,HIF1A;INSR
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.5406376379065123,0.8598581420565272,0.6857142857142857,0.9751197036521149,1.0,2/10,14.52%,HIF1A;INSR
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.4862963699103547,0.8597010355899668,0.7307692307692307,0.9749009267613378,1.0,6/19,23.52%,VAPA;NSF;NAPG;SNAP23;USO1;DNM2
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.5428087820676599,0.8595151780609307,0.7121212121212122,0.9748062554110979,1.0,3/6,29.52%,SLC1A2;SLC1A1;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.4610646498187152,0.8594077658233443,0.6829268292682927,0.9745497249028606,1.0,5/25,17.28%,NR4A3;SIN3A;RUNX1;CBFB;ZFPM1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.5361829117232222,0.8592088905932668,0.726027397260274,0.9743934143717671,1.0,3/9,22.35%,ZBTB16;TAPT1;TRPS1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.44129895943536657,-0.8586721497047313,0.7619047619047619,1.0,1.0,1/10,0.40%,IL34
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.5027880141949014,-0.8586613121955672,0.6551724137931034,1.0,1.0,1/6,1.14%,PLA2G4C
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.46010887543924134,-0.8582993426328555,0.6,1.0,1.0,1/6,0.82%,CD4
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5122760856902557,0.8581152724425885,0.6666666666666666,0.9755792074908302,1.0,2/15,11.05%,CNOT8;TUT7
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5622362517767788,0.8577948033306915,0.8169014084507042,0.9756698990541817,1.0,3/8,26.66%,RPS27A;RPA1;POLK
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.5887271143965558,0.8570727829856083,0.75,0.9764546284464706,1.0,1/5,5.77%,RUBCN
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.4998143429593253,-0.8570301031843962,0.6666666666666666,1.0,1.0,1/5,12.96%,FLOT1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.5786842460764307,0.8563040836714829,0.7702702702702703,0.977300401005151,1.0,4/7,32.63%,INSR;BNIP3;FYCO1;SETX
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.47994866790362023,-0.8561495187677424,0.6,1.0,1.0,1/6,1.97%,PARP9
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.496903104907072,0.855923421851925,0.7368421052631579,0.9775136569783673,1.0,1/15,2.39%,KDM1A
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.43259945602896316,0.8554482158276406,0.7708333333333334,0.9777741898923767,1.0,8/62,11.08%,TAF7;NR4A3;PPARA;ESR2;NRBP1;CCN2;PPARGC1A;CCNH
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.5229569953002542,0.8547975177346616,0.7058823529411765,0.9784995279307891,1.0,4/12,19.68%,CTR9;RNF168;WAC;SKP1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.4871118398192539,0.8547111324984453,0.726027397260274,0.9781569744783493,1.0,7/11,30.90%,VAPA;PRNP;TRAM1;ALDH3A2;TRAM2;EMC3;APP
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.3386427339685168,-0.8541604106377074,0.625,1.0,1.0,5/37,7.57%,SPRY1;PHLDB2;TIAM1;DAG1;EPHA3
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.5221474904216489,-0.8538117096347315,0.59375,1.0,1.0,2/5,3.66%,BCL2L11;RHOT1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.37794508786441494,-0.8531473381369781,0.46153846153846156,1.0,1.0,2/19,1.59%,DAPK2;BCL2L11
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.4590430015693606,0.8525227562530617,0.7093023255813954,0.9814652841865263,1.0,2/18,1.80%,PLAA;GNPAT
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.5694480779847049,0.8523562413163555,0.75,0.981311218258387,1.0,2/5,12.53%,PPARA;ABCA1
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.4181241030659978,0.8519959039436047,0.7157894736842105,0.9813893867762504,1.0,14/56,22.99%,PSMB1;PSMB2;BTRC;PSMA7;PSMA4;PPP3CA;PSMD14;MAPK1;VAV3;SKP1;GRB2;GAB2;TAB2;JUN
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.422062754867342,0.8518986565959717,0.7204301075268817,0.9810982036431783,1.0,18/57,28.42%,PRKACA;NRG1;IL18;STK4;PRLR;TNFRSF10B;INSR;ABL1;PRKAR2A;MT3;TAOK3;CCDC88A;TOM1L1;VEGFA;PTK2B;PRKAR1A;PAK1;ADCY5
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.5406851966404378,0.8515737752529677,0.7397260273972602,0.9811385414036103,1.0,3/7,21.53%,ACVR2A;ACVR1B;SMAD7
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.3953654527865443,-0.8511567162445177,0.631578947368421,1.0,1.0,2/13,4.65%,PPP1CB;PER2
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.5296359177910939,0.851057915980255,0.7037037037037037,0.9815383171127998,1.0,2/8,20.39%,SEMA4D;BOD1L1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.46216694788079526,0.8506631092321782,0.7472527472527473,0.9816256901731548,1.0,13/39,21.56%,TBK1;OXSR1;GALNT11;ROCK2;LRRK2;TNKS;MAP2K1;ACVR1B;MAPK1;STK39;CSNK2A1;CAMK2D;NLK
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.5363516343830952,0.8504783208098216,0.7142857142857143,0.9814578026250548,1.0,2/7,27.72%,TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.4790973933875665,0.8500235316148697,0.6835443037974683,0.9818238095503442,1.0,8/18,27.72%,KDM1A;SMCHD1;TP53BP1;WDR48;ARID2;SPIDR;SETD2;SHLD2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.45964082901996606,0.8499704696166875,0.7058823529411765,0.9814624184773172,1.0,3/23,11.28%,PRKACA;ATP1B3;ABCC9
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.43313588737927033,0.849907423814558,0.7634408602150538,0.981096643835953,1.0,15/39,27.57%,CRY1;NDFIP2;DCUN1D4;NDFIP1;TANK;LRRK2;WDR48;DCUN1D1;UBA2;SMAD7;RCHY1;SENP2;UBE2L3;UBQLN1;DCUN1D2
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.4916947257733204,0.8497616273537225,0.7802197802197802,0.9808727118229085,1.0,10/22,28.67%,EPN1;ERRFI1;EGFR;ARHGEF7;PTPN2;GRB2;EPS15;SH3KBP1;STAM2;RNF115
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.5450046955918133,0.8497151860075965,0.6923076923076923,0.9804934059530785,1.0,5/7,44.31%,WAPL;TERF1;ATR;PDS5A;TSPYL2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.4232627916829613,0.8496686001458292,0.7362637362637363,0.9801003144002097,1.0,23/64,27.03%,DNAJC6;WASF1;AP2A1;SCARB2;CTSL;SGIP1;CD9;INSR;SCARB1;CANX;AP2B1;HSPH1;GRB2;EPS15;CD81;LDLRAP1;GAK;PIP5K1C;DNM2;ADM;CLTC;AP2M1;GPR107
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.4632713491309009,0.8492718583432132,0.7283950617283951,0.9802633933284803,1.0,3/19,14.92%,HIF1A;TANK;USP10
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.428537304592137,-0.8487847394677251,0.5416666666666666,1.0,1.0,4/10,12.85%,PRDM5;SETDB2;SETDB1;SMYD3
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.5548874605614508,0.8485568996887329,0.7246376811594203,0.9809018335555032,1.0,1/6,14.47%,SLC25A4
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.44506379061521284,-0.8484100586093778,0.6153846153846154,1.0,1.0,3/10,4.03%,WDFY4;CD4;PPARD
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.3960200443305085,0.8483560007155949,0.7634408602150538,0.9808008622736343,1.0,16/64,30.88%,PPP1CC;SEC13;STMN1;NUP133;TNKS;PAFAH1B1;GOLGA2;GPSM2;NUP160;CENPP;LSM14A;RANBP2;RAB11A;CLIP1;ZNF207;SMC1A
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.4707677270877279,0.848184216266488,0.6533333333333333,0.9805823922150548,1.0,2/13,14.39%,CACNA1B;TRPC4
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.49608356029295925,0.8480816753856264,0.68,0.9803077060109215,1.0,1/13,3.50%,RAB27A
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.4800243767131371,0.8472286759953361,0.7037037037037037,0.9812645007742008,1.0,4/16,20.21%,NRG1;EGFR;ERBIN;GRB2
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.34842040392114515,-0.8471315799455721,0.7142857142857143,1.0,1.0,2/28,0.80%,CDK6;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.32524096245193623,-0.8470853273034386,0.875,1.0,1.0,7/36,7.68%,BCL2L11;TRABD2B;SYNPO2;RPS3;VCP;TPR;MPP7
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.4020368092880232,0.847058051818646,0.723404255319149,0.9810085419379655,1.0,13/72,16.62%,NEDD4L;CDH2;SEMA4D;ADGRB3;TGFB1;LZTS1;KIF13B;BCL6;FGFR2;CAPZB;LRRK2;CFL1;HECW1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.4460801897859735,0.8465491725598457,0.7590361445783133,0.9813960345651114,1.0,4/21,14.13%,NDUFB9;NDUFV1;NDUFB2;NDUFS2
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.44864991344705657,0.8465039764680716,0.75,0.981027623240635,1.0,5/26,24.17%,SEC13;NUP133;REEP3;NUP205;NUP160
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.5696779456729392,0.8456244921771287,0.7101449275362319,0.9818838165710522,1.0,2/5,10.51%,F3;CEBPB
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.46659749707544196,0.8454627016247569,0.7160493827160493,0.9816796178134638,1.0,4/18,15.37%,KLF9;GNB1;ROCK2;GNAI1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.36571929537821446,-0.8452201347854496,0.6153846153846154,1.0,1.0,2/22,4.04%,SDAD1;SHQ1
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.537637572013508,-0.8449064932523721,0.6666666666666666,1.0,1.0,1/5,1.68%,AK5
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.462916575639753,0.8443217218630554,0.7528089887640449,0.9829330610200689,1.0,11/25,37.47%,EGFR;ANKRD17;ATAD5;RBBP6;CCDC88A;WAPL;ZBTB38;SMC3;USP37;TERF1;ATR
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.46261616802393196,0.8436375810188049,0.7471264367816092,0.983745035849803,1.0,7/25,25.86%,TGFB1;SDCBP;TWIST1;SMAD2;LEF1;OLFM1;RGCC
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.4734636096337095,0.8436155908095959,0.7,0.9833295708127174,1.0,8/14,25.38%,HIF1A;STAT3;BRD1;ACVR2A;ACVR1B;ABCB10;FOXO3;ETS1
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.4886921586531238,-0.84305790759819,0.6388888888888888,1.0,1.0,3/6,15.19%,ADCY6;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.42293400213854465,-0.8430122056716701,0.65,1.0,1.0,4/10,20.48%,MDFIC;GTF2F2;NELFA;SUPT5H
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.4669153136391413,0.842842883538431,0.7037037037037037,0.9842248536198894,1.0,3/17,12.86%,ACTR3;AKIRIN1;CAPZB
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.4761130898273417,0.842738518517318,0.7444444444444445,0.9839498818071272,1.0,4/21,15.91%,TRMT9B;WDR6;TRMT13;TYW1B
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.564275239479484,0.8424386786966717,0.7,0.9840819377185084,1.0,1/5,10.03%,EIF2AK4
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.5162983359620839,0.8420366065465111,0.7662337662337663,0.9842652799254845,1.0,2/10,17.63%,EIF2AK4;ABL1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.430327597116367,-0.8416574632621189,0.7419354838709677,1.0,1.0,1/10,2.39%,ATP2B4
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.29382380233059524,-0.8415806151205943,1.0,1.0,1.0,9/80,7.06%,TAGLN;ACTA2;LMOD1;MYL9;COL14A1;CYP27A1;IGFBP7;COL15A1;ACADSB
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.5589677155088468,0.841432818914962,0.7702702702702703,0.984710045257259,1.0,1/5,7.81%,TGFB1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.4656639845506839,0.8413555543140321,0.7555555555555555,0.9843699878103547,1.0,5/22,17.56%,TAF1B;ARID1A;DDX21;POLR1C;SF3B1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4952138032026093,0.8408597197258224,0.7246376811594203,0.9845762803536547,1.0,2/8,18.51%,ADAM17;SP1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.45230256768911936,0.8404261555693928,0.7411764705882353,0.9847590593902351,1.0,8/21,25.10%,PTPRD;ROBO2;SYNDIG1;LRFN5;NRXN1;NLGN1;GPC4;IL1RAPL1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.46753917515617044,-0.840334370569608,0.6451612903225806,1.0,1.0,1/5,3.74%,RYR2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.41508599215144826,0.8402146030672607,0.7708333333333334,0.9846805590205007,1.0,5/67,6.80%,CSF1;PTPN1;DDX3X;CSF1R;STK4
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.5268301359253292,0.8399325801788102,0.782051282051282,0.9845695065872246,1.0,3/11,12.37%,CPSF2;TUT7;DCP2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.41525674092780124,0.8398201301948395,0.8172043010752689,0.9842955105387076,1.0,10/41,20.64%,GRIN1;TMEM165;TMCO1;TRPM3;GRIN2B;NALCN;TRPC4;SPG7;RYR3;ITGAV
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3950264206666245,0.8395220487897321,0.89,0.9842778622224635,1.0,40/191,24.14%,IFT52;DDX3X;ACTR3;WIPI1;LZTFL1;IFT140;CSNK1D;ATG16L2;DHX29;NUDCD3;CSDE1;TRAF3IP1;EHD2;EIF4ENIF1;EXOC1;GALNT11;TTC8;RAB7A;DCDC2;C9ORF72;MAK;AMBRA1;TNKS;WDR45B;ARF4;VTA1;GOLGA2;GOLGA8B;RAB8B;WDR19;ASAP1;MAP1LC3B;SEPTIN7;STX12;TP53INP1;ARMC9;CEP290;PATL1;RFX3;SH3PXD2B
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.45976624071025773,-0.8392436824427206,0.7142857142857143,1.0,1.0,2/8,6.58%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.4086743625236819,0.8391300693013171,0.7717391304347826,0.9844231261778761,1.0,13/55,26.90%,HDAC2;PHF20L1;RCOR1;MORF4L1;SIN3A;USP3;PHF20;UBE2B;MT3;RPS6KA5;USP22;NEK11;KAT6A
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.46858626434381395,0.8389522608405755,0.7241379310344828,0.9842472660757073,1.0,2/19,6.24%,HDAC2;ADAM17
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.44890975988165027,-0.8389137275661397,0.6538461538461539,1.0,1.0,3/11,5.68%,LMCD1;ATP2B4;SLC9A1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.52030438920544,0.8385684921347091,0.7323943661971831,0.9843784614222942,1.0,2/8,23.68%,FUT8;UGP2
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.43497561825794,0.8380198716995074,0.7380952380952381,0.9847977000357373,1.0,4/33,17.05%,CSF1R;MED14;CEBPB;CBFB
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.47517728644779667,0.8379289491045432,0.7682926829268293,0.9844732483873142,1.0,6/17,29.34%,OTUD7A;BRCC3;PSMD14;USP25;USP8;CYLD
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.5278208638510118,0.8375984886552517,0.7205882352941176,0.9845855866307041,1.0,1/9,13.33%,MDM4
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.5132274449292749,0.8375422545342,0.7564102564102564,0.9842429622433726,1.0,6/11,16.84%,DUT;GUK1;GLRX;GSR;AK9;CMPK1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4402455138896379,0.8369742454742916,0.8,0.9847496445662419,1.0,9/43,15.29%,PSMB1;FHL1;PSMB2;ZFP36L2;PSMA7;MYO16;PSMA4;RBX1;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.5456814827197836,0.8369298841036525,0.7464788732394366,0.9843840718575592,1.0,1/5,13.86%,STAT3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.4002259302149598,-0.8368619887808976,0.5769230769230769,1.0,1.0,3/15,7.31%,SCN1A;CACNA1D;HCN2
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.41115942175214537,-0.8366708028421634,0.7037037037037037,1.0,1.0,2/15,2.95%,CTNNA3;CACNA1D
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.46029995764826226,0.8365514169891043,0.7307692307692307,0.9845843125120219,1.0,1/21,0.42%,CSF1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.47297456806176963,-0.8364041371813963,0.7419354838709677,1.0,1.0,1/7,3.74%,RYR2
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3975078586733231,-0.8363491387468548,0.72,1.0,1.0,2/11,2.98%,SLIT2;EVL
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.40203208396320145,0.8363168732806276,0.7708333333333334,0.9844693286692827,1.0,5/79,5.02%,CD44;GJA1;DCLK1;PTPRD;PCDH17
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.46768684594607407,0.8362116322033203,0.7590361445783133,0.9841738459481728,1.0,4/18,15.66%,TGFB1;GLUL;SIN3A;LATS2
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.5551679344960303,0.8359253448867088,0.7808219178082192,0.9841424711762912,1.0,2/6,5.20%,ANK3;SCN3A
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5476425857490743,0.8356038715985812,0.7702702702702703,0.9841620180789233,1.0,2/7,17.10%,MAP2K1;MAPK1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5068227420505856,0.8354237268152381,0.7631578947368421,0.9831578736424742,1.0,1/10,9.30%,DNMT1
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.5068227420505856,0.8354237268152381,0.7631578947368421,0.9831578736424742,1.0,1/10,9.30%,DNMT1
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.5068227420505856,0.8354237268152381,0.7631578947368421,0.9831578736424742,1.0,1/10,9.30%,DNMT1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.4964495752183204,-0.8341900140934241,0.6551724137931034,1.0,1.0,2/6,5.36%,FGF13;CKAP5
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.5180669561024999,0.8341867430292544,0.8095238095238095,0.984461703833751,1.0,3/12,25.02%,SCD;ACSS3;SCD5
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.5074376895127093,0.8339710154607527,0.72,0.984319496317814,1.0,1/8,6.24%,ADAM17
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.47839393324930934,0.833961536777649,0.759493670886076,0.9838959606387053,1.0,4/13,26.93%,INSR;TBC1D5;ATAD1;VEGFA
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.4331162175040226,0.83369620320921,0.797752808988764,0.983795646322514,1.0,9/45,17.00%,KCNQ1;SSH1;DIAPH1;SLC38A9;IPO5;RAP1B;AKAP6;GABRB1;CPEB4
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.4892421701866947,0.8333477765860671,0.6842105263157895,0.9838613782517814,1.0,4/10,15.83%,TBC1D20;VAPA;PPIB;CFL1
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.5191990088624794,-0.8332045732072288,0.6578947368421053,1.0,1.0,2/5,12.96%,RFTN1;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.5117389153441979,-0.8325403872994454,0.5833333333333334,1.0,1.0,1/6,3.91%,YWHAB
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.5497833236875233,0.8324464969936503,0.7945205479452054,0.9847472355714273,1.0,4/6,39.01%,SH3KBP1;PRKDC;CYRIB;HSPD1
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.4969165467074844,-0.8318720119552705,0.7714285714285715,1.0,1.0,2/5,11.90%,MCU;AFG3L2
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.44690200089482224,0.8314339353406925,0.7142857142857143,0.9858027011547155,1.0,4/27,11.07%,HDAC2;RCOR1;MORF4L1;SIN3A
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.5401492191959756,0.831352317558324,0.6984126984126984,0.98503481320871,1.0,1/5,8.05%,ALKBH5
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.5401492191959756,0.831352317558324,0.6984126984126984,0.98503481320871,1.0,1/5,8.05%,ALKBH5
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.46297366919749594,0.8312948784128275,0.7349397590361446,0.9846628888022835,1.0,5/18,21.09%,KDM1A;PIAS2;ZBTB7A;SMARCA4;NCOA2
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.5089330694420185,0.8312260728384785,0.7945205479452054,0.9842913006747057,1.0,4/11,31.94%,ACOT11;ACBD6;ACSF2;DLST
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.45759836832802886,0.8312239735287595,0.7738095238095238,0.9838465237652277,1.0,6/23,24.14%,SMOC1;RAB18;ATF6;FBN1;CEP290;SH3PXD2B
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.4305421625364998,0.8312013056685936,0.6976744186046512,0.9834205214905596,1.0,7/28,25.99%,MORF4L1;FAN1;PSMD14;ZSWIM7;RPA1;SPIDR;SFPQ
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.4412972027968926,0.8311064246409637,0.7586206896551724,0.9830729532235941,1.0,7/27,19.41%,PTPRD;SYNDIG1;KDR;CNTNAP2;NRXN1;ABL1;NLGN1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.4676812342036262,0.8304504469356812,0.7105263157894737,0.9831814817750436,1.0,4/15,18.88%,GNPAT;AGPAT4;ABHD5;DGKH
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.4676812342036262,0.8304504469356812,0.7105263157894737,0.9831814817750436,1.0,4/15,18.88%,GNPAT;AGPAT4;ABHD5;DGKH
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.47548721173056235,0.8302368233957029,0.8095238095238095,0.9830133036113711,1.0,12/22,29.23%,ANK3;GGA3;RAB7A;NSF;PREPL;BLZF1;NECTIN3;VAMP5;GOLGA4;GGA2;RILPL1;GOLPH3
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.408906991796648,-0.830159877693812,0.5263157894736842,1.0,1.0,3/10,12.45%,BAIAP2L2;PLS3;ADD1
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.5209481907889412,0.8295701369743304,0.6714285714285714,0.9836472779673081,1.0,2/7,32.68%,DLG1;PRKX
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.4966246843060927,-0.8295336228978875,0.7741935483870968,1.0,1.0,1/5,3.21%,IGFBP4
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4523100648431599,0.8293464516070219,0.7721518987341772,0.9835111070845015,1.0,5/22,17.58%,CSF1R;IL18;STAT3;NF2;PTPN2
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.5457352613178087,0.8290283786815511,0.7236842105263158,0.9835261570998841,1.0,2/6,25.31%,HSPA5;EIF2AK3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.42493741197698254,0.8287217650758721,0.7528089887640449,0.9835915369942076,1.0,8/41,15.29%,PSMB1;PSMB2;BTRC;PSMA7;PSMA4;FBXL13;RBX1;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.5033619684327355,0.8287031124905547,0.6621621621621622,0.9831765233614953,1.0,2/11,14.52%,HIF1A;INSR
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.5512237310341068,0.8285625683177493,0.782608695652174,0.9829127773998162,1.0,3/5,38.68%,DNM2;SNAP91;DNM3
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.5359827880271285,0.8282905156144412,0.7391304347826086,0.9828366591866025,1.0,1/6,7.33%,NUP88
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5046291785248656,0.8282747602283216,0.7088607594936709,0.9824179755389727,1.0,2/10,6.75%,NEDD4L;ATP1B3
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.4891096967224753,0.8278774906396361,0.7380952380952381,0.9826572294408237,1.0,4/15,12.83%,TGFB1;WNT2B;RUNX1;CREB3L2
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5139993840528734,0.8275474440027304,0.7333333333333333,0.9826543580198893,1.0,4/5,31.81%,CD9;C1QTNF1;SH2B3;RDX
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.5172595595228043,0.8274949483317902,0.7567567567567568,0.9822865049882966,1.0,3/10,19.46%,FLT1;ABL1;ABL2
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.3322985113745207,-0.8274371274682634,0.7333333333333333,1.0,1.0,5/29,5.29%,LMOD1;EVL;BAIAP2L2;RPS3;NCK1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.3287771114253494,-0.827411758691426,0.7142857142857143,1.0,1.0,7/27,7.31%,SCN1A;ANO6;ATP1B2;SCN7A;SLC9A1;SLC6A1;HCN2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.4304147991825881,0.827322111485498,0.7582417582417582,0.9821606754622758,1.0,5/37,19.51%,UBA5;RPS27A;RAB7A;AMBRA1;MAP1LC3B
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.41594887920857604,0.8273110194763229,0.7741935483870968,0.9817295585050202,1.0,7/37,14.58%,RHOB;XRCC4;RNF168;CLOCK;TANK;BRCC3;IKBIP
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.48626024710994054,0.8271798119627424,0.7432432432432432,0.9814810746617494,1.0,2/15,8.95%,GJA1;MBP
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.4536036202867368,-0.8270272051719932,0.6,1.0,1.0,1/5,2.69%,ARHGEF10L
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.4536036202867368,-0.8270272051719932,0.6,1.0,1.0,1/5,2.69%,ARHGEF10L
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.5310159942128005,0.8268223605915778,0.7857142857142857,0.9815834813715231,1.0,4/8,13.86%,RARRES1;PRLR;KDM3A;STAT3
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.461593943095711,0.8267439845295733,0.7375,0.9812487956385848,1.0,4/17,12.72%,ROBO2;ROBO1;ZFPM2;FGFR2
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),0.42197195301011364,0.8265846660211983,0.7608695652173914,0.9810827614189476,1.0,11/35,34.25%,TBK1;TRAF3IP1;POLR1C;POLR2F;NPLOC4;IRF1;CYLD;PRKDC;STAT6;XRCC5;NFKB1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.4025823780448473,0.8264300266382164,0.7653061224489796,0.9808895875915127,1.0,21/73,32.53%,DDX52;NOP58;RPL21;WDR43;RPL28;RPL41;RPLP2;DIS3;RPL9;RPL18;TEX10;RPS14;NOL8;RPL27A;RPL13A;RCL1;RPL32;RPL31;RPS2;RPL34;XRN1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.5211293816552518,0.8256971011798507,0.7012987012987013,0.9815375939837764,1.0,3/7,17.24%,IL18;IGFBP2;PRNP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.47727406911215575,0.8256269390247748,0.782051282051282,0.9811808071653855,1.0,4/18,6.24%,CSF1;AKIRIN1;CSF1R;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.3874861367240377,0.8252470198569876,0.84,0.9813057831859229,1.0,28/140,18.01%,SOD1;RHOB;DDX3X;EPHA7;MTCH2;ARHGEF9;STK4;CCAR1;TP63;MCF2L;BNIP3L;APBB1;RPS27A;BCL6;PTRH2;ARHGEF7;APAF1;SIAH1;TNFRSF10B;MELK;ATF6;PAWR;LATS2;ARHGEF4;PRNP;ABL1;DNAJA1;VAV3
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.5530527056478897,0.825133042387898,0.7910447761194029,0.981062915868535,1.0,1/6,12.32%,CFH
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.5604047440791691,0.8250857372176255,0.7733333333333333,0.980697742747041,1.0,1/6,13.86%,STAT3
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.5281083357180089,0.8247500109251942,0.782608695652174,0.9807456575783923,1.0,2/7,21.64%,CCT3;EIF3B
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.4957924413722056,0.8237928578136945,0.782051282051282,0.9818317758597201,1.0,4/11,28.73%,TGFB1;CLTC;AP2M1;PID1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.47926221789697215,0.8233030719489837,0.7468354430379747,0.982015096793834,1.0,2/12,13.46%,RHOJ;KDR
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.439969303775233,0.8232863885910419,0.7386363636363636,0.9815912629492656,1.0,6/32,17.23%,ARID3A;CNOT8;MDM2;MDM4;USP10;CDKN1B
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5424121654894454,0.82260960166176,0.8157894736842105,0.9821231660331141,1.0,3/10,18.48%,CCT4;DCP2;CCT3
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.4460248214039052,-0.822445748471589,0.6666666666666666,1.0,1.0,1/7,5.07%,MRTFB
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.4870685970090264,-0.8218209217841487,0.7142857142857143,1.0,1.0,1/7,1.14%,PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5465392667070021,0.8213519179383522,0.7538461538461538,0.9826624739984806,1.0,3/5,44.11%,MACROH2A1;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5465392667070021,0.8213519179383522,0.7538461538461538,0.9826624739984806,1.0,3/5,44.11%,MACROH2A1;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5465392667070021,0.8213519179383522,0.7538461538461538,0.9826624739984806,1.0,3/5,44.11%,MACROH2A1;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.5553685340393885,0.8210111296396233,0.7894736842105263,0.9827816607856974,1.0,3/6,28.31%,TGFB1;ALDH1A2;ARL13B
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.43298211448478335,0.8209382012959566,0.7608695652173914,0.9824489703784125,1.0,8/31,26.07%,NEDD4L;HIF1A;PPP3CA;TTN;AHCYL1;MT3;HVCN1;MTF1
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.5241748628862817,0.8204685781046014,0.7183098591549296,0.9828029628803252,1.0,1/6,12.72%,FGFR2
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.537312387958587,0.8203656258773149,0.7538461538461538,0.9824615309439214,1.0,3/6,27.01%,DCDC2;ADORA2B;PTK2B
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.48839516671861755,-0.8203263613461007,0.6666666666666666,1.0,1.0,1/7,4.20%,CDC27
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.48839516671861755,-0.8203263613461007,0.6666666666666666,1.0,1.0,1/7,4.20%,CDC27
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.48839516671861755,-0.8203263613461007,0.6666666666666666,1.0,1.0,1/7,4.20%,CDC27
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.39679249513798465,0.8202214167892242,0.8297872340425532,0.9823008699659791,1.0,17/72,18.13%,TPT1;RAF1;TP63;BNIP3L;SRA1;BCL6;MADD;IFT57;APAF1;SLK;TNFRSF10B;LRRK2;NF2;ZBTB7A;ABL1;FBXO11;ACER3
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.4304768846141963,0.8201454819160878,0.7934782608695652,0.9820501574952235,1.0,7/33,18.69%,PSMB1;PSMB2;PSMA7;RPS27A;PSMA4;PSMD14;ANAPC4
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.4878106039759186,0.8196942917103349,0.75,0.9824397607321431,1.0,3/13,16.19%,TNFRSF1B;CEBPB;LGALS3
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.5249531487307677,0.8189731078109689,0.7692307692307693,0.9830588095876108,1.0,2/9,5.20%,CACNA1B;SCN3A
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.36967078560116085,-0.8184536540124471,0.84,1.0,1.0,2/14,6.06%,MECOM;FKTN
prerank,PanglaoDB_Augmented_2021__Macrophages,0.4542880711350439,0.8180168252313743,0.7411764705882353,0.984114169770714,1.0,5/19,8.10%,NCEH1;CSF1R;NR4A3;TNFRSF1B;CPM
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.4024651719953417,0.8177018133657479,0.8172043010752689,0.9840701773787778,1.0,7/63,10.52%,NUP153;SEC13;NUP88;EGFR;HIF1A;SDCBP;NUP133
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5242471967244878,0.817347519969818,0.8076923076923077,0.9841207180819505,1.0,2/6,12.64%,PTPN1;HSPA5
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.5115526677298814,0.8169591907509909,0.75,0.984171214078619,1.0,1/9,2.68%,NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.5062525246620502,0.8160417764667101,0.7936507936507936,0.9851298056253889,1.0,1/7,16.54%,LGR4
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.43370660915208853,0.8159374478296668,0.7682926829268293,0.9848742356169373,1.0,8/17,25.38%,HIF1A;STAT3;BRD1;ACVR2A;ACVR1B;ABCB10;FOXO3;ETS1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5141100128803127,0.815820926055706,0.7671232876712328,0.9845964325168138,1.0,1/9,6.95%,NR4A3
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.32959119712810087,-0.8157719261040257,0.75,1.0,1.0,1/24,0.45%,PGR
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.41970475836243487,0.8151242249845504,0.7619047619047619,0.9850956082012647,1.0,3/27,8.25%,RHOB;CAMKK2;EGFR
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.4574794046197431,0.8138350382146656,0.8266666666666667,0.9859849785467848,1.0,4/17,14.13%,NDUFB9;NDUFV1;NDUFB2;NDUFS2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.4574794046197431,0.8138350382146656,0.8266666666666667,0.9859849785467848,1.0,4/17,14.13%,NDUFB9;NDUFV1;NDUFB2;NDUFS2
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.4481558955697057,0.8137712814504248,0.8045977011494253,0.9856399179029148,1.0,11/24,23.20%,HDAC2;CRMP1;CBFA2T2;EFNB2;GRIN2B;PTPN9;PRNP;KANK1;GAK;MT3;SPOCK1
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.5493360715312765,0.8132168149476341,0.7761194029850746,0.9859181418853666,1.0,1/5,17.28%,ZFPM1
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.4253497627071516,0.8132077734920324,0.7472527472527473,0.9854972564112927,1.0,6/29,12.72%,MCC;NR4A3;TGFB1;EGFR;DEAF1;FGFR2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.45870567345597607,0.8125232878881632,0.7415730337078652,0.9860394958743097,1.0,5/23,17.23%,ARID3A;CNOT8;MDM2;MDM4;CDKN1B
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.5436136568463015,0.8123628675965519,0.7936507936507936,0.9854492724105287,1.0,3/6,29.03%,ROCK2;GCLC;SCPEP1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.5436136568463015,0.8123628675965519,0.7936507936507936,0.9854492724105287,1.0,3/6,29.03%,ROCK2;GCLC;SCPEP1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.395078917440362,0.8122868889710573,0.7717391304347826,0.9851366619308571,1.0,10/47,18.51%,RHOB;ADAM17;TGFB1;HIF1A;ROCK2;TMSB4X;KDR;SCARB1;ABL1;SP1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.37539999388860074,0.8122081109061287,0.8315789473684211,0.984788565844882,1.0,7/95,7.64%,COL4A6;CD44;ADAMTS9;ADAMTS4;ITGA5;SMOC1;MMP16
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.4986907245143629,0.8121285032479562,0.7466666666666667,0.9844497118221743,1.0,2/11,14.02%,FGFR2;RARB
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.49967004377564517,0.8117187122151746,0.7530864197530864,0.9845800988002822,1.0,3/11,14.37%,TMEM165;ABCA1;LRRK2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.45730911358535076,0.8112486837032764,0.7625,0.9847862621385992,1.0,4/16,15.34%,NOS1AP;EGFR;HIF1A;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.5088967228574588,0.8105237678116247,0.7164179104477612,0.9854072298916529,1.0,1/8,13.86%,STAT3
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.40422651245005997,0.8103939592598536,0.8020833333333334,0.9851802052767771,1.0,17/45,23.24%,GFAP;CHL1;CSF1R;GLUL;GALNT15;EPOR;CDH20;SLC1A2;LRRK2;PDK4;NRXN1;MAPK1;GRIA3;GRIA2;PLP1;MT3;RTN1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.4354350456727935,0.810146435473762,0.7625,0.9850692954005924,1.0,4/23,10.99%,C1GALT1;ROBO2;ZBTB16;TRAF3IP1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.4375342876163572,0.8099268513324707,0.8181818181818182,0.9849718517538071,1.0,7/26,16.19%,HDAC2;BASP1;ACADVL;FGFR2;KDR;PGK1;LGALS3
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.5045802789618616,0.8095723563601392,0.7710843373493976,0.9849858532165733,1.0,1/7,9.56%,CTNND2
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.42960467135264907,0.8092379093685018,0.810126582278481,0.9850265570561125,1.0,2/19,10.97%,PTPN1;RIOK3
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.3932277498083915,0.8091549813246168,0.7777777777777778,0.9847067354984566,1.0,8/81,10.68%,DDX52;DHX29;NOP58;RPL21;WDR43;GLUL;RPL28;RPL41
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.47616018612421573,0.8090413921982,0.7368421052631579,0.984422782102837,1.0,4/11,27.16%,GBE1;PHKB;UGP2;PYGB
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3530589324997424,-0.8090115254004527,0.7,1.0,1.0,1/11,10.89%,CDC42
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.45969075217015865,-0.8089428514976585,0.59375,1.0,1.0,1/5,1.59%,BCL2L11
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.42231571702468507,0.8081951800995621,0.7619047619047619,0.985157348197708,1.0,6/26,21.16%,RPS27A;FAN1;RBX1;DCP1A;RPA1;IHO1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.41032377859071134,-0.8073106589924829,0.7857142857142857,1.0,1.0,1/9,2.98%,EVL
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.44927141796286,-0.8072693755893338,0.6129032258064516,1.0,1.0,1/6,1.59%,BCL2L11
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5198090836185232,0.8070783716739266,0.7945205479452054,0.9863446270560774,1.0,1/9,2.05%,NRG1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.4704739122312627,0.8070076828131437,0.7674418604651163,0.9860336739824999,1.0,3/15,19.02%,CHCHD3;SPG7;DNAJC11
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5298891382084356,0.8069473120547149,0.7377049180327869,0.9856519401034846,1.0,5/6,46.39%,SOX13;HNRNPU;NAPEPLD;SIRT1;RREB1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.43669188886119403,0.8068680024755676,0.7710843373493976,0.9853104889896244,1.0,3/21,15.43%,TGFB1;SYMPK;PPP6R2
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.4002998505206313,0.8067916767171521,0.7894736842105263,0.9850225786110074,1.0,12/49,16.96%,STC1;SGPL1;CCN2;ZFPM2;MYL3;SLC25A4;MYOM2;PDE4D;CKB;TTN;CKMT2;PTH1R
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.47540492347502833,0.8062716983369282,0.8266666666666667,0.9852937247878774,1.0,3/11,14.37%,ANK3;ZC4H2;LRRK2
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.4289198523867831,-0.8060747701290689,0.75,1.0,1.0,1/12,1.75%,ERCC6
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.37425803525950785,0.806056648891569,0.8526315789473684,0.9851346306125827,1.0,7/96,7.64%,COL4A6;CD44;ADAMTS9;ADAMTS4;ITGA5;SMOC1;MMP16
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.49752101074410093,0.8060132613289074,0.7662337662337663,0.9847541201378223,1.0,4/9,29.48%,ACER3;SPTLC1;CYB5R3;SPTLC3
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.36910766969616104,-0.8058729345745326,0.7692307692307693,1.0,1.0,2/15,3.40%,ERCC6;THOC1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.5495612533886742,0.8055879915285912,0.835820895522388,0.9848567205338854,1.0,5/7,37.62%,CEBPB;PRNP;PRKAR1A;RC3H1;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.509443848594632,-0.8052228739054186,0.65625,1.0,1.0,2/5,3.55%,WNK2;ATP1B2
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.44119845224056964,-0.8049443344156547,0.6206896551724138,1.0,1.0,2/5,6.37%,TNIP1;VCP
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.4261566816932345,-0.8048983440456839,0.6666666666666666,1.0,1.0,2/8,12.03%,KCNB1;RPTOR
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.5203822411647938,0.8042978523630736,0.8831168831168831,0.9861545865875806,1.0,4/8,31.34%,ZBTB1;AXL;ZMIZ1;PRKDC
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.3903154323085183,0.8042312619874701,0.8210526315789474,0.9858051062167524,1.0,12/57,21.72%,DDX3X;EGFR;IRS1;ELAVL1;KDR;METTL14;INSR;ATAD5;ABCB10;HSPH1;SLC25A37;IRS2
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.4599224029349239,0.8035879266781338,0.725,0.9862388697733941,1.0,1/12,6.34%,ENPEP
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.3661320019523462,-0.8033287260525335,0.7619047619047619,1.0,1.0,2/17,7.19%,PHLDB2;WASF2
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.38060350375807794,0.80330816590904,0.8709677419354839,0.9861637875487099,1.0,22/95,23.72%,PPME1;PRKACA;CCP110;TUBA1A;CSNK1D;BTRC;CCNH;CEP70;CEP57;MELK;LATS2;ACVR1B;CDKN1B;CRLF3;PAFAH1B1;SKP1;CNTRL;YWHAG;CCND3;CEP290;DNM2;ENSA
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.3149781065760868,-0.8030074472081531,0.75,1.0,1.0,2/27,5.61%,PARP9;RIC3
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.404105747225742,0.8028983786545577,0.8125,0.98619483965273,1.0,11/58,15.29%,PSMB1;PDE4B;PSMB2;RC3H2;BTRC;PSMA7;PAG1;NFKBIZ;PSMA4;PDE4D;PSMD14
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.5099156142247396,0.8026677460465254,0.8428571428571429,0.9860712479161137,1.0,1/9,13.33%,MDM4
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.39078994054118654,-0.8025949115862694,0.6666666666666666,1.0,1.0,3/8,11.68%,VCP;CHMP4B;TMEM50B
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.4837147757796998,0.8024643456892453,0.7831325301204819,0.9859080221526891,1.0,3/11,14.58%,XRCC4;BRCC3;IKBIP
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.4573056649617324,-0.8024218822879593,0.6785714285714286,1.0,1.0,1/7,3.06%,ZDHHC21
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.3670189592760643,-0.8023702397699896,0.7142857142857143,1.0,1.0,2/17,4.68%,DAPK2;RPS3
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.44894527056795924,0.8018942789142802,0.8048780487804879,0.9863981789823962,1.0,6/18,22.36%,SGPL1;AGK;SAMD8;ACER3;CERS6;SPTLC1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.4036128781629963,-0.801764261303299,0.8076923076923077,1.0,1.0,3/9,13.12%,RPS3;TRAF6;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4535782211723818,0.801216891293922,0.7894736842105263,0.9869187936384498,1.0,2/15,12.95%,SDCBP;WAC
prerank,MSigDB_Hallmark_2020__Androgen Response,0.39276672600661566,0.8010781819009142,0.7526881720430108,0.9867201329904927,1.0,17/62,19.27%,ANKH;FKBP5;CAMKK2;HOMER2;UBE2J1;SCD;ELL2;VAPA;GSR;SEC24D;MAK;STK39;STEAP4;LIFR;APPBP2;MAP7;ELOVL5
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.389282211632548,0.8004197698750658,0.851063829787234,0.9872004843043127,1.0,6/64,10.68%,RPS21;ETF1;RPS27A;RPL21;RPL28;RPL41
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.3813221880398547,0.7997211481798351,0.8469387755102041,0.9876980439305341,1.0,8/74,10.35%,GJA1;WASF3;CRMP1;DCLK1;PTPRD;SYNDIG1;SHC2;CCN2
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.5342900596131285,0.7995449814455889,0.7941176470588235,0.9874948996791726,1.0,3/5,32.07%,UBR5;UBE3A;NEDD4
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.400587076912971,0.7993652119075877,0.7764705882352941,0.9873403568908156,1.0,2/35,1.38%,S1PR3;PRKACA
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.3962104283456696,0.799001899747168,0.7956989247311828,0.9873399625674149,1.0,7/56,11.18%,MID1;TENM3;FHL1;SMARCA1;EGFR;NXN;EHD2
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.5073544408997429,0.7984428734022243,0.7837837837837838,0.9875375018619678,1.0,1/8,3.66%,RIMS2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.4026527119430716,0.7982497764854363,0.7582417582417582,0.9873479681747271,1.0,7/49,10.19%,CNTN3;PHYHIPL;PTPRD;PCDH17;SMARCA1;SNAP25;SHC2
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5029953956483926,0.7980991930375854,0.7976190476190477,0.987101466999376,1.0,2/11,6.95%,PTPN1;NR4A3
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.529654709877181,0.7979542721032629,0.8194444444444444,0.9868639644184851,1.0,2/5,39.01%,PPP3CB;HSPD1
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.4767091874830164,0.7974451705413976,0.7323943661971831,0.9871535773966016,1.0,2/10,11.47%,CD38;BCL6
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.3812236740282907,0.7972180572082584,0.9072164948453608,0.9871005964018519,1.0,21/100,21.72%,DOK6;NRXN3;SPTBN4;EPHA7;NIBAN2;SEMA4D;NCAM1;ROBO2;ROBO1;EFNB2;SEMA3B;RANBP9;SIAH1;NRXN1;MAPK1;UNC5B;GRB2;DAB1;GAB2;PTPRM;IRS2
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.41682148766817323,-0.7969174718935904,0.5625,1.0,1.0,1/6,8.10%,CENATAC
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.3273901777689736,-0.7958567084798776,0.8095238095238095,1.0,1.0,3/22,7.62%,MAPK14;AATF;AKR1C3
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.4281355387827204,-0.7958254549546703,0.7931034482758621,1.0,1.0,7/7,57.25%,SMYD3;PRMT2;NSD3;EHMT1;PRMT7;NSD1;CREBBP
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.4379769136853425,0.795718870673811,0.7831325301204819,0.9887981267768492,1.0,4/21,15.37%,KLF9;GNB1;GRAMD1A;GNAI1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3755532133390598,0.7954699934117528,0.898989898989899,0.9886567775088608,1.0,31/142,25.76%,PARVB;IFT52;ACTR3;LZTFL1;IFT140;EMP1;NUDCD3;RAP1B;SDCBP;TRAF3IP1;EHD2;EXOC1;GALNT11;TTC8;ARHGEF7;DCDC2;MAK;ARHGEF4;ARF4;RAB8B;WDR19;ASAP1;SEPTIN7;ARMC9;CEP290;CYFIP1;RFX3;PIP5K1A;CCDC88A;ATP6V1D;RAB3IP
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.4128863149686434,-0.7953930286106418,0.7647058823529411,1.0,1.0,3/11,14.12%,TOPBP1;ORC5;NOC3L
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.5647638505040963,0.7951963865921925,0.7611940298507462,0.9885506168933883,1.0,2/5,18.75%,PPARA;ABHD5
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.4567447201139695,0.7951656885559986,0.72,0.9881991859177824,1.0,5/15,16.47%,ROBO2;ROBO1;TGFB1;ROCK2;TWIST1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.45982213234838,0.7950736048828995,0.7432432432432432,0.9878830942347052,1.0,1/13,0.75%,KLF2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.5408140823652927,0.7949217546754748,0.8285714285714286,0.9876592061648558,1.0,2/5,37.22%,VEGFA;LRP6
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.4413994945907919,0.7949191936668902,0.7439024390243902,0.9872385995236111,1.0,4/17,17.29%,RPS27A;FAN1;RBX1;RPA1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.5010210338308221,0.7941260786166972,0.782051282051282,0.9879030876985301,1.0,4/6,49.09%,RFX3;BTG1;AHI1;FGF2
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.40897579113394256,0.7940418282285707,0.7926829268292683,0.9875701787228053,1.0,6/31,13.86%,ROBO2;NR4A3;KLF9;SRA1;CTSL;STAT3
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.36609028683293443,-0.7939195152863042,0.7894736842105263,1.0,1.0,2/18,7.19%,PHLDB2;WASF2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5343759877939008,0.7930925344509823,0.7846153846153846,0.9883781687101708,1.0,1/5,17.58%,PTPN2
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.5035827480053736,0.79308926280209,0.7590361445783133,0.9879536076411373,1.0,1/7,1.80%,GNPAT
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.4718049692961678,0.7926253378235704,0.7721518987341772,0.9881887392646431,1.0,3/11,19.70%,SOD2;BNIP3;NDUFS1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.44827253632714004,0.7922529066751607,0.7922077922077922,0.9882403584917661,1.0,1/12,1.03%,RHOB
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.4107793794492652,-0.7919371233905035,0.6071428571428571,1.0,1.0,1/6,0.80%,SLIT2
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.3590434225574537,-0.7919083502431832,0.75,1.0,1.0,1/21,1.09%,TNFRSF19
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.4313846707743496,0.7915910940009431,0.788235294117647,0.9886278586278586,1.0,4/20,11.89%,CDC42EP4;CRACD;WASHC2C;SPIRE1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.4801819958610232,-0.7913618555142913,0.7037037037037037,1.0,1.0,3/5,12.96%,MAPK14;RIPOR2;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.3746867231163875,0.791070108687096,0.8556701030927835,0.9888536770482417,1.0,20/104,15.59%,MYDGF;CAMKK2;EPHA7;CSNK1D;CSF1R;SEMA4D;ADAM17;STK4;TGFB1;EGFR;HIF1A;SDCBP;ROCK2;PDE8A;FLT1;FGFR2;KDR;LRRK2;INSR;ACVR2A
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.41725757418277437,0.7901127089246112,0.8681318681318682,0.989689551375572,1.0,8/39,20.74%,KDM1A;RHBDD1;EGFR;EIF2AK4;ZBTB1;UVSSA;UBE2B;UBE4B
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.5286608545552254,0.790018022235068,0.863013698630137,0.9894136598132965,1.0,2/7,20.36%,CEBPB;NF1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.40573308788833495,0.7898810161972377,0.8351648351648352,0.9891467149435048,1.0,7/40,20.21%,ACTR3;WIPF1;NR4A3;MAPK1;ABL1;VAV3;GRB2
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.40502526538323874,0.7885845579450609,0.8295454545454546,0.9904036630784698,1.0,3/33,3.59%,NRCAM;DNER;DDIT4
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.45929444299414185,0.7885773573245237,0.8051948051948052,0.9899929247184608,1.0,10/19,35.23%,ACADVL;ECHDC1;ACADL;SLC25A17;HSD17B4;HADHB;ABCD3;HADHA;ACOX3;AUH
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.4521028422145931,-0.7885025889522099,0.8181818181818182,1.0,1.0,2/7,3.77%,EDN3;CYB5R4
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.4299862068059411,0.7884982022612684,0.8048780487804879,0.9896651801749862,1.0,6/22,17.28%,ROBO2;ROBO1;ZFPM2;MDM4;HECTD1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.37767084169142406,-0.7884222016614452,0.7142857142857143,1.0,1.0,1/12,2.39%,ATP2B4
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.4650645398776208,0.7879667919722747,0.7974683544303798,0.9900159638518774,1.0,3/12,17.16%,DUSP1;OXSR1;STK39
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.4570113686221036,0.7875772147484478,0.7746478873239436,0.9902013040672181,1.0,4/13,14.32%,SLC7A2;SLC3A2;SLC1A2;SLC36A4
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.509524860488212,0.7874754676738703,0.7974683544303798,0.9899086427486822,1.0,5/8,38.10%,EIF4ENIF1;PATL1;LSM14A;RC3H1;ATXN2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.5300215044431125,0.7873647389041034,0.8059701492537313,0.9892285825041996,1.0,1/5,6.43%,GBE1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.5300215044431125,0.7873647389041034,0.8059701492537313,0.9892285825041996,1.0,1/5,6.43%,GBE1
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.41964668252993514,-0.7872432506098382,0.5909090909090909,1.0,1.0,1/10,1.67%,ZNF568
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.4715394980956823,0.7871504806424006,0.7625,0.9891015725671454,1.0,1/10,7.81%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5181993552528404,0.7868740951623797,0.8194444444444444,0.9890353836222657,1.0,1/5,6.75%,ATP1B3
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.49383829302397075,0.7868563677647123,0.7654320987654321,0.9886224694535541,1.0,2/8,27.05%,UBA2;ZMIZ1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.39755991861242046,0.7864568906756131,0.8588235294117647,0.988695194604202,1.0,10/32,19.46%,NRG1;RAF1;DIAPH1;ADAM17;EGFR;ROCK2;CD9;ZSWIM8;ABL1;ABL2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.3709666740851608,0.7863602970704348,0.9278350515463918,0.9883867229155822,1.0,25/126,18.01%,SOD1;RHOB;DDX3X;MTCH2;ARHGEF9;STK4;CCAR1;MCF2L;BNIP3L;APBB1;RPS27A;BCL6;ARHGEF7;APAF1;SIAH1;TNFRSF10B;MELK;LRRK2;ATF6;PAWR;LATS2;ARHGEF4;ABL1;DNAJA1;VAV3
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.49235559561088027,0.7862967097647948,0.7733333333333333,0.9880525384606371,1.0,3/8,37.44%,PAFAH1B1;MTOR;SUN2
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.4477578503101442,0.7857114300954592,0.7887323943661971,0.9884283307557171,1.0,1/14,1.38%,PRKACA
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.3841251577107998,-0.7850654477345105,0.7619047619047619,1.0,1.0,3/15,12.06%,RYR2;SETDB2;PKD2
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.43253766129341015,-0.78481165038287,0.85,1.0,1.0,1/6,8.50%,NSFL1C
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.41667857137663955,0.7847269726578678,0.8192771084337349,0.9892493351828243,1.0,3/16,12.30%,RHOB;CLOCK;TANK
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.37492877748824766,-0.7845518086959434,0.6818181818181818,1.0,1.0,1/12,1.17%,SPRY1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.3933230261411417,-0.7838506693158184,0.8888888888888888,1.0,1.0,2/13,2.97%,PGR;SYTL2
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.3865963487609548,0.7833777585209045,0.8602150537634409,0.9906230766830374,1.0,11/69,17.29%,RAD21;XRCC4;APBB1;RNF168;MORF4L1;FAN1;BRCC3;TP53BP1;PSMD14;ZSWIM7;RPA1
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.43442433610297426,0.7821973807857961,0.8313253012048193,0.9917060849060989,1.0,6/19,22.17%,TGFB1;SMURF2;LATS2;SMAD2;SMAD7;PCSK6
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.477213136885961,0.781875251565168,0.7878787878787878,0.9916390426002017,1.0,1/8,10.83%,SLC3A2
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.44894718180504195,-0.781777506298842,0.7391304347826086,1.0,1.0,2/7,3.74%,EDN3;RYR2
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.4978233678013637,0.7815560165336704,0.7808219178082192,0.991597966458248,1.0,1/5,11.89%,SPIRE1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.41591463455475486,0.7811711797782663,0.8241758241758241,0.9917252636850851,1.0,6/34,16.27%,RAB27A;TGFB1;APBB1;SYTL4;EXOC1;TTN
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.3772271929993521,-0.7811182274889392,0.8,1.0,1.0,4/16,13.60%,PPARD;NOTCH3;TCF7L2;HEYL
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.42392621722726376,0.7809219871106433,0.8045977011494253,0.9916453549525445,1.0,6/29,12.78%,MCC;ROBO1;KLF9;TGFB1;FGFR2;CASK
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.4278781960946684,0.7808974760147326,0.7380952380952381,0.9912593115345408,1.0,7/24,26.93%,TBX3;MDM4;INSR;TTN;ZFPM1;OLFM1;VEGFA
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.4458515743856102,0.780599496686574,0.7746478873239436,0.9911322483630763,1.0,2/15,14.92%,MDM4;USP10
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.44345499555031964,-0.7803492392388012,0.717948717948718,1.0,1.0,1/5,6.37%,VCP
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.44647134972422287,0.7803449685092994,0.8292682926829268,0.9910526924871118,1.0,5/15,36.41%,ACVR2A;ACVR1B;TGFBR1;CPNE3;BMPR1A
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.43237346588406356,-0.7799860242312339,0.6875,1.0,1.0,1/7,1.68%,AK5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4224776619534186,0.778254975933914,0.7738095238095238,0.9933335664797609,1.0,4/18,17.29%,RPS27A;CCNH;RBX1;RPA1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.365314715569624,0.7781841058765078,0.8617021276595744,0.9930206540036105,1.0,12/85,13.92%,SRGN;RHOJ;APOLD1;EMP1;SLC2A1;C1R;CCN2;CFH;RGS5;FLT1;KDR;CD9
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.5112484497695926,-0.778182602679879,0.7941176470588235,1.0,1.0,3/5,16.19%,APOE;CLU;PSEN1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.37354866261001535,0.7780825930973577,0.8279569892473119,0.992776863734634,1.0,19/67,34.46%,RPS21;RPS27A;RPL21;RPL28;RPL41;RPLP2;RPL9;RPL18;TRAM1;RPS14;RPL27A;SSR1;RPL13A;RPL32;RPL31;RPS2;RPL34;RPL3;RPS4X
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.3413330287433013,-0.7780671939366508,0.9047619047619048,1.0,1.0,1/20,0.79%,NRP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.38469658701584636,0.7776410848028406,0.7640449438202247,0.992997870312987,1.0,8/45,19.62%,PDK1;DDX3X;TNFRSF1B;CEBPB;APAF1;TNFRSF10B;ABL1;BNIP3
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.4076292897104005,0.7775362296335775,0.8409090909090909,0.9927069964385945,1.0,5/28,9.74%,DPM1;WIPI1;PIGL;UGCG;GLUL
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.5046507503903733,0.7770722211039135,0.8157894736842105,0.9928934607003116,1.0,1/7,1.64%,TSC2
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.46923950043975804,0.7770671891129801,0.7432432432432432,0.9924782836454794,1.0,2/7,35.27%,SGPP1;PLPP1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.3709679736822193,-0.776516290047214,0.8095238095238095,1.0,1.0,1/17,2.29%,ATM
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.5106927948502038,0.7764130363058122,0.78125,0.9928321724379637,1.0,2/5,19.07%,PWP1;SMARCA4
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.4381769831754978,0.7761052731308219,0.7976190476190477,0.9927564939156173,1.0,2/18,8.18%,PTPN1;UGCG
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.41587236777008796,0.7760851867584864,0.88,0.9923590636901518,1.0,3/21,6.54%,SEMA4D;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.4332005266889188,0.7759436971512771,0.810126582278481,0.9921035078356535,1.0,3/14,19.46%,EGFR;FLT1;ABL2
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5210998640558366,0.7754590642184018,0.8153846153846154,0.9923712127252668,1.0,1/5,7.62%,PPARA
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.3417517607870224,-0.7751531394913782,0.8,1.0,1.0,5/16,16.97%,MDFIC;TRIM62;GTF2F2;UBP1;NELFA
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.4960751558255405,0.7744083143201496,0.8108108108108109,0.9932043713370334,1.0,2/8,7.03%,ZFP36L2;KLF9
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.4814226829732014,0.7743725743417883,0.8055555555555556,0.9928459748902929,1.0,6/10,34.02%,LRRK2;ARF1;MTMR2;ATAD1;SLC24A2;STXBP1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.5097625278591307,0.7742900927830958,0.7894736842105263,0.9925692352263863,1.0,2/5,28.55%,SLC25A37;SLC40A1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.44811831396929924,0.7733910621038433,0.8292682926829268,0.993242897096108,1.0,3/15,18.70%,ACVR2A;RBPJ;SMAD2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.459963933976193,0.7733045741459578,0.7792207792207793,0.9929319973908982,1.0,1/11,0.42%,CSF1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.3772751519967082,-0.7732381423685187,0.8421052631578947,1.0,1.0,1/10,1.99%,PRMT3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.46706163171375337,0.7727926865718875,0.8266666666666667,0.9931730197950751,1.0,2/11,17.85%,PPP2R1B;UNC5B
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.40010349101812215,-0.7727766228583465,0.8148148148148148,1.0,1.0,1/10,0.83%,FGF1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.48891087815250034,0.7724789338369665,0.7971014492753623,0.9931317132412728,1.0,2/6,13.73%,GALNT11;DNAH11
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.47179678275777925,0.7723515682060069,0.821917808219178,0.9928297978330359,1.0,3/8,14.05%,C1R;CTSL;PGK1
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.5180798376169033,0.7721848771328091,0.855072463768116,0.9926562675521368,1.0,3/5,46.66%,GNAL;ADCY3;GNAS
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4232812124950214,0.7708706524682389,0.8089887640449438,0.9938106221265466,1.0,8/32,20.81%,PSMB1;PSMB2;PSMA7;PSMA4;PSMD14;SNAP23;ITGAV;LNPEP
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4840956268066981,0.7707458279261337,0.7974683544303798,0.9935557440361346,1.0,7/13,35.24%,TDG;RPA1;ABL1;SETD2;PMS1;MLH3;RPA3
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.3766534953307386,-0.770507071138969,0.9090909090909091,1.0,1.0,3/12,11.63%,HSPA1A;TPR;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.4483605127290155,0.7703488335812325,0.7692307692307693,0.9936167398038205,1.0,1/14,4.78%,NIBAN2
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.49701892055114993,0.7702706389359723,0.8205128205128205,0.9933067262013082,1.0,2/6,14.50%,PTPN1;ATF6
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.4195873862486086,0.7700132765795412,0.7831325301204819,0.993171718581871,1.0,2/16,5.74%,NRG1;IL18
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.46233896186250534,0.7695487865978595,0.76,0.993258360461675,1.0,5/14,14.98%,RNF152;GPR137C;SZT2;SESN1;C9ORF72
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.32222813723376376,-0.768930160443726,0.8235294117647058,1.0,1.0,3/16,9.64%,NRP1;SEMA6D;PLXNB2
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.40130419741769524,0.7685723445533436,0.8214285714285714,0.9940688800388676,1.0,2/20,13.46%,RHOJ;KDR
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.4153260024490819,-0.7685072713319,0.7272727272727273,1.0,1.0,4/8,17.98%,ADCY6;ADCY2;ADCY9;GUCY1B1
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.5037024558017407,0.7683553587284269,0.8382352941176471,0.9938911554457578,1.0,1/7,17.23%,CDKN1B
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.5138422328101215,0.7680170371064244,0.84375,0.99390505310589,1.0,3/6,30.51%,SLCO1A2;NCOA2;ATP8B1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5031909617824634,0.7679821458738476,0.8533333333333334,0.9922826237553423,1.0,1/6,2.31%,PANK2
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.5031909617824634,0.7679821458738476,0.8533333333333334,0.9922826237553423,1.0,1/6,2.31%,PANK2
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5031909617824634,0.7679821458738476,0.8533333333333334,0.9922826237553423,1.0,1/6,2.31%,PANK2
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.5031909617824634,0.7679821458738476,0.8533333333333334,0.9922826237553423,1.0,1/6,2.31%,PANK2
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.45700971393203416,0.7679494521875132,0.7763157894736842,0.9919277546877094,1.0,2/11,20.79%,PDE4D;ENTPD4
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.38856599008124487,0.7678888933837712,0.8539325842696629,0.9915816704622971,1.0,13/59,16.14%,PHYHIPL;GJA1;GFAP;ALDH1L1;ADGRB3;SYNDIG1;SNAP25;CADM2;CDH20;SLC1A2;PTPRZ1;NRXN1;TEAD1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.5286275402750501,0.7671730920038587,0.8108108108108109,0.992088625837578,1.0,2/5,31.06%,KMT2A;HDAC5
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.43990451961525645,0.7663143452916766,0.8255813953488372,0.9927859931500197,1.0,8/19,26.71%,ANK3;GGA3;NSF;PREPL;BLZF1;VAMP5;GOLGA4;GGA2
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.4571266567772579,0.7650832914627705,0.8518518518518519,0.9937455973628155,1.0,2/13,14.37%,CST3;LRRK2
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.4279793119685103,0.765030256709111,0.8170731707317073,0.9933823835568102,1.0,5/20,22.38%,MTMR9;MTMR1;PIP4P2;MTMR2;SGPP1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.4238655516756267,0.7649630191103697,0.872093023255814,0.9930364141969782,1.0,4/25,14.57%,CSNK1A1;WNT2B;LRRK2;FZD3
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.4662779995074544,0.7646615089471517,0.8352941176470589,0.9929320543865763,1.0,4/11,21.99%,CD38;VAV3;IRS2;CD81
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.4365262766202364,0.7643380629508781,0.8333333333333334,0.9928743328660864,1.0,4/16,14.95%,ACADVL;CRY1;ROCK2;ACADL
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.47967980121803055,0.764144806101496,0.7631578947368421,0.9927066744792554,1.0,1/6,7.94%,PIGL
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.4715485284575524,0.7631971519246689,0.8493150684931506,0.9936131765009677,1.0,5/8,25.20%,SLC6A17;SLC3A2;SLC36A4;SLC38A2;SLC1A1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.4416337669888723,0.7631708655872003,0.8214285714285714,0.9932297901447277,1.0,6/16,18.40%,HOMER2;PDE4B;RUNX1;PDE4D;PRNP;NAV3
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.4713569273074386,0.7631388000784715,0.7837837837837838,0.9928551721792385,1.0,1/8,13.86%,STAT3
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.4114940731107076,0.7630400581993817,0.8255813953488372,0.9925948907077562,1.0,7/27,26.05%,CCT4;TNKS;MAPK1;CCT3;MAPKAPK5;RGCC;CCT8
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.4158235026105556,0.7629807711549361,0.813953488372093,0.9922588399828566,1.0,10/27,32.90%,SRSF10;KHDRBS3;RBM39;AHCYL1;METTL16;KHDRBS2;SRSF3;RBM23;PAPOLA;SRPK2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.4602339333121514,0.7628037447433385,0.8648648648648649,0.9920496578300835,1.0,3/8,33.27%,AKAP6;PLCG1;GPER1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.45585963869644625,0.762183097923893,0.8309859154929577,0.9924269381659631,1.0,4/10,18.00%,ELF1;RUNX1;CBFB;LIFR
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.3875932630452326,0.7621174733965874,0.8260869565217391,0.9921082396767047,1.0,10/51,19.55%,PSMB1;PSMB2;PSMA7;RPS27A;CCNH;PSMA4;RBX1;PSMD14;RPA1;NAP1L1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.46140922207785023,0.7619815771194364,0.8024691358024691,0.9918740935435294,1.0,1/10,5.74%,IL18
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.41608262217017755,-0.7612489944805507,0.7586206896551724,1.0,1.0,5/8,19.49%,ST6GAL1;ST3GAL1;PARN;ST3GAL4;ST3GAL2
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.49918137790176786,-0.7609917412206677,0.7419354838709677,1.0,1.0,1/5,0.19%,WDFY4
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.5237306761964429,0.7608704658881121,0.8225806451612904,0.9927396468144246,1.0,1/5,0.42%,CSF1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.3623849060491227,0.7607655194708597,0.875,0.9924549020983006,1.0,13/77,13.65%,CD44;PTPN1;EPHA7;CSF1R;APIP;TGFB1;EGFR;CCN2;PDE8A;FGFR2;RANBP9;KDR;CAMK2N1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.35255097184156114,-0.7603601949088034,0.85,1.0,1.0,1/20,2.29%,ATM
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.4695134671332786,0.760246257742696,0.7714285714285715,0.9927049585917453,1.0,2/8,23.45%,RIOK3;UBE2K
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.3659590640500092,0.7599868301695154,0.8526315789473684,0.9925593092214083,1.0,7/71,10.19%,GJA1;CRMP1;DCLK1;TENM3;SMARCA1;SYNDIG1;SHC2
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.37465396609941504,0.758852252578174,0.8526315789473684,0.9935787579976803,1.0,14/87,18.88%,LPIN1;GNPAT;MTMR9;SELENOI;MTMR1;AGK;AGPAT4;LPCAT3;ARF1;RUFY1;CSNK2A1;CHKA;ABHD5;DGKH
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.4370469984884855,0.758681774427905,0.8674698795180723,0.9933950322123463,1.0,2/17,9.43%,RHEB;CLOCK
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.45195652009181264,0.7585924562740322,0.7654320987654321,0.9930853916725477,1.0,7/13,38.39%,ENTPD4;NUDT5;RNASEH2C;PNPT1;XRN2;HNRNPD;NCBP1
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.4202541121945135,0.7583403578401774,0.7804878048780488,0.9929608282270197,1.0,2/16,5.15%,ANK3;FHL1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.4948423105441523,0.7580718039873026,0.8356164383561644,0.9928825538888115,1.0,2/8,14.23%,DUSP1;PPP3CA
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.4104384377370215,0.7571118580581947,0.7792207792207793,0.9936689296383663,1.0,4/20,13.99%,PANK2;PAPSS1;GMPS;PAPSS2
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.3988618189161644,0.7570529081341254,0.8804347826086957,0.9933387106353543,1.0,9/37,19.68%,PSMB1;PSMB2;BTRC;PSMA7;PSMA4;PSMD14;CDKN1B;ANAPC4;SKP1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.4220421046125213,-0.7566940569121096,0.71875,1.0,1.0,1/8,0.69%,CDK6
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.4321163732598841,0.7566488194143592,0.7792207792207793,0.9934700550749733,1.0,7/16,31.15%,AGK;SAMD8;CERS6;SPTLC1;ASS1;SPTLC3;SGMS1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.4493581713633634,0.7564819893690308,0.8433734939759037,0.9932533696062592,1.0,4/17,17.63%,CDH2;CTNNA2;FGFR2;ABL1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4007722988546051,0.756466761577087,0.8260869565217391,0.9928441181148681,1.0,6/42,14.52%,ATP6V1G1;ATP6V1H;ATP6V1E1;IRS1;PDK4;INSR
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.429757080599079,0.7563072238602982,0.8024691358024691,0.9925692316993345,1.0,5/19,20.77%,CCT4;TNKS;MAPK1;CCT3;MAPKAPK5
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.420077143158188,0.7561951987495313,0.8255813953488372,0.9922736383728372,1.0,7/30,20.64%,PSMB1;PSMB2;PSMA7;PSMA4;PSMD14;SNAP23;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.4244403144531337,0.7561132944857547,0.7654320987654321,0.9919448089193247,1.0,3/16,6.24%,PTPN1;CSF1R;ADAM17
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.4797806560285144,0.7560951851709974,0.7941176470588235,0.9915535019175684,1.0,1/7,8.25%,EGFR
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.3773059484834886,-0.755475366923513,0.8620689655172413,1.0,1.0,2/6,6.54%,MECOM;ETV6
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.4079778701523815,0.7552335136511171,0.8735632183908046,0.9921786176085502,1.0,3/27,12.72%,CCP110;TP63;FGFR2
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.4831261547519766,0.7540746213464851,0.8133333333333334,0.9927128616071195,1.0,1/8,19.38%,CAMK2D
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.4831261547519766,0.7540746213464851,0.8133333333333334,0.9927128616071195,1.0,1/8,19.38%,CAMK2D
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.5323863436187659,0.7537107056007029,0.8714285714285714,0.9926810466627733,1.0,1/5,4.38%,OGN
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.3855564609441774,0.7536538275798628,0.851063829787234,0.9923653837462759,1.0,4/39,7.81%,NUP153;XPO4;CSE1L;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.4144884377402432,-0.7535320789150807,0.64,1.0,1.0,1/5,6.11%,RAD51B
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.5304548131093971,0.7529669810885415,0.8571428571428571,0.9927593739077252,1.0,2/5,32.56%,IQSEC1;MTOR
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.406441531169154,0.7527240602137247,0.8045977011494253,0.9926316415632745,1.0,7/23,25.78%,NEDD4L;SGIP1;NLGN1;LDLRAP1;AXL;TF;CD151
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.36171523321507426,0.7525587370937066,0.8762886597938144,0.9924081158242776,1.0,15/67,18.37%,NRCAM;DNER;PTPRD;DDIT4;SMARCA1;WNT2B;ADNP2;ACSL4;RUNX1;DCDC2;MYT1L;FZD3;MAP2K1;PAFAH1B1;THOC2
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.5166336618778287,0.7521772959732118,0.8840579710144928,0.9923931620717981,1.0,2/5,30.72%,ABL1;PPP2CB
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.3681843830879244,0.7519900784344724,0.8969072164948454,0.9921282564933273,1.0,23/78,32.35%,DDX52;NOP58;RPL21;WDR43;RPL28;RPL41;RIOK3;RPLP2;DIS3;RPL9;RPL18;TEX10;RPS14;NOL8;RPL27A;RPL13A;RCL1;SRFBP1;RPL32;RPL31;PRKDC;RPS2;RPL34
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.47164545270934966,0.7518660807099403,0.8507462686567164,0.9918760609586298,1.0,1/8,12.51%,SMCHD1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.3460989654091459,-0.7515258375168594,0.8333333333333334,1.0,1.0,3/20,12.86%,RHOT1;CDC42;UBB
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.36373190268928907,0.751437162451703,0.8494623655913979,0.9919487591612405,1.0,17/63,34.46%,RPS21;RPS27A;RPL21;RPL28;RPL41;RPLP2;RPL9;RPL18;RPS14;RPL27A;RPL13A;RPL32;RPL31;RPS2;RPL34;RPL3;RPS4X
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.4479541694053628,0.7509319418706544,0.7746478873239436,0.9921628703133681,1.0,1/7,8.85%,IRS1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.4253841175904054,-0.7508833342361647,0.7083333333333334,1.0,1.0,2/7,10.75%,MTERF1;HMGB1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.5196599663284305,0.7508525364710786,0.8714285714285714,0.991815307260796,1.0,2/5,30.85%,CD9;PMP22
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.5180115487919219,0.7495764553322378,0.8307692307692308,0.9929148564533803,1.0,1/5,26.93%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.40156194502733555,-0.7492374144156201,0.7391304347826086,1.0,1.0,3/8,11.63%,MTM1;TMEM39A;CHMP4B
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.4709267189839162,0.7491486847351835,0.8181818181818182,0.9929412969202565,1.0,1/9,5.74%,IL18
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.49523547250333155,0.748883156278656,0.8714285714285714,0.9928846326815836,1.0,4/6,30.46%,ACER3;SPTLC1;SPTLC3;QDPR
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.3732737463214779,0.748591060863622,0.9139784946236559,0.9928197098004659,1.0,7/64,11.69%,MID1;TENM3;SMARCA1;ERRFI1;EGFR;TBX3;TTC23
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.418855598833532,-0.748256101192998,0.75,1.0,1.0,2/8,7.88%,SUN1;LEMD3
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.4297453098685803,0.7481875725469759,0.8395061728395061,0.9929167197154091,1.0,3/13,17.16%,DUSP1;OXSR1;STK39
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4746637830887489,0.748115801329197,0.8382352941176471,0.9925945943455741,1.0,2/6,19.07%,PWP1;SMARCA4
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.41434451352317647,0.7480680155184692,0.7738095238095238,0.9922478474501537,1.0,1/17,3.98%,GGA3
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.4904647243455875,0.7476731268211356,0.8767123287671232,0.9923200977243022,1.0,2/6,39.64%,LEF1;PML
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5127795703746606,0.7472691511925749,0.8714285714285714,0.9924130091064436,1.0,3/7,26.05%,CCT4;CCT3;CCT8
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.4409046460230482,0.7467177657854577,0.8518518518518519,0.9926508256593273,1.0,4/17,20.89%,MTMR9;MTMR1;PIP4P2;MTMR2
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.4537817738976812,0.746613445975351,0.8148148148148148,0.9923336049689784,1.0,7/11,43.57%,ARHGEF7;PIP5K1A;CTTN;PTPRK;PEAK1;FERMT2;SORBS1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.4660934805830389,0.7460521925371127,0.8205128205128205,0.9925795381335254,1.0,4/9,14.26%,CDH2;CD9;NDUFS2;METTL14
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.3909899936863219,-0.7460416296322651,0.8125,1.0,1.0,2/14,4.38%,GLB1;ARSB
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.4988412085900149,0.7456673395848438,0.7777777777777778,0.9925935849297127,1.0,1/6,20.34%,NUP205
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.3548591285345784,0.7455176508755658,0.9393939393939394,0.9924008416936847,1.0,8/108,5.34%,CD44;RHOB;GJA1;CADM1;ITGA5;BASP1;WIPF1;CDH2
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.495135778078806,0.7454744430427975,0.8028169014084507,0.9920263639545359,1.0,2/7,24.51%,LRRK2;RGN
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.40787867893667806,-0.7454716418133749,0.696969696969697,1.0,1.0,2/7,3.74%,EDN3;RYR2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.4802771632861532,0.7445790711243498,0.8356164383561644,0.9922737795149649,1.0,2/5,38.68%,DNM2;DNM3
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.4802771632861532,0.7445790711243498,0.8356164383561644,0.9922737795149649,1.0,2/5,38.68%,DNM2;DNM3
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.32229795517953813,-0.7441752415862599,0.9,1.0,1.0,3/18,4.03%,CYP4V2;CYP27A1;PPARD
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.3236435731352131,-0.743887820550905,0.88,1.0,1.0,1/17,2.44%,TTC7A
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.41454323750174366,0.7436515818980339,0.8666666666666667,0.9929320234459413,1.0,3/14,20.64%,XKR4;SCARB1;ITGAV
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.3750013744616188,0.7432488646422966,0.8901098901098901,0.9929128755418893,1.0,13/41,28.91%,RHOB;CSF1R;ROCK2;CORO2B;C9ORF72;ABL1;ABL2;GPM6B;CCDC88A;PTK2B;PAK1;RHOBTB3;CRK
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.48068560245068226,-0.7430216348119234,0.7741935483870968,1.0,1.0,2/6,3.55%,WNK2;ATP1B2
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.4117824758597756,0.7428622804914818,0.8928571428571429,0.9929886298081396,1.0,9/24,20.21%,CDC5L;STK33;CLOCK;MDM4;TP53BP1;USP10;ABL1;DONSON;GRB2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4269162352305451,0.7422850557340029,0.8148148148148148,0.9932993811102697,1.0,5/21,20.77%,CCT4;TNKS;MAPK1;CCT3;MAPKAPK5
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.46925269966458794,-0.7421807290683657,0.7,1.0,1.0,2/5,3.48%,SLIT2;SLIT3
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.43356437166184814,0.7421404297947242,0.8705882352941177,0.9930946103241689,1.0,5/14,21.53%,TGFB1;SMURF2;LATS2;SMAD2;SMAD7
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.48826836198279056,0.7417876335339678,0.8513513513513513,0.992997138246049,1.0,1/5,20.81%,LNPEP
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.443886362819513,0.7413444977270904,0.8356164383561644,0.9931303991656028,1.0,3/10,27.98%,ZBTB16;TRPS1;PTPN11
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.4113482530596668,0.7411638915813912,0.8651685393258427,0.99291359403884,1.0,1/19,1.40%,TRMT9B
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.5048283610907136,0.7409773745759116,0.863013698630137,0.9927216573223279,1.0,3/5,44.90%,WRNIP1;WRN;SIRT1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3984505039314449,-0.7407518595811529,0.8095238095238095,1.0,1.0,2/11,4.20%,HECW2;CDC27
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.40557479653721273,-0.7400891176616224,0.6956521739130435,1.0,1.0,2/6,5.00%,NRP1;VPS35
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.4266907523125892,0.7398277764671188,0.8837209302325582,0.99355833179172,1.0,5/15,30.37%,TGFB1;TFPI;UBE2L3;NR1H3;UBE3A
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.4707072742445685,0.7396607546336518,0.8767123287671232,0.993321055829208,1.0,1/8,4.14%,WASF1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.4234813397730083,0.739573765219243,0.8809523809523809,0.9930223142131948,1.0,5/20,15.29%,PSMB1;PSMB2;PSMA7;PSMA4;PSMD14
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.45018857637440535,0.7395513015660022,0.8227848101265823,0.992633419587548,1.0,7/11,43.66%,FGFR2;ANKRD11;TGFBR1;FGFR1;LRP6;WWOX;DSCAML1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.3585299599045205,0.7384951149915074,0.9583333333333334,0.9932921693992746,1.0,14/85,16.71%,AGO2;NDFIP2;ROBO1;TGFB1;DNMT1;HIF1A;SDCBP;PTRH2;ROCK2;NDFIP1;RUNX1;KDR;TIPARP;MAP2K1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.3963632927251348,0.738379016342759,0.9080459770114943,0.9929896957442487,1.0,8/28,26.66%,RPS27A;CCNH;RBX1;RPA1;HMGN1;UVSSA;POLR2F;POLK
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.46034110764272496,0.7381753786985908,0.8533333333333334,0.992822893687456,1.0,5/8,35.27%,ACER3;SPTLC1;SGPP1;SPTLC3;PLPP1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.48263907205761125,0.7380305927972076,0.8717948717948718,0.992578284263893,1.0,3/6,32.40%,LDLRAP1;OSBPL5;NPC1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.3502448864196756,0.7378351165703337,0.9494949494949495,0.9923666765315183,1.0,11/101,11.31%,DDX3X;ETF1;IGF2BP2;GIGYF2;EIF2AK2;ELAVL1;RBM4B;CNOT8;EIF2AK4;CSDE1;EIF4ENIF1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.44276769947021993,-0.737798529589094,0.7142857142857143,1.0,1.0,5/5,55.77%,PIK3CD;PIK3CA;PIK3C2A;PIK3C3;PIK3CB
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.43197494964517347,0.737637035183251,0.8513513513513513,0.992183931684614,1.0,1/14,6.24%,ADAM17
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.40907361461144237,0.7375965805191841,0.8536585365853658,0.9918210551397018,1.0,7/22,26.66%,RPS27A;USP10;ZBTB1;RPA1;UBE2B;RAD18;POLK
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.4849825067219774,0.7368757190492521,0.8529411764705882,0.9922079654707764,1.0,2/5,19.62%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.44394197292628124,0.736156643734539,0.8611111111111112,0.992529061079121,1.0,2/11,11.07%,EIF2AK4;SIN3A
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.4035356621904507,0.7359926054684747,0.8651685393258427,0.992334268135276,1.0,9/21,32.64%,STMN1;ABL1;NAV3;CAMSAP1;SLAIN2;PAK1;DRG1;CLIP1;AKAP9
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.49535532673240845,0.7358369880892922,0.8169014084507042,0.9920823627131982,1.0,2/6,19.41%,SYN3;NLGN1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.3826280370764025,0.7340408238947268,0.8681318681318682,0.9936666260886886,1.0,18/47,35.48%,HNRNPC;PPARGC1A;TCERG1;SRSF10;NOVA1;SF3B1;DHX15;TRA2B;SFPQ;SNRNP48;SRSF2;SRPK2;HNRNPH3;TXNL4A;TARDBP;CDK12;RNPC3;SF3B3
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.44679481176010416,0.7338321410453224,0.84,0.9933939508086238,1.0,4/9,28.07%,EIF2AK2;IFITM3;AXL;RO60
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.4526165821838831,0.7326022274121925,0.875,0.9943594695984845,1.0,2/10,6.54%,ROBO2;ROBO1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.3570001698993052,-0.7322711497461564,0.8636363636363636,1.0,1.0,2/11,14.02%,CHMP4B;RMDN1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.35867188130278027,-0.7320124389817565,0.8421052631578947,1.0,1.0,1/11,0.79%,NRP1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.41131196233674555,0.7316400292303221,0.8658536585365854,0.9949974860628116,1.0,8/17,21.94%,NEDD4L;ANK3;GLRX;FGF14;HECW1;STK39;CAMK2D;FGF12
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.41535682432620735,0.7316217626957131,0.8571428571428571,0.9946225437687176,1.0,6/21,17.84%,PSMB1;PSMB2;PSMA7;PSMA4;PSMD14;PPM1K
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.3521741408684461,0.7311601653669122,0.9052631578947369,0.994704952814426,1.0,19/68,23.40%,CDC42EP4;NECTIN2;EGFR;C1R;SHC2;SEMA3B;PRLR;TBX3;CST3;NF2;PTH1R;C1QTNF1;GPX3;ANGPTL4;COL18A1;TF;MATN2;DIAPH2;FAM114A1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.42959271476338434,-0.7310178015790105,0.8214285714285714,1.0,1.0,2/5,10.75%,ATF7IP;HMGB1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.43111660884897185,0.7296463080121316,0.8902439024390244,0.9957581383130352,1.0,5/15,17.93%,CDC5L;STK33;CLOCK;TP53BP1;DONSON
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.3836563451245922,0.729349911570717,0.8555555555555555,0.9956443042695553,1.0,5/40,7.54%,CBFA2T2;TENM3;LRRC7;PRKCI;SCARB2
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.37028942495529765,-0.7288322088223609,0.6666666666666666,1.0,1.0,1/8,3.45%,HDAC9
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.45104815364349377,0.7287155921952015,0.7936507936507936,0.9959340756318565,1.0,3/6,28.65%,CD9;C1QTNF1;SH2B3
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.43796937999712693,0.7282502432565924,0.7922077922077922,0.9959506388768252,1.0,1/12,4.09%,NUP153
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.3746125536365052,0.7281835955905354,0.8902439024390244,0.9956087968936046,1.0,5/37,16.27%,PDLIM1;FRMD5;ROCK2;MYOM2;TTN
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.4144168177694284,0.7277553832457946,0.8214285714285714,0.9956010510596197,1.0,4/14,9.43%,PPP1CC;CRY1;RBM4B;CLOCK
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.4150770657801249,0.7277453660258677,0.8518518518518519,0.995210790032315,1.0,5/17,13.41%,KCNQ1;NOS1AP;ATP1B3;GNB1;AKAP6
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.4551419367828039,0.7275447897547298,0.8125,0.994995754410727,1.0,3/7,46.09%,ARHGAP24;PIK3CB;OGT
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.4287715353956553,0.7266941282168983,0.9036144578313253,0.9954924621541644,1.0,5/14,23.03%,CHD1;SP1;SMARCA4;JUN;LEF1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.3697283604078619,0.7261741446653436,0.8461538461538461,0.9956067101153234,1.0,12/42,27.64%,RPS27A;FAN1;CCNH;RBX1;RNF111;RPA1;HMGN1;UVSSA;POLR2F;POLK;FANCC;RAD23B
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.4030437829844002,0.7257491311191276,0.7954545454545454,0.9956274207013688,1.0,7/19,26.66%,RPS27A;USP10;ZBTB1;RPA1;RCHY1;NPLOC4;POLK
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.46668933167977866,0.7254779716825819,0.8289473684210527,0.9955425222255542,1.0,3/6,27.01%,DIAPH1;UBASH3B;PTK2B
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.4993652369316152,0.7254110599297572,0.835820895522388,0.9952303522806187,1.0,1/5,18.59%,RBPJ
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.4849027799922153,0.7252928013980761,0.8428571428571429,0.9945702519888561,1.0,3/5,20.02%,SECISBP2L;TRNAU1AP;SELENOT
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.4849027799922153,0.7252928013980761,0.8428571428571429,0.9945702519888561,1.0,3/5,20.02%,SECISBP2L;TRNAU1AP;SELENOT
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.4444238045615875,0.7248897772616472,0.8690476190476191,0.9946197179610989,1.0,4/11,34.57%,VTA1;STAM2;RAB11A;IST1
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.3419209490189854,-0.7246548809701175,0.9545454545454546,1.0,1.0,1/16,1.27%,JADE3
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.48893759205045123,0.7246177951165163,0.8552631578947368,0.9945394434657674,1.0,2/7,33.59%,PRKDC;NSA2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.4230211693665785,0.7245819030178059,0.8554216867469879,0.9941918311229323,1.0,1/14,10.38%,XKR4
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.4795676478593426,-0.7244022985097737,0.7857142857142857,1.0,1.0,1/5,8.81%,HOOK3
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.5121145536669695,0.724247310912355,0.8769230769230769,0.9941968394814403,1.0,1/5,10.12%,GNB1
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.38706231671671987,-0.7240334737676648,0.7586206896551724,1.0,1.0,2/6,6.46%,CKAP5;HSPA1A
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.38866050911972505,0.7239681446703651,0.8395061728395061,0.9940399111786361,1.0,9/22,27.24%,SDCBP;INSR;ARF1;TBC1D5;MTMR2;ANKRD13D;ATAD1;VEGFA;LRPAP1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.46091799032512626,0.7239064469143132,0.868421052631579,0.9937090994155725,1.0,4/8,38.05%,AP3D1;AP1G1;DTNBP1;AP3B1
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.4090056922943037,0.7233664469822805,0.8928571428571429,0.9939165486262111,1.0,7/15,40.17%,EZH1;NAP1L1;CTCF;ANP32B;MACROH2A1;RBBP4;SART3
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.4490311782068305,0.7232619444532415,0.8441558441558441,0.9935981794483627,1.0,1/7,7.62%,PPARA
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.4783021159269424,0.7212115186537275,0.8513513513513513,0.9954141763707333,1.0,3/5,47.82%,TGFBR1;TGFB2;TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.4808835704078268,0.7210952404822628,0.8260869565217391,0.9947366203980599,1.0,2/5,17.24%,HOMER2;PRNP
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4808835704078268,0.7210952404822628,0.8260869565217391,0.9947366203980599,1.0,2/5,17.24%,HOMER2;PRNP
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.3998004121115825,-0.721018822987229,0.7391304347826086,1.0,1.0,1/6,0.80%,SLIT2
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.4646834363571133,0.7207689841328366,0.8533333333333334,0.9947010259081089,1.0,4/7,39.65%,KDR;VEGFA;MYO1C;HSPB1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.40407213583386503,0.7206325761734745,0.8607594936708861,0.9944273672301195,1.0,3/17,13.86%,F3;TMSB4X;STAT3
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.4329137780386748,0.720589565728404,0.7692307692307693,0.9940853499622229,1.0,2/7,11.73%,DGUOK;GMPS
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.4582222485837435,0.7201656997283004,0.8260869565217391,0.9941307013454501,1.0,1/6,11.05%,TUT7
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.44530666337917624,0.7197416363205499,0.8734177215189873,0.9941840781115783,1.0,4/11,35.50%,RBPJ;CCDC88A;GPER1;RTN4
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.34261499591835615,-0.7193288713943583,0.9,1.0,1.0,1/10,0.83%,FGF1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.44510503867487905,0.719035653375697,0.8611111111111112,0.9944952730428674,1.0,1/8,5.49%,AKIRIN1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3874772018113067,0.7186143370564182,0.84,0.9944759686130928,1.0,6/18,21.96%,EAPP;TCERG1;HMGN1;SUPT16H;CCNK;ELL
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.40913353762832605,0.7186020624608909,0.8414634146341463,0.9941024020616079,1.0,5/19,13.35%,HNRNPC;ELAVL1;EIF4ENIF1;MAPKAPK2;PABPC1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.3515715492034991,0.7180821337163014,0.9101123595505618,0.9942281426926526,1.0,11/62,16.11%,WASF1;PITRM1;MIGA1;BNIP3L;AGTPBP1;MTFR1;PPARGC1A;CHCHD3;LRRK2;SLC25A4;SPG7
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.426406086456357,0.718051992167703,0.7794117647058824,0.9938549697167308,1.0,2/7,17.74%,HIF1A;SYBU
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3792495377313676,0.716852064549761,0.9146341463414634,0.9947045074594129,1.0,4/27,20.64%,MADD;TNFRSF10B;LGALS3;ITGAV
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3954700120919519,0.7163422727004692,0.9146341463414634,0.9948620171212911,1.0,4/20,20.77%,CCT4;TNKS;MAPK1;MAPKAPK5
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.4234503834388159,-0.7158634085388016,0.6923076923076923,1.0,1.0,1/5,5.10%,NBL1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.3704129308582851,0.715806698091322,0.8488372093023255,0.9949993126864146,1.0,10/33,26.93%,ADAM17;TGFB1;HIF1A;TMSB4X;KDR;SP1;NF1;ETS1;RGCC;VEGFA
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.3464741020641643,0.7156764114098539,0.8804347826086957,0.994758963879143,1.0,5/68,10.68%,RPS21;RPS27A;RPL21;RPL28;RPL41
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.3240160358909529,-0.7152737306295283,0.9411764705882353,1.0,1.0,1/21,3.40%,THOC1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4030815223322677,-0.7142845582389729,0.7111111111111111,1.0,1.0,2/5,15.09%,ITGB1;JAM2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.4030815223322677,-0.7142845582389729,0.7111111111111111,1.0,1.0,2/5,15.09%,ITGB1;JAM2
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.40093077040817776,0.7123928540546912,0.9069767441860465,0.9976342539592412,1.0,5/21,13.46%,ADAM17;TGFB1;F3;TMSB4X;KDR
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.4027597188570443,0.7118870057224858,0.8690476190476191,0.9977662797945123,1.0,2/16,4.76%,GLRB;GABRE
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.36319046191391996,0.7117942229444407,0.825,0.9975130891582766,1.0,4/22,13.46%,CAMKK2;PPARGC1A;SPIRE1;KDR
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.43845055097865016,-0.7114823702105973,0.7777777777777778,1.0,1.0,3/5,24.48%,DOCK10;DOCK11;PPP2R3C
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.3433834010056668,-0.7106841356101036,0.7272727272727273,1.0,1.0,3/9,10.86%,PGF;NTF3;CXCL12
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.3294541728637166,-0.7106154039791731,0.9230769230769231,1.0,1.0,7/21,17.79%,PIP4K2B;MTM1;TMEM39A;CHMP4B;TBC1D12;PIKFYVE;SEC22B
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4344757356180827,0.710555842093531,0.855072463768116,0.9982906694064191,1.0,1/10,5.90%,MGAT4A
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.4413118306042465,-0.7101135158726344,0.7941176470588235,1.0,1.0,1/5,5.00%,VPS35
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.3977146545786382,0.709636507908728,0.8352941176470589,0.9988752323063961,1.0,7/20,26.39%,NIBAN2;INSR;CFL1;TDG;SEPTIN7;TRIP12;RAB14
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.4082854639524265,0.7095012296456695,0.8518518518518519,0.9986259108550735,1.0,5/14,19.79%,PARP11;TIPARP;TNKS;ARF4;PARP6
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.32755699340754263,0.7092311422134365,0.9484536082474226,0.9984889332621409,1.0,27/126,21.93%,COL4A6;CD44;ADAMTS9;ADAMTS4;ITGA5;SMOC1;MMP16;TGFB1;CTSL;KDR;PPIB;ST7;PXDN;COL7A1;ADAMTS17;COL11A1;FBN1;DST;LOXL3;JAM3;P4HA3;COL5A3;NF1;ITGAV;COL18A1;COL4A4;COL4A3
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.4305345163520314,-0.7089835515405942,0.7894736842105263,1.0,1.0,1/6,3.06%,ZDHHC21
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3631495640755966,0.7082418103144291,0.8461538461538461,0.9990807350563184,1.0,7/27,15.34%,PITPNC1;TMEM30A;ATP11A;SCARB2;ABCA1;ATP11B;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.365621405132079,0.7074034953790778,0.9230769230769231,0.9994679632294311,1.0,10/40,16.71%,DDX3X;CSF1R;ADAM17;ROBO1;TGFB1;EGFR;FLT1;LRRK2;MTCP1;MAP2K1
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.4512211379034314,0.7070090621459015,0.9315068493150684,0.9994908376258393,1.0,3/9,31.81%,LRRK2;CPEB2;RDX
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.35026394754496093,-0.70689897421641,0.9,1.0,1.0,5/11,13.47%,CD4;RPS3;ANXA1;TRAF6;GLMN
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.43371761237145806,0.7064251068802111,0.8421052631578947,0.999665654760699,1.0,4/8,30.49%,GALNT11;DNAH11;RFX3;BBS7
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.39350990201754177,0.7063970964016695,0.8809523809523809,0.9992926913978065,1.0,4/22,14.95%,ACADVL;ECHDC1;PPARGC1A;ACADL
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.452420018524351,0.7058758217529857,0.8253968253968254,0.9993955241780623,1.0,3/5,48.54%,NSMCE2;SMC5;RAD52
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.4467656592932378,0.7057915413366762,0.8961038961038961,0.9991108334936395,1.0,2/10,16.27%,CDH2;TTN
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.44736085468122405,0.7049691226634931,0.8734177215189873,0.9995530352589386,1.0,1/11,4.38%,OGN
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.3536519950413529,0.7047949942905442,0.925531914893617,0.9993124085310797,1.0,14/65,21.98%,ENPEP;SLC35D1;MARCHF6;MCCC2;TMBIM6;GSR;PAPSS2;PDK4;CA2;PTGR1;ELOVL5;PROS1;SLC6A12;GCLC
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.3997679277442679,0.7044735092031061,0.9024390243902439,0.9992395318517813,1.0,6/19,26.66%,RPS27A;USP10;ZBTB1;RPA1;WRNIP1;POLK
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.45263383061763196,0.7042339498110619,0.8714285714285714,0.9990710005950156,1.0,2/5,31.34%,LGALS3;PRKDC
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.34946490810660424,0.7035966086279936,0.9042553191489362,0.9992534069277494,1.0,19/74,27.64%,RAD21;CASP8AP2;STMN1;TGFB1;HIF1A;MTF2;SRSF10;CDKN1B;PAFAH1B1;ABL1;NSD2;CTCF;TRA2B;RPS6KA5;SFPQ;FANCC;PDS5B;AMD1;RAD23B
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.4207727994108579,0.7034491671252184,0.8148148148148148,0.9990292142214002,1.0,4/12,26.42%,RPS27A;RPA1;RCHY1;NPLOC4
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.3365966139065788,-0.7019624336487406,0.782608695652174,1.0,1.0,1/13,0.79%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.3911670280433234,0.7012364041755422,0.8607594936708861,1.0,1.0,3/18,15.75%,ZBTB16;CEBPB;TMEM64
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.3684344015838974,-0.7010758252039564,0.7727272727272727,1.0,1.0,2/13,7.96%,ERCC6;FUS
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.4394393927658744,0.7007149706585308,0.8333333333333334,1.0,1.0,1/10,8.18%,UGCG
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.44793696322516685,0.7007027483178612,0.855072463768116,1.0,1.0,2/5,35.71%,LOXL3;EMP2
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.4761880875003738,0.7005696794528476,0.9027777777777778,0.9996528383622635,1.0,3/5,29.48%,ACER3;SPTLC1;SPTLC3
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.4761880875003738,0.7005696794528476,0.9027777777777778,0.9996528383622635,1.0,3/5,29.48%,ACER3;SPTLC1;SPTLC3
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.44672963627628126,0.7005246498379084,0.8985507246376812,0.9992938477981266,1.0,2/9,11.07%,EIF2AK4;SIN3A
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.4527040806426825,0.7005142400753988,0.8378378378378378,0.9989033460991043,1.0,4/6,25.47%,PTPRD;LRFN5;GPC4;LRRC4C
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.3635628230973116,-0.7001448159750343,0.75,1.0,1.0,1/10,0.80%,SLIT2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.46725880974584943,0.6999878960662558,0.84,0.9989540870898024,1.0,1/6,5.28%,CSNK1D
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.4553280860667044,0.6998056073716159,0.8734177215189873,0.9986990322510422,1.0,2/7,16.88%,NR4A3;CA2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.43344250948944957,0.6993577518435877,0.9027777777777778,0.9986982123506414,1.0,1/9,7.62%,PPARA
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.464163635137004,0.6985936150263937,0.8787878787878788,0.9990425883129745,1.0,2/5,31.26%,HSPH1;CD55
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.4059619007192571,0.698493821432834,0.8513513513513513,0.9987560676738996,1.0,3/10,19.07%,PWP1;WDR43;SMARCA4
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.4129693572548274,0.698480964665484,0.8765432098765432,0.9983746184248358,1.0,2/17,7.91%,FHL1;MYO16
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.43761496733595684,-0.697030455218312,0.75,1.0,1.0,1/5,10.04%,ANXA1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.44421772772530954,0.6969721147621833,0.922077922077922,0.9992973337345044,1.0,1/9,3.18%,CD38
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3526047141825455,0.696970563542208,0.9775280898876404,0.9989080476676035,1.0,14/66,19.68%,PSMB1;PSMB2;BTRC;PSMA7;TGFB1;SDCBP;SRA1;PSMA4;MDM2;HECA;PSMD14;CDKN1B;ANAPC4;SKP1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.3939078928709541,-0.6967848706406533,0.8620689655172413,1.0,1.0,3/7,15.58%,HSPA1A;BCL2L1;CLU
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.4126590093197437,0.6966546568493622,0.8674698795180723,0.998808147395775,1.0,5/13,21.53%,ROBO2;ROBO1;HECTD1;NF1;SMAD7
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.43337084033620044,0.6966016868753988,0.8181818181818182,0.9984589397553425,1.0,2/9,14.37%,NECTIN2;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3314445839589352,-0.6963737255435717,0.9047619047619048,1.0,1.0,2/16,6.06%,MECOM;FKTN
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.4093467766033805,-0.6962039932594601,0.76,1.0,1.0,1/7,2.29%,ATM
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.44882782775998187,0.6954248687586366,0.9452054794520548,0.9990952854306654,1.0,4/7,36.77%,ITGAV;DCC;MCL1;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.4373955955716682,0.695307881109472,0.8051948051948052,0.998825346057637,1.0,3/7,47.82%,TGFBR1;TGFB2;TGFBR2
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.42844650549515806,0.6952836461552496,0.84,0.9984528157860943,1.0,4/8,17.63%,TNFRSF1B;PAG1;LGALS3;ABL1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.43694920532238235,0.6952415974709847,0.8970588235294118,0.9981082414663319,1.0,2/8,29.90%,LRFN5;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.41299538154831195,0.6948072515283892,0.8536585365853658,0.9981353105453317,1.0,2/16,7.91%,FHL1;MYO16
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.45334007776875956,0.6947881940528201,0.8405797101449275,0.9977753300765325,1.0,2/5,30.90%,ABL1;APP
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.43606441361611414,0.6944531672467669,0.9411764705882353,0.9977077616739064,1.0,3/6,28.65%,CD9;C1QTNF1;SH2B3
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.40250428496532453,0.694290043778372,0.891566265060241,0.9974547740461808,1.0,4/19,23.71%,ZFP36L2;DCP2;METTL16;RNASEH2C
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.43746480245548114,0.6939865517113505,0.8767123287671232,0.9973282122820917,1.0,2/9,14.74%,WASF1;PACSIN2
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.33526405381224617,0.6929283295761797,0.9354838709677419,0.9979588325772218,1.0,15/81,17.77%,CD44;GJA1;ITGA5;EMP1;EFNB2;HIF1A;C1R;EHD2;FGFR2;INSR;NF2;PTH1R;SVEP1;COL11A1;FBN1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.3047389558232932,-0.6925431402020776,0.9166666666666666,1.0,1.0,9/9,69.59%,HMGB1;EXOG;BLCAP;KPNB1;ACIN1;DICER1;KPNA1;GPER1;CECR2
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.42454341275362284,0.6923568169700484,0.925,0.9980647289557041,1.0,1/12,11.66%,TBX3
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.36369954242951197,0.6923093151606593,0.9010989010989011,0.9977489536614262,1.0,8/37,22.84%,CPSF2;SYMPK;GRSF1;CSTF3;PABPC1;THOC2;AHCYL1;SRSF5
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.4498168174082447,0.6919776304387445,0.828125,0.997634289721961,1.0,1/5,30.46%,QDPR
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.4541406844420392,-0.6916997073989687,0.9166666666666666,1.0,1.0,1/5,3.30%,AP3M1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.4541406844420392,-0.6916997073989687,0.9166666666666666,1.0,1.0,1/5,3.30%,AP3M1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.39432785439028595,0.6915312081233526,0.88,0.9976575109334116,1.0,6/18,28.59%,SDCBP;PSME3IP1;WAC;USP25;MARCHF7;EIF3H
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.35358405657344905,-0.6913820505387499,0.782608695652174,1.0,1.0,12/12,64.73%,CXCL12;WDR1;PLEKHG2;LATS1;GBA2;FCHSD2;ARHGAP28;PAK3;RASA1;ARHGAP35;ESAM;CTTN
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.4522900082700476,0.6911250497382914,0.8857142857142857,0.9976256169555442,1.0,3/7,35.76%,LGALS3;CD55;RC3H1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.3711900449841671,-0.6910745491115887,0.7727272727272727,1.0,1.0,2/8,7.76%,EPHA5;CRTC1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.4017771690408342,0.6902713888573414,0.8795180722891566,0.997967476989144,1.0,5/13,24.09%,ADAM17;ZBTB7A;PTPN2;KLF6;DCAF1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.38530020377248897,0.6898332978001248,0.8461538461538461,0.9980180697212775,1.0,3/15,16.19%,IL18;NFKBIZ;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.38154883228229125,0.6896982359032747,0.863013698630137,0.9977502162568993,1.0,2/15,11.82%,ROBO2;ROCK2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.3410778768899644,-0.6886240141672917,0.8,1.0,1.0,2/17,5.68%,LMCD1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.3349268092515312,-0.6885681370971614,0.8846153846153846,1.0,1.0,2/13,5.00%,RALBP1;VPS35
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.27940675912882285,-0.6881679114855674,1.0,1.0,1.0,5/18,15.34%,ATP2B4;HMGB1;APOE;PDCD10;THBS1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.40511429603107246,0.6868222021268298,0.9154929577464789,0.9997970056686363,1.0,1/9,6.14%,SEMA4D
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.3214383476913768,0.6862192780748858,0.9489795918367347,0.9999253914217716,1.0,16/87,23.56%,TBC1D20;MMUT;RGS7;SEMA4D;ARHGEF7;SIPA1L2;GARNL3;TBC1D15;RALGAPA2;TBC1D8;TBC1D5;NF1;ZC3H15;RABGAP1L;USP6NL;TBC1D4
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.3861214530639112,0.6860017252352276,0.925,0.9997160077710536,1.0,2/16,20.36%,OMG;NF1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.40188337177994365,-0.68595513084191,0.7727272727272727,1.0,1.0,4/7,20.45%,ACTN4;CORO1C;FBLN1;SPRY4
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.40188337177994365,-0.68595513084191,0.7727272727272727,1.0,1.0,4/7,20.45%,ACTN4;CORO1C;FBLN1;SPRY4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.44903743400369867,0.6858695972587853,0.9,0.9990466295512167,1.0,2/5,10.33%,NECTIN2;CTSL
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.44903743400369867,0.6858695972587853,0.9,0.9990466295512167,1.0,2/5,10.33%,NECTIN2;CTSL
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.4203781676832465,0.6854333975775379,0.8923076923076924,0.9989986231319814,1.0,4/8,41.64%,VEGFA;MAP3K4;SASH1;MINK1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.2876533153916621,-0.6854239467346308,0.8260869565217391,1.0,1.0,3/13,12.00%,CIRBP;NCL;SNW1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.3723923413529192,0.6854028741522379,0.927710843373494,0.998633105875401,1.0,7/27,25.04%,EGFR;RNF168;SMCHD1;BRCC3;UBR5;TRIP12;WRNIP1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.3703391764435908,0.6853107550002338,0.9285714285714286,0.9983658411553622,1.0,5/27,13.46%,MYDGF;ADAM17;HIF1A;F3;KDR
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.43982168639180286,0.6851588725815574,0.9090909090909091,0.9980752783991006,1.0,3/8,37.57%,WAPL;XRCC5;HNRNPD
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.3475923799625298,0.6850622875894782,0.956989247311828,0.9977771077805698,1.0,9/47,19.47%,NRG1;DDX3X;TGFB1;RAP1B;ABCA1;RBX1;LGALS3;RPA1;ASAP1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.42949767491868374,0.6847008659042142,0.8571428571428571,0.9977179394822465,1.0,1/8,15.61%,PIP4P2
prerank,MSigDB_Hallmark_2020__Myogenesis,0.3249756375312027,0.684389492753007,0.9595959595959596,0.9976509911118847,1.0,13/83,17.24%,LPIN1;TSC2;FHL1;SCD;SMTN;NCAM1;TGFB1;PDE4DIP;MYL3;MYOM2;CKB;CKMT2;PRNP
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.41326727256397033,0.6842179569581179,0.8783783783783784,0.9974471988491397,1.0,1/10,5.26%,IFT140
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.30913217998651743,-0.6839667843075424,1.0,1.0,1.0,5/22,9.18%,PRMT3;PER2;RPS3;HSPA1A;N4BP1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.34957512899387144,-0.6839212390629611,0.9166666666666666,1.0,1.0,2/7,13.39%,HOOK3;KIF3A
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.4254199852497531,0.6838993912439106,0.9178082191780822,0.9973334885312284,1.0,6/12,35.29%,RPS27A;RPA1;POLK;REV3L;RPA3;REV1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.3498447051661564,-0.6835825501210969,0.896551724137931,1.0,1.0,2/6,13.39%,HOOK3;KIF3A
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.35355773372479166,0.6831202971819813,0.9444444444444444,0.997094609634234,1.0,6/39,20.21%,ACTR3;WIPF1;MAPK1;ABL1;VAV3;GRB2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.35355773372479166,0.6831202971819813,0.9444444444444444,0.997094609634234,1.0,6/39,20.21%,ACTR3;WIPF1;MAPK1;ABL1;VAV3;GRB2
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.34858603119595943,0.6827557685040563,0.9438202247191011,0.9970475556307163,1.0,13/48,21.88%,PHYHIPL;PTPRD;PCDH17;SNAP25;SHC2;PPARGC1A;NRXN1;UNC5B;GRIA3;GRIA2;KCNT2;GABRB3;MAPK4
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.4249028093133342,0.6826444010388772,0.8055555555555556,0.9967585027978062,1.0,1/8,11.07%,SIN3A
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.3170988708452224,0.6821350128737176,0.94,0.9968716078362131,1.0,29/153,20.98%,FMN2;CRY1;TNFRSF1B;STK33;APBB1;RNF168;ZBTB40;FAN1;BCL6;TANK;WAC;MAPKAPK2;MAP2K6;TP53BP1;SUSD6;WDR48;USP10;USP3;ZBTB1;RBBP6;RPA1;ABL1;VAV3;STXBP4;GRB2;UBE2B;BOD1L1;UBR5;CCNK
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.35041494174154514,0.6818609319408484,0.891566265060241,0.9967622808036233,1.0,2/33,6.83%,CSF1;TRIOBP
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.37275171708673804,0.6804435959810167,0.8823529411764706,0.9976941504561179,1.0,4/23,20.34%,WDR73;NUP133;REEP3;NUP205
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.30446756075168213,-0.6797532162797933,0.9411764705882353,1.0,1.0,4/16,13.52%,TNIP1;N4BP1;SETDB1;IFI16
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4444170403296336,0.6794822561706217,0.8904109589041096,0.9981419780018842,1.0,1/9,9.30%,DNMT1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.336267467237894,0.6794029700866266,0.967741935483871,0.9978179927914189,1.0,8/54,17.63%,RHOB;DIAPH1;IQCJ-SCHIP1;TRAF3IP1;ROCK2;CORO2B;MAPK1;ABL1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.35405622489959837,-0.6784579825964957,0.8888888888888888,1.0,1.0,9/9,64.66%,MAP2;PTEN;HSP90AA1;GBA2;HSP90AB1;NTRK2;ARHGAP35;RAPGEF2;B4GALT5
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.4146462909525725,0.6784187041692967,0.9444444444444444,0.9982771143311764,1.0,4/13,19.09%,BASP1;SMCHD1;FGFR2;LOXL3
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.46649995876655853,0.6783664681781142,0.8840579710144928,0.9979611121137878,1.0,2/5,35.71%,CAMK2D;EMP2
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.454483856585188,0.6780174225286346,0.8939393939393939,0.997902213053942,1.0,2/6,37.38%,NF1;APPL2
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.3700337733660978,0.6767703232606948,0.9634146341463414,0.9985202797595488,1.0,6/27,19.91%,CSF1R;PIGL;AGK;PAFAH1B1;DGKH;SERINC1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.3296437666398932,-0.6762543171857437,0.8888888888888888,1.0,1.0,1/11,2.29%,ATM
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.3491796547141515,0.6762093268819014,0.8764044943820225,0.9986050997785697,1.0,3/30,15.30%,ZFP36L2;TANK;ERBIN
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.4160647688680331,0.6757830333884679,0.8873239436619719,0.9985926705858741,1.0,5/11,21.72%,MYRIP;ACSL4;GLUD1;SELENOT;IRS2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3301893253285725,-0.6748188192424389,0.9130434782608695,1.0,1.0,2/10,10.43%,DDB2;CUL4B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3301893253285725,-0.6748188192424389,0.9130434782608695,1.0,1.0,2/10,10.43%,DDB2;CUL4B
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.3092547042969216,-0.6744457240947265,1.0,1.0,1.0,1/18,0.79%,NRP1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.33061555375641977,0.6742933274865817,0.96875,0.9994701195079456,1.0,7/81,7.56%,RHOB;RHOJ;ARHGAP31;ARHGEF9;ARHGAP15;FAM13A;MCF2L
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.3858201676831121,-0.674039584037045,0.71875,1.0,1.0,1/6,9.83%,MSH6
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.43398051836728435,0.6735158132532996,0.8333333333333334,0.9998302722641633,1.0,2/7,13.17%,EIF2AK4;SESN1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.33438471526230107,0.6730870758285006,0.945054945054945,0.999813506585473,1.0,6/51,10.57%,SMARCA1;TACC2;EGFR;F3;CCN2;SEMA3B
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.3886529079193607,0.6721542321928992,0.9230769230769231,1.0,1.0,3/13,26.03%,UBN1;RBBP7;CENPP
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.4035609855835157,0.6721449637640525,0.8717948717948718,0.9998537328245858,1.0,2/12,7.14%,SSH1;STMN1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.41650562004870284,-0.6720880926817018,0.8181818181818182,1.0,1.0,1/5,2.21%,TNIP1
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.4693990669452469,0.6712917507887286,0.9264705882352942,1.0,1.0,1/5,16.81%,MAGT1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.4450212115068854,0.6703712398751722,0.9305555555555556,1.0,1.0,1/8,9.30%,DNMT1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.41358090585686635,0.6703277890214373,0.8658536585365854,0.999790661693047,1.0,2/8,13.17%,UBR1;SESN1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.41358090585686635,0.6703277890214373,0.8658536585365854,0.999790661693047,1.0,2/8,13.17%,UBR1;SESN1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.35523097135431303,-0.6700576972577102,0.9583333333333334,1.0,1.0,3/9,10.04%,BCL2L11;AKR1C3;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.3130675407493934,-0.6697751631980121,0.9047619047619048,1.0,1.0,2/17,4.14%,ANKRD13A;AATF
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.34306145109438985,0.6693324964292925,0.9101123595505618,1.0,1.0,11/32,34.38%,CSNK1D;TNKS;GOLGA2;GOLGA8B;LSM14A;RAB11A;ZNF207;SMC1A;GOLGA8A;MAP9;SMC3
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.4274128125809096,0.6681172596935375,0.8888888888888888,1.0,1.0,3/7,22.36%,AGK;SERINC1;SPTLC1
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.33977714852548335,0.666727827409926,0.9230769230769231,1.0,1.0,8/55,14.23%,CYTH1;EPHA7;IL18;SEMA4D;FRMD5;DUSP1;ROCK2;PPP3CA
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.4230902154995742,0.6666431053875714,0.825,1.0,1.0,2/7,9.74%,SNAP25;GLUL
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.32589497105486204,0.666371940095176,0.9479166666666666,1.0,1.0,6/46,17.63%,RHOB;HIF1A;ROCK2;KDR;SCARB1;ABL1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.3560923890442389,0.666030171953618,0.9325842696629213,1.0,1.0,10/28,27.98%,HNRNPF;FGFR2;CEP57;MAPK1;GRB2;POLR2F;HNRNPM;SPRED1;RAB14;PTPN11
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.43825173481047686,0.665362649766277,0.9444444444444444,1.0,1.0,2/5,17.24%,GRIN2B;PRNP
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.2962816342307805,-0.6651972774836596,1.0,1.0,1.0,2/13,5.37%,YWHAB;YWHAQ
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.2962816342307805,-0.6651972774836596,1.0,1.0,1.0,2/13,5.37%,YWHAB;YWHAQ
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.3151234087396762,0.6640382049470237,0.9591836734693877,1.0,1.0,17/80,25.34%,EMP1;TP63;PPARA;EGFR;ZC3H7A;EHD2;FILIP1L;SLK;TEAD1;FBN1;DST;ITGAV;FAM114A1;SH3PXD2B;STARD13;NRP2;COL4A1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.44399447108939755,0.6639311722193675,0.9027777777777778,1.0,1.0,1/5,5.29%,EMP1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.37020331655053806,-0.6635656380027743,0.9354838709677419,1.0,1.0,1/7,8.74%,NTF3
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.3660856992793745,0.6631557551135548,0.898876404494382,1.0,1.0,7/19,39.75%,PPARGC1A;FYCO1;SURF4;SORBS3;GSK3B;ATL3;UVRAG
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.431241088387888,0.6630816042794635,0.9154929577464789,1.0,1.0,1/6,13.12%,MDM2
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.3666535585121966,0.6629405300804211,0.9012345679012346,1.0,1.0,4/20,16.22%,GLRB;GABRE;SLC4A10;GABRB1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.3699557436088342,0.6624402071801317,0.896551724137931,1.0,1.0,4/21,22.54%,CSNK1A1;LIX1L;MAP1LC3B;LAMP2
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.346173696175233,-0.6616621641423837,0.95,1.0,1.0,3/15,9.38%,NRP1;SEMA6D;CORO1C
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.32735150042998395,0.6610280574142128,0.9777777777777777,1.0,1.0,19/70,27.13%,GJA1;TACC2;EGFR;C1R;PRLR;PDE8A;KDR;SVEP1;LIFR;C1QTNF1;ADGRF5;MATN2;FAM114A1;COL21A1;COL4A1;TJP1;ESRRG;TIMP3;ASS1
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.43552352586511545,0.6603637068962831,0.9032258064516129,1.0,1.0,1/5,24.54%,RAD18
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.41145761516440316,0.6601167551104722,0.835820895522388,1.0,1.0,3/9,31.78%,ROCK2;FMNL2;DLG1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.3114537118052016,-0.6597032312861422,0.9545454545454546,1.0,1.0,1/14,2.23%,PRPF6
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.40834708162543365,0.6595182697061461,0.9090909090909091,1.0,1.0,5/10,37.38%,TRIM5;IRF1;CD55;ERAP1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3729861083816505,0.6594189178494246,0.8961038961038961,1.0,1.0,3/22,18.25%,SDCBP;WAC;CSNK2A1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.37795929877437956,0.6591029564976773,0.9210526315789473,1.0,1.0,4/14,23.23%,MDM4;ZFPM1;SMAD6;OLFM1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.38816687289887497,0.6585315821915488,0.9113924050632911,1.0,1.0,2/12,6.24%,ZFP36L2;ADAM17
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.309153666682879,-0.6585189973694642,0.9230769230769231,1.0,1.0,1/9,2.21%,TNIP1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.4021763355472978,0.658484258499828,0.9,1.0,1.0,3/10,12.99%,MYRIP;ACSL4;GLUD1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.34481491037356665,-0.6584622024848875,1.0,1.0,1.0,2/16,5.04%,PSMF1;QRICH2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.3526634979855319,0.6583388888423309,0.9397590361445783,1.0,1.0,8/28,25.86%,NIBAN2;ROCK2;PGK1;PTPRM;COL4A3;SARS1;SPRED1;RGCC
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.3665211539600348,0.6579773746348474,0.9358974358974359,1.0,1.0,5/19,21.53%,ROBO2;ROBO1;ZFPM2;ZFPM1;SMAD7
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.4408213802125909,0.6572934255354355,0.9142857142857143,1.0,1.0,1/6,30.61%,HNRNPU
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.3874961498184744,0.6571750117699404,0.8947368421052632,1.0,1.0,5/14,42.17%,ABL1;CAMSAP1;CTTN;ESAM;RASA1
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.40808629962111187,0.6571098312194278,0.8780487804878049,1.0,1.0,3/9,24.45%,SLC4A10;CA2;SLC9A9
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.33024293800523047,-0.656893635943666,0.9032258064516129,1.0,1.0,3/9,19.02%,IWS1;SRPK1;SUPT6H
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.4123376803754661,0.6557376478302334,0.9125,1.0,1.0,2/9,12.37%,TUT7;DCP2
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.3568172909122655,0.6554375741608339,0.9318181818181818,1.0,1.0,4/28,6.75%,NEDD4L;SCN3A;SLC6A17;ATP1B3
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.276502975548982,-0.655207262857113,0.9523809523809523,1.0,1.0,1/16,2.34%,LAMC1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.4184119136848451,0.6547955567227789,0.9253731343283582,1.0,1.0,1/9,3.43%,ITGA5
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.2902700464811741,-0.6546735290742252,0.88,1.0,1.0,3/11,12.00%,CIRBP;NCL;SNW1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.38437866936023846,0.6543868962660618,0.8450704225352113,1.0,1.0,4/12,22.36%,AGK;SAMD8;CERS6;SPTLC1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),-0.36576376736442073,-0.6524312159057094,0.9375,1.0,1.0,1/5,10.51%,ACACA
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.39424614104208433,0.6524172380829985,0.8831168831168831,1.0,1.0,4/14,16.19%,PDE4B;PPIB;ADGRE2;LGALS3
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.36854078012016145,-0.6519406014294999,0.9230769230769231,1.0,1.0,1/7,1.97%,PARP9
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.365405433613657,-0.6515962637294966,0.9,1.0,1.0,1/6,3.74%,RYR2
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.3642002032751408,0.6514001094396494,0.8837209302325582,1.0,1.0,4/18,17.24%,GGA3;BTRC;MDM2;PRNP
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.39056444341483093,0.6508555667105659,0.9487179487179487,1.0,1.0,3/14,13.35%,ELAVL1;EIF4ENIF1;PABPC1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.36890061161732174,0.6500967451373888,0.9176470588235294,1.0,1.0,9/16,32.16%,SOAT1;ABCA1;LDLRAP1;MT3;ABCA5;OSBPL5;FDFT1;FDPS;INSIG2
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.3655061621244932,0.6499175775240532,0.926829268292683,1.0,1.0,3/16,16.44%,RPS27A;RBX1;RNF111
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.430258948321381,0.6496149077999781,0.8648648648648649,1.0,1.0,3/6,13.17%,RNF152;SZT2;SESN1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.3771456840475612,0.6486762696304891,0.9047619047619048,1.0,1.0,2/13,12.72%,TRAF3IP1;FGFR2
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.4382480878358745,0.6482735723388398,0.9,1.0,1.0,1/5,10.99%,TRAF3IP1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.37385874699590926,0.6479377062495433,0.9523809523809523,1.0,1.0,1/15,2.52%,TENM2
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.37614437143881746,0.6479194513161344,0.925,1.0,1.0,6/15,40.17%,UBN1;NAP1L1;ANP32B;MACROH2A1;RBBP4;SART3
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.324816730221837,0.6477847353093377,0.9651162790697675,1.0,1.0,4/36,13.59%,EGFR;RNF168;SMCHD1;BRCC3
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.36099665050185636,0.6463100246047031,0.9367088607594937,1.0,1.0,8/26,27.21%,SMURF2;ACVR2A;FBN1;SMAD6;SMAD7;SPART;UBE2D3;TRIM33
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.4206560686453813,0.6454687667822554,0.9104477611940298,1.0,1.0,3/5,30.51%,JAM3;GOPC;ATP8B1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.41845939587204206,0.6454191495423015,0.9565217391304348,1.0,1.0,1/6,21.43%,PLEKHH2
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.3717255316880379,0.6453026916237256,0.881578947368421,1.0,1.0,1/15,4.36%,ETF1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.355709663394346,0.6442000622981208,0.974025974025974,1.0,1.0,4/20,14.77%,FMN2;SPIRE1;SMCHD1;WDR48
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.335952331271579,0.6440159606573391,0.9560439560439561,1.0,1.0,1/32,2.09%,RAD21
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.35120428243194,0.6438978800239271,0.9512195121951219,1.0,1.0,4/18,19.27%,SCD;FADS2;PTGR1;ELOVL5
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.3932923666188488,0.642000866807566,0.9210526315789473,1.0,1.0,4/10,33.67%,IFITM3;UBE2K;IRF1;PNPT1
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.3876472912485445,0.6419424675017477,0.9358974358974359,1.0,1.0,2/11,32.53%,DIS3;XRN1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.31284993249526705,-0.6414039093369842,0.9583333333333334,1.0,1.0,3/11,10.99%,SLC9A1;CDC42;ACTG1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.35812978412524726,0.6413958611632377,0.9125,1.0,1.0,3/16,17.29%,RPS27A;RBX1;RPA1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.36582624056528024,-0.6410127228421743,0.76,1.0,1.0,7/7,63.47%,ANXA1;PIK3CD;MEF2C;SIRT1;PIK3CB;LYN;RAPGEF2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.28547654919651994,-0.6405002341414943,1.0,1.0,1.0,2/14,5.37%,YWHAB;YWHAQ
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.3505600367529889,0.6402569032856591,0.9518072289156626,1.0,1.0,5/15,26.02%,SSH1;IQCJ-SCHIP1;KANK1;PLEKHH2;TJP1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.4032399249457376,0.6402281874537489,0.8780487804878049,1.0,1.0,1/8,12.00%,DEAF1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.3582474939758291,0.6397173304794299,0.9186046511627907,1.0,1.0,4/21,20.68%,TENM2;CAPZB;NLGN1;GPM6A
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.368608985253758,-0.639528766147221,0.8918918918918919,1.0,1.0,3/5,19.91%,ADAM19;FLOT1;DENND6A
prerank,PanglaoDB_Augmented_2021__Podocytes,0.30302065652211296,0.6391633352628783,0.9797979797979798,1.0,1.0,19/125,21.93%,MID1;GJA1;ETF1;SMARCA1;ENPEP;EGFR;CCN2;THSD7A;CORO2B;TEAD1;LGR4;PTH1R;LIFR;DST;PROS1;KANK1;PLEKHH2;COL4A4;COL4A3
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.31977292138863234,-0.6389902472828638,0.9473684210526315,1.0,1.0,3/11,11.05%,AK5;RNASEH2B;CTPS2
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.36300961510995666,0.6389809062939918,0.9647058823529412,1.0,1.0,3/19,13.35%,ELAVL1;EIF4ENIF1;PABPC1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.38444330156919704,0.6389120966632347,0.8987341772151899,1.0,1.0,3/11,20.23%,RNF168;SKP1;UBE2B
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.4331136698805569,0.6386650340605234,0.8985507246376812,1.0,1.0,3/5,41.63%,PCSK6;LPL;PCSK5
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.3839727876516147,0.6385627818504639,0.9166666666666666,1.0,1.0,3/9,22.94%,KANSL3;PHF20;JADE2
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.3839727876516147,0.6385627818504639,0.9166666666666666,1.0,1.0,3/9,22.94%,KANSL3;PHF20;JADE2
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.40904756581475377,0.6380048183531033,0.9444444444444444,1.0,1.0,2/9,17.77%,FGFR2;FBN1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.33086935561626224,-0.6377501511851658,0.92,1.0,1.0,11/11,66.99%,ACACA;APOE;SLC27A1;ACACB;RPS6KB1;CPT1A;PRKAG2;ACSL1;ACSL3;PRKAA2;ABCD3
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.30469000963700615,-0.637712095435696,0.9259259259259259,1.0,1.0,8/8,69.59%,HMGB1;EXOG;DNASE1;KPNB1;FBH1;DICER1;KPNA1;CECR2
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.35956319254857877,-0.6373081740673517,0.8333333333333334,1.0,1.0,7/7,64.10%,MSH6;MSH3;SSBP1;MSH2;SIRT1;CHTOP;POT1
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.32410137653095983,0.6369477759806749,0.9775280898876404,1.0,1.0,8/41,18.19%,PPARA;TGFB1;TRAF3IP1;LRRK2;C9ORF72;CDKN1B;PRNP;PRR5L
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.44683131916901975,0.6365029321977557,0.9041095890410958,1.0,1.0,2/6,24.57%,MT3;HVCN1
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),-0.3977363197017139,-0.6362263706648904,0.8947368421052632,1.0,1.0,2/5,6.46%,SACS;HSPA1A
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.3017058299163236,0.6357777802010744,0.9583333333333334,1.0,1.0,18/90,21.93%,ITGA5;TMEM184B;WBP1L;SMOC1;ATL2;NXN;EFNB2;C1R;EHD2;KDR;SVEP1;FBN1;STXBP6;C1QTNF1;ADGRF5;SMAD6;COL4A4;COL4A3
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.33224863898059664,0.6351155041563369,0.9431818181818182,1.0,1.0,5/33,18.37%,CPSF2;SYMPK;TUT7;CSTF3;THOC2
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.33205015817432215,0.6350390305961635,0.9047619047619048,1.0,1.0,19/39,40.70%,SMURF2;ACVR2A;RBPJ;SMAD2;SMAD6;SMAD7;PCSK6;SPART;UBE2D3;TRIM33;FOXD1;SMURF1;BMPR1A;FSTL1;HIPK2;ELAPOR2;SKIL;CCN1;UBE2D1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.3236754722936167,0.6347779143998677,0.9753086419753086,1.0,1.0,7/33,22.47%,BTRC;RPS27A;ADORA2B;MAPK1;SKP1;MAP3K8;TAB2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.3930016105169567,0.6346225110557531,0.96875,1.0,1.0,1/8,8.39%,AGTPBP1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.3234008383755689,0.6345054801637894,0.9655172413793104,1.0,1.0,4/30,13.59%,EGFR;RNF168;SMCHD1;BRCC3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.34272880195594846,0.6344386189112128,0.9873417721518988,1.0,1.0,4/18,19.62%,SPIRE1;KDR;LRRK2;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.3591225198474387,-0.6342876001312521,0.8333333333333334,1.0,1.0,1/6,4.09%,INPP5F
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.4231489890125322,0.6342642225573705,0.9710144927536232,1.0,1.0,1/5,14.98%,C9ORF72
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.3854545162701689,-0.6341769489065123,0.8,1.0,1.0,2/5,18.19%,DDX5;DDX17
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.367838469751903,0.633863388754027,0.8941176470588236,0.9998713487293052,1.0,5/13,39.01%,ZBTB1;CD55;MALT1;CYRIB;HSPD1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.3127015479382744,0.6334152003074695,0.956989247311828,0.9997872126717143,1.0,4/65,8.41%,DPM1;MTMR9;PIGL;MTMR1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.3495319662550428,0.6332517932319627,0.9259259259259259,0.9995486579493229,1.0,2/18,10.99%,STMN1;TRAF3IP1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.34035927060991805,0.6321958127806016,0.925,0.9994335222298022,1.0,4/19,30.90%,STAT3;TWIST1;PTPN11;APP
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.34035927060991805,0.6321958127806016,0.925,0.9994335222298022,1.0,4/19,30.90%,STAT3;TWIST1;PTPN11;APP
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.3731488494413595,0.6318725761133666,0.9333333333333333,0.9992518179638492,1.0,2/15,10.94%,GRIN1;GRIN2B
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.34441233140655103,-0.6302138882501465,0.9285714285714286,1.0,1.0,6/6,65.61%,BRCA1;ALMS1;TRIM37;CDK5RAP2;CEP295;KAT2B
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.35246825216533795,0.6301935429275801,0.9012345679012346,1.0,1.0,2/14,9.79%,CTNNA2;ULK4
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.344093155005522,0.6298930406213468,0.9375,0.9998967237433865,1.0,4/13,26.90%,TBX3;MAP2K1;MAPKAPK5;KAT6A
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.40275786053660967,0.6288404834952944,0.8695652173913043,1.0,1.0,2/5,26.93%,CD81;VEGFA
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.3303181643348137,0.6279950268275376,0.9666666666666667,1.0,1.0,15/36,35.95%,MANBA;ABL1;FBXO11;ABL2;USP25;UBE2D3;UBE2L3;MSRA;UBA3;PRKDC;CPE;PARP4;UBE2D2;SERP1;PLOD2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.3901647095040476,0.6270754724186719,0.9473684210526315,1.0,1.0,3/8,37.38%,LGR4;IRF1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.3329050907339008,-0.6269867286513909,0.8695652173913043,1.0,1.0,7/7,66.76%,ASXL3;PRKAA1;PPP2R5A;CCDC3;APOD;NCOR1;GPER1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3733324492149694,0.6269025990617211,0.9342105263157895,1.0,1.0,3/11,14.37%,SELENOS;TMBIM6;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.3135790280503664,0.6261409790927345,0.9550561797752809,1.0,1.0,11/48,20.05%,NRG1;NEDD4L;TMEM30A;TGFB1;RUNX1;INSR;NRXN1;LGALS3;ASAP1;BNIP3;FRMPD4
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.3531001613791379,0.6254142689002421,0.9493670886075949,1.0,1.0,3/17,15.99%,NEXMIF;CASK;NF2
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.35636228395398056,0.6252944483327496,0.9629629629629629,1.0,1.0,4/16,26.24%,NIBAN2;TNKS;RGCC;TOM1L1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.35560755534699945,0.6252444971320352,0.9583333333333334,0.999969489219611,1.0,1/12,4.11%,KANSL3
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.34711185881176143,0.6246507960301597,0.9761904761904762,0.9999457563507314,1.0,5/19,34.68%,GRM7;GNAI1;ADCY5;GRM8;GNAL
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.3468916724356407,0.6243778002061644,0.9285714285714286,0.9998096308172839,1.0,4/16,17.24%,PTPN1;CSF1R;SH3BP5;PRNP
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.33637226804670234,0.6231960484921694,0.9302325581395349,1.0,1.0,1/21,2.63%,HABP4
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.371327660940761,-0.622583676125854,0.9130434782608695,1.0,1.0,5/5,62.91%,HLA-E;STX7;HLA-A;HLA-B;CYRIB
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.32936826876707925,-0.6206171561816214,0.96,1.0,1.0,13/13,67.15%,MRE11;PPP1R10;SMG6;DHX36;SMG1;YLPM1;ATRX;TERF2IP;NBN;PML;HNRNPD;USP7;XRCC5
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.3458514522570386,0.6205753811804903,0.926829268292683,1.0,1.0,2/20,10.99%,DIAPH1;TRAF3IP1
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.3701600558767115,0.6202825768899962,0.922077922077922,1.0,1.0,1/8,19.09%,LOXL3
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.3637804431090267,0.6199826457552602,0.8888888888888888,1.0,1.0,2/11,14.95%,ACADVL;ACADL
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.3521194605009634,-0.6199186617318729,0.9090909090909091,1.0,1.0,6/6,64.84%,FOXC1;NUMA1;PRKCH;SFRP4;NCOA3;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.31706615192561416,0.6197427855809768,0.9666666666666667,1.0,1.0,4/32,17.63%,AMFR;STK4;LRRK2;ABL1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.3187978410103267,0.6196676706893299,0.9666666666666667,1.0,1.0,3/33,12.38%,RHOB;ROCK2;CORO2B
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.3723506743737957,-0.6186671278768319,0.8846153846153846,1.0,1.0,6/6,62.82%,SKI;FBXW4;MBNL1;PTCH1;TGFB2;LRP6
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.33430297719537916,0.6186217638035176,0.9425287356321839,1.0,1.0,5/35,19.55%,DUT;TBRG1;RPA1;DONSON;NAP1L1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.34441233140655103,-0.6156426330910464,0.8666666666666667,1.0,1.0,6/6,65.61%,ESCO1;EP300;KAT7;SIRT1;CREBBP;KAT2B
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.32296835254325246,-0.6153750019582886,0.9166666666666666,1.0,1.0,3/7,17.82%,FLOT1;DAB2IP;APPL1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.369901732566817,0.614397781317698,0.9210526315789473,1.0,1.0,2/11,11.28%,ATP1B3;ABCC9
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.3631276134578274,0.6140880058598124,0.9746835443037974,1.0,1.0,3/15,35.88%,PAFAH1B1;FYCO1;RAB1A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3368109792067632,0.6129522593279478,0.9425287356321839,1.0,1.0,2/23,7.68%,DDIT4;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.3225589546854611,0.6112800489565638,0.9655172413793104,1.0,1.0,3/25,14.37%,PPARGC1A;SREBF1;LRRK2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.39392025784045337,0.6101158150052511,0.9411764705882353,1.0,1.0,3/8,32.88%,RPS14;PRKDC;XRCC5
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.29079973407503173,0.6099716242301936,1.0,1.0,1.0,15/118,20.36%,MID1;CDC42EP4;WASF1;CSNK1D;FARP1;ARHGEF7;CAPZB;RANBP9;CEP57;PAFAH1B1;ABL1;ATG4B;DST;CNTRL;NF1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.4271897392127787,0.6099173436101779,0.9375,1.0,1.0,3/6,33.67%,UBE2K;IRF1;PNPT1
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.3548490687219011,-0.6089933633811645,0.9285714285714286,1.0,1.0,6/6,64.57%,PSEN1;DYRK1A;IDE;APH1B;BACE1;BACE2
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.36055015506622246,-0.608002687042362,0.9,1.0,1.0,1/7,3.42%,GPRC5C
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.3107731559442896,-0.6074751850668746,0.9411764705882353,1.0,1.0,3/8,20.85%,PSEN1;SMG6;SIRT2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.3582009607203416,0.6073608904372041,0.972972972972973,1.0,1.0,3/14,17.42%,PRKCI;KDR;PDCD4
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.38050508464299887,-0.6062588600437221,0.8076923076923077,1.0,1.0,1/5,9.02%,COMT
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.3381142272980837,0.6061386276650365,0.9518072289156626,1.0,1.0,2/20,4.76%,GLRB;GABRE
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.323989817704622,0.6060590853071949,0.9615384615384616,1.0,1.0,7/19,18.29%,HIF1A;STAT3;BRD1;ACVR2A;ACVR1B;ZFPM1;ABCB10
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.36262380860815785,0.6057150521214495,0.9753086419753086,1.0,1.0,4/14,17.93%,CDC5L;CLOCK;TP53BP1;DONSON
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3866045615162223,-0.6051186923397232,0.8333333333333334,1.0,1.0,8/8,61.41%,ATP5PF;ATP5F1A;ATP5MC2;ATP5ME;ATP5F1E;ATP5F1B;DMAC2L;ATP5F1C
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.3866045615162223,-0.6051186923397232,0.8333333333333334,1.0,1.0,8/8,61.41%,ATP5PF;ATP5F1A;ATP5MC2;ATP5ME;ATP5F1E;ATP5F1B;DMAC2L;ATP5F1C
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.31277240930075506,0.6045545801122226,0.9767441860465116,1.0,1.0,8/34,22.07%,XRCC4;RNF168;BRCC3;TP53BP1;PSMD14;ZBTB7A;KDM2A;NSD2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.3803225871383694,0.6037259444251128,0.9178082191780822,1.0,1.0,6/10,27.72%,SMCHD1;TP53BP1;TWIST1;UBR5;TRIP12;SHLD2
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.4031686752289275,0.6034474658525217,0.9594594594594594,1.0,1.0,2/5,19.33%,NAA15;METAP1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.28379279669439333,-0.6031016819572218,0.9629629629629629,1.0,1.0,2/11,13.25%,EVC2;GLI2
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.4182406467229005,0.6024666289048497,0.9384615384615385,1.0,1.0,2/5,22.06%,ABCB10;COX10
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.31314173917571225,0.6015910591354473,0.967741935483871,1.0,1.0,3/33,9.56%,PRKCI;TGFB1;CTNND2
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.4147572102808232,0.601545074289576,0.9736842105263158,1.0,1.0,1/5,16.73%,ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.35903889976568726,0.6006343701165314,0.9605263157894737,1.0,1.0,2/11,15.16%,IL18;IGFBP2
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.3677722081318772,0.6005319626298433,0.9620253164556962,1.0,1.0,3/12,16.19%,PDE4B;PPIB;LGALS3
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.3677722081318772,0.6005319626298433,0.9620253164556962,1.0,1.0,3/12,16.19%,PDE4B;PPIB;LGALS3
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.27966722700523283,-0.6001056030678837,1.0,1.0,1.0,3/8,19.97%,APOE;CLU;LRP1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3275407017160324,0.6000591394240363,0.9761904761904762,1.0,1.0,4/26,17.63%,PTPRD;TRIOBP;ARHGEF7;ABL1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.38654240874494683,0.5999350194251937,0.9594594594594594,1.0,1.0,1/5,22.44%,MITD1
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.3884794229503207,0.5993896881307937,0.9436619718309859,1.0,1.0,1/7,6.75%,ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3258390878432632,-0.5992363037379023,0.9354838709677419,1.0,1.0,7/7,67.47%,PPP1R12A;PDGFRB;CALM1;HSP90AB1;MAGI2;ITGA1;MTOR
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.3044999961667332,0.5987100752201564,1.0,1.0,1.0,5/47,13.41%,PITRM1;PRKCI;KIF13B;SDCBP;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.3520629314496709,-0.5986317757090824,0.8888888888888888,1.0,1.0,5/5,64.84%,FOXC1;NUMA1;PRKCH;NCOA3;MACROH2A1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.38342599243997144,0.5985103233812119,0.9459459459459459,1.0,1.0,1/6,22.38%,SGPP1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.36875903034194896,-0.5984681169444991,0.8214285714285714,1.0,1.0,5/5,63.17%,PCGF3;MECP2;DNMT3A;PRMT7;PCGF5
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.30896236331636673,0.5980780329171342,0.9512195121951219,1.0,1.0,9/36,27.21%,TGFB1;SMURF2;JUNB;SMAD6;SMAD7;UBE2D3;TJP1;NCOR2;TRIM33
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.3566667374091637,0.596866975098115,0.9166666666666666,1.0,1.0,2/10,13.86%,F3;STAT3
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.28747648381868485,0.5961133102235857,1.0,1.0,1.0,29/118,29.39%,RAD21;XRCC4;ALKBH5;APBB1;RNF168;RPS27A;FAN1;BRCC3;TP53BP1;WDR48;USP3;ZBTB1;TDG;RPA1;ABL1;UBE2B;ERCC6L2;NSD2;RAD18;WRNIP1;SETD2;POLK;FANCC;PDS5B;RAD23B;PWWP3A;USP47;APTX;PMS1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.3477281120278638,-0.5954991388765748,0.8571428571428571,1.0,1.0,1/6,2.07%,ANKRD13A
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.40743872139609677,0.5954704956587497,0.9866666666666667,1.0,1.0,2/5,26.11%,P4HA3;P4HB
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.40743872139609677,0.5954704956587497,0.9866666666666667,1.0,1.0,2/5,26.11%,P4HA3;P4HB
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.3578497874896872,0.5950191264074067,0.9540229885057471,1.0,1.0,5/11,26.72%,SOAT1;ABCA1;LDLRAP1;ABCA5;OSBPL5
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.40170954841002604,0.5941306081184891,0.9726027397260274,1.0,1.0,1/6,14.37%,LRRK2
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.34521515735388564,-0.5930566762261442,0.8888888888888888,1.0,1.0,6/6,65.53%,ULK2;ATG7;ATG13;ULK1;ATG2B;RB1CC1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.34521515735388564,-0.5930566762261442,0.8888888888888888,1.0,1.0,6/6,65.53%,ULK2;ATG7;ATG13;ULK1;ATG2B;RB1CC1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.3968534275164553,-0.5930268541181573,0.9285714285714286,1.0,1.0,5/5,60.36%,RAB3GAP1;LNPK;RAB3GAP2;TMEM33;ATL3
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.3997946686600783,0.5929410153456373,0.9629629629629629,1.0,1.0,2/5,26.93%,CAMK2D;VEGFA
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.4081404518603018,0.5924711937046058,0.9411764705882353,1.0,1.0,4/5,25.97%,GUK1;EPOR;CCND3;RASSF1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.3476844165262579,-0.5921425916074347,0.896551724137931,1.0,1.0,3/5,22.18%,BIN1;ATP1A2;YWHAE
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.34688477438957305,-0.5921186929936598,0.9090909090909091,1.0,1.0,4/8,22.18%,PKD2;THADA;ATP1A2;YWHAE
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.304592164418754,-0.5918950099300488,0.9642857142857143,1.0,1.0,6/6,69.59%,HMGB1;EXOG;KPNB1;DICER1;KPNA1;CECR2
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.2779152095792779,-0.5915095715376884,1.0,1.0,1.0,7/28,12.86%,TNIP1;MAP3K1;RFTN1;PIK3R4;HMGB1;TRAF6;UBB
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.3389812406737616,0.5904420563398585,0.9746835443037974,1.0,1.0,5/17,20.74%,CRY1;CLOCK;UVSSA;UBE2B;UBE4B
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.3383163803917607,0.5900155338942609,0.975609756097561,1.0,1.0,2/17,9.74%,SNAP25;GLUL
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.3120942570727131,-0.5895151407529863,0.8888888888888888,1.0,1.0,1/16,2.29%,ATM
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.36255680696695836,0.5893979589324355,0.9466666666666667,1.0,1.0,4/8,25.10%,PTPRD;LRFN5;GPC4;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.36255680696695836,0.5893979589324355,0.9466666666666667,1.0,1.0,4/8,25.10%,PTPRD;LRFN5;GPC4;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.35603300703207263,-0.5889827152631265,0.8571428571428571,1.0,1.0,1/7,4.09%,INPP5F
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.2995502730485063,-0.5889111706330543,0.9629629629629629,1.0,1.0,8/8,70.10%,NSL1;INO80;LATS1;TOP2B;RB1;KLHL22;SMC1A;ZNF207
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.3266152137777175,0.5884973425617357,0.9655172413793104,1.0,1.0,6/13,43.58%,VAV3;RDX;MTOR;PRR16;LARS1;RAC1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.3206601212650319,0.5880462772925144,0.9647058823529412,1.0,1.0,9/31,21.00%,ACADVL;ERRFI1;TGFB1;FGFR2;KDR;PGK1;LGALS3;LOXL3;ALDH1A2
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.39316623654843574,0.5874320538643992,0.9672131147540983,1.0,1.0,1/5,22.57%,HK1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.3346735279554265,0.5867052254690944,0.9629629629629629,1.0,1.0,4/18,34.07%,IFIT3;IFITM3;IRF1;IFNAR1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.3346735279554265,0.5867052254690944,0.9629629629629629,1.0,1.0,4/18,34.07%,IFIT3;IFITM3;IRF1;IFNAR1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.31957603982656174,-0.5861058979323224,0.9032258064516129,1.0,1.0,7/7,68.09%,SLC25A21;PHYKPL;OGDH;ALDH7A1;AASS;DLD;DLST
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.31957603982656174,-0.5861058979323224,0.9032258064516129,1.0,1.0,7/7,68.09%,SLC25A21;PHYKPL;OGDH;ALDH7A1;AASS;DLD;DLST
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.37664099295886516,0.5858187755578954,0.9493670886075949,1.0,1.0,5/10,38.39%,NUP205;BACH2;MALT1;NEMF;NCBP1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.2966672186446167,0.5851830158581801,0.9666666666666667,1.0,1.0,12/37,26.72%,PITPNC1;UGCG;SLCO1A2;ABCA1;SCARB1;CHKA;PEX3;NCOA2;PITPNA;ABCA5;SLC25A17;OSBPL5
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.3601407534471551,0.5847886658915333,0.9620253164556962,1.0,1.0,4/9,26.47%,ABO;MANBA;FUT8;MAN2C1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.38049515820296675,0.5813606571542439,0.8987341772151899,1.0,1.0,1/6,20.36%,NF1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.29661153043198973,-0.5800514334974364,0.875,1.0,1.0,7/7,70.39%,STX5;LMAN1;SNX1;TRAPPC10;SNX2;SURF4;RAB6A
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.3085630615546846,0.5800381355364473,1.0,1.0,1.0,4/38,13.12%,AMFR;RNF10;UHRF2;MDM2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.30977240876851087,-0.578212194126473,0.9,1.0,1.0,3/9,17.15%,SLC6A1;SLC1A3;SFXN1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3429740053139104,0.5781104102433213,0.9746835443037974,1.0,1.0,6/12,32.64%,NAV3;SLAIN2;PAK1;DRG1;CLIP1;AKAP9
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.36196575852227786,0.5778327625214356,0.927536231884058,1.0,1.0,1/6,9.72%,WDR43
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.38613956894827783,0.5772846149411796,0.935064935064935,1.0,1.0,1/8,13.30%,TRIM5
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.2882280987229394,0.5769343541071354,0.9891304347826086,1.0,1.0,10/51,23.31%,CRY1;NDFIP2;NXN;NDFIP1;LRRK2;DCUN1D1;DNAJA1;SMAD7;RCHY1;SENP2
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.32554678109293433,0.5765471254347299,0.9876543209876543,1.0,1.0,7/22,25.01%,CRY1;NXN;ABL1;DNAJA1;SMAD7;SENP2;MARCHF7
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.3378260345409819,0.5762374261996203,0.987012987012987,1.0,1.0,1/12,11.66%,TBX3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.3378260345409819,0.5762374261996203,0.987012987012987,1.0,1.0,1/12,11.66%,TBX3
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.3092369477911647,-0.5757286196074214,0.9230769230769231,1.0,1.0,9/9,69.14%,CDC42;SPG11;DYNC1I1;DYNC1I2;APBA1;ARHGAP21;COPG2;BORCS5;APP
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.3566205768441857,0.5754761069534892,0.958904109589041,1.0,1.0,3/8,23.15%,JAM3;SMAD7;PIP5K1C
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.3863273075958733,0.5754729511428399,0.9466666666666667,1.0,1.0,2/5,27.96%,STK39;SLC12A6
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.3251878540616573,0.5753006683925868,0.9753086419753086,1.0,1.0,3/18,12.62%,PRLR;LIPA;CYP3A5
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.33071532301596007,0.5744593138354038,0.95,1.0,1.0,8/13,40.82%,ANAPC4;UBE2B;UBE2D3;UBE2L3;ANAPC1;RNF4;UBE2E2;UBE2H
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.3674431512502051,0.5736086791607757,0.972972972972973,1.0,1.0,2/10,19.81%,RAB7A;EEA1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.3395157082636131,0.5727094954087464,0.9473684210526315,1.0,1.0,1/12,7.09%,DHX29
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.31283121888549864,-0.5720210234862285,0.9166666666666666,1.0,1.0,7/7,68.77%,TRAF6;HLA-E;B2M;MAP3K7;HLA-A;MALT1;CD55
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.280165198873084,0.5706119009970261,0.9896907216494846,1.0,1.0,12/108,17.39%,GJA1;ARHGEF9;BCKDHB;MMP16;DUSP1;IRS1;F3;RUNX1;ACVR2A;ADORA2B;CDKN1B;COL11A1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.3390587972289988,0.5689940071384378,0.9154929577464789,1.0,1.0,2/10,17.28%,MDM4;ZFPM1
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.2819592510037318,-0.5688939032654522,0.9615384615384616,1.0,1.0,4/12,10.99%,MYLK;ANXA1;ITGB1;ACTG1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.34948846150395285,0.568251221456391,0.972972972972973,1.0,1.0,3/7,35.93%,PRKDC;TERF1;POT1
prerank,MSigDB_Hallmark_2020__Apical Junction,0.2786829881779058,0.5680205393692296,1.0,1.0,1.0,12/73,20.36%,MPZL1;NECTIN2;EGFR;SYMPK;IRS1;CADM2;GNAI1;NF2;FBN1;NEGR1;JAM3;NF1
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.37552454635390653,0.5673136547521292,0.9452054794520548,1.0,1.0,2/5,29.90%,AXL;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.2940758067417444,0.5671468529976565,0.9883720930232558,1.0,1.0,5/40,18.51%,DDX3X;ELAVL1;ROCK2;METTL14;SP1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.2652476946915224,-0.5669565570585197,0.9523809523809523,1.0,1.0,4/16,13.57%,NCK1;DOCK8;ANXA1;IL7
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.3837189139857313,0.5668514823225597,0.9342105263157895,1.0,1.0,3/5,24.69%,TWIST1;UBR5;TRIP12
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.3174344163377763,-0.5667489920676793,0.9166666666666666,1.0,1.0,3/6,15.34%,APOE;ST3GAL4;THBS1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.27786049878995117,0.5652408570614363,1.0,1.0,1.0,10/97,17.29%,RAD21;DDX21;RPS27A;DNMT1;UHRF2;FAN1;USP3;ZBTB1;TDG;RPA1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.29160504351988215,0.5643209721704148,0.9883720930232558,1.0,1.0,2/29,11.47%,NECTIN2;BCL6
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.32020587140060125,0.564131483206762,0.9761904761904762,1.0,1.0,4/16,32.56%,VAV3;AP2M1;RDX;MTOR
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.29873383253449576,0.5640107544737366,0.9655172413793104,1.0,1.0,4/21,28.31%,RPS27A;WDFY3;UBQLN1;ARL13B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.3200678297112383,0.5622333049329009,0.9759036144578314,1.0,1.0,2/14,14.93%,RPS27A;RBX1
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3602094162600207,0.5618460907235465,0.9565217391304348,1.0,1.0,2/6,27.93%,VTA1;TMEM50A
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.35537891734107463,0.5617500320770654,0.9253731343283582,1.0,1.0,2/8,17.58%,NF2;PTPN2
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.3329050907339008,-0.5607113055313572,1.0,1.0,1.0,7/7,66.76%,PJA2;GPR137B;MYO18A;MFHAS1;PLSCR1;LYN;GPER1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.27627772420443586,-0.5574076728979316,0.95,1.0,1.0,12/12,72.44%,DAB2IP;CLU;PTK2;PTEN;PSMC2;PRKN;TMTC3;FBXW7;FMR1;SMURF1;PSMC6;RNF139
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.31157967263829817,0.5572551143290498,0.9887640449438202,1.0,1.0,7/26,23.31%,NR4A3;CTBP2;PPARGC1A;ZBTB7A;STEAP4;SMAD6;SENP2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.31639923716226803,0.5561258386668256,0.9615384615384616,1.0,1.0,2/14,14.93%,RPS27A;RBX1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.3106936416184971,-0.5558256059850742,0.9230769230769231,1.0,1.0,6/6,68.98%,HDAC4;HDAC1;SOX6;NOTCH1;FRS2;HDAC5
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.3274484380690355,0.5552938013160745,0.9565217391304348,1.0,1.0,6/11,30.90%,SDCBP;ITGAV;MTMR2;ANKRD13D;LRPAP1;APP
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.3665218271335992,0.5537641153967494,0.9154929577464789,1.0,1.0,1/5,17.08%,POMP
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.35010070704814433,0.553075013456312,0.9726027397260274,1.0,1.0,5/8,40.60%,ASPA;DLST;DLD;AASS;ALDH7A1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.3128589892049763,0.5529286162223972,0.967032967032967,1.0,1.0,5/23,22.62%,TGFB1;DEAF1;FGFR2;ALDH1A2;FUT8
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.3604109808958099,-0.5526941892864289,0.8888888888888888,1.0,1.0,5/5,64.00%,HLA-E;IDE;B2M;HLA-A;ERAP1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.36558943544955874,0.550167670640369,1.0,1.0,1.0,2/5,26.93%,JCAD;VEGFA
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.31875367129067417,0.5494055292303417,0.975609756097561,1.0,1.0,5/17,27.30%,LIX1L;MAP1LC3B;LAMP2;VMP1;UBQLN1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3598488333458716,0.545601646121953,0.9523809523809523,1.0,1.0,2/7,17.58%,NF2;PTPN2
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.30674582805078177,0.5450753776111513,0.9759036144578314,1.0,1.0,6/22,30.99%,BCL6;TMSB4X;AREL1;IRF1;CYLD;BRD4
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.33550694956653637,0.5441389345196566,0.975609756097561,1.0,1.0,3/10,22.28%,ABCA1;LRRK2;TMEM106B
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.35448602295418324,0.5427798805940871,0.9230769230769231,1.0,1.0,3/6,30.99%,ATAD5;RAB11A;BRD4
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.3452608807715766,0.5425359826680921,0.9571428571428572,1.0,1.0,3/8,21.72%,SELENOS;SELENOT;IRS2
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.34182815164870467,0.5415979488682687,0.9692307692307692,1.0,1.0,3/8,37.38%,FBN1;GSK3B;APPL2
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.3116450128421245,-0.5406980112795889,0.9642857142857143,1.0,1.0,1/8,5.52%,NEXN
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.2834269266806175,0.5400877661959242,0.9879518072289156,1.0,1.0,3/26,17.29%,RPS27A;RBX1;RPA1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.26686327252023395,0.5398253612676815,1.0,1.0,1.0,12/60,26.39%,MTMR9;CSF1R;MTMR1;PLAAT3;PIP4P2;ARF1;RUFY1;MTMR2;PIP5K1C;PIP5K1A;PLEKHA1;RAB14
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.3199674129479968,0.5391217303423296,0.9879518072289156,1.0,1.0,3/16,25.86%,RPS27A;ANAPC4;RGCC
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.271910580284294,0.5390476239326906,1.0,1.0,1.0,3/43,10.76%,DIAPH1;SCARB2;PDE4DIP
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.19370364929402836,-0.5382425075371576,1.0,1.0,1.0,3/28,11.63%,CEP192;NSL1;CHMP4B
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.32706915206188125,-0.5382088888030068,0.9259259259259259,1.0,1.0,1/5,7.07%,ATG5
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.32706915206188125,-0.5382088888030068,0.9259259259259259,1.0,1.0,1/5,7.07%,ATG5
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.3507097680926098,0.5370064477781183,0.9864864864864865,1.0,1.0,1/7,23.12%,MT3
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.3172446142328473,-0.5361349641831445,0.9166666666666666,1.0,1.0,2/8,9.26%,RALBP1;SLCO1C1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.3066395789835059,-0.5329987686565119,0.8888888888888888,1.0,1.0,1/6,9.16%,DLG2
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.3066395789835059,-0.5329987686565119,0.8888888888888888,1.0,1.0,1/6,9.16%,DLG2
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.3066395789835059,-0.5329987686565119,0.8888888888888888,1.0,1.0,1/6,9.16%,DLG2
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.29310482540765537,0.5322303577166947,0.975609756097561,1.0,1.0,6/23,26.16%,STK33;WAC;BRCC3;DONSON;TAOK3;NEK11
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.29387743001163324,0.5318536320784438,0.9770114942528736,1.0,1.0,2/20,10.99%,C1GALT1;TRAF3IP1
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.3132271477013705,0.5306998130288926,0.9863013698630136,1.0,1.0,2/8,24.24%,SIDT1;YBX1
prerank,MSigDB_Hallmark_2020__Coagulation,0.27841628769758736,0.5303235887319201,1.0,1.0,1.0,10/35,24.51%,F3;C1R;CFH;CD9;ARF4;FBN1;PROS1;LAMP2;TF;RGN
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.2891170218241625,0.5298262223819209,1.0,1.0,1.0,4/14,32.19%,MDM2;USP22;APP;EIF4E
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.35103155719355883,0.5295343131751588,0.974025974025974,1.0,1.0,1/6,23.12%,MT3
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.30523091556120097,-0.5289385135778103,1.0,1.0,1.0,4/13,17.89%,SYNE1;SUN1;TAF8;MORC3
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.32017812779217497,0.5287918294921067,0.9875,1.0,1.0,6/13,32.74%,GNAI1;GPSM2;CLTC;DRG1;HNRNPU;MAP9
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.3736411273184392,0.5281923181025138,0.9859154929577465,1.0,1.0,2/6,32.56%,IQSEC1;MTOR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.34036303269870616,0.5279694680872727,0.9701492537313433,1.0,1.0,2/6,28.42%,GNAI1;ADCY5
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.34036303269870616,0.5279694680872727,0.9701492537313433,1.0,1.0,2/6,28.42%,GNAI1;ADCY5
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.2753590055733246,0.5275435000370208,1.0,1.0,1.0,5/33,20.64%,ITGA5;ERBIN;ABL1;DST;ITGAV
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.2657607564475478,-0.5275005881050732,1.0,1.0,1.0,1/14,4.04%,SHQ1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.2657607564475478,-0.5275005881050732,1.0,1.0,1.0,1/14,4.04%,SHQ1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.2836565291379333,0.5246523378609571,0.975,1.0,1.0,4/23,19.27%,ACSL4;FADS2;ACADL;ELOVL5
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.34637003860334237,0.5230631459079285,0.9746835443037974,1.0,1.0,3/6,32.87%,PDK4;SLC12A6;SLC12A2
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.33648833251053145,0.5225783368508266,0.9848484848484849,1.0,1.0,4/5,41.98%,AXL;RAPGEF2;LYN;GAS6
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.3686499912068083,0.5211646559825954,0.9859154929577465,1.0,1.0,1/5,18.25%,CSNK2A1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.30903836891956976,-0.5209838958940242,0.9615384615384616,1.0,1.0,5/5,69.14%,CLU;IFNGR1;JAK2;CRTC3;APP
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.31346269330173815,-0.519810849271131,0.95,1.0,1.0,2/7,10.25%,POLDIP3;IWS1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.29694282670026906,-0.5190871879126927,1.0,1.0,1.0,1/6,8.69%,SPTLC2
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3323314639979818,0.5183863382305768,0.9558823529411765,1.0,1.0,1/5,26.16%,NEK11
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.3257203163337831,0.5179783128754943,1.0,1.0,1.0,2/8,32.56%,ELL;MTOR
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.3368116872692246,-0.5172427766954374,0.9629629629629629,1.0,1.0,5/5,66.36%,NEK4;NUAK1;MARCHF5;LMNA;PNPT1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.26161142405615545,0.5157712838963333,0.9893617021276596,1.0,1.0,14/42,30.93%,SIPA1L2;GARNL3;TBC1D15;RALGAPA2;TBC1D8;TBC1D5;RABGAP1L;USP6NL;TBC1D4;PIP5K1A;TIAM2;ABR;RALGAPB;ARHGAP42
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.2867217988146528,0.5147586740163503,1.0,1.0,1.0,7/19,34.38%,GOLGA2;LSM14A;RAB11A;ZNF207;SMC1A;MAP9;SMC3
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.30535250425017435,0.5141234569434829,0.9493670886075949,1.0,1.0,2/10,19.68%,RNF168;SKP1
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.34274340697746813,0.5137995911878582,0.9545454545454546,1.0,1.0,3/5,40.15%,C1QTNF1;LYN;PRKCA
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.324994850868138,0.5116720166332318,0.9857142857142858,1.0,1.0,1/5,18.16%,GOLGA2
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.29323923942363733,-0.5114681472125229,1.0,1.0,1.0,1/5,8.74%,NTF3
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.27571156586823015,0.5101264900450495,0.9887640449438202,1.0,1.0,3/21,19.57%,EIF2AK2;TRIM5;IFITM3
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.26573677507100724,-0.5095417819070954,1.0,1.0,1.0,1/15,4.04%,SHQ1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.32282847481738736,0.5090697097080386,0.9850746268656716,1.0,1.0,2/5,29.60%,ETS1;NFAT5
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.24745290144287896,-0.5089395051086137,1.0,1.0,1.0,1/11,5.69%,ADGRA2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.3050364208993232,0.5081543181398263,1.0,1.0,1.0,5/11,33.27%,PRKCI;PDCD4;RGCC;PLCG1;GPER1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.2579976545945012,-0.5056249176518737,1.0,1.0,1.0,4/11,16.88%,APOE;SRGAP2C;PSEN1;TANC2
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.2772572989655889,0.5023876469442943,0.975,1.0,1.0,2/18,20.39%,PPP6R2;BOD1L1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.30457649376893703,0.49956777112630085,1.0,1.0,1.0,5/9,45.03%,SGPP1;ABCD3;PRKAA2;PRKAG2;PLEKHA8
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.30715024596878715,0.49948387961632307,0.987012987012987,1.0,1.0,6/11,41.53%,STAT3;APP;MALT1;HSPB1;GSTP1;LPL
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.29157684058550914,0.4988381652080281,0.9873417721518988,1.0,1.0,5/14,29.36%,PDCD4;DNAJA1;TAOK3;PAK1;AIDA
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.26726209820731645,0.4978292296400679,1.0,1.0,1.0,5/27,20.53%,TRIOBP;WASHC2C;ARHGEF7;ABL1;KANK1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.32237330032299294,0.49750734405877406,1.0,1.0,1.0,2/8,13.75%,GRIN2B;TSHZ3
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3048492119800241,0.49750190886000617,0.9861111111111112,1.0,1.0,2/8,31.06%,STARD13;HDAC5
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.29351316634553626,-0.4970774909019576,1.0,1.0,1.0,6/6,70.69%,TRPM7;RIPK1;DNM1L;ITPK1;IPMK;CYLD
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.29351316634553626,-0.4970774909019576,1.0,1.0,1.0,6/6,70.69%,TRPM7;RIPK1;DNM1L;ITPK1;IPMK;CYLD
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.2812128456530472,0.49646452971795946,0.9879518072289156,1.0,1.0,2/17,13.52%,ROCK2;SLK
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.30369221932669166,0.4954453419270842,0.974025974025974,1.0,1.0,3/10,31.68%,STAT3;APP;MALT1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.3303266026228091,0.48846762567994617,0.9855072463768116,1.0,1.0,3/6,32.16%,FDFT1;FDPS;INSIG2
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.3169448242304997,0.4883944075012945,0.9714285714285714,1.0,1.0,2/5,40.20%,PGM3;OGA
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.27093041941185925,-0.4846803953901105,0.967741935483871,1.0,1.0,11/11,72.97%,ILK;DHX9;FMR1;B2M;FXR1;BCLAF1;IL15;SIRT1;MAVS;TGFB2;YPEL3
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.291265493538692,0.48287940182881595,0.9850746268656716,1.0,1.0,2/7,28.42%,PDE4D;ADCY5
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.273121387283237,-0.48084027768609405,1.0,1.0,1.0,6/6,72.73%,SVIP;NFE2L2;HERPUD1;CAV1;USP14;UBQLN1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.32275625117330026,0.48079104653570737,1.0,1.0,1.0,2/5,38.79%,AP2M1;RAB5A
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.2809890815671162,-0.4789733235609139,1.0,1.0,1.0,6/6,71.94%,PLEKHA3;SLC27A1;DISP1;CERT1;PLEKHA8;SLC19A1
prerank,MSigDB_Hallmark_2020__Apical Surface,0.28268851986048105,0.47680510478789695,1.0,1.0,1.0,7/14,41.85%,DCBLD2;ATP8B1;APP;LYN;ADAM10;HSPB1;NCOA6
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.28265050200679154,0.4761364501281625,1.0,1.0,1.0,2/16,23.03%,SMARCA4;LEF1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.28757106474611394,0.47580451220600384,0.9868421052631579,1.0,1.0,3/11,37.44%,PAFAH1B1;CEP120;SUN2
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.25451462936072944,0.4745301296302879,0.9882352941176471,1.0,1.0,11/26,39.65%,PPIB;MT3;SPRED1;PUM3;CCDC88A;GRM5;NDUFS4;KAT2B;LYN;PML;HSPB1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.30867102800129564,0.47277220261249375,0.9852941176470589,1.0,1.0,5/8,33.27%,PRKCI;PDCD4;RGCC;PLCG1;GPER1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.28848929748670704,0.4684840674706044,0.9868421052631579,1.0,1.0,3/9,32.96%,UNC5B;MCL1;EYA2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.28848929748670704,0.4684840674706044,0.9868421052631579,1.0,1.0,3/9,32.96%,UNC5B;MCL1;EYA2
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.301084564729588,0.4652780989210383,1.0,1.0,1.0,3/5,34.07%,AXL;RO60;IFNAR1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.3003653938922738,0.4618736644656872,1.0,1.0,1.0,2/5,28.31%,WDR19;ARL13B
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.23827120822622105,-0.4600822087195814,1.0,1.0,1.0,10/10,76.23%,ITGB3BP;MIS18BP1;SMARCA5;RNF8;CENPC;RSF1;NASP;RBBP4;CENPP;RBBP7
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.2845967957558607,0.45995052452907037,1.0,1.0,1.0,3/10,22.57%,CHST15;IRS2;HK1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.2828781255837442,-0.45739577704478823,1.0,1.0,1.0,2/7,16.57%,ANXA1;PIK3CD
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.2035804668933946,-0.4559143603660324,1.0,1.0,1.0,5/10,20.56%,AKR1C3;NR3C1;TRERF1;URI1;ATP1A2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.22654935980601615,0.4532402267638203,1.0,1.0,1.0,7/62,24.05%,STRAP;DHX29;SRSF10;SF3B1;MCTS1;SRSF5;RPS14
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.3221435116384889,0.45244481687285737,0.9848484848484849,1.0,1.0,1/5,15.34%,SCARB1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.2885383852826963,-0.4499530759080286,1.0,1.0,1.0,1/5,12.06%,PKD2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.26372777649231216,0.44780117387864427,0.9878048780487805,1.0,1.0,2/11,32.56%,ELL;MTOR
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.28557355454565614,0.44774488489616415,1.0,1.0,1.0,1/6,22.14%,AXL
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.2921286661095309,0.44420219582127785,1.0,1.0,1.0,1/6,22.14%,AXL
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.23782473162617396,-0.44175370926153773,1.0,1.0,1.0,3/7,17.89%,SKI;DAB2IP;MORC3
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.23827120822622105,-0.44164574849187105,1.0,1.0,1.0,10/10,76.23%,ITGB3BP;MIS18BP1;SMARCA5;POGZ;CENPC;RSF1;NASP;RBBP4;CENPP;RBBP7
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.2835293419170154,0.43584920174608355,1.0,1.0,1.0,1/6,19.57%,IFITM3
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.2776144397594212,0.4354299398260914,1.0,1.0,1.0,5/8,43.49%,USP22;FGFR1;STOX2;TGFB2;RICTOR
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.28283400376758644,0.43244106813295125,1.0,1.0,1.0,3/6,32.98%,STXBP4;ADCY5;PPP3CB
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.2779026734724748,-0.43004025602765594,1.0,0.9996344655643847,1.0,1/5,6.66%,KDSR
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.25836849604000034,0.42250146912003955,1.0,1.0,1.0,3/9,31.50%,SPG7;PMPCB;MICU1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.2913649213064621,0.4191302090627174,1.0,1.0,1.0,3/5,36.64%,HK1;FGGY;GNPTAB
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.2711494155053002,0.40515064737690026,1.0,1.0,1.0,2/5,38.48%,COL4A1;MTSS1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.2396458046378294,0.40222435569132486,1.0,1.0,1.0,2/9,26.03%,RBBP7;CENPP
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.2396458046378294,0.40222435569132486,1.0,1.0,1.0,2/9,26.03%,RBBP7;CENPP
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.2396458046378294,0.40222435569132486,1.0,1.0,1.0,2/9,26.03%,RBBP7;CENPP
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.17533408468845596,-0.40035625745974013,1.0,0.9996226415094339,1.0,23/23,82.55%,ACTN4;MYO1E;TANC2;MYO1D;HTT;MYO1B;DYNC1I1;NDE1;WASL;CCDC186;FBXW11;MYO5A;NDEL1;FNBP1L;TRAK2;MYO6;TRAK1;KIF5B;MYO19;MYO1C;RAB1A;PPFIA2;PAFAH1B1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.23511393677937278,0.39807849824114977,1.0,1.0,1.0,3/13,31.68%,STAT3;APP;MALT1
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.27235835793387236,0.39107861747833794,1.0,1.0,1.0,2/5,35.37%,PLP1;B4GALT5
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.25945692120819946,0.38086173623384995,1.0,1.0,1.0,1/5,21.77%,SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.22525864787902963,0.35160337702060734,1.0,1.0,1.0,1/5,22.14%,AXL
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.19735244539617755,0.3476789304200682,1.0,0.9999294283697954,1.0,8/26,39.64%,CSNK2A1;PTK2B;RNF139;RAD23B;UBE3A;SMURF1;HIPK2;PML
